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Abstract
Knowledge is a dynamic human process to justify our personal belief in pursuit of the truth.
The intellectual output of any organisation is reliant upon the individual people within that
organisation. Despite the eminent role of personal knowledge in organisations, personal
knowledge management and measurement have received little attention, particularly in
pharmaceutical manufacturing. The pharmaceutical industry is one of the pillars of the global
economy and a knowledge-intensive sector where knowledge is described as the second
product after medicines. The need of measurement to achieve effective management is not a
new concept in management literature. This study offers an explanatory framework for
personal knowledge, its underlying constructs and observed measures in the pharmaceutical
manufacturing context.
Following a sequential mixed method research (MMR) design, the researcher developed a
measurement framework based on the thematic analysis of fifteen semi-structured interviews
with industry experts and considering the extant academic and regulatory literature. A survey
of 190 practitioners from the pharmaceutical manufacturing sector enabled quantitative testing
and validation of the proposed models utilising confirmatory factor analysis. The
pharmaceutical personal knowledge framework was the fruit of a comprehensive study to
explain and measure the manifestations of personal knowledge in pharmaceutical
organisations.
The proposed framework identifies 41 personal knowledge measures reflecting six latent
factors and the underlying personal knowledge. The hypothesised factors include: regulatory
awareness, performance, wisdom, organisational understanding, mastership of product and
process besides communication and networking skills. In order to enhance the applicability
and flexibility of the measurement framework, an abbreviated 15-item form of the original
framework was developed. The abbreviated pharmaceutical personal knowledge (2P-K)
framework demonstrated superior model fit, better accuracy and reliability.
The research results reveal that over 80% of the participant pharmaceutical organisations had
a form of structured KM system. However, less than 30% integrated KM with corporate
strategies suggesting that KM is still in the early stages of development in the pharmaceutical
industry. Also, personal knowledge measurement is still a subjective practice and
predominately an informal process. The 2P-K framework offers researchers and scholars a
theoretically grounded original model for measuring personal knowledge. Also, it offers a basis
for a personal knowledge measurement scale (2P-K-S) in the pharmaceutical manufacturing
context.
Finally, the study had some limitations. The framework survey relied on self-ratings. This
might pose a risk of social desirability bias and Dunning–Kruger effect. Consequently, a 360degree survey was suggested to achieve accurate assessments. Also, the model was developed
and tested in an industry-specific context. A comparative study in similar manufacturing
industries (e.g. chemical industries) is recommended to assess the validity of the current model
or a modified version of it in other industries.
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Chapter 1 : Introduction

CHAPTER 1: Introduction

Background
By the end of the twentieth century, the notion of managing knowledge had evolved at the
corporate level as organisations acknowledged the need to leverage and exploit their
knowledge resources (Carmeli & Tishler, 2004). Knowledge Management (KM) is considered
a vital organisational function and a key source of sustainable competitive advantage
(Anatolievna Molodchik et al., 2014). While KM is concerned with the use of technology and
management processes for effective management of organisational knowledge, personal
knowledge management (PKM) helps the individual be more effective in the personal,
organisational and social environment (Pauleen & Gorman, 2010). PKM illustrates the
knowledge workers’ endeavour to use knowledge to support their day-to-day activities through
problem-solving and learning practices (Hine et al., 2008). However, the value of PKM is not
just limited to the individual level as the combination of both PKM and Organisational
Knowledge Management (OKM) can lead to a more effective management of knowledge
across the whole organisation (Kassim et al., 2018).
Moreover, the economic impact of KM within the organisation and its influence on financial
performance and market competitiveness has been evident (Andreeva & Kianto, 2012). The
recognition of the fundamental role of knowledge in value creation spawned the concept of the
Knowledge Economy, making it one of the pillars of contemporary management thinking
(Roberts, 2009). This made KM a predominant field within the business and management
landscape for both researchers and practitioners (Moustaghfir & Schiuma, 2013). In the
pharmaceutical industry, knowledge is described as the second product after medicines
(Riddell & Goodman, 2014) making it an important part of the contemporary knowledge
economy. The pharmaceutical industry is not only a knowledge-intensive industry but also a
leading economic partner with huge investments in innovation and research. According to the
European Federation of Pharmaceutical Industries and Associations (EFPIA), the
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Pharmaceutical industry employs more than 700,000 employees in Europe, 16% of them
working in pharmaceutical R&D. It was the preeminent sector regarding R&D intensity and
expenditure as a percentage of net sales (14.4%) in 2014 followed by software & computer
services (10.1%) and technology hardware & equipment (8.0%) (EFPIA, 2015, 2016). It is also
considered the top investing sector in R&D according to the Industrial R&D Investment
Scoreboard in both US and EU (EU, 2015). More than 19% of total business R&D expenditure
worldwide comes from the pharmaceutical and biotechnology sector (EFPIA, 2018). In 2016
alone, the European pharmaceutical sector invested over 34 billion euros in R&D to counteract
the wild competition with its rivals from the US and emerging economies (EFPIA, 2018).
This research represents a study of the personal knowledge measurement in the
pharmaceutical manufacturing context. The research aims to address the identified knowledge
gaps in both the theory and application of KM and measurement as explained in the next
section.

Research rationale
This section presents the rationale for the research. It outlines the apparent need to measure
the personal knowledge of knowledge workers, the lack of research to date, the potential
contribution to knowledge and finally the motives for selection of the pharmaceutical
manufacturing as a context for this study.
The duality of the organisational knowledge and personal knowledge was pointed out in
several studies arguing that they are distinct but interdependent (Bhatt, 2002; Chatti, 2012;
Gang & Yi, 2009; Hine et al., 2008). It has been argued that a successful PKM would result in
an improved utilisation of personal knowledge and effective social exchange of knowledge at
individual employee level (Razmerita et al., 2009). The OKM integrates a variety of individual
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knowledge bases for more efficient performance. That is to say, the intellectual output of any
organisation is reliant upon the individual people within that organisation (Hine et al., 2008).
Furthermore, individual participation is important for successful KM in any organisation.
One of the explanations is the notion that knowledge is personal by its nature (Chatti, 2012;
Vladova et al., 2016). The philosophical foundations of knowledge view the person as a
legitimate participant of KM (Rechberg & Syed, 2014). In knowledge creation literature,
Nonaka’s SECI model acknowledged the role of socialisation and personal interactions for
knowledge creation (Nonaka & Takeuchi, 1995). Nonaka emphasised the human and personal
nature of knowledge as he described it as: “a dynamic human process of justifying personal
belief toward the truth” (Nonaka et al., 2000). Bhatt (2002) affirms that knowledge monitoring
and control is challenging for organisations. The organisation internalises only a part of the
generated knowledge while the rest is internalised by individuals. Thus, capturing and
codifying knowledge won’t help if the organisation failed to identify who can find and interpret
this knowledge or to maintain the social networks required to get the work done (Parise et al.,
2006).
Despite this eminent role of personal knowledge in organisations, the research on personal
knowledge is quite scant. Cranefield & Prusak (2016) argues that our knowledge on individual
approaches to KM is incomplete as little is known on how individual employees handle
knowledge-related problems. The personal knowledge has so far received little attention by
KM scholars in contrast to the organisational knowledge.

Although the organisational

knowledge has been the focus of KM scholars, a proper explanation of individual-knowledge
relationships is missing from KM literature (Tom H Davenport, 2016; K. Wright, 2005). PKM
is a relatively new topic that emerged in the recent years to manage knowledge efficiently
(Gang & Yi, 2009). Pauleen & Gorman (2010) confirms that little conceptual or empirical
research has been carried out in the field of personal knowledge (Pauleen & Gorman,
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2010). KM literature traditionally explored KM efforts of organisations and neglected to study
how knowledge workers leverage their knowledge at the individual or personal level (Kassim
et al., 2018). This growing need to manage personal knowledge is transforming KM from
organisation-centric to worker-centric with more attention to the personal knowledge of
individuals (Jarrahi et al., 2019).
Knowledge measurement is not an exception from the lack of attention to personal
knowledge. Whereas several models (e.g. Tobin’s Q (Tobin, 1969), Skandia Navigator
(Edvinsson, 1997) and the IC Rating (Jacobsen et al., 2005)) offer a method to quantify
knowledge assets within the organisation (Ragab & Arisha, 2013a), the extant literature
provides little or no way to measure the personal knowledge of individual employees. The need
of measurement to achieve effective management is not a new concept in management. Since
Peter Drucker coined what is known as Management by Objectives (MBO), managers have
adopted several measures for key organisational objectives leading to the notion that “If it can’t
be measured, it can’t be managed” (Dumay & Rooney, 2011; Greenwood, 1981).
The current study addresses this theoretical gap and proposes a framework to explain and
measure the personal knowledge of individual employees enabling organisations to identify
knowledge holders. As knowledge is context-specific that depends on a particular time and
space (Hoe, 2006; Nikkhah et al., 2018; Nonaka et al., 2000; Vladova et al., 2016), the
pharmaceutical manufacturing was chosen as the context for this study. The pharmaceutical
industry is a knowledge-intensive sector, however, this sector has not received adequate
attention from KM scholars. According to a Scientometric review carried out by the author of
over 500 KM articles in 17 different industries, less than 1% of the reviewed research articles
had empirical applications in the pharmaceutical industry (Ramy et al., 2018).
It is worth noting that personal knowledge receives high consideration in pharmaceutical
regulations. Pharmaceutical personnel are required to have adequate knowledge before
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engaging in any manufacturing task (Volume 4: Good Manufacturing Practice Annex 6, 2010;
WHO, 2005, 2014). The increasing business and regulatory pressures for managing knowledge
make the ability to locate and visualise this valuable abstract resource within organisations
vitally important. In addition, Pauleen and Gorman (2010) found that the effective management
of personal knowledge leads to effective OKM. In other words, the identification of knowledge
holders can enable management to utilise their knowledge to achieve organisational objectives.
Moreover, effective measurement of personal knowledge could provide solid evidence that the
organisation has the necessary knowledge capabilities to meet its regulatory commitments.
In 2008, the ICH Q.10 pharmaceutical standard introduced KM as an enabler to the
Pharmaceutical Quality System (PQS). Product and process knowledge is required to be
managed throughout the product life cycle including the transfer of product and process
knowledge between development and manufacturing as well as within or between
manufacturing sites to achieve product realisation. This knowledge forms the basis for the
manufacturing process, control strategy, process validation approach, and ongoing product
improvement. KM is believed to facilitate continual improvement, the establishment of a state
of control, and achievement of product realisation (ICH, 2009). The World Health Organisation
(WHO) demands a science-based understanding of the KM process and Quality Risk
Management (QRM) to support their quality decisions and regulatory commitments (WHO,
2013). Similarly, the US Food and Drug Administration (FDA) encourages process
understanding and KM initiatives for preventing and detecting data integrity issues (FDA,
2016c). However, current guidelines provide flexible principles rather than rigid frameworks
for KM (WHO, 2011b). Hence, the development of better understanding of the personal
knowledge in the pharmaceutical industry would assist the progress and the implementation of
the regulatory expectations based on a bottom-up KM approach.
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Consequently, in the absence of effective KM policies, Knowledge loss is a growing risk
for business (Jennex, 2014). The author assumes that the lack of personal knowledge
measurement frameworks would hinder the early identification of knowledge holders before
they leave or retire. Warnings of the potentially catastrophic effect of the retirement of baby
boomers and the subsequent knowledge loss have concerned both academics and practitioners
(Trugman‐Nikol, 2011). The research-based pharmaceutical industry is one of the main hightech employers in Europe and globally. It employes a significant portion of knowledge workers
in Europe making this industry a barrier against “brain drain” from the European continent
(EFPIA, 2018). In 2013, the Pharma Engagement survey conducted by Randstad - a
multinational human resource consulting firm - showed that 37% of respondents from the
pharmaceutical sector intend to leave their job and move to other employers in the next six
months (Randstad, 2013) confirming the fears of the loss of knowledge holders in this
particular sector.

Research Aim and Questions
A research question is a fundamental element of research work, serving to narrow down the
focus of the study and therefore, must be clear and well-formulated (Bryman, 2015). This
research encompasses one major research question to address the overarching research aim:
o RQ: How is the personal knowledge conceptualised and measured in the
pharmaceutical manufacturing context?
The study seeks to examine the Personal Knowledge (PK) measurement in the underresearched context of pharmaceutical manufacturing. The following represents the research
aim:
Exploration, development and validation of a personal knowledge measurement
framework in the pharmaceutical manufacturing context.
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Research Objectives
Objective 1 Gain an in-depth understanding of the current practices of the personal knowledge
management and measurement focusing on the pharmaceutical manufacturing context.
This objective is tackled in two phases of this study: the literature review and the exploratory
interviews. A literature review is needed to provide the necessary awareness and ability to
interpret the published knowledge. It enables the researcher to identify potential contradictions
and address the gaps in the existing theories (Jesson et al., 2011). Both quantitative and
qualitative approaches are used in this thesis to identify and map the growing research trends
in the PKM and knowledge measurement. This review provides an in-depth understanding of
the existing theories and frameworks that have been developed by previous researchers.
As the study adopts an industry-specific context, the review included a contextual chapter
to review the KM literature in the pharmaceutical industry and explore the regulatory
expectations. The pharmaceutical industry is a highly regulated industry (Calnan et al., 2018).
KM is recently seen as a better way for proactively managing patient risk and making better
risk-based decisions. Historically, and up until the release of the ICH Q, 8, 9, and 10 standards,
pharmaceutical regulators paid more attention towards science and risk-based approaches for
drug manufacturing and control. Concepts such as “science” or “product/process
understanding” routinely replaced the word “knowledge” (Calnan et al., 2018). In 2008, the
International Conference on Harmonization (ICH) described KM along with quality risk
management as the enablers of pharmaceutical quality systems (ICH, 2008).
Moreover, the WHO dedicated a special annex (TRS 961 Annex 7) for technology transfer
in pharmaceutical manufacturing (WHO, 2011b). Similarly, several international regulatory
bodies issued regulations for managing and regulating knowledge and ensuring its
communication and transfer (e.g. FDA, 2016; WHO, 2016). As the proposed measurement
framework is designed to work in the pharmaceutical industry, the review of all relevant
regulatory guidelines is necessary to understand the regulatory expectations of authorities and
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compare it with the current practices. The study addresses the gap between regulatory
requirements (regulators) on one hand and KM research (academics) and application on the
other (practitioners).
Finally, the researcher’s objective of the exploratory phase is to discover the current
practices and unveil the underlying truth or the inner character of the phenomena under study.
The study combines the knowledge extracted from literature with primary data collected from
industry experts to draw a clear picture of KM practices in pharmaceutical manufacturing with
a particular focus on personal knowledge measurement. This picture reflects not only the infield interpretations of regulatory guidelines about KM but also the level of maturity of KM in
the pharmaceutical industry. It also assesses the value of the personal knowledge measurement
among knowledge holders in the pharmaceutical sector.

Objective 2 The development of a personal knowledge measurement framework for knowledge
workers in the pharmaceutical manufacturing context.
Identification and critical analysis of the extant frameworks is a necessary step that proceeds
the framework development phase. This step outlines the commonalities that can be identified
as well as the gaps to be addressed. As the study of the personal knowledge is a relatively new
field of research (Cranefield & Prusak, 2016), particularly in the pharmaceutical industry, both
primary data collected during the exploratory study, along with learnings from previous models
are utilised to develop a new personal knowledge measurement framework for the
pharmaceutical manufacturing sector. The developed framework offers an explanation of the
different elements and manifestations of personal knowledge in the featured context.
During the exploratory phase, the main constructs of the measurement framework are
identified and refined to build the main constructs of the measurement framework. The next
step is testing of the proposed constructs in the validation phase. The study sheds light on
knowledge measurement process in KM literature. An abductive approach is taken where the
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researcher engages both the extant literature with the exploratory study findings in what is
known as “dialectal shuttling” (Bryman & Bell, 2015) to develop the measurement framework.
The developed model would be tested in the subsequent deductive phase.

Objective 3 Validate and optimise the proposed PK measurement framework in the
pharmaceutical manufacturing sector.
Representing the final phase of the empirical study, the conceptual framework, developed
during the abductive phase, is tested and validated through a survey of a suitable sample of
practitioners from the pharmaceutical industry. After the identification of the factors
underlying the personal knowledge, Confirmatory Factor Analysis (CFA) is employed to test
and optimise the proposed framework. CFA is a widely-used statistical tool in the
organisational sciences (Crede & Harms, 2019). CFA is a technique of Structural Equation
Modelling (SEM) with a particular focus on the analysis and measurement of priori
measurement models. This means that the number of measures and their relationship with the
underlying factors must be specified before analysis (Kline, 2015).
At the end of the validation phase, the proposed framework would be assessed for its
applicability within the pharmaceutical manufacturing sector. More details about the validation
process are included in chapter four.

Operational Defintions
Knowledge: can be defined in this report as “a dynamic human process of justifying personal
belief toward the truth” (Nonaka et al., 2000).
Knowledge context: is the circumstances in which knowledge is produced, transferred, and
applied (Lisciandra & Herfeld, 2019). This research is conducted in the pharmaceutical
manufacturing context.
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Knowledge workers: are those workers who think for a living and their main capital is their
knowledge (Thomas H Davenport, 2005). In this report it refers to the qualified employees
(e.g. chemists, pharmacists, biologists and engineers) working in the pharmaceutical
manufacturing in technical roles.
Manufacturing: According to the WHO technical report (Series 986, Annex 2), manufacturing
is defined as “all operations of purchase of materials and products, production, quality control,
release, storage and distribution of pharmaceutical products, and the related controls” (WHO,
2014).
Measurement is the act of collecting data to quantify the value of a business metric (tangible
or intangible) (Evans & Lindsay, 2013).
Personal Knowledge (PK): this term is used within this report to refer to the knowledge held
be individuals. PK and individual knowledge (IK) are used interchangeably in this report.

Report Layout
The outline of this report is comprised of eight chapters as follows:
1. Chapter One introduces the research project and its objectives and outlines the structure of
the thesis.
2. Chapter Two is a comprehensive review of the theories of the Personal Knowledge, PKM
and knowledge measurement frameworks. This is the main literature review chapter of the
thesis.
3. Chapter Three presents a contextual chapter that reviews KM in the pharmaceutical
industry. It also focuses on the regulatory expectations of the different regulatory authorities
regarding KM. Different knowledge processes and themes are classified in a comprehensive
taxonomy and the main approaches for developing knowledge assessment measures are
identified.
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4. Chapter Four describes the research methodology adopted to address the research
questions. Based on the critical realistic stance of the research, the mixed-method research
design is discussed and justified for its ability to achieve the research objectives in an inclusive
manner. A research plan of five distinct stages is detailed by elucidating the aims, methods and
techniques used in each stage.
5. Chapter Five investigates conceptualisations of personal knowledge and the current status
of knowledge measurement in pharmaceutical organisations. This chapter encompasses a
thematic analysis of a set of interviews conducted with a number of pharmaceutical industry
experts. Thematic analysis is utilised at this stage for data analysis and the interpretation of key
patterns and associations. The conceptual framework is developed at the end of this chapter in
light of the current literature and the primary data.
6. Chapter Six presents the results of the quantitative phase. The conceptual model is tested
in a suitable sample of pharmaceutical practitioners. The collected data is used to validate and
optimise the proposed models using confirmatory factor analysis.
7. Chapter Seven is the discussion chapter where the findings are critically examined and
relevant literature is consulted. Moreover, the theoretical and practical implications of the
research are approached. Limitations and future research opportunities are tackled at this
chapter.
8. Chapter Eight is where the conclusion of the research and the anticipated contribution to
knowledge are presented.

Summary and Conclusion
The first chapter introduces the research phenomena and provides an overview of the
research rationale, aims, research questions, research objectives, operational definitions and
the thesis layout. The next chapter will demonstrate the PK and knowledge measurement
theories and growing trends as presented in the academic literature.
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Introduction
Research in “knowledge” is as old as humankind. Over centuries and millennia,
philosophers were concerned with the search for the ontological interpretations of the word
“knowledge” (Zaidan, 2012). Epistemology is a stand-alone branch of philosophy concerned
solely with the theory of knowledge (Lehrer, 2018). In his dialogue with Socrates and
Theaetetus, Plato introduced his definition of knowledge which is commonly translated as
“Justified true belief”. In spite of the criticism of Plato’s classic definition (e.g. Gettier, 1963),
it is still widely accepted (Rechberg & Syed, 2014). According to this definition, a person can
claim he/she knows that (P) only if that (P) is true because false knowledge is not possible.
He/she also believes that (P) and this belief is justified. In other words, “There is objective
knowledge if there is a body of propositions which are true and which it is rational to believe”
(Dawson, 1950).
Knowledge is a social process (Edwards, 2015a; Sense, 2007). It is worth noting that, the
western epistemology often demonstrates a static non-human view of knowledge. This
understanding fails to address the social and context-specific nature of knowledge. If
knowledge loses its context, it is nothing more than information. This leads to a definition of
knowledge as “a dynamic human process of justifying personal belief toward the truth”
(Nonaka et al., 2000). Knowledge is a state of conscious contact of the person with reality
(Zagzebski, 2017). It can be also presented as information, professional insights, values,
experience and context (Thomas H Davenport & Prusak, 1998). Knowledge also implies
having a special competence, acquaintance with someone or something as well as the
recognition of something as information (Lehrer, 2018). To make matters more complicated,
13 distinguishable uses of the phrase ‘to know’ were outlined by Mingers (2008) emphasising
the notion that there is no one form of “knowledge”. In this dilemma of definitions, the highly
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cited definition by Nonaka, Toyama and Konno (2000) is the adopted definition of knowledge
throughout this report as it magnifies the humanistic and personal nature of knowledge.
In the last decades, the growing interests in information science and bibliographic materials
contributed to the emergence of joint frameworks for data, information, knowledge and
wisdom to explain the underlying connections (Bernstein, 2011). One of the commonly
accepted illustrations for the interrelationships between data, information, knowledge and
wisdom is “Knowledge pyramid” or “DIKW hierarchy” (Ackoff, 1989). Wilson’s processing
hierarchy is another illustration of the knowledge pyramid incorporating decision and action
as the ultimate purpose of knowledge (Edwards, 2015b; Wilson, 1996). However, inaccurately
defining data, information and knowledge by each other presented a logical fallacy in the form
of circular definitions (Liew, 2013). For the purpose of this research, data can be defined as a
stream of raw facts or simply a flow of events and/or transactions that can be captured by
organisational systems (Laudon & Laudon, 2016). In order to generate information from this
data, data must be processed and organised into categories which are meaningful and useful to
users. Knowledge can be extracted from the generated data in the form of patterns, contexts
or rules. The collective capability of applying knowledge to solve problems is called “wisdom”
which includes when, where and how to apply knowledge (Laudon & Laudon, 2016). At the
economic level, knowledge is distinguished from other resources within the organisation by
non-excludability and non-exhaustibility and consequently a higher risk of knowledge
spillover to competitors who did not share the cost of knowledge creation (Arrow, 1962;
Audretsch & Keilbach, 2007). Arrow (1962) emphasised that in the absence of legal protection
to propriety information, it cannot simply be sold as a commodity in an open market. While
full monopoly can offer the needed protection, it would ultimately lead to inefficient allocation
and exploitation of information resources (Arrow, 1962). The ability of an organisation to
incorporate and utilise the transferred knowledge to create value is known as the Absorptive
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Capacity (ACAP) (Carayannis, 2012). However, the success in exploiting the transferred
knowledge is a function of prior knowledge of the organisation as it is necessary to evaluate
the acquired knowledge and to use it effectively. The prior knowledge includes (but not limited
to) basic skills, languages and awareness of modern technologies (Cohen & Levinthal, 1990).
In the next sections, the researcher will explore the prevalent trends of personal knowledge
and knowledge measurement literature. This review is deemed to provide a working definition
of personal knowledge, to outline the main processes of PKM and to review the prominent
knowledge measurement efforts.

Knowledge and Personal Knowledge
Personal knowledge can be understood as skills, talents and expertise necessary to handle
many situations. It allows the person to solve personal and organisational problems and
consequently to access new markets and to use new technologies that need specialised expertise
(Tajedini et al., 2018). Personal knowledge is particularly concerned with knowledge held by
an individual employee in an organisation in contrast to the collective knowledge held
commonly by a group (Chua, 2002; Hoe, 2006).
Personal knowledge is not only raw data but a complex spectrum of talents, innate abilities,
insights, facts, connections and experiences that generates human decisions, insights and ideas
(McLaughlin & Stankosky, 2010). It can refer also to the legitimate and personal beliefs of an
individual that enable him/her to respond to problems rapidly without the application of
predetermined rules (Tajedini et al., 2018). It is acquired from our memories, documents,
intuitions, personal contacts, books or learning from other colleagues (Razmerita, Sudzina, et
al., 2009a).
The relationship between knowledge and individuals has been discussed by several scholars.
Knowledge is argued to be personal as it is stored in people’s head, created and embodied in a
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person, applied or even misused by a person (Wright, 2005). Similarly, Davenport and Prusak
emphasised that knowledge is created and applied in the mind of the knower ( cited in
Razmerita, Sudzina and Kirchner, 2009). By the same token, knowledge is inherently personal
as all knowledge is in a way or another tacit or intertwined with tacit knowledge which is
personal (Chatti, 2012). While knowledge can be “computerised”, this is considered as “a
shadow knowledge” (Völkel & Haller, 2009) as most of the critical organisational knowledge
remains in the minds of people (D. G. Pauleen & Gorman, 2010).
However, some scholars defend the subjective nature of personal knowledge. From this
perspective, knowledge is personal as people interpret information differently and adopt
different ways of reasoning (Razmerita, Sudzina, et al., 2009a). The researcher advocates a
realist understanding of human knowledge where the knowledge has an objective reality
independent of the person (Popper, 1966). Similarly, Polanyi (1962) referred to the same
controversy as the words “Personal” and “knowledge” might sound contradicting. He argued
although true knowledge is universal, impersonal and objective, the apparent contradiction can
be resolved by modifying the conception of knowledge. The personal participation of the
knower in all acts of understanding does not make our knowing subjective as comprehension
is not an arbitrary passive experience. Knowing is objective as it creates a contact with a hidden
reality (Polanyi, 1962). In fact, knowledge is created, used and shared among persons in a
dynamic human process to justify true personal beliefs (Nonaka et al., 2000; Nonaka &
Takeuchi, 1995). The proposed understanding is that personal or human nature of knowledge
does not contradict the objective reality of knowledge as it is only related to the generation and
transfer dynamic processes, not the reality of what we know. The knowing process is an active
comprehension of things known that utilises certain skills (Polanyi, 1962) these skills are
owned by the human.
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The extant literature makes a distinction between two types of knowledge: personal and
organisational knowledge. The ISO 9001:2015 standard defines the organisational knowledge
as the organisation-specific information, gained by experience, shared and used to achieve the
organisational goals. Although the OKM is a must for any organisation seeking a competitive
edge, personal knowledge is the essential core of KM (Zhang, 2009). The identification of
personal knowledge is not only a personal responsibility but also an organisational one
(Tajedini et al., 2018). However, it seems difficult to convince traditional companies by the
value of personal knowledge for the success of OKM (Pauleen & Gorman, 2010). By the same
token, the use of technology for OKM is insufficient for successful KM as the core knowledge
assets reside in people (Zhang, 2009). Knowledge can be articulated in the formal business
processes and patents but creative and innovative tacit knowledge is held by individuals
(Pauleen & Gorman, 2010). It is believed that the bottom-up approach for PKM would reduce
friction and mistrust associated with the traditional top-down KM (McLaughlin & Stankosky,
2010). From this understanding, PKM is not about self-promotion, but instead about making
employees more effective in the organisation (Agnihotri & Troutt, 2009; Mittelmann, 2016).
PKM is the path for successful KM in the organisation as a whole (D. G. Pauleen & Gorman,
2010).
Indeed, the idea of managing PK is intertwined with Drucker’s concept of “knowledge
worker” (Drucker, 1999). A person holding mission-critical knowledge who uses knowledge
to solve problems and make decisions is described as a knowledge worker (Mittelmann, 2016;
Razmerita, Sudzina, et al., 2009a). A successful knowledge worker needs to develop critical
thinking, problem solving, creativeness and decision making skills (Agnihotri & Troutt, 2009).
In addition, effective communication, ability to learn, the ability for physical and virtual
collaboration, critical thinking, digital skills and managing information in a particular context
are recommended skills for a knowledge worker (Mittelmann, 2016). Those individual skills
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are influenced by education and work experience (Wright, 2005) where the role of experience
can be easily realised by comparing experienced and novice workers (Beijaard et al., 2000).
PKM focuses on how people become knowledge workers in the organisation (Pauleen, 2009).
Moreover, the nature of employment of knowledge workers is changing because a life-long
job is no longer the norm (McLaughlin & Stankosky, 2010) and dramatic changes in the future
of employment have taken place in response to Information and Communications Technology
(ICT) breakthroughs that allow the computerisation of job tasks (Schmitt, 2016). In response
to that, the knowledge worker has to act as a personal knowledge entrepreneur and engage in
lifelong learning to stay competitive in the jobs’ market (Jarrahi et al., 2019; McLaughlin &
Stankosky, 2010). Last but not least, the performance (of a knowledge worker) is a proxy
indicator of his/her knowledge and experience as it is continuously assessed through social
interactions (Wright, 2005). This consorts with the common understanding of knowledge as a
capacity to act and is being associated with human actions (Iazzolino & Laise, 2013; Nonaka
& Takeuchi, 1995).
Knowledge provides the power that managers need to overcome business challenges, shape
and enhance performance. It can be either declarative/explicit knowledge (easy to be
articulated and coded) or performative knowledge that can also be described as tacit (Spender
& Marr, 2006). Tacit knowledge is context-specific, acquired through personal experience or
internalisation and would reside within people rather than any physical media or information
system (Hoe, 2006; Hsiao & Huang, 2019). Knowledge can be also classified as (1) contextspecific knowledge, about a specific setting, team or organisation; (2) technology-specific, e.g.
programming knowledge; (3) a combination of both (Nikkhah et al., 2018). A similar
classification of knowledge is made between the knowledge privately owned by the
organization and the public knowledge which isn’t proprietary to any particular organization
e.g. industry and occupational best practices (Hoe, 2006). Millar, Demaid and Quintas (1997)
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suggested five types of knowledge: know-what, know-why, know-how, know-who and
experiential knowledge overlapping with all other types. Similarly, Rechberg and Syed (2014)
presented three dimensions of knowledge: practical knowledge acquired by doing things,
emotional knowledge important for decision-making process and finally situational knowledge
gained through experiences. A more comprehensive framework of knowledge and its
representation is proposed by Mingers (2008) who distinguished between four forms of
knowledge as follow:
I.

Propositional knowledge: it is merely related to common sense, direct perception,
receipt of information and communication with others i.e. know-what.

II.
III.

Experiential knowledge: received from previous individual experiences.
Performative knowledge: usually involves some kind of physical motor skills or
performance. It is about the know-how.

IV.

Epistemological knowledge: it is to know-why through formal or scientific methods
of discovery.

Early KM models illustrated knowledge as a thing or object that can be captured, stored and
reused as managing information was the real focus rather than managing knowledge (Chatti,
2012). Knowledge nowadays is mobile, global and difﬁcult to contain (McLaughlin &
Stankosky, 2010). Moreover, tens of frameworks describe KM processes and activities. A
qualitative and quantitative content analysis of a total of 160 KM frameworks concluded six
basic categories of KM processes: use, identify, create, acquire, share and store (Heisig, 2009).
Other taxonomies included more activities such as refine and forget (Edwards, 2015a) or
securing knowledge (Van der Spek & Spijkervet, 1997). A review of 119 KM frameworks
from around the world identified four contextual success factors that influence knowledge in
the organisation: human factors (culture, people and leadership), organizational factors
(structures and processes), information technology, as well as management (strategy and
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control) (Schmitt, 2015). Similarly, several processes are recognised specifically for the PKM.
Jones (2009) suggests problem-solving, exploring and learning as core processes for PKM.
PKM implied also the collection, absorption and innovative use of knowledge (Liu et al., 2017).
PKM is often presented as a set of skills for problem-solving and decision making. These skills
are (1) retrieving information; (2) evaluating/assessing information; (3) organising
information; (4) analysing information; (5) presenting information; (6) securing information;
and (7) collaborating around information (Agnihotri & Troutt, 2009). It is noteworthy that
problem-solving requires self-talk and/or engagement with a group (Jones, 2009) which
supports the personal and social nature of knowledge. Pauleen and Gorman (2010) summarise
PKM strategy in the following activities: management, lifelong learning, communication and
interpersonal skills, use of technology, forecasting and anticipating.
In today’s complex environment, knowledge workers are responsible for solving the nonstandardised organisational problems using their knowledge and experience (Mittelmann,
2016). Solving problems outside of expertise was associated with limited performance and lack
of confidence (Wright, 2005) confirming the value of experience in the decision-making
process. Non-routine problems require ‘extensive conscious thinking’ which allow workers to
identify and close gaps in knowledge or in other words to learn. It entails the critical thinking
and iterations of deductive and inductive reasoning (Wright, 2005). This requires them to
develop certain types of information-oriented skills such as critical thinking, innovation,
flexibility, creativity, decision making and secured sharing (Agnihotri & Troutt, 2009;
Mittelmann, 2016). Also, experience facilitates the effective recall, use or combination of
relevant information to solve a problem in different contexts (Beijaard et al., 2000). The
process of problem-solving can be envisaged as a process of sense-making where tacit
knowledge is applied in a social and continuous manner and utilising person’s experience and
worldviews. Effective problem-solving demands team building and collaboration and
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interaction skills to make the right decision (Wright, 2005). Such higher-level skills in PKM
have been traditionally called “wisdom” (Pauleen & Gorman, 2010).
Communication and networking is another basic element in PKM including perception,
intuition, expression, visualization, interpretation and design (Pauleen & Gorman, 2010). It is
a must-have skill particularly in the modern virtual world of self-employment (McLaughlin &
Stankosky, 2010). However, the organisational focus must be on the individual rather than the
social networks and technology (Völkel & Haller, 2009). More recent studies focus on the
human element or in other words the personal and cultural dimension of KM (Sense, 2007).
For instance, Personal Knowledge Network (PKN), as distinct from the traditional view of
PKM, considers knowledge a continuous creation of personal networks (Chatti, 2012). Unlike
the (inter-)organizational networks that are assembled for the duration of a specific project,
personal networks develop gradually and remain beyond the project boundaries (Grabher &
Ibert, 2006). Those external personal knowledge networks refer to knowledge interactions
between individuals in different organisations, who know each other personally and interact
formally and informally beyond the ofﬁcial work duties. The strength of such networks can
influence the knowledge sourcing process and can imply a trade-off between maintaining a
high number of weak ties versus few strong ties (Huber, 2013). In contrast to common notion,
studies reveal that local contacts are not socially and cognitively closer than non-local contacts.
Essentially, the social proximity can be maintained over spatial distances (Huber, 2012). It is
worth noting that social networking usually results in “know-who” type of knowledge (Jarrahi
et al., 2019). The “know-who” is a form of tacit knowledge that is difficult to find in firm’s
yellow pages but rather in more fluid personal interactions (Grabher & Ibert, 2006).
The personal knowledge identification is crucial for a successful implementation of KM in
organizations since personal knowledge identification is not a personal concern but rather an
organizational one necessary for optimal and efficient knowledge application (Tajedini et al.,
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2018). One effective approach to manage personal knowledge is to locate the workers with
particular knowledge (Gang & Yi, 2009). This agrees with the notion that it is impossible to
manage assets that are not measured (McLaughlin & Stankosky, 2010). However, finding
personal knowledge can be a big challenge within the organisation. According to some studies,
knowledge workers are unable to locate their own documents (rather than others’ knowledge)
in 50% of the cases (Agnihotri & Troutt, 2009). The awareness of personal knowledge would
lead to the identification of skills and experiences that the individual needs to perform tasks
and consequently improve his/her performance (Tajedini et al., 2018). The self-managing of
personal knowledge is a characteristic for knowledge workers as work tasks and challenges are
continuously changing (Völkel & Haller, 2009).
Several approaches were adopted by organisations to find knowledge such as codification,
knowledge mapping, network analysis and Personal Knowledge Registration (PKR)
(Haraldsdottir et al., 2018). PKR is the registration process of personal (employees’)
information into a central database to generate an overview of knowledge embedded in the
staff that allow management to look for and find valuable knowledge about their employees
(e.g. education; language, information technology, writing or mentoring skills; participation in
courses and conferences; teaching experience, former work experience and communication
skills). However, the incoherent (or not updated) registration of employee’s personal
knowledge on automated PKR systems limits its value for the organisation (Haraldsdottir &
Gunnlaugsdottir, 2018). A proper knowledge culture would facilitate access, storage and
update of knowledge that has a potential value for the organisation. Without an efficient
extraction process of the identified and organised knowledge, the organisation would fail to
utilise this knowledge and might fall into knowledge forgetting (Tajedini et al., 2018).

2-23

CHAPTER 2: Personal Knowledge and Knowledge Measurement

Figure 2-1 Personal Knowledge Review Themes
Finally, knowledge management must be distinguished from Human Resource Management
(HRM). In fact, effective HR practices are considered as enablers for a successful KM in the
organisation (Currie & Kerrin, 2003; Jimenez-Jimenez & Sanz-Valle, 2013; Klumpp et al.,
2013). Knowledge oriented HRM practices are deemed to encourage knowledge dissemination
and re-use (Jimenez-Jimenez & Sanz-Valle, 2013). At the same time, without the proper
knowledge, HRM won’t make the right decisions (Arun Kumar, 2016). Similarly, there is often
a confusion between Human Capital (HC) and HRM which is concerned with the management
of HC, and the former which is the blend of unique attributes of employees (Chrysler-Fox &
Roodt, 2014). HC plays a mediator role between HR practices and performance (P. M. Wright
& Mcmahan, 2011). It combines knowledge, skills, experiences and individual capabilities of
employees and management (Agostini & Nosella, 2017). The value of HC comes from its direct
impact on organisational performance. HC can have a positive impact on a company’s RC due
to the skills and competencies of employees that are believed to enhance the firm’s reputation
and attract new collaborations. Together with structural capital, it is also believed to enhance
innovation and strategic renewal (Agostini & Nosella, 2017; Vidotto et al., 2017).
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Adapted from Kumar (2016)

Knowledge Measurement
A literature review is a critical analysis of a published body of knowledge to interpret what
is known about a research field and to identify gaps in the existing knowledge (Jafari &
Kaufman, 2006; Jesson et al., 2011). A review of “knowledge measurement” frameworks was
found necessary to understand the meaning of measurement in KM context. First, a review
protocol was created. A set of review questions and search strings (Table 2-1) were developed
after a brainstorming session in order to outline the frames of the review process as follows:
a. What are the current trends of knowledge measurement in business literature?
b. How is knowledge measured at an organisational, group and individual level?
The inclusion criteria included English-written, refereed articles, from peer-reviewed
journals in business and management field. A total of 138 articles were collected from TU
Dublin library electronic databases “TU Dublin Summon”. TU Dublin Summon is a search
engine providing access to TU Dublin library’s online collections in a single search. The
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collections include but not limited to: Emerald Insight, Science Direct, Sage Journals Online
and Scopus together with tens of other resources in different fields (DIT, 2018). Last but not
least, references in the found articles were further examined to find more relevant papers that
would contribute to the review even if not fulfilling the inclusion criteria e.g. not from the
mentioned databases, not journal article, etc. The search results were sorted based on relevance
to the search strings and manually filtered according to the inclusion criteria. The following
are the main themes in the reviewed literature.
Table 2-1 Search Strings
Concept
Intellectual capital
Human capital
Relational capital
knowledge
measurement
Individual
knowledge
Intangible assets

Search string (s)
intellectual capital in
IC in pharmaceutical
pharmaceutical
human capital/ determinants
human capital /pharmaceutical
human capital/measurement

Human capital/ assessment

relational capital determinants

relational capital/ assessment

relational capital/measurement

relational capital in pharmaceutical
knowledge/ measurement /
pharmaceutical
Intellectual capital or IC and
Assessment

knowledge measurement
IC/ measurement

individual knowledge
elements of individual knowledge
measurement
individual knowledge assessment
measurement /intangible assets / pharmaceutical

Pharmaceutical
knowledge

Pharmaceutical knowledge

Measuring Talent

Talent/Measurement

Areas of expertise/pharmaceutical
talent/ assessment

2.3.1 Measuring knowledge at the organisational and group level:
The literature has highlighted that the organisations that employ skilful, knowledgeable and
innovative employees and at the same time develop good infrastructures and systems are
performing better (Chahal & Bakshi, 2016). What’s more, it has been argued that effective
management of IC, in general, has a positive influence on business performance (Sharabati et
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al., 2010).This may explain the growing attention towards intellectual capital in academia and
industry (Chahal & Bakshi, 2016). The history of intellectual capital research includes
prominent scholars who developed and introduced this area of research. In the eighties, KarlEric Sveiby introduced the concept of intangible assets to management in Northern Europe and
Scandinavia. Thomas Stewart followed in 1997 with his popular book “Intellectual Capital:
The New Wealth of Nations” in 1997. This was accompanied by contribution from a number
of brilliant minds proposing new accounting practices this time to measure and manage firms’
intangible assets e.g. Kaplan & Norton‘s Balanced Scorecard approach in 1996, and Sveiby &
Edvinsson’s Intellectual Capital methods in 1997 (De Beer & Barnes, 2003).
Indeed, the world’s modern economy has transformed from an economy of tangible assets
to a new order where intangible resources such as knowledge and competencies are prevailing.
With the aid of ICT, knowledge is increasingly recognized as a commodity where the
knowledge agents have grown to global levels (Dumay, 2009). The measurement of IC at an
organisational level requires monetary metrics which are repeatable and quantifiable that did
not exist in the traditional accounting practices. Instead, broad terms such as “goodwill” have
been used to refer to IC. Goodwill is not exactly the IC although it includes it in addition to
other intangible assets. The need to measure intensifies when an organisation is involved in a
merger, information alliance or even issuing shares. For instance, Watson-Wyatt, one of the
biggest HR consulting companies, referred to the relationship between human capital within
the company and its financial performance. In order to reflect the value of the company-owned
IC on its stock price, IC must be valued and disclosed (De Beer & Barnes, 2003).
On the other hand, a firm’s intellectual capital can be classified into organisational or
structural capital, human capital and relational capital. The Human Capital (HC) includes
individual knowledge, skills, abilities, attitudes and due to its weight in literature, it will be
discussed in more details in a separate section. Structural Capital is the component which
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remains within the organisation when employees leave e.g. patents, networks, procedures and
management processes. Relational or Customer Capital refers to external relationships with
third parties of relevance to business life such as customers and vendors. Examples for that
may include brand, customer loyalty, distributions channels, favourable contracts (Bueno et
al., 2014; De Beer & Barnes, 2003; Keong Choong, 2008). While human capital can be
assessed based on management and HR capabilities, structural capital reflects the innovation
and internal process capabilities. However, networking capabilities and reputation are
indicators of relational capital of a firm (Anatolievna Molodchik et al., 2014). The
measurement of relational capital indirectly protects firm’s relationships with its stakeholders
not to be lost to market rivals (Hosseini & Owlia, 2016).
Despite the famous maxim “If it can’t be measured, it can’t be managed”, IC measurement
is still a controversial discipline. Edward Deming considered running a company on visible
numbers only as a deadly sin. He argued that important things could not be measured as they
are either unknown beforehand to the observer or their importance has not been yet established
(Deming, 1982). However, measurement is a potential enabler to control, evaluate and improve
processes (Ahmed et al., 2006). While it is relatively easy to describe the IC qualitatively, a
quantitative measurement is a big challenge for any organisation. Measurement is traditionally
defined as “the assignment of numerals to the properties of objects or events according to
rules” (Bandalos, 2018). The main issue with the measurement of social phenomena is its
dependence on proxies and assumptions. It is not as accurate as applied science either (Sveiby,
2010). Measurement is required but as part of the IC reporting process not to be confused with
other intangible assets in the balance sheet. The development of an accounting framework for
IC is an ongoing journey for academics and practitioners with no one answer for the dispute
between accounting and narratives of IC mobilisation (Dumay & Rooney, 2011). Albeit
numerous frameworks were developed over the last two decades for IC measurement, it is
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incompletely implemented. Few companies have implemented these frameworks, and fewer
reported any benefit. Even worse, some leading companies in the development and
implementation of IC measurement, such as Skandia, have abandoned the whole initiative
(Serena Chiucchi, 2013).
The general concept of IC valuation that any excess value over the company’s book value
can be truly attributed to its intellectual assets (Bramhandkar et al., 2007). The four main
approaches for valuation of knowledge assets in accounting and management literature are:
•

A scorecard describing and not necessarily measuring the value of intellectual
assets through a set of both financial and non-financial indicators.

•

IC expense-investment methods that measure certain IC expenses as a proxy
indicator of IC investment and knowledge capital earnings,

•

Assessing the overall influence of interactions among IC components within the
organisation generally through the gap between market and book value,

•

Finally, the measurement of knowledge per individual and using it to calculate the
aggregate IC per the whole organisation (Forte et al., 2017).
Kianto et al. (2018) highlight four critical themes that should be better
understood about knowledge for any successful IC measurement model: multidimensionality, human agency and action, contextuality, as well as temporality and
dynamics. Discounted cash flow was also considered an evaluative tool for
measuring intangible assets (Russell, 2016a). However, financial measures of IC
has been long criticised for obscuring where the problem exists and what should be
done to solve it (Kannan & Aulbur, 2004). It is worth noting that the concept of IC
measurement was also expanded to cover entire geographic regions rather than
organisations as a proxy for the regional value creation dynamics (Schiuma et al.,
2008).
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Generally speaking, four main methodologies have been developed for organisational
knowledge measurement:
a. Financial methods: utilising financial models to calculate company’s IC value e.g.
Tobin’s Q and Economic Value Added;
b.

IC methods: splitting company value to smaller categories through IC classification,
development of quantitative metrics and financial valuation e.g. the Skandia navigator ;

c.

Human capital methods: considering human capital as a key component of IC e.g. HR
scorecard and Human Capital Index (HCI);

d. Performance methods: focusing on the impact on knowledge on performance perhaps
through statistics on KM systems’ use and effectiveness (Matoskova, 2016). The
following is an overview of the major measurement frameworks of the organisational
IC.
Financial methods
These methods measure the amount of IC in the organisation utilising accounting
information from the balance sheet and the stock prices (Matoskova, 2016). One of the leading
approaches is Tobin’s Q (Tobin, 1969). Tobin’s Q uses the market-to-book ratio (MTB) to
evaluate the company’s intangible assets. It can also support investment decisions where the
higher Q value discloses an intangible advantage for the rival company (Sveiby, 2010). Tobin’s
Q replaces book value with the replacement cost of tangible assets in the MTB ratio (Forte et
al., 2017). However, like other methods that utilised MTB ratio, Tobin’s Q method was
criticised for being reflective to changes of the stock market rather than be a robust measure of
IC (Ragab & Arisha, 2013).
Human Resource Costing and Accounting (HRCA) is a process of measuring the cost and
investments as well as quantifying the economic value of people in the organisation (Biswas,
2013). IC is estimated as the ratio of the contribution of human assets in the organisation to
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their capitalised salary expenditures (Sveiby, 2010). The framework was criticised for the lack
of reliability and dependence on a multitude of assumptions e.g. service life and forecasted
revenues (Ragab & Arisha, 2013).
Economic Value Added (EVA) is determined by deducting the sum of operating expenses,
taxes and capital charges from the net revenue (Matoskova, 2016). EVA is a modified form
from Market Value Added (MVA) model. In contrast, MVA quantifies the gap between what
investors spent since the start-up of the company and the current value of their shares (Bontis,
2001). The unsupported assumption that an increase in EVA is a proxy indicator of the
effective management of IC in an organisation makes the reliability of the measurement
method questionable (Ragab & Arisha, 2013). Ante Pulic argues that the traditional
performance measurement methods ( e.g. EVA) are not suitable to measure the IC performance
as they do not really show how much value has been created (Pulic, 2000).
Similarly, the technology broker evaluates the company’s IC through the diagnostic analysis
of 20 questions followed by a specific audit questionnaire (Bontis, 2001). It defines IC as the
sum of four elements: market assets, human-centred assets, intellectual property assets and
infrastructure assets (Sveiby, 2010).
Value Added Intellectual Coefficient (VAIC) introduced by Pulic (2000) as a methodology
to measure the IC based on the concept of added value for knowledge-based organisations.
Knowledge was traditionally used to increase the physical productivity. Now, the productivity
of Intellectual work is the priority. From this perspective, IC is not a collection of assets, but
a set of knowledge workers who have the capability of transforming and incorporating
knowledge into product and service that create value (Iazzolino & Laise, 2013). VAIC
measures how much and how efficiently IC and capital employed add value employing: (1)
capital employed; (2) human capital; and (3) structural capital (Sveiby, 2010). The value added
is the value created per time unit by the knowledge workers. Thus, the Value Added Income
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Statement can be usefully employed for measuring the value creation in a knowledge
organization. The main criticism of this model is the mono-criterial vision of the firm
performance measurement (Iazzolino & Laise, 2013). Moreover, in a recent study employing
VAIC as a measure of efficiency in the Islamic banking sector of Malaysia, VAIC failed to
establish a consistent correlation with performance and productivity (Aziz & Hashim, 2017).
Finally, a measurement framework was proposed by Clausen and Hirth (2016) to examine the
impact of intangibles on the firm’s value. The tool employs intangible-driven earnings to assess
the intangibles value. Traditional proxies for intangible intensity such as R&D spending, R&D
stock and number of patents were used to validate the measure (Clausen & Hirth, 2016).
Scorecard methods
Scorecard methods are based on non-financial measures of IC that are reported in a
scorecard or a graph (Matoskova, 2016). Balanced Score Card (BSC) integrates
multidimensional financial, customer; internal process, and learning perspectives where the
measures for each perspective are directed by the strategic objectives of the firm (Tuan, 2012).
However, BSC neither measure the knowledge nor provide a direct link to KM (Ragab &
Arisha, 2013b).
Skandia Value Scheme and Skandia Navigator are other attempts to measure the IC led by
the Swedish insurance company, Skandia. The tool involves numerical indicators that provide
a balanced overview of financial and non-financial dimensions. The Navigator acted as a
planning and follow up tool as well as for the individual performance appraisal (Edvinsson,
1997). The tool has found its way to other enterprises e.g. Dow Chemical inspired by Skandia’s
multidimensional conceptualisation of organisational value (Bontis, 2001). The navigator
consists of 164 indicators covering five components: (1) financial; (2) customer; (3) process;
(4) renewal and development; and (5) human. It is worth noting that Skandia has stopped
issuing its IC report (Sveiby, 2010). IC Rating
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model incorporating measures from the Intangible Assets Monitor; rating efficiency, renewal
and risk that has found its way to consulting companies.
Intangible Asset Monitor (IAM) measures four modes of creating value from three forms of
intangible assets: People’s competence (education and experience), Internal Structure (the
organisation, management, legal structure, R&D, software) and External Structure (brands,
customer, supplier relations). The management is required to consider the organisational
strategic objectives during the selection of IC indicators (Matoskova, 2016; Sveiby, 2010). The
model has been criticised for being formatted for internal reporting and lacking a quantitative
(overall) figure for IC (Ragab & Arisha, 2013). Likewise, Intangible Assets statement is an IC
measuring framework for the public sector based on the IAM with Indicators of: growth,
renovation, efficiency and stability (Sveiby, 2010)
Value Chain Scoreboard is a matrix of non-financial indicators assembled into three classes
according to the innovation cycle: Discovery/Learning, Implementation, Commercialization
(Sveiby, 2010). However, the model and indicators might not fit for all organisations (Ragab
& Arisha, 2013).
The IC-Index was first developed by Goran Roos at Intellectual Capital Services Ltd. Then
shortly adopted by Skandia in its 1997 IC annual report. Since then, the model has been
endorsed by other firms (Roos et al., 1997). The IC-Index consolidates multidimensional
indicators in one index as a second-generation model. Thus, the changes in the index score are
correlated with changes in the firm’s market valuation (Sveiby, 2010). The model provides a
managerial advantage as it avoids having a long list of individual indicators that need to be
compared and investigated (Bontis, 2001). On the other hand, the discrepancy between ICIndex and the market value over the long term outlined that the tool might be flawed and not
reliable. Moreover, the model showed a limited ability to compare IC among different
organisations (Ragab & Arisha, 2013).
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ICU Report is an IC measurement framework designed for the higher education sector. It
consists of three components as follow: (1) Vision of the institution, (2) Summary of intangible
resources and activities, (3) System of indicators (Sveiby, 2010). The adopted indicators are
classified into human, organisational and relational capital indicators. The main contribution
of ICU is presenting IC information in a single document with homogeneous language and
criteria. However, few shortcomings have been found. For instance, some indicators require a
further clarification and the synergies between teaching and research needs to be highlighted
(Sáchez et al., 2009). Last but not least, Pirozzi and Ferulano (2016) proposed an integrated IC
and leadership measurement model for healthcare organisations. The proposed framework
assesses the performance based on the organizational, citizen-user/customer, human resources
and social responsibility results. Also, the new integrated model facilitates the measurement of
IC and financial/non-financial performance in a single measurement system. However, the
framework is limited to healthcare non-profit organisations (NPOs) and application outside
this sector may imply further modifications (Pirozzi & Ferulano, 2016).
Knowledge Management Evaluation Methods
This section can be seen as complementary to the IC measurement process. As investments
in knowledge management dramatically increased, the need to formally track and capture the
knowledge developments within organisations is growing too. Knowledge maturity level
reflects the capabilities within the organisation and how it influences the KM processes
(Khatibian et al., 2010). Maturity assessment frameworks can be also seen as an internal
benchmarking that motivate businesses to embrace successful KM practice allowing strengths
to be shared and consolidated. Furthermore, they can be an enabler for product and process
understanding and continuous improvement with a direct effect on quality, innovation and
employees’ development (Jochem et al., 2011). KM can be also presented as an approach to
achieve corporate sustainability. This implies the implementation of a methodological
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approach for managing knowledge. That is to say, KM maturity models enable corporate
sustainability through providing the necessary structure for assessment and benchmarking
which in turn facilitate continuous improvement and enhance stakeholder value (Robinson et
al., 2006).
Several models were developed in order to evaluate the level of maturity of KM practices
within organisations. Many of the proposed models adopt the Capability Maturity Model
(CMM) proposed by Carnegie Mellon University (Oliva, 2014). Jochem, Geers and Heinze
(2011) proposed five levels of maturity of KM based on knowledge use and renewal. These
levels of maturity include either: initial with non-formal characters, repeated implementing
proactive initiatives, defined with formally established processes, managed with quality-driven
designs and finally optimised showing a sustainable knowledge-intensive process.

KM

lifecycle within the organisation inspired business researcher to develop more models where
the history of KM within the organisation predicts futures KM activities. For instance, an
organisation’s lack of awareness of the need for KM qualifies it to stage zero on the KM
maturity scale. The first stage of the KM lifecycle implies awareness but lack of actions to
implement KM. The organisation is qualified to stage two of maturity when it is actively
implementing knowledge management but not part of the organisation-wide strategy. It is more
like isolated silos. The last stage of maturity is reached when KM becomes a part of the
organisational strategy and routinely reviewed (Edwards et al., 2005). Similarly, STEPS
framework offered a KM maturity roadmap passing through five stages: start-up, take-off,
expansion, progression and sustainability (Robinson et al., 2006).
Whereas previous models ignored the role of knowledge culture, Oliva (2014) implicitly
outlined the role of culture oriented towards knowledge creation as well as the use of
knowledge. Based on this understanding, his model distinguished between four levels of
maturity: insufficient, structured, oriented and integrative. Last but not least, APQC’s levels of
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KM Maturity

SM

is a diagnostic tool helping KM practitioners assess their KM programs. It

consists of five levels starting from initiate, develop, standardise, optimise and finally innovate
(Hubert & Lemons, 2017).
On the other hand, KM performance methods measure the impact of knowledge. These
methods can be classified into financial, non-financial and survey-based methods. The
financial performance measures employ financial metrics to assess the performance of KM
system such as stock process, profitability and ROI (Matoskova, 2016). A study of over 700
Flemish manufacturing and service firms reveals an indirect positive impact of KM on the
financial performance that surpasses the KM implementation costs over the long term (Andries
& Wastyn, 2012).
Non -Financial methods evaluate the KM outcomes based on the responses to interviews or
surveys. Thus, it depends on the respondent’s judgement and their perception of KM
(Matoskova, 2016). Choy, Yew and Lin (2006) propose 38 metrics for measuring KM
outcomes that can be classified into five categories as follow: (1) systematic knowledge
activities; (2) employee development; (3) customer satisfaction; (4) good external relationship;
and (5) organisational success. Other non-financial indicators are suggested such as increase
in sales, reduction in cycle time or the number of complaints. However, the assumed correlation
between these measures and KM effectiveness might not be established in all cases (Ragab &
Arisha, 2013). Some of the performance methods focus on evaluating the performance of
particular systems e.g. electronic knowledge repositories or electronic communities of practice
(Matoskova, 2016).
Evaluation of the success in some KM processes such as knowledge creation and knowledge
sharing is another approach for KM performance measurement. In their study in the banking
sector, Shih, Chang and Lin (2010) emphasise on the role of knowledge creation in the
accumulation of human capital which in turn positively impact both structural and customer
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capital. Likewise, a total of 914 survey responses from 14 Korean organisations were utilised
to develop and validate a reliable and valid psychometric measurement model on
organizational knowledge conversion and creation practices (Song et al., 2012). Knowledge
creation is generally measured through monitoring the undertaken initiatives towards the
generation of new ideas, new ideas that elaborate existing knowledge and the knowledge
incorporated into new products (Mitchell & Boyle, 2010).
The measurement of knowledge sharing can take the form of hard data measures such as the
frequency of length of something (number of personal postings or contributions to meetings),
as well as via surveys that examine the willingness to share knowledge and the underlying
factors (Matoskova, 2016). Wang (2013) developed a 20-item scale for knowledge sharing in
Chinese cultural context based on knowledge donating measures and knowledge collecting
measures (Wang, 2013). A similar study in the public sector (Dubai Police Force) used a 5point Likert scale to measure the attitude towards knowledge sharing, willingness to share
knowledge, trust, organisational structure, leadership, reward, time, and information
technology (Seba et al., 2012). Social network analysis (SNA) is concerned with knowledge
diffusion at the group level. This includes network density analysis ( the number of actual links
per network over the overall number of possible links) and average number of downward links
(the span of control) (Matoskova, 2016). Su, Yang and Zhang (2017) have adopted a weighted
network and knowledge diffusion efficiency measurement approach. The new approach
examined network topological parameters, knowledge collaboration level and knowledge
collaboration relationship strength and has proved superior to traditional unweighted or
subjective methods.
Human Capital (HC) measurement
HC can be understood through three key dimensions: knowledge either from training,
education, experience or personal development; abilities as a way of doing things and
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behaviours that lead individuals to do their tasks via mental models, paradigms and beliefs
(Martín-de-Castro et al., 2011). To that end, Mehralian, et al. (2013) suggested three main
indicators of HC in the Pharmaceutical sector: learning and education; experience and
expertise; and innovation and creation. Human Capital Value Metric (HCVM) proposed wages
as a proxy indicator of employee value assuming that qualified employees bring value above
and beyond his/her wage (Bukowitz et al., 2004). A review of the major models in the last 60
years revealed that the key indicators of HC in the organisation are talent, education,
experience, knowledge, skills, attitudes, creativity and leadership (Vidotto et al., 2017).
Regardless of the apparent significance of HC for business progress and its popularity in
academic research, there are few consistent frameworks dedicated to measure it (Bukowitz et
al., 2004; Mehralian et al., 2013b; Vidotto et al., 2017) which rarely provide any financial
justification for investments in HC (Cantrell et al., 2006).
Furthermore, the diversity of HC scales sheds light on the context-specific nature of HC
measurement. Having said that, the most appreciated measures for HC are those identifying
the performance levers and evaluating HC contributions to the organisational value (Baron,
2011; Robinson, 2009). Furthermore, company strategy was found to influence their choice of
HC measures. For instance, innovation measures are more employed in differentiation-oriented
firms, and efficiency measures are preferred in companies following a cost-leadership strategy
(Gates & Langevin, 2010).
Vidotto et al. (2017) proposed a HC measurement framework relying upon three factors:
leadership and motivation; qualifications; as well as satisfaction and creativity. Another scale
from the Indian banking sector chose competence, creativity, manager’s attitude and staff
attitude as dimensions of HC in addition to other dimensions describing RC and SC (Chahal &
Bakshi, 2016). Family firms displayed some unique intangibles characterising their HC
including leadership, self-motivation, entrepreneurship, feeling of membership, emotional
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family component, creativity, skills, knowledge acquired from family members and knowledge
owned by non-family members (Claver-Cortés et al., 2015). Watson Wyatt’s Human Capital
Index® is another attempt to assess the HC based on five dimensions: rewards and
accountability; workplace; recruiting and retention excellence; communication integrity; HR
service technologies (Watson Wyatt, 2001).
The British Civil Aviation Authority (CAA) developed a balanced scorecard to measure the
HC based on three bases: external customer perception of CAA’s performance, achievement
of objectives and assessment of staff expertise. The proposed measures included strategic
performance measures, outcome measures (e.g. turnover rates, absence rate), operational data
(e.g. number of training days) and workforce data (e.g. headcount, demographics). However,
the adoption of CAA approach for HC measurement is challenging because of the time required
for data collection and analysis (Robinson, 2009). Other studies distinguished between projectbased organisations in comparison with traditional businesses of repetitive operations as the
temporary nature of projects implies different HC measures (Demartini & Paoloni, 2011).
Proxy measures were also utilised as rough assessment tools of HC (Wright & Mcmahan,
2011). These diverse approaches advocate the context- specific nature of HC measurement as
previously argued by Robinson (2009) and Baron (2011). Regarding the design of the HC
measurement tool, Massingham, Nguyen and Massingham (2011) advocated 360-degree peer
review to minimise the bias associated with self-reporting assessments.
Talent is typically noted as part of HC. Employees who have unique capabilities and possess
a high value for their organisations are called “talents” (Nijs et al., 2014). Many organisations
identify groups of high-potential talents (talent pools) through structured, semi-structured or
even informal procedures. The identification includes a nomination process followed by an
additional assessment of the nominees, e.g. leadership competency rating (Silzer & Church,
2010). Despite that the global talent measurement market is expanding (over US$3 billion per
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annum), talent measurement is a sophisticated process and many firms lack the necessary
expertise to measure it (Bell, 2013; Nijs et al., 2014).
2.3.2 Measure Knowledge at Individual Knowledge:
While HC describes the knowledge within a group or the whole organisation, measurement
of personal knowledge focuses on the knowledge of individual employees. Individual
employees are envisaged as key players in knowledge management and development
(Rechberg & Syed, 2014). However, the individual versus the collective distinction of HC is
an arguable topic. On the one hand, macro-level scholars argue that HC is the aggregate of
knowledge, skills and experiences owned by individuals. They argue that knowledge is scalefree; it applies similarly either at an individual or organisation level (Faucher et al., 2008). On
the other hand, psychologists and micro-level scholars advocate the synergistic effect of the
aggregate of individuals, i.e. the unit-level knowledge is more (can be less) than the sum of
each (Wright & Mcmahan, 2011). Measures such as the replacement cost of tangible assets
(Tobin, 1969), market share (Edvinsson, 1997) or retention excellence (Watson Wyatt, 2001)
are not suitable predictors of knowledge at the individual level. Taking into consideration the
definition of knowledge as “a justified true belief”, the review of the IC measures in the above
section (2.3.1) demonstrate that many of the employed metrics are not knowledge measures
(e.g. market share, customers lost, IT expenses in Skandia Navigator). This supports the notion
that the measures of the organisational knowledge and IC are not always accurate measures for
the personal knowledge of individuals which in turn urge the need to develop specialised
models for individuals.
Davenport (1999) has envisaged an individual employee as a human capital investor who
can invest his knowledge and gain profits. A high level of education (as a measure of
knowledge) was associated with higher earnings (Davenport, 1999). Similarly, Schultz (1961)
affirms that differences in earnings correspond closely to differences in education suggesting
that one is the result of the other (Schultz, 1961). Yet the research on personal knowledge
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measurement is relatively scarce and measurement scales are considerably few. Measurement
of Individual Knowledge (Mink) framework (Ragab and Arisha, 2013b) suggests ten individual
knowledge indicators (IKI) in the organisational context: education, training, experience, IT
literacy, business communications, business process interactions, personal network
performance, creativity and financial indicators. It can be a tool for both internal monitoring
and/or external presentation (Arisha & Ragab, 2013). A standardised test can be another
approach to measure knowledge at the individual level. However, this method is criticised by
being limited only to the explicit knowledge component (Matoskova, 2016) in addition to the
complexity of finding the right answers for the questions (Borgatti & Carboni, 2007). In order
to overcome the latter problem, Borgatti and Carboni (2007) proposed a consensus method
that analyses the pattern of agreement among participants to a knowledge quiz.
A situational Judgement Test (SJT) is another technique for measuring personal knowledge.
SJT consists of a set of situations within certain professional context. In order to solve or react
in these situations, the individual is supposed to possess certain knowledge. However, these
methods were criticised for fakability and bias (Matoskova, 2016). Peeters and Lievens (2005)
examined the impact of faking on the incremental validity of SJT in a sample of college
students. The study found that faking significantly impacts SJT validity where students selected
the more favourable responses to achieve higher scores (Peeters & Lievens, 2005). Finally yet
importantly, know-how form of knowledge (performative knowledge), which is predominately
tacit and acquired through experience, is generally evaluated via practical testing (e.g. success
or failure in riding a bike and to which level) (Mingers, 2008).
On the other hand, performance appraisal refers to the organisational HRM activities to
assess employees, improve their performance, develop their competencies and justify
rewarding (Fletcher, 2001). This process is often used to allocate bonuses, merit pay, employee
promotions based on the periodic assessment. The outcome has a direct impact on the
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organisation and economy, such as the distribution of wages, who leads organizations, and who
is laid off (Cappelli & Conyon, 2018). Different measures of performance are adopted
including objective indicators (e.g. the number of units produced), subjective measures (e.g.
relationship with customers) or a combination of objective and subjective measures. While
objective measures are simple and standardised, they are not suitable to assess multitasking
jobs. Subjective measures are flexible and comprehensive but they depend on the evaluator’s
judgement (Bayo-Moriones et al., 2019).
The performance measurement can take the form of self-assessment, feedback from coworkers and customers or a direct assessment by manager(s) (Lloyd, 2009). Performance
appraisal is apparently not a knowledge measurement process. Cappelli and Conyon (2018)
argue that appraisal score is not a reflection of the employee’s initial human capital at the
recruitment stage but it informs about the variance of his/her performance over time. However,
knowledge is acquired over a longer period of time through individual processes such as direct
experience and lifelong learning (Hoe, 2006; Mingers, 2008). Unlike performance appraisal,
knowledge measurement aims to identify and allocate knowledge assets, benchmarking against
other companies and monitoring the development of the firm’s IC overtime (Matoskova, 2016).
Moreover, while performance appraisal is a standard practice in nearly all organisations (Ward,
1997), the literature review reflects a sporadic implementation of different knowledge
measurement approaches.

Summary and Conclusion
Measurement is a popular topic in KM literature; nevertheless, most of the measurement
literature address the organisational level at macro-level. Either measurement of IC, HC or
maturity models focus on the knowledge of the group, the whole organisation and sometimes
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the entire region or society. Despite the growing interest in the PKM, relatively few studies
focus on the personal knowledge of individuals in the organisational context, and even fewer
aim to objectively measure it. Few papers in KM provided categorisation and anatomy of
knowledge forms and its truth, e.g. Millar, Demaid and Quintas (1997) and Mingers (2008),
but neither utilised this for identifying knowledge holders. The need to measure knowledge
and identify knowledge holders is justified at both macro and micro-level. The context-specific
nature of knowledge justifies the need to customise the measurement frameworks to one or a
group of similar industries to avoid validity problems. This highlights an urgent need to
develop a measurement framework considering the nature of the pharmaceutical industry. As
knowledge measurement process is context-specific, as previously mentioned, chapter five (the
exploratory study) will provide more insights about current measurement practices, the level
of KM maturity, components of personal knowledge and the significance of its measurement
from practitioners’ perspective within the pharmaceutical industry.
In the next contextual chapter, the researcher will explore the prevalent trends of KM in the
pharmaceutical industry with a focus on the personal knowledge. The regulatory expectations
of the main global regulatory bodies are critically reviewed and compared with the trending
academic research themes.
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Introduction
The acknowledgement of knowledge as a pivotal strategic resource in the current smart
economy has impelled considerable organisational change in knowledge management (KM),
where organisations endeavour to exploit their intellectual assets to drive value creation. This
progressive movement by individuals and organisations to manage their intellectual assets
developed into KM (Davenport & Völpel, 2001). The pharmaceutical industry is not an
exception of this trend, not only as a knowledge-intensive industry but also as a leading
economic partner with transcendent investments in innovation and research. According to the
European Federation of Pharmaceutical Industries and Associations (EFPIA), the
Pharmaceutical industry employs more than 750,000 employees in Europe, 16% of them
working in pharmaceutical Research and Development (R&D). It was the preeminent sector
regarding R&D intensity and expenditure as a percentage of net sales (15%) in 2016 followed
by software & computer services (10.6%) and technology hardware & equipment (8.4%)
(EFPIA, 2018). The pharmaceuticals and biotechnology sectors are among the top investing
sector in R&D worldwide according to the Industrial R&D Investment Scoreboard (European
Commision, 2018).
It comes as no surprise that major pharmaceutical regulatory authorities have realized the
significance of KM. International Council for Harmonisation (ICH) recommends the
management of drug and process knowledge from development and up to product
discontinuation as an enabler of effective quality management systems. On the other hand,
technology transfer between development and manufacturing, and within or between
manufacturing sites is considered as an integral part of new drug product realisation (WHO,
2011b). From this perspective, KM creates the basis for the manufacturing process, control
strategy, process validation approach, and ongoing continual improvement (ICH, 2009). Food
and Drug Administration (FDA) has paid close attention in successive guidelines to the
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management of Electronic Records along with its efforts to enhance data integrity in
pharmaceutical premises ensuring delivery of safe, effective and quality product to the patient
(FDA, 2003, 2016b).
Thus, as knowledge is another core product of the pharmaceutical industry (Riddell &
Goodman, 2014), managing stocks and flows of knowledge in this sector emerges as a key
economic and regulatory objective as well as a growing area of academic research.
Nonetheless, some knowledge-intensive industries such as pharmaceuticals have not received
adequate attention in industry-specific publications (Ramy et al., 2017). With few other review
articles surveying the applications of KM in specific fields (e.g. construction industry (Walker,
2016), energy sector (Edwards, 2008) and public sector (Massaro et al., 2015), this contextual
chapter comes as a comprehensive industry-specific systematic review of KM research within
the pharmaceutical sector identifying key themes, addressing extant research gaps, assessing
regulatory expectations, and providing an overview of the progress of KM with a particular
focus on the role of PK.

3.1.1 Systematic Review Questions
A comprehensive, unbiased search is considered as one of the crucial differences between
a traditional narrative review and a systematic review. Moreover, traditional reviews suffer
from lack of thoroughness, inconsistency and bias by researchers that they are not always
undertaken as a genuine piece of investigatory science (Jesson et al., 2011; Tranfield et al.,
2003). For this reason, the author committed to systematic review techniques in order to
synthesize a reliable and enhanced knowledge stock as will be clarified in the methodology
section. Several research papers in the field of KM have followed systematic review
methodology as the basis of the review process for example: Costa and Monteiro (2014),
Klammer and Gueldenberg (2016), and Massaro et al. (2016). These papers were also taken
into consideration while developing the review protocol.
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In order to develop a systematic review, the author developed a set of research questions
and a review protocol in the early stages of the review. The review questions are developed to
achieve the first research objective and to gain an in-depth understanding of KM practices in
the pharmaceutical manufacturing context. The proposed questions are believed to develop the
researcher’s collective understanding of the field which is a pre-condition for doing good
empirical research (Boote & Beile, 2005). Also, those questions are critical to the systematic
review as the other aspects of the process flow from it (Tranfield et al., 2003). The questions
embody a mixture of quantitative and qualitative review aspects. They are designed to provide
a comprehensive overview where both the academic literature and industry-specific regulations
are reviewed. Regarding the questions structure, questions are organized as a major question,
followed by thorough minor questions.
Q.1 How is the KM literature in pharmaceutical/biopharmaceutical industry developing?
1.1. Which knowledge processes/ themes are predominantly studied by current research? Or
what is the focus of KM process research in the pharmaceutical industry?
1.2.What are the recent trends in co-authorship distribution and author affiliations?
1.3.Which countries are leading in this track?
1.4.Which department or function was more represented in pharma industry KM research?
1.5.What are the most utilized research and data collection methods in pharmaceutical
industry KM research?
Q 2. What is the significance of the identified academic research themes from a regulatory
perspective? Or What are the expectations of regulatory agencies with regard to the identified
academic research themes?
Q 3. What is the future of KM research within the pharmaceutical industry?
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3.1.2 Review Methodology
The high expectations of improving the quality of reviews through well-defined
methodologies led to the development of systematic review protocols (Jesson et al., 2011).
Systematic review protocol encompasses specific research questions, the population that is the
focus of the study, the search strategy and terms for identification of the relevant studies.
Studies that meet all inclusion criteria and manifest none of the exclusion criteria needs to be
integrated into the review (Davies & Crombie, 1998; Tranfield et al., 2003).
The author commenced his review by identifying the research questions. These questions
are deemed to construct the pillars of the whole literature review (Jesson et al., 2011; Tranfield
et al., 2003). After refining the review questions, the timeframe of review is set to be the last
twenty years (1996-2016). This period represents the prosperous period of KM research (Ma
& Yu, 2010; M. A. F. Ragab & Arisha, 2013). Furthermore, the timeframe took into account
the relative novelty of online KM journals. According to Serenko & Bontis (2013) ranking of
the KM journals, the top ranked four KM journals ( JKM, KMRP, IJKM and JIC) have been
published online only since 1997, 2003, 2005 and 2000 respectively.
The criteria for inclusion comprise peer-reviewed electronic business journals in the English
language retrieved from the Emerald Insight and Science Direct database as the top KM
journals are published on them e.g. Journal of Knowledge Management (JKM) and Journal of
Intellectual Capital (JIC) (Serenko & Bontis, 2017). Peer reviewed journals are favoured
because they are quality assured (Jesson et al., 2011). Search strings were synthesised from the
top ranked keywords in two comprehensive keyword analysis studies in the KM discipline:
Fteimi and Lehner in (2016) along with Ribière and Walter in (2013). Thus, potential search
strings were enumerated based on relevance (Table 3-1). The list was updated during the search
process. It was meant not to tightly plan the review process as this may inhibit researchers’
capacity to explore, discover and develop ideas (Tranfield et al., 2003).
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Table 3-1 Review Search Strings List
KM in pharmaceutical

Knowledge sharing in
Knowledge creation in
pharmaceutical
pharmaceutical
Biotechnology knowledge
Data mining in
Creating knowledge in
pharmaceutical
pharmaceutical
Intellectual capital
knowledge measurement in
Knowledge transfer in
Pharmaceutical
pharmaceutical
pharmaceutical industry
Articles that appeared in the research results were manually checked for relevance through
title, keywords and abstract analysis. After the exclusion of duplicates, articles were screened
against the inclusion and exclusion criteria by reviewing the titles and abstracts (Pati &
Lorusso, 2018). If the pharmaceutical or biopharmaceutical industry was not the research
field/sample, the article was excluded. Articles which cannot be classified under knowledge
management research domain were also excluded. The exclusion criteria covered editorials,
unpublished works and/or journals that do not have online domains (Table 3-2).
Table 3-2 Inclusion and exclusion criteria
Inclusion criteria
KM theories and processes
With applications in pharmaceutical industry
Peer reviewed journal articles
In English language
Published online between 1996 and 2016

Exclusion criteria
Not related to KM
Applied exclusively in other industries
Editorials and position papers
Articles that use languages other than
English
From journals that don’t have online
domains and unpublished work.

A full-text assessment followed where the full-text articles were scrutinised to assess
relevance to the review questions. The retained articles addressed a KM related topic
exclusively in the field of pharmaceutical industry or in conjunction with other industries. To
mitigate the risk of bias of the reviewed studies (Moher et al., 2015), 141 eligible articles were
quality- assessed for the clarity of research objectives, adequacy of description of the data
collection methods and finally the link between data, results and conclusion as advised by
Kitchenham and Charters (2007). Four articles were excluded at this stage due to ambiguous
methodology and irrelevance to the pharmaceutical industry. Ultimately, 137 articles were
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retained for analysis after application of inclusion/exclusion criteria and quality assessment. A
limited number of non-business journal papers (e.g. medical journals) and papers identified by

Records identified through
database searching (n=2046)

Additional records identified
through other sources (n=18)

Records after titles
and abstract screening
(n= 141)

Records excluded
(n= 1218)

Eligibility

Records after duplicates removed
(n= 1359)

Full-text articles
assessed for eligibility
and quality (n= 141)

Full-text articles
excluded with reasons
(n= 4)

Included

Screening

Identification

cross-referencing citations were included during the review process (Figure 3-1).

Studies included in the
qualitative and
quantitative synthesis
(n=137)

Figure 3-1 Systematic review process -PRISMA flow diagram (Moher et al., 2015)
After acknowledgement of main themes and processes in KM literature; the identified
themes were scrutinised in the regulatory guidelines of five major regulatory bodies. The
reviewer collected all the published guidelines for the pharmaceutical industry on the official
websites of World Health Organisation (WHO), FDA, ICH, The Pharmaceutical Inspection
Convention and Pharmaceutical Inspection Co-operation Scheme (jointly referred to as PIC/S)
and EudraLex- European Union (EU) Legislation. At the end, 128 guidelines were searched
for KM related topics in light of the identified themes from the academic literature review. The
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analysis recognises the significance of research themes from regulatory perspective as well as
the possible research gaps in this field.

Findings
Scientometric Trends
Initially, findings indicate that KM in the Pharmaceutical industry has become a wellestablished academic research area. Authorship trends show that approximately 93% of articles
are published by academic researchers, while the remaining 7% are the product of practitioner
work. A significant increase in collaborative research is also evident, as the number of coauthored papers has increased from 62% to 85% over the past ten years. In order to identify
the leading countries in the KM field, the relative contributions of 36 countries whose papers
were included in this review are traced and ranked using the Equal Credit counting method
(Chua and Cousins 2002; Lowry et al. 2007). The USA and UK were ranked highest with
regards to productivity (18% and 11% respectively of all reviewed articles); followed by Iran
(7%), Australia (7%) and India (6%) as shown in (Figure 3-2). It is worth nothing that country
contribution in this research addresses the country of residence of the author not necessarily
where the research was carried out.
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Figure 3-2 Country Productivity
From a functional perspective, more than 60% of the articles do not specify the particular
department where the study was conducted. Among articles which do specify the function
under study, 83% fall within pharmaceutical development and innovation functions in contrast
to only 8% in production, 4% in sales and 4% in the supply chain. It is worth noting that 72 %
of the reviewed papers were conducted exclusively in the pharmaceutical industry.
In terms of Methodology, only 29% of the articles are literature review papers; while over
70% are empirical studies employing one or more data collection methods, e.g. surveys (29%),
case studies (10%) and interviews (17%) (Figure 3-3).

Research Method
29%
20%

17%

Case Study Interview

29%
12%

Literature
Review

Modeling

9%

Survey

Other
Qualitaitive

Figure 3-3 Research and Data Collection Methods
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Research Themes
A hybrid method of quantitative keyword analysis and qualitative thematic analysis was
proposed to identify the common research topics or themes. Over 20 concepts were used to
code the articles according to the prevalent research theme. The most frequent themes and
keywords (after exclusion of generic keywords, e.g. knowledge management, pharmaceutical,
etc.) are presented in (Table 3-3). More than 20% of the reviewed papers included “Intellectual
Capital” as the most frequently used keyword. Innovation, Knowledge Sharing and Knowledge
Transfer come in the second, the third and the fourth rank respectively regarding keyword/
research theme frequency.
Table 3-3 Themes and Keyword Analysis
Rank
1
2
3
4
5
6
7
8
9
10

Themes & K.
processes
Intellectual Capital
Innovation
Knowledge Transfer
Knowledge Sharing
Organisational
Performance
Organisational Culture
Intellectual Property
Knowledge Creation
New Product
Development
Organisational
Learning

Frequency

Keywords

Frequency

29
25
14
13

Intellectual Capital
Innovation
Knowledge Sharing
Knowledge Transfer

27
18
10
10

12
12
10
9

New Product Development
Research and Development
Intangible Assets
Organizational Learning

9
9
8
7

6

Organizational Culture

5

6

Project Management

5

The identified themes and keywords offer a birds-eye view of the KM landscape through a
taxonomy of KM research in the pharmaceutical industry providing researchers with a map of
the current literature and insights into future research. The paper presents a classification of
KM publications into six areas: knowledge sharing and technology transfer, Intellectual
Property Protection (IPP), knowledge measurement and Intellectual capital (IC) reporting,
innovation and knowledge creation, organisational knowledge culture and structure as well as
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pharmaceutical firm performance (Figure 3-4). Table 3-4 presents the key articles under each
of the featured themes.

Knowledge Sharing
and Technology
Transfer

Intellectual Property
Protection

Knowledge
Measurement and IC
Disclosure

Research, Innovation
and Knowledge
Creation

Managing Patents

Measurment of IC

GovernemntUniversity-Industry
Collaboration

Role of Culture

How IC Influences
Performance

Co-location and
Geographic
Proximity

Patents and
knowledge
Creation

IC Disclosure

Enablers of
Innovation

Types of Culture

KM Strategies

knowledge
Networks

Regulatory Threats
and Opportunities

Merger and
Acqusition

Outsourcing of
R&D

Organisational
Structure

Profitability,
productivity and
Market Valuation

New Product
Development

Barriers
& Enablers

Figure 3-4 Literature Map
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Table 3-4 Key articles under the featured themes
Category
Knowledge
Sharing and
Technology
Transfer
Pharmaceutical
Firm Performance

Reviewed Articles
(Yang et al., 2014); (Iwasa & Odagiri, 2004); (Boasson & Boasson, 2015);
(Allarakhia & Walsh, 2011); (Sternitzke, 2010); (Kale & Little, 2005);
(Hohberger, 2016); (Chávez & Víquez, 2015); (Russell, 2016a); (L. Bollen
et al., 2005)
(J.-K. Wang et al., 2006); (Mehralian et al., 2016); (Rémy MagnierWatanabe & Senoo, 2008); (Rémy Magnier-Watanabe & Senoo, 2010);
(Rémy Magnier-Watanabe et al., 2011); (Remy Magnier-Watanabe &
Senoo, 2009); (Lindner & Wald, 2011); (Guzman, 2008); (J. Evans &
Brooks, 2005); (Ebrahimi et al., 2008); (Bigliardi et al., 2012); (Filieri et al.,
2014)
Research,
(Vishnu & Kumar Gupta, 2014); (Tahvanainen & Hermans, 2005);
Innovation and
(SubbaNarasimha et al., 2003); (Singh & Kansal, 2011); (A.-A. A. Sharabati
Knowledge
et al., 2010); (Palacios-Marques & Garrigos-Simon, 2003); (Pal & Soriya,
Creation
2012); Narula2016; Naidenova2013; (Mehralian, Rasekh, et al., 2013);
(Mehralian, Rasekh, et al., 2013); (Kamath, 2008); (Y.-C. Huang & Wu,
2010); (Hine et al., 2008); (Ghosh & Mondal, 2009); (Erickson & Rothberg,
2009); (Chizari et al., 2016); (L. Bollen et al., 2005); (Boekestein, 2006);
(Boekestein, 2009); (Abhayawansa & Azim, 2014); (Sydler et al., 2014);
(Russell, 2016b); (Rossi et al., 2015); (Nito, 2005); (Mehralian et al., 2012);
(Mehralian et al., 2014); (L.-S. Huang et al., 2011); (Boekestein, 2009)
Intellectual
(Wakefield, 2005); (Styhre et al., 2008); (Qureshi & Evans, 2015); (Akhavan
Property
et al., 2015); (Pedroso & Nakano, 2009); (Mets, 2006); (Lilleoere & Hansen,
Protection
2011); (Lawson & Potter, 2012); (Hemmert, 2004); (Gray et al., 2011);
(Dooley & Kirk, 2007); (Delaney, 1999); (Criscuolo, 2005); (Coradi et al.,
2015); (Chávez & Víquez, 2015); (Brachos et al., 2007); (Bourouni et al.,
2015); (Azan & Huber Sutter, 2010); (Allen et al., 2016); (Santos, 2003);
(Mohan et al., 2007); (Malik, 2012); (Iwasa & Odagiri, 2004); (Filieri et al.,
2014); (Chang et al., 2007); (Buchel et al., 2013); (Bourouni et al., 2015)
Knowledge Culture (Mehralian et al., 2012); (Malik, 2012); (Kim et al., 2014); (Vishnu & Gupta,
and Organisational 2014); (SubbaNarasimha et al., 2003); (A.-A. A. Sharabati et al., 2010); (Pal
Structure
& Soriya, 2012); (Kamath, 2008); (Garcia Morales et al., 2008); (L. Bollen
et al., 2005); 1
Knowledge
(Terziovski & Morgan, 2006); (Styhre et al., 2002); (Sternitzke, 2010);
Measurement and
(Standing & Kiniti, 2011); (Sharma & Goswami, 2009); (Roth, 2003); (C.
IC Disclosure
Parisi & Hockerts, 2008); (Palacios-Marqués et al., 2016); (O’Dwyer et al.,
2015); (Nightingale, 2000); (Mehralian et al., 2014); (Lowman et al., 2012);
(Lauto & Valentin, 2016); (Kneller, 2003); (Khemka & Gautam, 2010);
(Kazadi et al., 2015); Kale2005; Huang2011; Hohberger2016; (Herrmann &
Peine, 2011); (van Geenhuizen & Reyes-Gonzalez, 2007); (Gassmann &
Reepmeyer, 2005); (Garcia Morales et al., 2008); (Filieri et al., 2014); (Chen
et al., 2008); (Chang et al., 2007); (Cardinal & Hatfield, 2000); (Styhre et al.,
2008); (Mets, 2006); (Lowman et al., 2012); (Lauto & Valentin, 2016);
(Kazadi et al., 2015); (Gassmann & Reepmeyer, 2005); (Cardinal & Hatfield,
2000); (Boasson & Boasson, 2015); (Mohan et al., 2007)
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Publication years
The review shows that the majority of included articles have been published between 2004
and 2016 as shown in (Table 3-5).
Table 3-5 Publications per year

Miscellaneous

Research, Innovation and
Knowledge Creation

Pharmaceutical Firm
Performance

Knowledge Sharing and
Technology Transfer

Knowledge Measurement
and IC Disclosure

Knowledge Culture and
Organisational Structure

1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016

Intellectual Property
Protection

Year

1
1
1
3

1

1
1
1
1
4

1
2

1
1
5
5
2
4
9
3
2
3
1
3
4
3
3

2
7
8
17
7
11
21
10
10
13
11
7
15
16
14

1

2
1
2

1
1

1
2
2

1
1

3
1

3
1
1
2
1

2
4
2
2
2
3
4
1
3

1
1

1
2
2
1
4
1
1
1
2
2
1
1
6
1
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1

2
1
3
2

Total

3
2
3
4
1
2
3
2
2
4
4
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Knowledge Sharing (KS) and Technology Transfer:
More than 19% of the reviewed articles addressed knowledge sharing and transfer
signifying that Knowledge transfer (KT) holds a special significance in the Pharmaceutical
industry. Knowledge transfer (KT) and sharing are the fundamental knowledge processes and
the leading research topic in KM/IC publications (Ramy et al. 2017). While World Health
Organisation (WHO) dedicated Annex 7 of Technical Report Series no.961 to discuss
dynamics and controls of process/technology transfer occurring at some stage in the life-cycle
of most products in the pharma industry (WHO, 2011b), the real significance of KS comes
from the fact that it is the component that facilitates continuous knowledge creation (Akhavan
et al., 2012) and is a key driver of long-term success in a knowledge-intensive organisation
(Coradi et al., 2015). Accordingly, enablers and deterrents of knowledge sharing come to the
focus of the field studies in various industrial domains. Within the pharmaceutical context, a
thorough investigation by Qureshi and Evans (2015) identifies nine categories of deterrents
which are classified as either structural barriers, cultural barriers, or managerial barriers.
Structural factors include lack of physical proximity and the associated high cost of KS as well
as IT infrastructure limitations. Cultural factors encompass knowledge-hiding, the lack of
socialisation, the lack of trust, the organisational politics and the non-educational mindset as a
pure commercial drive dominates the interactions within the pharmaceutical organisation.
Additionally, poor leadership and time pressure are classified as managerial barriers for KS.
Conversely, documentation, education and training, reading standard operating procedures,
recognition of work, meetings, seminars and conferences, staff updates and voluntary
mentoring are identified as intra-organisational knowledge sharing mechanisms in pharma
(Qureshi & Evans, 2015). Although the perceived loss of knowledge power, the perceived
reputation enhancement, and the perceived enjoyment in helping others as well as social ties
and trust can influence employees’ attitude towards KS (Akhavan et al., 2015); empirical
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evidence indicates that trust, motivation to transfer knowledge, management support and
learning orientation are crucial for the effectiveness of knowledge transfer and innovation
(Brachos et al., 2007). As enablers and deterrents for KS are found not to be the same for
everyone within the pharmaceutical firm, the diverse nature of roles in this industry needs to
be considered in any knowledge sharing initiatives within the organisation. For example,
scientists and technicians in R&D present different views and practices regarding their
perception of the enablers/barriers. Indeed, reinforcing the KS enablers to leverage knowledge
among pharmaceutical R&D professionals would potentially accelerate the innovation process
and thus decrease new products’ time to market and consequently reduce cost (Lilleoere &
Hansen 2011).
Also, Knowledge Networks (KN) are increasingly considered vital channels to achieve
strategic objectives in project-based organisations particularly the pharma R&D (Bourouni et
al., 2015; Mohan et al., 2007). The structural indexing and knowledge dictionaries can identify
knowledge agents and evaluate intra-organisational knowledge sharing. Enhancing knowledge
flow among development phases can be crucial to shortening the product to market timing.
Indeed, structural indexing contributes to KT through the identification of members who
actively share knowledge and evaluation of the degree of knowledge sharing as well
(Wakefield, 2005).
As physical proximity is one of the suggested barriers for Knowledge Sharing and
Technology Transfer (Lilleoere & Hansen, 2011), several studies handle this topic in the
pharma explicitly. For instance, studies conducted in the R&D department of the multinational
drug manufacturer Novartis reveal that the co-location of dispersed project teams increases
face-to-face communications leading to a faster and more precise flow of personal knowledge.
In the same study multi-space work areas were found to simulate knowledge creation SECI
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model (Nonaka & Takeuchi, 1995) by enabling socialisation, externalisation and combination
of knowledge (Boutellier & Ullman, 2008; Coradi et al., 2015).
On a macro scale, an equally significant aspect of inter-organisational KS is geographic
distribution. Higher quality risk can accompany offshore manufacturing due to challenges of
KT from headquarters (Gray et al., 2011). The location of the pharmaceutical firm is found to
influence the intensity of communication between different firms but not innovation.
Relocation (e.g. into industry clusters) and expensive real estate investments can be replaced
by enhancing the social connections through technology (Allen et al., 2016; van Geenhuizen
& Reyes-Gonzalez, 2007). However, it has been argued that having an R&D laboratory near
corporate headquarters can enhance new drug productivity as proximity is necessary for the
integration of R&D with other functions and strategic goals for product innovation (Cardinal
& Hatfield, 2000).
It was also found that pharmaceutical firms often cite more patents from other
geographically close firms. An elaborate analysis of US pharmaceutical patent citations
between 1963 and 1999 affirmed that 37% of cited firms are less than one mile away from the
citing firm and more than 50% are within 50 miles apart or 26% if we excluded self-citations.
Further, a positive relationship was found in the same study between patent quality and
geographic proximity to other knowledge-intensive institutions and activities (Boasson &
Boasson, 2015). In order to overcome geographic proximity challenges, researcher mobility
within the R&D networks is the commonly adopted approach. Whereas the use of international
assignments is limited to the transfer of project-specific knowledge, building social relations
between researchers through assignments was found to increase KT and reduce inter-unit
attrition as well (Criscuolo, 2005; Iwasa & Odagiri, 2004).
Intellectual Propriety Protection (IPP):
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There is no industry where firms build their competitive advantage more closely to IPP than
the pharmaceutical industry. However, in response to dramatic transitions in bioscience and
computational chemistry, biopharmaceutical companies commence newer approaches for
managing their IP and innovation including open access, closed pool, exclusive and nonexclusive licensing (Allarakhia & Walsh, 2011). Although exclusive licensing is more
preferred in the pharmaceutical industry (2:1), the findings support the notion that nonexclusive licensing contributes more to the overall firm’s performance. This can be explained
by the increase in the organisational knowledge exchange, decrease the cost of knowledge
transaction, and the value of increased use of knowledge returns to the innovator through nonexclusive links. Moreover, non-exclusive licensing provides a strategic advantage to the
company and reduces market uncertainty by decreasing competition. The organisational
performance was measured in terms of efficiencies of sales and Human Capital (HC) in
addition to Return on Asset (ROA) and Return on Investment (ROI) (Malik, 2012).
The significance of IP for the pharmaceutical industry comes from the notion that patents
are used as a proxy indicator for knowledge creation (Nerkar, 2003). Also, patent citation
studies in pharma exploit patent-related data to estimate the quality of innovation, diffusion of
knowledge and geographic localisation of knowledge (Chávez & Víquez, 2015). For this
reason, patents can affirm the firm’s value and market performance. Association between
company value, reported intangible assets and R&D capitals have been found to exist (Russell,
2016b).
In a highly dynamic global economy, enforcing IP protection laws implies significant
economic costs (Mazzoleni & Nelson, 1998). Considering the importance of IPP as an
incentive for innovation in advanced countries where there is both a superior scientific and
technological infrastructure and a rich market for new drug products, WHO was conscious of
the challenges that can face developing countries due to IPP regulations (WHO, 2006a). For
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instance, from 1990 onwards, innovative Indian pharmaceutical firms targeted generic market
in advanced countries which enforced them to comply with IPP regulations not only for the
product but also for processes. Indian firms are facing challenges due to changes in patent law
and the development of new technologies, particularly in the biotechnology field. Since 1995,
a progressive increase in R&D budgets has been observed in order to build the required
knowledge bases in addition to hiring experienced scientists and targeting retiring postgraduates from overseas universities. Moreover, building research networks with overseas
research institutes has emerged as a key mechanism for knowledge acquisition (Kale & Little,
2005).
Knowledge Measurement and IC Disclosure:
Empirical evidence supports the notion that the nature and value of knowledge assets differ
from one industry to another with a direct impact on investment decisions. By using Tobin’s
Q model for knowledge measurement, it is noticed that not only the level of intellectual capital
(IC) and competitive intelligence are both higher in consumer industries (such as
pharmaceuticals) in comparison to business to business industries, but also investments in
knowledge assets are less promising in business markets (Erickson & Rothberg, 2009).
Measurement of pharmaceutical IC at the organisational level relies on the identification of
most relevant constructs or indicators in each industry. According to a Delphi study in the
pharmaceutical and telecommunication sectors, the management experience and technical
knowledge are on the top of the HC indicators in pharma (Palacios-Marques & GarrigosSimon, 2003).
Regarding structural capital, organisational culture, the ratio of investment in R&D and the
number of R&D projects are the highest priority indicators. Additionally, mutual trust with
customers and their satisfaction are the highest priority RC indicators in comparison to the coauthorship with academic centres (Mehralian et al., 2013). However, the disclosure of IC in the
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balance sheet (BS) is still a measurement barrier and an opportunity for improvement in the
pharmaceutical industry, particularly in developing countries. In studies of IC disclosure in top
pharma companies in India and Bangladesh, the computed figures of IC show that the
enormous value of IC remains unreported in BS. This highlights that the lack of standardised
accounting guidelines on this vital asset results in unreporting of resources of billions in firm’s
annual reports which impacts their performance in the stock market (Abhayawansa & Azim,
2014; Singh & Kansal, 2011).
Intellectual capital is widely adopted as a predictor for firm’s profitability in the
pharmaceutical sector and the intangible asset capitalisation is associated with firm’s market
value (Sydler et al., 2014). Healthcare patents perform both disclosure and signalling functions;
reflecting firm’s innovative capabilities and enhancing the capacity to raise necessary start-up
capital (WHO, 2006a). However, no significant relationship was observed either between IC
and productivity or market valuation. Also, it was found that Market to Book (MB) and Return
on Asset (ROA) are significantly correlated with IC. While Return on Equity (ROE) in pharma
is double the ROE in less knowledge-focused industries such as textile (i.e. the investors are
getting more return on their shareholder equity), ROA is nearly equal for both. A better
understanding of IC may enhance the profitability and the productivity of companies (Pal &
Soriya, 2012). Likewise, in the pharmaceutical sector in Iran and India, two comparable studies
found that the performance of IC can explain profitability but not productivity or market
valuation (Ghosh & Mondal, 2009; Kamath, 2008). However, this argument is subject to
controversy as companies which generate more profits are able to invest more in IC (Naidenova
& Parshakov, 2013).
Merger and Acquisition (M&A) can be used as a cost-effective way to gain access to new
product platforms, technologies and patents. Traditional pharmaceutical companies with
depleted research pipelines but sufficient cash can acquire innovative biotech firms as a source
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of new products (Rossi et al., 2015). A study of the influence of M&A on the total value of the
pharmaceutical company acquired revealed that the total value of the companies in 135
acquisition situations under investigation have increased approximately 6 times on acquisition.
This increase is mainly attributed to knowledge related intangible assets and goodwill which
substantially overlap with IC. The Pharma companies which are not being acquired are
potentially undervalued because of intangible assets underestimation under current accounting
systems (Boekestein, 2009).
Research, Innovation and knowledge creation (KC):
The emergence of new discoveries in the twenty-first century will urge Pharmaceutical
manufacturing to employ innovation and cutting edge knowledge and technology as ways of
doing business (FDA, 2004b). Genetics, bioinformatics, High-Throughput Screening (HTS)
and in-silico simulation have allowed pharmaceutical research to exploit economies of scale
and economies of speed in drugs experimentation and development. Nowadays,
pharmaceutical industries do not typically fit to the classic economy of scales theories as they
transformed into R&D intensive rather than production intensive. In other words, the industry
has become more dependent on patents rather than production volumes to secure profits. Due
to the low success rates for drugs under development (two drugs of every 10,000 synthesised
substances will become a marketable medicine), long development time (up to 10 years) as
well as high cost for drug development (€ 1,926 million) (EFPIA, 2018), the increase of success
rates and development speed would substantially reduce the development cost and avoid late
costly failures (Gassmann & Reepmeyer, 2005; Nightingale, 2000).
The Pharmaceutical industry, more than other industries, is dependent on scientific advances
developed in the public sector particularly in basic sciences. It was found that following a basic
science patent, at least 19 research publications and 23 additional patents are filed. If the
innovation is of radical type and associated with a market breakthrough, additional patents are
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expected to be filed earlier (Sternitzke, 2010). Historically, the role of the public sector in drug
discovery was limited to basic research to elucidate the basic pathological mechanisms.
However, this role has significantly expanded in the biotechnology era (Stevens et al., 2011).
For example, the preliminary evaluation of innovation expenditure structure of the Estonian
biotechnology sector reflects the prominent role of public fund, which is estimated to be more
than 80% of the total budget. In spite of that, the low level of R&D expenses in Estonian biotech
companies (15.7% compared to revenues) against 60% in Europe and 45.7% in the USA
reflects the challenges facing emerging countries in the biotechnology industry (Mets, 2006).
In contrast with publicly funded drug research model in EU and US universities, it is noticed
that drug discovery in Japanese companies occurs predominately in-house which may be no
longer compatible with the global competitiveness (Kneller, 2003). In Ireland, governmental
investment in research and innovation is a strategy to compensate the loss of its old competitive
mandate of low-cost manufacturing capabilities by the emergence of new competitors
(O’Dwyer et al., 2015). Thus, the collaboration between industry and universities provides
local competitive capabilities to solve industry problems in Multinational Enterprises (MNE)
subsidiaries without the need to refer problems back to head offices (O’Dwyer et al., 2015).
In such a complex R&D environment, information sharing and intrinsic motivation are
recognized as important drivers for organizational creativity (Sundgren et al., 2005); there is a
significant influence of knowledge transfer on firm innovative capability (r= 0.893) too
(Palacios-Marqués et al., 2016). As the bulk costs of R&D comes from the clinical phases,
sharing knowledge and experiences coming from terminated projects would be of high
significance too. Knowledge facilitators in clinical trials play an outstanding role in promoting
knowledge sharing. (Styhre et al., 2008). Knowledge facilitator plays a catalyst role in KC and
sharing by raising the level of trust between members of organisations and building a care
climate (Roth, 2003). Evidently, KC process has a direct positive impact on HC which in turn
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has a positive significant impact on both structural and relational capital (RC) (Mehralian et
al., 2014).
The surveyed literature highlights some of the dynamics of innovation within pharma
organisations. Management support, design of effective policies and effective management of
knowledge are found indispensable if the organisation wants to adopt an innovative
environment. Additionally, Job satisfaction explains up to 25% of the variance in innovation
regression models (Khemka & Gautam, 2010). Transformational leadership shows a positive
relationship with innovation (Garcia-Morales et al., 2008). Both information and organisation
capital play a mediating role in the impact of HC on innovation. Also, a significant positive
relationship has been established between organisation capital and innovation confirming the
remarkable role of intangible assets in generation and enhancement of innovative capabilities
(Huang et al., 2011). Wikis and Innovation contests are used in pharma to leverage collective
intelligence and enhance innovation in large companies (Lauto & Valentin, 2016; Standing &
Kiniti, 2011). Conversely, outsourcing of R&D and clinical studies for new product
development (NPD), combined with lack of integration among outsourced clinical research
organisations (CRO) and the associated knowledge losses as well as regulatory delays create
innovation risks (Lowman et al., 2012). Meanwhile, FDA warned from the threats of broad
interpretations of 21 CFR part 11 (electronic records and electronic signatures) on innovation
and technological advances without any benefit for patient health (FDA, 2003).
Knowledge Culture and Organisational Structure:
The American FDA encourages management to implement quality systems and procedures
that support a communicative organisational culture. Under such quality systems, knowledge
communication is promoted through the creation of a work culture that appreciates employee
suggestions and uses them for continual improvement (FDA, 2006). Specific beliefs and
knowledge-related values can be sources of competitive advantages in pharma. For instance,
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values such as love, care and trust contribute significantly to the firm’s performance and
knowledge creation (Magnier-Watanabe & Senoo, 2009). For similar reason, the know-how
or technical skills are not as important success factors as tacit knowledge sources held by
knowledge workers (Styhre, Roth and Ingelgrd, 2002; Magnier-Watanabe and Senoo, 2009).
Knowledge culture is a way of organizational life that empowers people to create, share and
use knowledge for the good of the organisation (Oliver & Kandadi, 2006). In the
pharmaceutical industry, knowledge culture is believed to compensate for the lack of
organisation memory in temporary project teams where ICT alone has a limited value. Factors
like the support of informal communication, tolerance towards mistakes, positive project
culture and commitment of top management significantly contribute to open knowledge
transfer within and/or between projects (Lindner & Wald, 2011). Similarly, Evans and Brooks
(2005) argued that just providing new technology in order to facilitate collaborative practices
does not necessarily create a more collaborative culture in pharmaceutical supply chain
environment (J. Evans & Brooks, 2005). Organisation memory held by ageing workers can be
transferred to the younger workers through bridges of socialisation and adequate organisational
climate to facilitate circulation of tacit knowledge (Ebrahimi et al., 2008).
The organisational characteristics of pharmaceutical firms such as structure and strategy
affect knowledge acquisition activities including knowledge storage, diffusion and application
where the national culture must also be considered (Magnier-Watanabe & Senoo, 2008). In
fact, the organisational characteristics can have even more influence over KM than the national
culture (Rémy Magnier-Watanabe & Senoo, 2010). In the pharma industry, open culture where
employees are able to raise questions and feel at ease explains 31% of the variance in four
modes of SECI process compared to only 16% for the bureaucratic culture (Magnier-Watanabe
et al., 2011). In pharmaceutical R&D, bureaucratic culture has a negative impact on knowledge
workers’ job satisfaction while innovative or supportive culture positively influence them
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(Bigliardi et al., 2012). Wang (2006) claims that the information culture, excessively concerned
about financial costs and technical compatibility of KM systems, can ultimately be hostile
towards KM implementation. Moreover, the Knowledge sharing and externalisation of tacit
knowledge can also be limited by intra-organisational political constrains (Wang, 2006) .
Pharmaceutical Firm Performance:
Human and Relational Capital is deemed to positively impact business performance
(Sharabati et al., 2010). Several empirical studies have underlined this paradigm utilising either
ROA/ return on sales (ROS) as performance measures (Vishnu & Gupta, 2014); whereas,
Value Added Intellectual Coefficient (VAIC) (Chizari et al., 2016) or generation of new patents
were used as proxies for technical knowledge of firms (SubbaNarasimha et al., 2003). Bollen,
Vergauwen and Schnieders (2005) argue that each of the three components of IC individually
and collectively influences firm performance. By way of illustration, in spite of the direct
relationship of HC and firm performance, it offers little value without appropriate Structural
Capital (SC). At the same time, HC is necessary for the proper formation of SC and RC (Bollen
et al., 2005). In contrast, Vishnu and Gupta (2014) research in Indian pharmaceutical firms
denies the relationship between RC and performance. Meanwhile, IC performance (particularly
the physical capital) and firm profitability not productivity or market valuation are thought to
be related (Mehralian et al., 2012). KM performance is considered as a predictor of superior
financial performance in terms of higher profit ratios (ROA, ROS) and lower cost ratios
(OPEX) (Holsapple & Wu, 2011).
The literature revealed that KM strategies influence organisational performance in the
pharmaceutical industry (Kim et al., 2014). Four types of KM strategies are identified in the
literature: external/internal codification strategy and internal/ external personalisation strategy.
Information system maturity in the pharmaceutical firm, as well as knowledge intensity, would
be the determinants for the most effective KM strategy (Kim et al., 2014). Also, integrating
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external and internal knowledge sources has increased the probability of obtaining higher level
of organisational performance. However, the internal organisational tensions between the
tacit-oriented and explicit-oriented strategies, which are difficult to reconcile, would negatively
impact the performance. (Choi et al., 2008).

Regulatory Insights
In order to understand KM from the pharmaceutical regulators’ perspective, the researcher
conducted a thorough review of KM requirements in 128 Good Practices (GxP) quality
guidelines. The review revealed a slightly different pattern of interests and expectations in
comparison with the academic business journals (Figure 3-5).
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Figure 3-5 Key themes in regulatory guidelines
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An overview of the current thinking and expectations of key regulatory bodies regarding
KM is presented as follow:
ICH
From the previous review sections, KM expresses a considerable level of maturity as an
academic research field in the pharmaceutical industry. Despite that, Calnan et al. (2018)
suggest that KM shows less mature roles at industry level which might hinder the achievement
of ICH Q10 desired state. Whereas Quality Risk Management (QRM) is assigned a full ICH
guideline (i.e., ICH Q9), KM received less attention by regulatory agencies (Rathore et al.,
2017). This section and the following highlights the major KM requirements as explained by
regulators.
For instance, ICH Q10 considers KM together with QRM as the enablers of its effective
implementation throughout the product lifecycle. Proper implementation of these guidelines
can facilitate innovation and continual improvement and strengthen the link between
pharmaceutical development and manufacturing activities. It summarises the goal behind the
technology transfer process in pharmaceutical firms in the transfer of product and process
knowledge between development and manufacturing, and within or between manufacturing
sites to achieve product realisation. In fact, one of the objectives of ICH Q10 is to facilitate
continual improvements, identify the appropriate product and process improvement as well as
innovation. Last but not least, ICH Q10 suggests monitoring of all innovations that might
enhance QMS (ICH, 2008).
Other ICH guidelines refers sporadically to KM with a focus on KS/KT. ICH Q9 suggested
the need for further studies related to technology transfer should be assessed through QRM
(ICH, 2005). ICH Q11 endorses the management and sharing of product/process related
knowledge throughout product lifecycle including knowledge related to drug substance and its
manufacturing process.
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It is argued that this enhances the manufacturing process and establish a control strategy
especially in cases of product ownership changes (e.g. through acquisition). Suggested sources
of drug knowledge include but are not limited to process development activities, technology
transfer activities to internal sites and contract manufacturers, process validation studies over
the lifecycle of the drug substance, and change management activities (ICH, 2012).
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WHO
For the purpose of earlier detection of potential problems, WHO guidelines pay close
attention to regulatory harmonisation and participation in information (e.g. from inspections
and clinical studies) sharing networks among regulatory agencies with special considerations
to confidentiality and intellectual property issues e.g. (WHO, 1999, 2003, 2017). WHO works
towards provision of high assurance of quality, efficacy and safety of drugs. Parallel efforts are
exerted to contain escalating costs of drug prices by minimizing duplication of inspection
activities through: better networking, improved information sharing, enhanced collaboration,
increased mutual trust and confidence. The organization help manufacturers actively
collaborate in information sharing among national, regional and international inspection
authorities (WHO, 1999). WHO efforts are also directed towards the collaboration among
Pharmacopeias through work-sharing and harmonisation in accordance with Good
Pharmacopoeial Practices (GPhP) (WHO, 2006b). Information sharing efforts with the
European Directorate for the Quality of Medicines & Healthcare (EDQM) extends to
certification programs (WHO, 1999). Risk communication and sharing risk-related knowledge
are also addressed in WHO guidelines (WHO, 2013). Finally yet importantly, sharing public
alerts and warning alerts for imported drugs or medical devices can prevent similar faulty
products from being exported to other markets (WHO, 2017).
WHO identifies the technology transfer (including process knowledge and product
development history) as the middle stage in the drug lifecycle where GMP regulations must
apply (WHO, 2013, 2014). The organisation requires validation of the process of data transfer
(WHO, 2016). Whenever the transfer involves analytical methods, it is required to conduct this
validation by the development department before the transfer to manufacturing quality control.
Periodic checks are necessary to ensure the accuracy and reliability of the process (WHO,
2006c). As a general requirement, mechanisms should be addressed to facilitate the transfer of
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information not only between manufacturers and customers but also to the relevant regulatory
bodies (WHO, 2010b).
With regard to IPP, the International Medical Products Anti-Counterfeiting Taskforce
(IMPACT) is led by WHO, where the focal point is public health protection from the
implications of counterfeiting (WHO, 1999). The ever-changing business strategies and their
accompanying intra- and intercompany transfers of technology obliged The WHO Expert
Committee on Specifications for Pharmaceutical Preparations in its 42nd report to assign a
special guideline to address this issue (TRS 961 Annex 7). However, this guideline is meant to
be a flexible framework rather than a rigid technology transfer guidance. Although a
multifunctional team is proposed to manage the transfer process, it is affirmed to be under the
umbrella of a quality system (WHO, 2011b).
WHO requires pharmaceutical manufacturers to build their quality decisions and regulatory
commitments on science-based understanding of the process and QRM which can offer greater
freedom of how to comply, hence enhances innovation (WHO, 2013). Development of quality
culture in the pharmaceutical organisation is believed to improve transparency about failures
and ensure good data management strategies are in place. Besides, data integrity and protection
occupied a featured position in WHO regulations. Pharmaceutical firms are expected to
develop appropriate tools and strategies for the management of data integrity risks based upon
their own GxP activities, technologies and processes (WHO, 2016).
EU GMP
EU Guidelines for Good Manufacturing Practices (EudraLex) has adopted

Good

Documentation Practices as an enabling tool for knowledge management throughout different
stages of product lifecycle (EudraLex, 2015). Similar to WHO, PIC/S and ICH
recommendations, the guidelines encourage agents, brokers, distributors, repackers or
relabellers to share regulatory and quality information with the manufacturers and customers
(EudraLex, 2004; ICH, 2000; PIC/S, 2017; WHO, 2010a). EudraLex requires analytical
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method transfer protocol (EudraLex, 2006) with no explicit transfer framework as in WHO
TRS961 Annex 7. However, it confirmed the coverage of technology transfer by cGMP
regulations as a part of product lifecycle (EudraLex, 2011).
FDA
FDA pays special attention to process understanding and knowledge management as
effective strategies for preventing and detecting data integrity issues (FDA, 2016c). On the
other hand, FDA accentuates the knowledge sharing and transfer in contract manufacturing as
explained in the quality agreement (FDA, 2016a). The agency highlights the role of senior
management in the creation of communicative organisational culture as a tool for improving
knowledge sharing and communication in addition to cross-functional groups to share ideas
for improvement purposes (FDA, 2006).
In addition, FDA commends the role other knowledge processes such as data acquisition and
accumulation over the lifecycle as an important way for continuous improvement which in turn
can facilitate the scientific communication with the agency (FDA, 2004a). Similarly, following
process validation FDA guidelines would support process improvement and innovation
(Services & FDA, 2011).
PIC/S
In response to the increasingly complex global supply chains in the pharma industry, PIC/S
facilitates voluntary inspection data-sharing between member authorities. This is deemed to
enable risk-based assessment of the need to carry out inspections based on shared confidence
in inspected firms (PIC/S, 2011b). It has not escaped our notice that data sharing and transfer
in PIC/S guides is focused on inspection data rather than knowledge created in pharmaceutical
firms. The statute of the International Medicinal Inspectorates Database (IMID), which aims
at establishing a database of GMP inspections carried out (or to be carried out) by IMID
participating Regulatory Authorities, was adopted by PIC/S to reduce the number of
duplicative inspections (PIC/S, 2012). The PIC/S committee is cooperating with other global
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agencies such as WHO, EMA, the ICMRA (International Coalition of Medicines Regulatory
Authorities) and United Nations Children's Fund (UNICEF) with regard to training and sharing
of inspections’ information (PIC/S, 2011a, 2015, 2016b; WHO, 2003).
The data integrity is essential for the successful implementation of GMP, as such, the
requirements for good data management are embedded in the current PIC/S guidelines to
GMP/GDP for Medicinal products. Good data management practices (GDMP) are envisaged
as fundamental enabler for the integrity of the generated data. The manufacturer or distributor
undergoing inspection is required to enforce GDMP that ensure the accuracy, completeness
and reliability of data. (PIC/S, 2016a). Moreover, the suggested expansion of the scope of QMS
to the development phase is presumed to facilitate innovation and continual improvement and
build up the link between pharmaceutical development and manufacturing activities (PIC/S,
2017).
The data lifecycle (from generation through to discard at the end of retention period) is also
featured in GMP guidelines including cross-boundaries data transfer emphasising the
relationship with the product lifecycle. In case of computerised systems, interfaces should be
assessed and addressed during computer system validation to guarantee the correct, accurate
and complete transfer of data (PIC/S, 2016a, 2017). Risk review should be considered
especially for supply chains and outsourced activities to assess the extent of data integrity
controls required (PIC/S, 2016a). It is noteworthy that PIC/S has repeatedly warned of
inappropriate interpretation of guidelines making them barriers to technical innovation or the
pursuit of excellence (e.g.PIC/S, 2011c).
Organisational culture and behaviour are a complementary part of the effective data
governance system when combined with an understanding of data criticality, data risk and data
lifecycle. The value behind this appears in the empowerment of employees to report failures
and opportunities for improvement. This reduces the incentive to falsify, alter or delete data
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(PIC/S, 2016a). GMP inspectors have to be sensitive to the effects of organisational culture
and structure on the organisation behaviour where data reporting differs between open and
close cultures. In order to ensure data integrity within the pharmaceutical organisation,
appropriate values, believes, thinking and behaviours need to be demonstrated consistently by
management, team leaders and quality personnel (PIC/S, 2016a).
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Table 3-6 Regulatory insights into Knowledge Management
KM Theme

EU GMP

ICH

FDA

Knowledge Sharing and
Technology Transfer:

N/A

ICH Q9 on quality risk
FDA Guidance for Industry:
management (4.5.); ICH Q9 Contract Manufacturing
on quality risk management. Arrangements for Drugs:
(II.3); ICH Good
Quality Agreements (1.e.);
Manufacturing Practice Guide FDA Guidance for Industry:
for Active Pharmaceutical
Contract Manufacturing
Ingredients Q7 (17.60);ICH Arrangements for Drugs :
Q11 - Development and
Quality Agreements (1.d.);
Manufacture of Drug
FDA Guidance for Industry:
Substances (9);ICH Quality Contract Manufacturing
Risk Management Q9
Arrangements for Drugs :
(II.3.);ICH pharmaceutical
Quality Agreements (1.e.);
quality system Q10
FDA Guidance for Industry:
(1.6.1);ICH pharmaceutical Quality Systems Approach to
quality system Q10 (3.1.2)
Pharmaceutical CGMP
Regulations (3);CFR Title 21
Part 820 Quality System
Regulations

WHO TRS 1003 Annex 4
(4.1.1.2.);WHO TRS 996 Annex
4 (1.1.);WHO TR S 996 Annex
1 (4);WHO TRS1003 Annex 4
(1.5.);WHO TRS 953
(2.1.3.);WHO TRS 953
(2.1.9);WHO TRS 953
(2.1.13);WHO TRS 953
(8.1);WHO TRS 953
(8.1.1);WHO TRS 953
(17);WHO TRS 1003 Annex 4
(4.2.4.3.);WHO TRS 1003
Annex 4 (4.4.);WHO TRS 981
Annex 2 (1.1.);WHO TRS 981
Annex 2 (glossary);WHO TRS
961 Annex 7;WHO TRS 957
Annex 2 (17.60);WHO TRS996
Annex 5 (7.6.);WHO TRS996
Annex 5 (Appendix 1);WHO
TRS 973 Annex 4 (1.4.);WHO
TRS 973 Annex 4 (3.3.);WHO
TRS 986 Annex 2 (1.4.);WHO
TRS 986 Annex 2 (7.17);WHO
TRS 981 Annex 2 (1.2.);WHO
TRS957 Annex 5 (14.11);WHO
TRS 953 (8.2.)

IPP

N/A

N/A

WHO TRS1003 Annex 4 (1.6.);
WHO TRS 953 (2.1.7., 2.1.11)

N/A
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Knowledge Measurement and EudraLex Annex 15:
IC Disclosure
Qualification and
Validation

ICH pharmaceutical quality
system Q10 (2.8.)

FDA Guidance for Industry: WHO TRS 961 Annex 7 (1.4)
PAT: A Framework for
Innovative Pharmaceutical
Development, Manufacturing,
and Quality Assurance (1.d.)

Research, Innovation and
Knowledge Creation

N/A

ICH Q11 - (3.1.3.); ICH Q10
(Glossary); ICH Q10 (1.1);
ICH Q10 (1.5.3.); ICH Q10
(1.6.); ICH Q10 (1.6.1.); ICH
Q10 (3.2.3.);
ICH Q10 (4.2.b);

Knowledge Culture

N/A

N/A

FDA Guidance for Industry: WHO TRS 981 Annex 2 (1.1)
Part 11, Electronic Records;
Electronic Signatures - Scope
and Application (III.B.); FDA
Guidance for Industry:
Process Validation: General
Principles and Practices
(1);FDA Guidance for
Industry: Data Integrity and
Compliance With CGMP
(Draft) (III.1.c)
FDA Guidance for Industry: WHO TRS 996 Annex 5 (1.4.)
Quality Systems Approach to
Pharmaceutical CGMP
Regulations (B.2.)

Pharmaceutical
Performance

N/A

N/A

Firm

N/A
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Discussion and Implications:
The pharmaceutical industry is not only one of knowledge-intensive sectors, but also an
industry with a direct effect on health promotion (Mehralian et al., 2016). It comprises distinct
characters making pharmaceutical knowledge management a unique process. Being researchintensive, highly innovative and a great source of IC (Kamath, 2008), building networks of
R&D personnel with research institutions, providing ultimate protection of IP rights, having
high influence of political, legal and administrative factors on technology acquisition
(Hemmert, 2004), achieving a high level of maturity in project management (Wakefield,
2005), involving suppliers in product development activities (Lawson & Potter, 2012),
involving collaborative research with universities and governments (Dooley & Kirk, 2007),
presenting sophisticated drug discovery and development systems (Criscuolo, 2005), facing
challenges of regulated prescription drugs (Pedroso & Nakano, 2009), being one of the fastgrowing economic sector (Singh & Kansal, 2011), together with huge economic productivity
and high number of employees (Bigliardi et al., 2012) are some of reasons for choice of the
pharmaceutical industry as the empirical research field of many articles in KM literature.
Nevertheless, 28% of the reviewed articles included mixed samples from different industries.
This might be attributed to selection of convenience sample of knowledge-intensive companies
without an industry-specific research scope.
Based on an in-depth review of the literature, key trends emerged. Domination of academic
authorship (93% of authors) along with 20% increase in co-authorship reflect the academic
maturity of the research area. Participation of practitioners is relatively limited (7%) in spite of
the colossal investments in KM by pharma companies (Riddell & Goodman, 2014). This also
supports Calnan et al. (2018) argument that the role which “knowledge” plays in the
pharmaceutical industry is still immature and disabling the ICH Q 10 desired pharmaceutical
quality system. This argument has also been made in other sectors e.g. public sector KM
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publications (Massaro et al., 2015). This can also accentuate what has been described by Ragab
and Arisha (2013) as a theory-practice gap in KM literature in general.
Furthermore, the review found that the UK and USA are responsible for nearly one third of
publications within the review period. This supports the findings of Ramy et al. (2017) which
underline the prevalent contribution of North America, Western Europe, and Australia in KM
publications. However, a compelling interest in KM has been recognized in Iranian, Indian and
Taiwanese academic institutions reflecting the future role of emerging economies in pharma
industry. Since R&D is considered the key space for knowledge creation (Ingelgård et al.,
2002; Parisi et al., 2006), most of the studies ignored other functions (e.g. manufacturing, sales
or quality) or other sources of knowledge in a pharmaceutical organisation (e.g. process
validation studies; manufacturing experience, continual improvement, and change
management activities). However, from a regulatory perspective, managing the knowledge
throughout commercialisation and manufacturing phases until product discontinuation is
believed to be as important as managing drug development knowledge (ICH, 2009).
Taxonomical analysis of literature affirms six main knowledge processes/ themes
extensively covered by researchers in the pharmaceutical industry.
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Publication years
The review shows that the majority of included articles have been published between 2004
and 2016 as shown in (Table 3-5).
Table 3-5 Publications per year

Miscellaneous

Research, Innovation and
Knowledge Creation

Pharmaceutical Firm
Performance

Knowledge Sharing and
Technology Transfer

Knowledge Measurement
and IC Disclosure

Knowledge Culture and
Organisational Structure

1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016

Intellectual Property
Protection

Year

1
1
1
3

1

1
1
1
1
4

1
2

1
1
5
5
2
4
9
3
2
3
1
3
4
3
3

2
7
8
17
7
11
21
10
10
13
11
7
15
16
14

1

2
1
2

1
1

1
2
2

1
1

3
1

3
1
1
2
1

2
4
2
2
2
3
4
1
3

1
1

1
2
2
1
4
1
1
1
2
2
1
1
6
1
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2
1
3
2

Total

3
2
3
4
1
2
3
2
2
4
4
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In spite of that, the research in some other potential areas is relatively scarce (e.g. PKM,
knowledge acquisition, knowledge integration). The reviewer observed an overemphasis on
the OKM while the PK received little attention in the reviewed literature. Only two out of 19
subthemes (Figure 3-6) have approached the personal dimension of knowledge. Conversely,
IC is the most frequently used keyword and research theme in pharmaceutical KM literature.
As a part of company intangible capital, patent-related keywords (e.g. patent citation, analysis,
research, count, etc.) are mentioned 10 times in the review pool reflecting the importance of IP
rights (structural capital) as a research subject. All the knowledge measurement articles were
dedicated for the IC measurement and disclosure.
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Figure 3-6 Personal versus organisational knowledge presentation in the reviewed literature
(black shading= personal knowledge; white shading= organisational knowledge; grey
shading= mixed)
The influence of pharmaceutical IC on profitability, productivity and market value is
addressed in several papers (e.g. Pal and Soriya, 2012). Pharmaceutical IC reporting in BS
suffers from inconsistency and lack of standardised guidelines. Indeed, this phenomena is not
exclusive to the pharmaceutical industry and was highlighted in other industries (Ragab &
Arisha, 2013). Yet, Intellectual Capital, knowledge measurement or disclosure are not
addressed by CGMP guidelines. While M&A implications were a subject of academic research
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in pharma companies, regulatory publications focus on knowledge transfer after
product/process acquisition or data acquisition during product lifecycle (FDA, 2004a).
Although KM is explicitly required in ICH Q10 1.6.1.(ICH, 2008), regulatory authorities didn’t
address either measurement or disclosure of IC. With poor reporting and disclosure of IC in
pharma (Abhayawansa & Azim, 2014), further research is needed to induce industry-specific
measurement frameworks not only at the organisational IC level but also at the personal
knowledge level.
Barriers and enablers of KS, as well as impact of co-location and geographic proximity on
knowledge sharing in the pharmaceutical facilities, are thoroughly studied in academic
literature and partially covered by the regulatory requirements to support a communicative
culture. No doubt, the return on investments in KS can be manifested in the creation of new
knowledge (Lilleoere & Hansen, 2011) and evading knowledge loss from pharmaceutical
organisation. Use of KS enablers, non-exclusive licensing, networks as well as workspace
designs and co-locations is believed to enhance the flow of knowledge and accelerate the drug
development phase. Technology transfer and method/process transfer are regulated practices
under pharmaceutical quality systems (ICH, 2009; WHO, 2011b); case studies or empirical
research is quite limited in this area.
Governmental role in innovation, either through the outputs of basic science or public
funding of growing industry R&D, is emphasised in the literature. Collaboration between
industry and universities as well as overseas research centres is found crucial for advances in
global competitiveness in the pharma industry. Dynamics of innovation as managed by the
Triple Helix model can be a meticulous explication of this phenomenon (Etzkowitz &
Leydesdorff, 2000; Leydesdorff & Meyer, 2006). When the FDA announced the
Pharmaceutical CGMPs for the twenty-first Century in 2006; corrective actions, innovation
and continuous improvement were considered as three complementary improvement
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approaches in Pharmaceutical Manufacturing (FDA, 2004b). However, only innovation has
received considerable attention in the surveyed literature. It is worth noting that the term
“creation” was mainly used by the regulators to signify creation of data and/or electronic
records (FDA, 2016b).
The review explored the role of pharmaceutical organisational culture and structure in
knowledge management. The review highlighted the notion that some values are found to be
associated with the prosperity of knowledge within workspace (Magnier-Watanabe & Senoo,
2009) and new technology is not able alone to bring about a successful KM system (Chatzkel,
2007). The KM performance of the company was found in general related to its market
performance. Yet, the organisational performance was not considered by any of the five
regulatory bodies.

Summary and Conclusion
The pharmaceutical sector is one of the pillars of the world’s economy. A significant
proportion of its value lies in intellectual assets generated through a continuous innovation
process and lengthy product development cycles within a strict regulatory environment. The
purpose of this chapter is to present an inclusive review of Knowledge Management processes
in the pharmaceutical industry with a focus on key regulatory concerns.
The review identified a range of knowledge processes that were investigated in the
pharmaceutical context and highlights their role in the organisation. The academic empirical
research within the pharmaceutical industry partially addresses the regulatory concerns.
Regulatory bodies require KM across the product lifecycle and outline the role of the individual
as a holder of knowledge, meanwhile, the KM scholars focus on the organisational rather than
the PKM (bottom-up) approaches. Also, the findings indicate that prior KM studies focused on
the pharmaceutical development and innovation activities, ignoring other ICH Q10 suggested
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sources of pharmaceutical knowledge such as pharmaceutical manufacturing. In this dilemma,
the industry practitioners refrain from serious contribution to academic research. This supports
the notion that knowledge management in the pharmaceutical industry is still a growing
research area, particularly in manufacturing (non-research) functions. This study attempts to
address this theory and practice gap by developing a framework for the identification and
measurement of personal knowledge in the pharmaceutical manufacturing context.
Chapter five is dedicated to the exploratory study in the pharmaceutical industry. The
proposed measurement framework is developed in light of the exploratory study findings and
the extant literature. In the next chapter, the author defines his research methodology and
embraced philosophy.
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Background
This study can be understood in light of Kothari's (2004) definition of research as an
academic activity that comprises definition and redefinition of problems; it can take the form
of an original contribution to the existing stock of knowledge through the formulation or
generalisation of a theory (Kothari, 2004). The research is undertaken to discover things in a
systematic way and thereby increase knowledge. The “systematic way” declares that the
research must be based on logical relationships, not just beliefs (Saunders et al., 2008). The
need for research reflects a state of incomplete knowledge or unanswered questions in many
science disciplines. It is also related to the compulsive need for growth experienced by Homo
Sapiens which drive humanity to endless requirements of increased performance in all aspects
of life (Remenyi et al., 1998). Also, the research is motivated by the identified research problem
and the highlighted gaps as outlined in the previous chapters.
It is clear that the good research should be capable of generating dependable data. This can
be achieved by following the structure of the scientific method which leads to a desirable,
decision-oriented research (Blumberg et al., 2014). This chapter outlines the researcher’s
approach to meet the criteria of good research at all the stages of this study. Although the choice
of appropriate data collection techniques and analysis procedure is important for any research
(Figure 4-1), issues underlying this choice should be considered by the researcher (Saunders et
al., 2008). This chapter discusses the research philosophies and approaches relevant to this
study. It provides explicit justification of the adopted methodologies, strategies, time horizon
and highlights their impact on the research process. It also outlines the research design, the
research plan and the ethical considerations of the study.
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Figure 4-1 The Research Onion (Saunders et al., 2008)

Research philosophy
Ontology defines the nature of the social reality upon which the research is based. It is the
recommended starting point for any research (Grix, 2003). Two main ontological positions are
recognised in the academic literature: objectivism and subjectivism (constructivism) (Bryman
& Bell, 2015). Objectivism is an ontological approach that assumes the reality exists external
to social actors’ minds. In contrast, the subjectivism suggests that the social reality is the
creation of the social actor and consequently, it is in a continual state of revision. It also implies
the existence of multiple realities (Saunders et al., 2016). Popper (1966) advocates that human
knowledge is objective and impersonal where people are not only theory producing but also a
consumer of others’ theories whether in science, religion or even poetical myths. Popper’s
objective knowledge is independent of the person’s subjective belief, in other words, it can be
understood without submerging in the subjective minds of people (Tell, 2004).
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This objective understanding of knowledge is in line with the researcher’s proposition of
the personal knowledge of pharmaceutical manufacturing employees. According to the law of
contradiction (one of the three fundamental laws of logic), two contradictory prepositions
cannot both be right or in other words for all propositions P, it is impossible for both P and not
P to be true (Encyclopedia Britannica, 2019). As previously explained, knowledge is a justified
true belief. This definition implies that knowledge must always be true as false knowledge is
impossible (Hunt, 2003). Therefore, the research adopts the single objective reality position
as multiple realities (subjectivism) would inevitably lead to a contradiction. The research thus
adopts that it is not possible to measure and compare the knowledge unless it is objective and
where external standards (not from the social actor mind) are used to evaluate the generated
knowledge (Tell, 2004).
Epistemology is the theory of knowledge or simply the possible ways of gaining knowledge
of social reality (Grix, 2003). The modern western epistemology recognises two great
epistemological traditions: Rationalism and Empiricism. While Rationalism claims that true
knowledge is the product of mental processing rather than sensory experience, Empiricism
limits true knowledge to sensory experiences (Nonaka & Takeuchi, 1995). Similarly, two main
paradigms are recognised in social science research which have their roots in the 20th–century
philosophical thinking: quantitative and qualitative paradigms. The quantitative paradigm is
also known as the positivist, the traditional or the empiricist paradigm (Creswell, 1994).
Positivism is adapted from natural science. It has three basic principles: objectivism, value-free
research, and research independence (Blumberg et al., 2014). In a positivist view of the world,
the research adopts the philosophical stance of a natural scientist where only observable
phenomena produce credible data (Saunders et al., 2008). It also proposes a nomothetic
epistemological approach with existent regularities and law-like generalisations in social
settings (Easton, 2010). However, as explained by Sveiby (2010), the measurement of a social
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phenomenon (e.g. the personal knowledge) depends on proxies and assumptions which make
it less accurate than measurement in the applied science settings (Sveiby, 2010). For this
reason, the positivist paradigm is not appropriate for this study. Furthermore, the conclusive
theory testing within social science is complicated by diversity, complexity and changing
nature of organisations as well as the element of personal volition in human behaviour
(Cusumano et al., 2008).
In contrast, the interpretivist approach advocates a value-laden nature of the study. The
interpretivist describes reality as subjective and multiple as the social actors interact with their
research outcomes (Creswell, 1994). Interpretivism appeared as a criticism of the application
of the scientific model to the study of social phenomena. Whereas the positivist aims to explain
human behaviour, the interpretivist aims to understand it (Bryman & Bell, 2015).
Interpretivism exploits the heritage of Phenomenology (Saunders et al., 2008). From this
perspective, each situation is perceived in a unique way as a function of circumstances and
involved individuals. In other words, research is not independent of the researcher, but it is an
intrinsic part of it (Remenyi et al., 1998).
For pragmatism, an idea is true if it is useful and has practical consequences or simply if it
works (Gray, 2013). Accordingly, there may be multiple realities as no single viewpoint
furnishes the complete picture (Saunders & Tosey, 2013). In other words, only concepts that
support actions are connected to the matter in hand. This can be described as a reconciliation
between subjectivism and objectivism (Saunders et al., 2016). According to Gray (2013)
pragmatism has become popular in recent decades as it provides an epistemological
justification for the use of mixed methods research (MMR). MMR is that type of research in
which a researcher join qualitative and quantitative research techniques to achieve breadth and
depth of understanding and corroboration (Schoonenboom & Johnson, 2017). However, the
pragmatist position underestimates the role of the philosophical assumptions in the appropriate
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exploitation of research methods (Maxwell & Mittapalli, 2010). The idea of multiple realities
was found incompatible with the researcher’s perspective of knowledge as both objective and
intransitive. Due to this ontological disagreement, both interpretivism and pragmatism
philosophies were excluded.
Realism as a research philosophy shares the principles of Positivism and Interpretivism
(Blumberg et al., 2014). Similar to positivism, it argues that social sciences can apply the same
principles of data collection and interpretation as natural science. It also endorses the view of
external reality to scientists’ minds. There are two major forms of Realism. Direct or Naïve
Realist believes reality can be accurately understood via the aid of our sensory experiences and
thus are deemed superficial (Bryman & Bell, 2015). Conversely, Critical Realism (CR)
emerged as a response to increasing critique to Positivism that dominated the early decades of
the 20th-century and was strongly associated with the British Philosopher Roy Bhaskar.
Bhaskar confirms that the world is structured, differentiated and changing (Danermark et al.,
2002).
Unlike Naïve Realist, Critical Realist differentiates between the objects under research, and
the terms used for their description. While the former positivist approach works well in the
natural science context where it is possible to measure reality in controllable systems, this
seldom happens in social science. Critical Realist claims that our knowledge of the world is
fallible where conditions and social relations affect our perception. In spite that the world is
socially constructed from a Critical Realist perspective, it is not entirely so (Easton, 2010). It
is argued that reality already exists independent of our perceptions, but it is impossible to attain
a “God’s eye point of view” purely independent of any particular viewpoint (Maxwell &
Mittapalli, 2010). The self-contradiction of Naïve Objectivism and Relativism comes from the
fact that in their more radical forms they entail that it is meaningless to search for general
knowledge. Critical Realism keeps the reality existing independently of our knowledge. It
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considers the facts theory-dependent but not theory-determined (Danermark et al., 2002). For
a critical realist, the reality is both independent of humans and stratified : the real, the actual
and the empirical (Mingers, 2004).
The Researcher assumes that personal knowledge must have an objective nature
independently existing and external to social actors. This assumption is found necessary to
measure and compare employee’s individual knowledge in an objective way. Also,
measurement error and biases are inevitable and need to be considered. The study design meets
the critical realist assumptions by offering an explanation for the observed organisational
events through understanding the underlying latent causes which in turn would reveal the deep
social structure behind them (Saunders et al., 2016).

Research Approach
As emphasised in chapter one, a key objective of this research is to understand the structure
behind the personal knowledge of knowledge workers in the pharmaceutical manufacturing
organisation then exploit this understanding to develop and validate a measurement framework.
To achieve this, three reasoning approaches are frequently encountered in literature: induction,
abduction and deduction. Induction is a theory-building approach. Through the analysis of
collected data, a theory is formulated (Saunders et al., 2008). However, the inductive argument
doesn’t build high strength in the relationships between premises and results; so it cannot be
generalised as a conclusion is seen only as a hypothesis (Blumberg et al., 2014). In other terms,
the truth of premises is not a guarantee of the truth of the conclusion (Schechter, 2013).
As this research topic is relatively new, limited literature and few frameworks explain the
dynamics of personal knowledge, particularly in the pharmaceutical manufacturing context
(Ramy et al., 2018). This suggested that the study commences with an exploratory phase.
During this phase 15 interviews with pharmaceutical industry experts were conducted to
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explore the current practices and provide more understanding of literature observations
(including regulatory literature). The discovered themes and structures of knowledge within
the pharmaceutical sector were further compared with evidence from the extant literature. The
new explanations are integrated to build the research hypotheses and the proposed framework.
This back-and-forth movement between induction and deduction is termed “abduction” where
new ideas are generated from the combination of both (M. Saunders et al., 2016). Similarly,
Bryman and Bell (2015) call the process of back-and-forth engagement with the social world
and literature “dialectal shuttling”. Abduction can also be described as a process of forming
concrete explanatory hypotheses (Denecker et al., 1996) and inference to the best explanation
or interpretation of data (Ketokivi & Mantere, 2010). Moreover, the critical realist method is
deemed to be abductive as it moves from experiences in the empirical domain to the underlying
structures in the reality domain (Mingers, 2004). As will be detailed later, this study adopts
Mixed Methods Research (MMR) to address the research problem by combining inductive and
deductive reasoning through abductive thinking (Creswell & Clark, 2018).
On the other hand, deductive theory exploits the available body of knowledge and relevant
theoretical ideas to deduce a hypothesis (or hypotheses) that can be subjected to testing
(Bryman, 2015). Therefore, the truth of the conclusion in deduction is dependent on the input
propositions (premises) conditional that the reasoning is made without mistakes (Schechter,
2013). .Deduction can be seen as the mirror image of induction. Whereas the induction uses
data to build a new theory, the deduction completes the cycle by using data to test the theory
(Eisenhardt & Graebner, 2007). The deductive approach demonstrates a highly structured rigid
methodology. The problem under study should be reduced to the simplest elements through
the process of Reductionism. However, the prominent feature of the deduction is
Generalisation when applied on a sufficient sample (Saunders et al., 2008). In pursuance of
validating the proposed framework, the deductive approach is suggested. The researcher
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deductively tests the model (hypotheses) developed from the exploratory phase in the following
explanatory phase. Abduction and deduction reasoning are sequentially used in research
through what can be described as the double movement of reflective thought. Abduction
proceeds by observing a fact then during the course of scrutinising (back-and-forth movement)
the reason behind it, hypotheses are generated. Deduction comes after to test the capabilities
of proposed hypotheses to explain the observed fact (Blumberg et al., 2014). Combining both
approaches can be represented in (Figure 4-2). As a side note, there is no rigid division between
the different reasoning approaches and it is common to combine more than one approach at
one stage of the study (Saunders et al., 2016).

Fact 1

Why?

(observed)

(Abduction)

Dialectal
shuttling

Hypothesis

What?
(Deduction)

Fact 2

Figure 4-2 Combining Abduction and deduction

Research Strategy
In critical realism philosophy, the researcher uses either or both quantitative and qualitative
data to explore not only what is immediately experienced but also the structures and
relationships that lie beneath (Saunders & Tosey, 2013). While quantitative research explores
the relationship between variables to validate objective theories, qualitative research help
discover how people interpret social or human phenomena (Creswell, 2014). This study adopts
Mixed Methods Research (MMR) techniques. The exploratory phase utilises qualitative semistructured interviews followed by quantitative surveys in the explanatory phase. In case of
relatively novel research topic, Creswell and Clark (2011) suggest to qualitatively explore to
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learn about the studied phenomena, theories and variables and then to follow up with a
quantitative study to validate the exploratory findings as the mixed method is the ideal
approach in such situations (Creswell & Clark, 2011). From a critical realist perspective,
quantitative methods (e.g. factor analysis) are employed in the deductive phase to confirm the
underlying structures of the latent variable “the personal knowledge” and to validate the
developed explanations from the qualitative phase (Mingers, 2004).
MMR design can be realised in two main philosophical positions: critical realism and
pragmatism (Saunders et al., 2016). Indeed, critical realism provides philosophical and
epistemological assumptions not only compatible with both qualitative and quantitative
research methods but also leverage the cooperation between them. MMR gains an advantage
from combining the benefits of qualitative and quantitative approaches which enable more
solid conclusions that wouldn’t be possible by any of them alone (Maxwell & Mittapalli, 2010).
Mixed methods are also deemed to provide the required dialogue between different
perspectives to deepen rather than triangulate the understanding of the research phenomenon
(Maxwell & Mittapalli, 2010). This research couples both a qualitative exploratory phase
(semi-structured interviews) to understand and explain the manifestations of personal
knowledge in the pharmaceutical organisation and a quantitative validation phase (survey) that
deductively test the proposed relations in the research phenomena and understand the
underlying factors.

Research Scope and Time Horizon
This study takes an industry specific approach where the pharmaceutical manufacturing is
the research field. According to EudraLex guidelines volume 4, pharmaceutical manufacture
can be defined as “All operations of purchase of materials and products, production, quality
control, release, storage, distribution of medicinal products and the related controls”
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(European Commission (b), 2017). From this perspective, the study explores the personal
knowledge of all technical employees (knowledge workers) in the following functions:
▪

Warehousing.

▪

Formulation, filling, tabletting, primary packaging, etc.

▪

Secondary packaging.

▪

Quality Assurance.

▪

Quality Control.

▪

Technical services.

Due to the similarities and overlap among manufacturing functions, only manufacturerelated technical jobs were considered during the framework development. The following
support functions are considered out of the scope of this study:
▪

Research and Development (R&D)

▪

Sales

▪

Marketing

▪

Procurement and logistics.

▪

Human Resource (HR)

▪

Occupational Health and Safety (HSE)

▪

Facilities, Utilities, Machines, Equipment (FUME) and maintenance engineers.

▪

Other supporting services.

While longitudinal studies allow researchers to study changes and development as he/she
observes people or events over time with control over the studied variables (Saunders et al.,
2008), this study adopts a cross-sectional time horizon where the data collection relies on
organised collections or snapshots at a particular time (Saunders & Tosey, 2013).

4-95

CHAPTER 4: Research Methodology

Research Design
In MMR, data is collected and analysed utilising both quantitative and qualitative
methodological paradigms. Quantitative and qualitative methods can be either concurrent
(conducted in parallel) or sequential (one dependent on the other) as in this research (Creswell
& Clark, 2018). It is believed that this combination offers more advantages for the research
rather than the use of any single methodology (Čížek, 2009). The purpose of the sequential
MMR in this study (QUAL

QUAN) is the development of the hypotheses (model) by

the qualitative techniques that would be confirmed quantitatively in the next phase
(Schoonenboom & Johnson, 2017). It is important to mention that this research adopts equalstatus mixed methods research (QUAL

QUAN) where qualitative and quantitative

elements share the same value and weight and are continuously interacting (Schoonenboom &
Johnson, 2017).
The first phase of this study is an extensive literature review for relevant academic and
regulatory literature (Figure 4-3). This is followed by 15 interviews (qualitative) with a selected
group of pharmaceutical industry experts. Thematic analysis is adopted to identify key themes
and relations (Braun & Clarke, 2006). The ultimate goal of this phase is to abductively develop
concrete hypotheses, explaining the personal knowledge, in the form of a conceptual
framework.
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Figure 4-3 Research Design
The subsequent phase is the validation phase employing quantitative techniques. The data
obtained through the survey are analysed to evaluate and confirm the underlying factors of the
personal knowledge using confirmatory factor analysis.

Research Plan
It was once recorded that Benjamin Franklin said “by failing to prepare, you are preparing
to fail”. In order to answer the research questions and achieve the subsequent objectives, a
detailed plan was prepared. The research plan consists of an exploratory study, framework
development and framework testing/validation. In the following sections, each stage of the plan
will be explained in further details.
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The exploratory study
This stage is seen as an extension and a complementary component to the previous stage.
There are three ways to conduct an exploratory study: reviewing relevant literature,
interviewing experts and conducting focus groups (Saunders et al., 2008). The focus group
method was excluded as it was technically impossible to join geographically dispersed industry
experts (in 9 countries) together in one session. Both the literature review and semi-structured
interviews were employed instead. A related point to consider, the exploratory stage is not
subsequent to the literature review phase. Both phases are interacting and engaged together and
abductively leading to the framework development. Chapter five is dedicated to the findings
of the exploratory study.

(i) Interviews
Interviews are one of the most commonly used data collection tool in the social sciences
(Brinkmann, 2014) and are considered a good subjective exploratory tool rather than an
objective scientific hypothesis testing tool (Kvale & Brinkmann, 2009). An interview is a
verbal exchange where the interviewer gains insights and understanding of the interviewee’s
experiences, opinions, predictions and processes (Rowley, 2012). It can be also defined as a
purposeful conversation where the interviewee responds to interviewer’s concise questions by
providing reliable data, relevant to research objectives. It is either structured, unstructured or
semi-structured (M. Saunders et al., 2016). Structured interviews follow a rigid structure and
highly standardised techniques. On the other hand, unstructured interview pursues a free and
flexible style for questioning as no predetermined questions are required (Kothari, 2004). As a
midway between the previously mentioned forms of interviews, semi-structured interviews
show some level of predetermined structure but maintain flexibility in addressing interview
topics too (Longhurst, 2010). They were chosen for the exploratory study as a tool for
understanding what is happening in relation to specific research (Saunders et al., 2008). It is
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clear that a well-crafted interview can achieve objectivity in the sense of being unbiased and
free from prejudice. By the same token, reliability can be attained once leading questions were
ruled out during interviews. This is deemed to enhance the consistency and the trustworthiness
of research (Kvale & Brinkmann, 2009).
Interviews can also be classified into face-to-face interviews, telephone interviews and
internet-mediated (Saunders et al., 2016). Both face-to-face and electronic (internet-mediated)
interviews were employed according to the geographic location of the participant. Face-to-face
interviews were limited to only one interviewee who was based in Dublin. For internetmediated interviews, several social media tools were used based on convenience including
Facebook messenger, WhatsApp and Skype. Camtasia Studio 8, a professional desktop
recording and video editing software, was utilised for recording the online interviews and
facilitate any necessary sound editing.

Theme

Table 4-1 Semi-structured interview themes
Rationale
Research Objective

Practitioners definition of
Knowledge
Establishment of KM in industry
The significance of knowledge in
pharma

KM Maturity
Individual Knowledge Assessment

Elements of Individual Knowledge
Framework Application

The introductory question, icebreaking
Reflects the extent of KM adoption in
the industry
To know the value of KM from the
subject’s perspective. Prepare for the
next question about
Knowledge measurement
To explore the status of KM in the
company
To examine the importance of IK
assessment, guides to the following
question
To identify parameters for framework
design
Explore the usability of the proposed
framework

Objective 1
Objective 1
Objective 1

Objective 1
Objective 2

Objective 2
Objective 2

The interview design started by identifying the key themes to be covered during the
interview process (Table 4-1). Later, a group of questions were suggested below each of the
ten interview themes. Both interview questions and themes were developed drawing on the
identified theory gaps and reflecting the research objectives (Rowley, 2012). The included
questions were not obligatory and the interviewer was allowed to rephrase them as required or
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add necessary probing questions. The researcher utilised open end questions to explore the
industry practices and provide suitable answers for the relevant research questions. As an
ethical commitment, the interviewer avoided any guiding enquiries in the course of interviews
and kept a neutral position. Probing questions are also used to clarify the answers and explore
the new topics opened by the interviewees. Those questions were non-directive such as “can
you elaborate?” or “can you give some examples?”. Active listening was practiced to allow
the interviewees to freely express their opinions. The interview themes along with the
suggested questions were reviewed by the researcher and the supervisors for clarity and
grammatical accuracy. Examples of the utilised question are represented in (Table 4-2).
Table 4-2 Suggested Interview Questions
How to explore the theme (a suggested question)
1. How do you understand/define the word “knowledge” in the pharmaceutical
industry context?
• Can you give some examples of knowledge in your function
(department)?

Theme
Practitioners
definition of
Knowledge

2. Do you think knowledge management is a well-established domain within
the pharmaceutical industry?
• If yes, please elaborate.
• If no, please explain.

Establishment
of KM in
industry

3. In your own opinion, is there a need to better manage knowledge across the
product lifecycle within the pharmaceutical sector?
• Please explain your answer with some examples of where more effective
management/use of knowledge could improve outcomes?

The
significance of
knowledge in
pharma

4. Does your organisation currently have a strategy for knowledge
management?
• If yes, please elaborate.
• If no, please explain.
5. Has your organisation adopted any specific initiative to promote knowledge
management practices (e.g. knowledge sharing platforms, social networks,
Wikis, etc.)?
• If yes, please elaborate.
• If no, please explain.
6. Do you think it is important to assess/ measure the knowledge of individual
employees? Please justify.
7. Does your organisation attempt to evaluate individual knowledge of
employees?
• If yes, please elaborate.
• If no, please explain.

KM Maturity
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How to explore the theme (a suggested question)
Tip: you can skip Q.7. if the answer to Q.6. is “yes” and the subject explained their
method of assessment.
8. Are you able to evaluate and compare the individual knowledge of your
employees?
• If yes, how do you evaluate their knowledge?
• If no, why not?
9. What are the main knowledge aspects you need to evaluate in your
employees?
• Give some examples, Please.
10. If you had a tool to measure and compare individual knowledge of your
employees, would this offer any value to the pharmaceutical industry from a
quality, regulatory or business perspective? How?

Theme

Elements of
Individual
Knowledge

Framework
Application

At the beginning of each interview, the basic demographic information about the participant
and his/her organisation was collected. Demographic information included: country of
residence, organisation type, the approximate number of employees, product category
(conventional, devices, biologics, etc.), ownership of the organisation, job title and participant
function or department. These data are obtained to aid the interpretation of the collected data
and the discovered trends. It was also used to establish a good rapport with the interviewee
before starting with the questions. After the collection of the demographic data, questions on
the interview themes followed. Every question was considered to set the context for the
following question (Rowley, 2012). The review of the relevant regulatory guidelines (chapter
three) did not provide a comprehensive definition of knowledge for practitioners. The first
theme introduced the knowledge concept to the interviewees and collected their insights within
the pharmaceutical manufacturing context. The literature outlines that KM is a well-established
academic domain (Ramy et al., 2018) and a regulatory requirement (ICH, 2008).
Understanding the degree of establishment of KM in the industry practices was the focus of
the second theme. The significance of knowledge is examined and the current efforts for KM
are assessed in the next theme. The fourth interview theme focuses on KM maturity in the
pharmaceutical organisation. Jochem, Geers and Heinze (2011) describe KM maturity based
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on knowledge use and renewal. The interviewer probed the KM strategies, processes and
initiatives taking place in the pharmaceutical organisations to assess KM maturity and the level
of KM standardisation. The fifth and sixth themes explore the understudied area of personal
knowledge measurement and identify the current processes for identifying knowledge holders
(if any). The interviewees then were asked to assess the value of the measurement framework
to understand the practical implications of the study.
The recorded interviews were saved as MP4 files and were uploaded to a private channel
on YouTube.com for automatic transcription. The YouTube account is managed by the same
DIT google account and has the same security features. The account is password protected and
private (not publicly broadcasted). The automatic transcription features in Youtube.com
facilitated the preliminary transcription of the recorded interviews. However, it was followed
by a manual quality check to ensure the accuracy of the transcription.

(ii) Interview pre-testing (Pilot interviews)
Pilot interviews were conducted with four volunteers from Technological University Dublin
(formerly Dublin Institute of Technology) in March 2018. The aim of the pilot interviews was
to ensure the clarity and coherence of interview questions as well as to familiarize the
interviewer with questioning and probing activities needed during the course of the interview.
The selection of the pilot interviewees is based on convenience and findings are not included
in the data analysis phase. All participants spoke fluent English and had an academic affiliation
(three PhD candidates and one lecturer in the College of Business). Despite that they did not
have relevant industrial experience, they were able to assess the clarity of the language and the
logical flow of the questions. It was also an opportunity to familiarise the interviewer with the
interview themes before the commencement of research interviews.
The pilot interviews were recorded for two reasons: first to ensure the reliability of the used
recording devices before the beginning of the research interviews (quality check); second to
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provide a reference to the recommendations as well as the learned lessons from the pilot
interviews. However, the pilot interviews were not transcribed as it was found unnecessary and
hand notes were sufficient at this stage. Notes taken during the pilot interviews helped refine
the questions and avert any potential misunderstanding. All interviews (including pilot
interviewees) were conducted in English. It was assumed that English is a commonly used
language in the pharmaceutical sector (including the pharmaceutical international regulatory
agencies) and all the selected interviewees spoke English fluently.

(iii) Interview sampling and selection
Sampling is the examination of a representative group from the entire population. The
purpose of which is to gain an understanding of the characters of the population through testing
a sample (Lucey & Lucey, 2002). The selected sample should represent the attributes of the
population; hence, it is called a “representative sample” (Bryman & Bell, 2015). The
population targeted in the exploratory study was industry experts who have long experience in
the pharmaceutical manufacturing industry. As defined in section 4.5, this includes production,
quality and technical services related functions. This would include senior and middle
managers, directors as well as industry consultants. The pharmaceutical industry is controlled
by internationally-harmonised regulations (FDA, 2020). Due to the global nature of the
pharmaceutical industry, there was no restriction on the country of the participant.
Furthermore, the sample includes participant from multinational enterprises as well as domestic
organisations of different sizes. This provided a bird’s eye view of the current practices in the
pharmaceutical industry. Sampling techniques are categorised as either probability or nonprobability sampling. In the probability methods, every member of the sample has a known
and equal chance of being selected. In contrast, the researcher deliberately selects participants
in non-probability sampling based on specific criteria or convenience (Saunders et al., 2016).
Table 4-3 provides a summary description of the main sampling techniques.
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Table 4-3 Sampling techniques Adapted from Kothari (2004)
Sampling Technique
Deliberate sampling
Simple random
sampling
Systematic sampling
Stratified sampling
Quota sampling
Cluster sampling
Multi-stage sampling
Sequential sampling

Description
Purposive non-probability selection e.g. convenience and
judgement sampling.
Probability sampling where all the members of the
population have an equal chance of being selected.
Random selection of every nth element until the full sample
is collected.
To obtain a random sample from a non-homogeneous
population.
Fixed sample size. Cost-efficient.
Grouping the population then selecting a cluster as a
sample.
For big inquiries over a large geographical area.
Based on a complex mathematical sampling plan.

As the researcher focused on the main functions in the manufacturing sector, nonprobability deliberate sampling is applied for sample selection. The non-probability sampling
approach is considered the most practical approach for exploratory studies (Saunders et al.,
2008). A purposive sample that represents all the key functions in the pharmaceutical
manufacturing is assumed to be suitable to this stage of research where senior managers and
experts are targeted as a source of data (Figure 4-4).
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Figure 4-4 Decision map for selection of non-probability sample (Saunders et al., 2008)
Note: The selected path is in colour

In purposive sampling, the interviewer deliberately selects the participants out of the
population (i.e. not randomly selected). The sample is considered a form of judgement
sampling rather than a random sampling technique. Purposive samples are quite common in
qualitative studies where the researcher’s main concern is to develop hypotheses rather than
generalising findings over wider populations (Kothari, 2004). Although formal generalisations
are overvalued as the only source of knowledge and development, it is often possible to
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generalise based on strategically selected critical case study as an alternative or supplemental
approach. Strategic case selection supports the assumption that if it is valid for this case, it is
valid for all (or many) cases. This can be attributed to the nature of social science and its
tendency to offer concrete context-dependent knowledge rather than general contextindependent theories (Flyvbjerg, 2011).
Regarding sample size, there is no consensus on the suitable sample size for qualitative
research. However, 12 interviews are the recommended sample size providing that it is
collected from a homogenous population (Rowley, 2012; Saunders et al., 2016). All the
interview candidates not only belong to the same industry but also to complementary functions
(production, technical services and quality) that share pre-requisite qualifications. WHO
requires scientific education in chemical, pharmaceutical and biomedical disciplines for key
personnel supervising pharmaceutical manufacturing and quality activities (WHO, 2011a).
Data saturation is suggested also to determine the acceptable sample size (Saunders et al.,
2016). Data saturation is achieved when new interviews bring little or no new ideas (Saunders
et al., 2008). For reasons above, the study population is considered homogeneous, covering all
key functions in the pharmaceutical manufacturing industry and the sample size is determined
to be 15 interviews or until data saturation whichever is more. After 15 interviews, the
researcher concluded that data saturation has been achieved and no more interviews are
required.

(iv) Thematic analysis
All interviews were transcribed and uploaded to NVIVO 12 for Mac software. NVIVO is a
Computer- Assisted Qualitative Data Analysis Software (CAQDAS) that was used during the
qualitative phase of this study. It provides a powerful tool for data classification, analysis and
visualisation. It organises, stores and retrieves data in several formats helping the researcher
find hidden connections (NVIVO, 2018). After a preliminary transcription using YouTube
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automatic captioning, the researcher completed the transcription of his own interviews to
ensure the accuracy of the transcription and to familiarize himself with the content. Transcripts
along with the researcher’s notes during interviews constituted the data corpus for the
qualitative study. Three stages of interview analysis are followed: coding, condensation and
interpretation (Kvale & Brinkmann, 2009).
The “code” in qualitative research is a word or short phrase that assigns a summative
meaning for a piece of data (Saldaña, 2015). The researcher utilises several coding techniques
in this study including in-vivo, process, descriptive, structural and focused coding to analyse
the data over several cycles. To identify the underlying patterns and structures of the research
phenomena hidden within the interview data, thematic analysis was chosen. Thematic analysis
can be described as a process to identify and analyse themes in qualitative data. This can also
examine the underlying ideas and assumptions contained in the latent themes (Maguire &
Delahunt, 2017). The research adopted the six-phases of thematic analysis (Figure 4-5)
following the guidelines of Braun and Clarke (2006) as well as the six-steps practical guide by
Maguire and Delahunt (2017).
1. Familiarising
yourself with data

6.Producing the
report

2.Generating intial
codes

5. Defining and
naming themes

3. Searching for
themes

4. Reviewing themes

Figure 4-5 Thematic analysis adapted from Braun and Clarke (2006)
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The analysis included six steps or stages as follow:
Step 1: become familiar with the data:
This phase is considered a preparation for the next coding phases. As explained above, the
researcher personally interviewed the selected cases and conducted the transcription himself.
Before starting the coding process, at least one more check of the transcript including proof
reading and grammar check. This repeated review (at least four times) enabled the researcher
to familiarise himself with the data corpus so as to have a holistic understanding of the aspects
of interviews.
At this stage, all the transcripts were uploaded to NVIVO 12 Mac version, the Computer
Assisted Qualitative Data Analysis software (CAQDAS) in this study. All transcripts and
NVIVO files were saved, and backup copies were saved on a private cloud (Google Drive).

Step 2: generating initial codes:
The study is exploratory and followed an open coding system, i.e. there weren’t any pre-set
codes from literature (Maguire & Delahunt, 2017). Several types of codes were utilised
throughout the thematic analysis process. In the first coding cycle, the process started with a
structural coding to split the data corpus into ten segments, i.e. one for each main question.
Despite that structural codes overlapped in the second coding cycle, it was found necessary to
link the generated in vivo, process and descriptive codes to the proper context in the first cycle.
In vivo coding emphasises on the actual spoken words by the interview participants. It is a
useful way to understand stories and experiences in the participant’s own words (Manning,
2017). Process codes use the gerund to describe or refer to a certain activity or process in the
interview (Saldaña, 2015). Descriptive codes describe the patterns in the data set (Maguire &
Delahunt, 2017). With all these types of codes, the researcher embraced a splitter approach
generating over 716 codes in the first cycle (Figure 4-6). The coded data could be a single
phrase, a sentence or a group of sentences. Stated thus, the coding process is speculated as a
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part of data analysis where data is aligned in meaningful groups (Braun & Clarke, 2006).

Figure 4-6 A screenshot showing a sample of initial codes in NVIVO (the first coding cycle)
Step 3: searching for themes
The theme is a patterned response that reflects a meaning within the data set (Braun &
Clarke, 2006). The goal of the thematic analysis is to discover the hidden patterns or themes in
data so as to address the research questions (Maguire & Delahunt, 2017). The second coding
cycle inspected the relations and patterns as they appear in the data corpus. Focused coding
was employed at this stage of assembling related codes under one category. Focused coding is
a second coding cycle technique which is led by a dominant theme. It recodes the data set to
investigate the recurrent patterns and layers of meaning (Saldaña, 2015). This process needs
further reading and back-and-forth scanning of the interviews’ transcripts. Focused codes
evolved to meaningful themes after two more cycles of coding. Initial themes were developed
based on researcher understanding of the analysed phenomena as explained by the
pharmaceutical industry practitioners. Using NVIVO 12 for Mac, the researcher was able to
assemble codes (called nodes in NVIVO) to create initial themes or categories that can be easily
revised in the next cycles. This enabled the researcher to speculate on the possible patterns and
themes in the provided data.
Forty-six categories were recognised within the first coding cycle and were used as a basis
for the initial themes. The preliminary themes are summarized in (Figure 4-7). The themes are
sorted by the number of interviews that manipulated each theme (colour coded in the tree-map).
Also, the size of each field in the tree-map reflects the sum of instances where underlying codes
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are used. This was considered as a quantitative measure of the relative significance of the
generated themes.
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Figure 4-7 Preliminary Categories
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Step 4: Review themes
Initial themes that were generated in the previous phase in the codes section of NVIVO 12
were further reviewed and refined. In order to facilitate the review of themes, mind maps were
adopted. The mind map is an effective and widely used data visualisation format that was used
to represent the identified themes and the underlying codes (Figure 4-8). It consists of a central
image surrounded by a radial diagram that represents the different connections among the
portions of the illustrated information. It is considered an efficient personal learning tool to
develop individual solutions and memorable results (Eppler & Usi, 2006). The main themes
identified at this stage are knowledge maturity, understanding knowledge, the value of
knowledge measurement, knowledge dynamics, industry practice (in relation to the personal
knowledge measurement), training, regulatory knowledge, experience, behavioural specialism,
learning and education, performance, technical knowledge, wisdom and organisational
specialism.
It is worth noting that the last nine themes are directly associated with the individual
employee knowledge (personal knowledge) that was further refined in (Figure 4-9). The first
five themes were more concerned with current KM practices in the pharmaceutical
organisations as will be discussed in detail in the next sections.

Following the

recommendations of Maguire and Delahunt (2017), a special miscellaneous category was
created to include codes that didn’t fit under any suitable theme.

4-112

CHAPTER 4: Research Methodology

Figure 4-8 Revised themes

At this step, the researcher re-examined the generated themes closely from the last phase.
Themes are deemed to show coherence and at the same time are distinct from each other
(Maguire & Delahunt, 2017). The data and codes associated with each theme were investigated
for relevance. As a result, some of the initial codes were changed and new codes were added.
The naming of some themes was revised to describe the underlying data more accurately.
Redundant themes were merged. Several initial themes were renamed or re-categorised as
subthemes under a more general theme. The forty-six preliminary themes and subthemes
evolved to 14 revised themes plus a miscellaneous category (Figure 4-8). As personal
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knowledge is the focus of this study, key themes and subthemes of personal knowledge are
further refined as shown in Figure 4-9.

Figure 4-9 The Personal knowledge Themes-Revised
Step 5: Define themes
As a final refinement of the captured themes, the researcher combines themes that sound too
similar to be independent themes. Some underlying subthemes and even codes were also
moved to a more relevant place on the mind map. At this phase, the final themes and subthemes
are appointed and the underlying interactions are illustrated in the form of a thematic map
(Figure 4-10). It is noteworthy that two academic researchers with experience in qualitative
methods were invited to check the classifications and coding. This practice is argued to reduce
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potential bias in the data interpretation (Rowley, 2012). All their recommendations were taken
into consideration during data analysis.
The first theme in the thematic map (Figure 4-10) is training, learning and education that
was regarded by interviewees as source of employee knowledge in the pharmaceutical
organisation. This included the knowledge of foreign languages that facilitates communication
and understanding of regulatory requirements especially in the multinational work
environment (80% of the sample). Training was considered as the second angle in the
knowledge base. Both adherences to training as well as training effectiveness were seen as a
determinant of knowledge acquired from training. It is worth noting that respondents did not
differentiate between assessing knowledge stock and assessing knowledge acquired after
specific training. Moreover, relevant experience in a similar function, as well as involvement
in pertinent projects, has been argued to be necessary to build employee knowledge.
The outcome of knowledge was repeatedly perceived by the interviewed managers as the
main indicator of knowledge. The performative knowledge theme included the Know-How
manifestations of knowledge. The product and process understanding theme refers to the
comprehension of the particulars of processes and products. It implies also the deep
understanding of the basic science base (including know-why). This dimension describes also
employee’s familiarity with modern manufacturing technologies. The organisational
understanding theme means employee’s understanding of the prevalent culture, company
values and the behaviours that fit within a certain work environment. Strategic goals and
organisational policies are another part of employee’s knowledge about the organisation. The
interviewees also referred to knowledge about weakness points and historical failures that have
been encountered. Wisdom theme comprises taking the right decision, critical thinking and
creative problem-solving skills. Finally, communication and networking theme encompasses
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those skills that the interviewees endorsed their role for the flow of knowledge and integration
within the organisation.

Figure 4-10 Thematic Map
Step 6: Writing-up
The findings of the thematic analysis are reported in the next chapter (chapter five) and will
be used to develop the conceptual framework. The comprehensive discussion of the thematic
analysis findings in light of the extant literature is presented in chapter five.

Framework development
The development of the research framework is based on abduction and theoretical redescription of the components of the research phenomenon. This encompasses theories about
the social structures and underlying relations united with conceptual thinking. This also reflects
how these components appeared and the related causal mechanism (Raduescu et al., 2009). It
is worth noting it is a back-and-forth movement between the literature review and thematic
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analysis rather than an independent stage. Framework development will be presented in details
at the end of the exploratory study chapter.

Framework optimisation and validation
After the theoretical grounding of the framework, the next stage is to test and validate the
proposed relationships deductively. This stage represents the explanatory study where the
relations and underlying factors that explain employee’s knowledge are examined. Explanatory
research uses data to test theories that have been already grounded and conceptualised
including cause-and-effect relationships (Saunders et al., 2008). Mixed methods implied an
integration between both open-ended qualitative data and close-ended quantitative responses
e.g. questionnaires (Creswell, 2014). The survey is the selected strategy at this stage. Selfcompleted questionnaires are used for data collection from pharmaceutical industry
participants.

(i) Questionnaires
The questionnaire is a data collection instrument where participants are asked to respond to
the same set of questions. It could be self-completed or completed through assistance, e.g. faceto-face or telephone (Saunders et al., 2016). It is a quite common technique when the targeted
sample is large (Kothari, 2004). The self-completion interviews are argued to be less costly to
administer, less time consuming, free from interviewer effects, less variable and more
convenient for participants (Bryman & Bell, 2015). Self-completion questionnaires are the
method of choice for data collection at this stage. Regarding the delivery of the questionnaires
to the participants (Figure 4-11), web-questionnaire was the selected delivery media.
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Questionnaires

Interviewerassisted

Self-completed

Internet
questionnaire

Web
questionnaire

Postal
questionnaire

Hand delivery
and collection
questionnaire

Telephone
questionnaire

Face-to-face
questionnaire

Mobile
questionnaire

Figure 4-11 Types of questionnaires- Adapted from Saunders, Lewis and Thornhill (2016)
Note: The selected pathway is highlighted in yellow.
Web questionnaires are often recommended when the research population have ready access
to the internet (Kaplowitz et al., 2004) as it provides high confidence that the right person has
responded. The method is also argued to result in a reasonable response rate among large
samples (Saunders et al., 2016). Moreover, Google forms is the adopted survey tool. This tool
is deemed to provide a high level of security and confidentiality as it is password protected and
linked to TU Dublin (formerly Dublin Institute of Technology) email system. One more feature
is the possibility of making critical questions obligatory or “required” to ensure they are not
missed by any of the participants. Screening questions were added at the beginning of the
survey to ensure that only relevant participants would participate in the survey. For instance, if
the respondent has no experience in the pharmaceutical manufacturing or occupies a support
or administrative role (e.g. accounting), he/she will be prompted to submit the form before
taking the survey.
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(ii) Questionnaire design
The questionnaire is generally divided into two sections. The first section is concerned with
the key demographic data such as education, function, position, experience of the participants
and data on the level of KM maturity in the participant’s organisation. The second section is
designed assess each of the identified personal knowledge indicators of the proposed model
(on a Likert scale of seven). One on Likert scale means “not at all” while seven signifies that
the respondent agrees to a great extent with the provided statement. The questions are designed
to test the hypothesised theoretical framework using confirmatory factor analysis (CFA)
statistics as described in the next section.

(iii) Confirmatory Factor Analysis
Structural Equation Modelling (SEM) is a powerful statistical modelling technique
combining Confirmatory Factor Analysis (CFA), regression models and complex path models.
It is concerned with latent factors imbedded in theoretical constructs. The argument behind
factor analysis is that the covariances between a set of observed indicators can be explained by
a smaller number of underlying latent factors (Hox & Bechger, 1998). Latent variables can
only be measured indirectly through a set of observed indicators (Skrondal & Rabe-Hesketh,
2007). Observed indicators can be broadly classified into two principal forms: effect
(reflective) and causal (formative) indicators (Bollen & Bauldry, 2011). Observed variables
can also be called measures or manifests. They are graphically represented by a square or
rectangle (Figure 4-12).

4-119

CHAPTER 4: Research Methodology

Figure 4-12- Structural Equation Model
In contrast, unobserved (latent) variables are known as constructs or latent factors and are
commonly illustrated as circles or ovals. Measurement component is depicted graphically by a
thin line and structural component by using bolded lines (Schreiber et al., 2006). Also, Figure
4-12 shows the measurement errors (e) or residuals in circles. Unlike the latent factors,
residual’s effect is associated with only one measured variable (Bollen & Bauldry, 2011). In
summary, SEM quantitatively tests a proposed theoretical model hypothesised by a researcher
outlining how observed indicators define underlying factors and how these factors are related
(Schumacker, 2010). Personal knowledge is a latent variable that cannot be directly measured
in the organisational context; instead, the underlying factors, as well as the observed indicators
(that can be empirically evaluated as a measure of PK), are explained through CFA. SEM is
deemed to provide a quantitative explanation of the theoretically grounded PK measurement
model hence provides the required validation of the research hypotheses.
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(iv) Pilot Study
As a final stage of questionnaire development, the researcher conducted a pilot study before
distributing the survey. The pilot study is a pre-testing of the questionnaire that can reveal
weaknesses (if any) and provides an opportunity to fix them (Kothari, 2004). The aim of the
pilot study was to ensure the clarity and the logical flow of the survey questions and to test the
electronic forms in practice. In line with Saunders et al. (2016) recommendations, a nonprobability purposive sample was adopted. A total of 14 respondents provided informative
feedback and suggestions that were considered sufficient for serving the pilot study. The
sample included ten practitioners with different levels of experience in pharmaceutical
manufacturing. Table 4-4 provides an overview of the selected pilot study sample. In addition,
four academics with experience in quantitative techniques and research methods have
participated in the pilot study.
The researcher contacted every participant individually and explained to him/her the
purpose of this study and the expected time required to complete the questionnaire. Each
participant was asked to provide feedback by filling special fields at the end of each section of
the questionnaire. All respondents consented to take part in the study before starting the survey.
Ethical considerations (highlighted in section 4.8. at the end of the study) were adopted at all
the stages of the research including the pilot study. The researcher reviewed the individual
feedback and edited the survey in response. The received feedback was generally positive and
helpful. Few corrections in the questionnaire wording were made in light of the pilot study.
Also, the screening questions wording was revised due to confusion between R&D and
technical services among some participants. Last but not least, although the researcher
personally contacted 27 pharmaceutical knowledge workers, only 14 agreed to participate in
the pilot study. Therefore, the researcher anticipated a low response rate from the surveyed
population.

4-121

CHAPTER 4: Research Methodology
Table 4-4 Participants in the pilot study
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.

Job title/level
Lecturer
Lecturer
Director
Supervisor
Specialist
Specialist
Specialist
PhD candidate
PhD candidate
Manager
Manager
Manager
Manager
Manager

Affiliation
Academic
Academic
Technical Services
QC
QA
QC
QA
Academic
Academic
Production
QA/QC
Production
QA
Technical Service- QC

Country
Ireland
Ireland
China
Egypt
Egypt
Egypt
Egypt
Ireland
Ireland
Egypt
UK
Egypt
Egypt
Egypt

(v) Sample size
The targeted population at this stage is the knowledge workers in the pharmaceutical
manufacturing sector. Employees from the production, technical services, warehouse, quality
control (QC) and quality assurance (QA) functions are exclusively chosen for the sample. As
mentioned previously, the knowledge workers within these functions share the basic
qualifications and might have occupied previous positions in one or more of these departments
as shown from the profiles of the interviewees (Table 5-1). The sample is not limited to one
country as pharmaceutical product and process knowledge and regulations are assumed to be
global.
In SEM and CFA, the sample size is an important determinant of stability of parameter
estimates. However, a review of the statistical literature reveals that there is no consensus on
the minimum sample size. For example, a sample of three to 20 responses per variable are the
widely accepted sampling rule (Bandalos, 2018; Mundfrom et al., 2005). It is worth noting that
the accepted sample size is also dependent on the developed framework, factor loading (level
of communality) and the number of observed variables per factor. The greater the variables
to factors ratio (at least three to four) and the higher the level of communality, the smaller the
minimum sample size that is required (Bandalos, 2018; Schreiber et al., 2006). Computer
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simulation studies of Mundfrom et al. (2005) suggested a minimum sample size of 150 to 180
conditioned that the variables-to-factors ratio is at least 7 even in the case of low communality.
Kline (2011) proposes 200 cases as the typical sample size in SEM studies based on the median
sample size in published articles in this field. As the variables-to-factors ratio in the proposed
framework is close to 7 (

41
6

= 6.8333), a sample size of 180 cases is considered the minimum

threshold for this study. At the end of the survey period, the researcher received 190 valid
responses.

Sample structure and collection
Due to the lack of a complete sample frame, it was found impossible to conduct a simple
random sampling. The researcher considered several options in order to collect a representative
sample of the pharmaceutical manufacturing sector including panel survey companies and
business mailing list brokers. However, none of them provided appropriate solutions. Cluster
sampling was considered a suitable alternative as it is possible to create a comprehensive list
of pharmaceutical factories in one country rather than the list of manufacturing professionals.
Cluster sample is recommended when it is impractical or impossible to create an inclusive
sample frame for all the elements of the population (Creswell, 2014).
In cluster sampling, the whole population is divided into groups called clusters, then a
randomly selected cluster(s) is used as the final sample (Taherdoost, 2016). Cluster sampling
can be one-stage where all the members of the randomly selected clusters are surveyed or may
be two-stage where the elements in the chosen clusters are randomly sampled (Žmuk, 2016).
As the researcher had no control over the survey distribution within the participating
organisations and due to confidentiality precautions that prevented the full access to full
employee lists, two-stage cluster sampling was found suitable for data collection. As the
researcher worked for 10 years in the Egyptian pharmaceutical sector and developed a wide
network of contacts, Egypt was chosen to commence cluster sampling. It’s worth noting that
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Egypt is among the largest pharmaceutical manufacturers and consumers in Africa and the
Middle East with a market value of EGP 35.6 billion (expected to exceed EGP48 billion by
2020) (Gage Consulting, 2017).
The researcher initially reached out to a random sample of 50 Egyptian pharmaceutical
manufacturing firms sourced from Egyptian yellow pages websites and verified individually
by checking the company website. Contact was made with senior or middle management from
one of the target functions of the research. A rapport was developed, and each contact was
asked to distribute the survey to 10 appropriate respondents in their firm. Follow up emails
were used to encourage participation. A total of 150 responses were received at the end of the
survey period.
The research also reached out to contacts within TU Dublin, the school of chemical and
pharmaceutical sciences who supported the distribution of the survey to three part-time
master’s programmes in which students commonly have current or prior experience in the
manufacturing sector:
a. MSc of Pharmaceutical validation technology.
b. MSc of Pharmaceutical quality Assurance and Regulation
c. MSc of Pharmaceutical quality assurance & biotechnology
A total of 18 responses were received within three weeks and after sending a reminder email
in week two. The researcher also used social media and popular pharmaceutical forums on
LinkedIn to communicate with pharmaceutical manufacturing professionals worldwide. The
following are the key forums that were used in this study:
•

PIC/S GMP Industry Forum (15,277 members).

•

Pharmaceutical Microbiology (25,790 members).

•

Pharmaceutical Discussion Group (18,795 members).

•

Quality Assurance, GMP and ICH Guidelines (76,110 members).
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•

ISPE Ireland Affiliate (557 members).

•

Global Pharmaceutical Contract manufacturing (861 members).

At the end of the survey period, only 22 responses have been received through these forums
from six continents as shown in Figure 4-13.

Figure 4-13 Response per country from social media sample
Maximisation of response
Self-completed electronic questionnaires can provide reasonable response rates (especially
when distributed within organisations) (Saunders et al., 2008). Nevertheless, some measures
are found necessary to maximise the response rate. Studies reveal that in populations with ready
access to the internet, a web survey with a mailed advance notice has a comparable response
rate to hard-copy mail survey (Kaplowitz et al., 2004). For this reason, the survey email is
accompanied by a pre-contact letter. This letter confirms the confidentiality of the shared data
and their exclusive use in research. The cover letter highlights the main objectives of the
research and the affiliation of the researcher as well as contact details. Furthermore, the mail is
personalised (by identifying the title and name of the contact person) using mail merge or
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manually as applicable. Last but not least, follow up emails were sent once after ten days to
two weeks after the initial contact to ensure the maximum response.
Regarding the design and language, the researcher uses a clear language, avoids jargons and
uncommon vocabulary. All readability and clarity features are examined during the pilot
testing of the questionnaire. Literature suggests the use of incentives to enhance the response
rate (Faria & Dickinson, 1995; Lorenzi et al., 1988). As an incentive to complete the survey,
the participants were informed that the researcher will donate $1 (one US dollar) per completed
survey for the Egyptian National Cancer Institute - Cairo (http://www.nci.cu.edu.eg/). The
Egyptian National Cancer Institute is a governmental organisation affiliated to Cairo
University. After the collection of 150 responses, a copy of the donation receipt was posted on
the researcher LinkedIn page as evidence of payment (as promised).
The average response rate for the questionnaire was 18-30% (global vs locally distributed
in Egypt) which is a reasonable response from an internet-mediated questionnaire (Saunders et
al., 2008). However, it was observed that the promised contribution to charity had an
insignificant effect on response rate. This goes in line with previous studies where personal
cash incentives (e.g. lottery) significantly increased mail survey returns in comparison with
promises of charity contributions (Furse & Stewart, 1982; Hubbard & Little, 2015). It was
argued that charity donation is usually associated with philanthropy and might look for some
potential participants as an improper incentive for taking part in a research survey (Pedersen &
Nielsen, 2016). Similarly, a comprehensive review of 1607 academic articles published
between 2000 and 2005 found that the use of incentives is not correlated with the response rate
(Baruch & Holtom, 2008).
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Ethical Considerations and the Researcher’s Role
Ethics are the principles of right and wrong that individual rely on for making choices and
taking decisions (Laudon & Laudon, 2016). The research has to follow certain standards of
behaviour to manage his/her relationship with research stakeholders (Saunders et al., 2016).
Four ethical issues are commonly encountered in research: harm to participants, informed
consent, invasion of privacy and deception (Bryman & Bell, 2015). The researcher
acknowledges the research ethics as the top priority through all the stages of this research. All
research participants are adults (over 18 years old) with no apparent mental or psychological
illness that can influence their free will. In addition, informed consent was obtained at all data
collection phases. Before data collection, all participants either in interviews or surveys were
clearly informed of the purpose of this study and that all the provided information are used
only for research purpose. For interviews, subjects’ names and their companies were removed
during the transcription process.
Moreover, the final copy of each interview transcript is sent to the participant for a final
quality check and to have a second chance to opt out of the interview process if needed.
Leading questions are strictly avoided ensuring the objectivity and reliability of the collected
data. This guarantees higher consistency as well as trustworthiness of data (Kvale &
Brinkmann, 2009). To avoid any stress of psychological harm for interviewees, they were
informed at the beginning that they have the right to end the interview at any stage or to refuse
to answer any question. The anonymity and confidentiality are also secured for all the survey
data. Finally, the author ensured a high level of integrity during the reporting of research
findings and accurately referenced all cited authors.
It is noteworthy that the researcher is a pharmacist with more than 10 years of experience
in the pharmaceutical manufacturing industry. He held several roles in the quality assurance
and technical services. This included managerial and non-managerial roles. This long
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experience is believed to familiarise the author with the industry operations, terminology and
regulations. The author also utilised his personal network to recruit the interviewed experts
from different functions. Also, personal contacts facilitated the distribution of the questionnaire
within the identified clusters. This was deemed inevitable to have access to employees within
the pharmaceutical manufacturing organisations. Having a practical experience avoids the
difficulty of failing to understand the terms and abbreviations commonly encountered in the
pharmaceutical industry. In addition, familiarity with the different manufacturing and
management processes enabled him to synthesise suitable probing questions during interviews.
However, from a critical realist understanding, the researcher believes that the objective
reality cannot be measured with certainty as our perception is influenced by conditions and
social factors (Easton, 2010). The critical realism’s reality is also stratified and we deal only
with outermost level “ the empirical” (Mingers, 2004). Hence, the reality is not simply what
can be empirically perceived as proposed by the positivist. Developing explanatory theories
that help identify causal mechanism driving the social events would definitely take us closer to
the reality (Fletcher, 2017). The author employed MMR in order to combine both the
qualitative and quantitative techniques to enhance the credibility and integrity of research
finding (Schoonenboom & Johnson, 2017). This combination of different methods, following
structured analysis methodology and deductively comparing the findings with extant literature
is deemed to reduce the researcher’s bias during data collection and analysis. Also, the
researcher utilised the data to explain the underlying social structure (causal mechanisms)
behind the personal knowledge (reality). The developed framework of causal factors from the
QUAL phase was further tested in a bigger sample of pharmaceutical knowledge workers using
CFA where the interference of the researcher became minimum.
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Dissemination of Research Findings
The dissemination of the research findings is planned at each milestone. Two literature
review papers have been published in the Knowledge Management Research and Practice
(KMRP) Journal. KMRP is one of the key peer-reviewed journals in the KM field. Available
online since 2003, KMRP is the first KM journal to gain an impact factor (Thomson Reuters,
2015). Moreover, KMRP was placed third in 2008 then the second in 2013, according to expert
survey rankings conducted on a sample of 25 key KM journals (Serenko & Bontis, 2013). In
addition, a Scientometric review paper has been presented in the 12th International Forum on
Knowledge Asset Dynamics (IFKAD) highlighting the major trends in KM research. The
empirical study findings are deemed to be published in a KM peer reviewed journal. A
measurement framework or scale for industrial application is another expected outcome from
this study.
Furthermore, the researcher was invited to speak about his early findings in the National
Pharmaceutical and Life Science Expo in 2018 and 2019. This was another opportunity to
disseminate the research findings and obtain direct feedback from industry practitioners. It is
noteworthy that the National Pharmaceutical and Life Science Expo is an annual meeting of
over 1000 senior managers and speakers from the pharmaceutical and life-sciences sector. It
provides a platform to disseminate the latest research updates, best industry practices and the
most innovative technology solutions (Premier, 2019).

Write-up: Presenting Research Results
Proper reporting of a research is of ultimate importance for the reader to judge the adequacy
of the research methods and findings. This implies a proper layout of the research thesis to
include: A) preliminary pages; B) the main text and C) the end matter (Kothari, 2004). The
primary part includes all the tables of content, figures and lists of tables. This part also includes
the abstract, the acknowledgements and the declaration. The main text of the thesis consists of
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eight chapters that include the literature review, research methodology, exploratory and
explanatory studies, discussions and conclusions. The final part includes references and
appendices.

Summary and Conclusion
This chapter provides an explanation and a justification of the research methodology in this
dissertation. It outlines the adopted paradigm, the research paradigm, the research strategy, the
scope and the data collections methods. A detailed research plan describes the research journey
from literature review until data analysis and conclusion. The next chapter is the first part of
the primary data collection where the researcher explores the research phenomenon in the
industry context.
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CHAPTER 5: Exploratory Study

Introduction
The aim of exploratory studies is to understand the research phenomena as we explore what
happens in the field (Gray, 2013). In other terms, a researcher endeavours to familiarise himself
with a certain phenomenon and formulate his hypotheses (Kothari, 2004). This familiarity can
be achieved via a literature review and/or communications with industry experts through
interviews or focus groups (Saunders et al., 2008). After the extensive literature review in
chapter two and three, the exploratory research was undertaken to portray the common
practices in the pharmaceutical industry regarding personal knowledge management and
measurement. The exploratory study would also examine, in the next sections, the KM maturity
in the pharmaceutical manufacturing sector. At the end of this chapter, the conceptual
framework will be developed and presented.

Interviews
In order to explore the current understanding of the “knowledge” and its management
practices among the pharmaceutical industry practitioners, a set of semi-structured interviews
were conducted with a selected sample from the pharmaceutical industry experts. The
interviews were intended to define the dimensions of the personal knowledge taking into
consideration the special nature of pharmaceutical manufacturing. A non-probability sample
was considered the most practical choice at the exploratory stage (Saunders et al., 2008).
Detailed justification of sampling techniques is described in the methodology chapter (chapter
four).
A total of 15 semi-structured interviews were conducted with senior managers from
different functions in the pharmaceutical industry. Interviews were conducted over the period
from March to September 2018. Interviewees were recruited from the researcher’s industrial
network, LinkedIn and by direct invitations during industry related exhibition (the National
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Pharma & Life Sciences Expo 2018). Over 29 candidates were suggested for the purposive
sample. All the nominated managers comply with the inclusion criteria as mentioned in chapter
three (4.7). Furthermore, a ranking system of three levels was utilised to define the priority and
relevance of each candidate to the inclusion criteria. Managers who had a superior rank or score
(i.e. rank one) were given the priority in the interviewing process. This ranking was based on
the position in the organisation and the relevance of experience either the single or multifunctional experience (Table 5-1).
Table 5-1 Interview list
No
1.
2.

3.

4.
5.

6.
7.
8.

9.

10.
11.

Title

Function

Affiliation

Location

Ranking

QC Manager

Quality

Multinational

KSA

1

Scheduled
on
02/03/2018

MEA Quality
Improvement
Senior Manager
Technology
Transfer
Manager
QA associate
director
Production
leader;
Consultant
scientist
Enterprise staff
supplier quality
Production
manager
Manager;
Pharmaceutical
and molecular
biotechnology
Research Centre
Associate
director
technical service
Quality
Assurance Lead
Consultant

Quality

Multinational

Turkey

1

12/04/2018

Skype

Quality

International

Cyprus

1

25/04/2018

Skype

Quality

Multinational

China

1

04/05/2018

Technical
Service;
production

Multinational

USA

1

09/05/2018

WhatsAp
p
Facebook
call

Quality

Multinational

UAE

1

10/05/2018

Skype

Production

Multinational

Egypt

1

01/06/2018

Facebook
call

Research;

Governmenta
l

Ireland

1

12/06/2018

Skype

Technical
Service

Multinational

China

1

14/06/2018

WhatsApp

Quality

Multinational

Switzerland

1

27/06/2018

Academia;

Governmental;
Multinational

Ireland

1

01/08/2018

Facebook
call
Face-toface

broad
industry
experience

broad
industry
experience
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12.

13.
14.

15.

IT Service
Manager Regional
Validation
leader
QA and
compliance
manager;
QA/QC
Manager

IT

Multinational

Egypt

2

01/08/2018

Facebook
call

Quality

Multinational

Egypt

1

28/08/2018

Quality;
Logistics;

Domestic
(private)

Egypt

2

05/09/2018

Facebook
call
Facebook
call

Production
Quality;
Production

Domestic
(private

Egypt

2

29/09/2018

Facebook
call

The sample covered several organisations in nine countries (Figure 5-1) from domestic
(private), governmental and multinational sectors in order to shed light on the different KM
practices including knowledge measurement where applicable. Eighty percent of the
participants are affiliated to multinational companies. The average organisation size is 355
employees (Max =1200; Min= 7). One-third of these organisations are mainly producing
biologics and vaccines. Another third described their experience to be in the conventional
pharmaceuticals. The rest of the sample is affiliated to organisations producing a mixture of
biologics and conventional products as well as medical devices. The median length of
interviews is 28 min 2 sec (maximum length= 38 min 36 sec; minimum length= 17 min 47
sec). The interviewees represented a broad range of expertise. Fifty-three percent of the
participants were affiliated with the quality unit as a core experience. Production, technical
services, logistics, KM consultancy and IT were also represented in the sample. The final
sample was intended to cover the key technical functions of the pharmaceutical manufacture
with a special focus on the quality unit. The researcher assumed that quality managers would
always be familiar with any KM initiative in their organisations where KM is mentioned in
quality guidelines and seen as the enabler for the pharmaceutical quality system (ICH, 2009;
WHO, 2011b). Last but foremost, 93% of the interviewees are currently affiliated to
manufacturing organisations. The research and development participant had also an extensive
manufacturing experience.
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Figure 5-1 Interviews by country map

Understanding knowledge from the Practitioners’ Perspective
During the course of interviews, knowledge was described from different angles.
Interviewees offered different definitions of knowledge that varied between broad or narrow
descriptions. From the narrow perspective, employee knowledge was portrayed as
multidisciplinary, job-related, depending on department or having a special definition for every
industry and perhaps for every area within the same industry. On the other hand, other
interviewees provided broader definitions. For instance, subject 12 defined knowledge as:
“A very abstract concept. Knowledge ...it is a collective understanding
based on practices and experiences that have been developed over the
years through execution and implementation".
It was also described as “a wide definition” and “a diversified aspect” by subjects two and
three respectively. The offered definitions are in line with knowledge definitions in literature
where it is gained over time by direct experience and lifelong learning (Hoe, 2006; John
Mingers, 2008). Davenport and Prusak (1998) proposed a similar definition of knowledge as a
fluid mix of experience, values, contextual information and expert insights. However, the
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preliminary definition of knowledge by interviewees limits sources of knowledge to the direct
experience or learning by doing.
Participants described two types of knowledge: one that can be found in written documents
or drawings “explicit knowledge” and another type which is difficult to articulate “tacit
knowledge”. The tacit knowledge is not written, but employees can use it to solve problems
(Polanyi, 1966). Moreover, attempts to code the tacit knowledge were recognised. Subject one
referred to an initiative to articulate tacit knowledge in his organisation:
“We have programs like after-action reviews where we try to articulate the
learning from every experience.”
There was an emphasis on the importance of the flow of this tacit knowledge throughout the
organisation. Subject 11 explained how current policies of incentivising knowledge holders
indirectly encourage knowledge hoarding in the form of Subject Matter Experts (SME’s).
Alternatively, the interviewee suggests that firms should spend more efforts to establish a
knowledge sharing environment and offer the appropriate incentives to maintain this.
By the same token, there was a consensus among the participants that there is a need to
leverage knowledge to improve operations. They elaborated that the efficient use of knowledge
could entail a reduction of process cost, optimum utilisation of equipment, decrease time and
efforts associated with operations, a better understanding of products and effective
implementation of the pharmaceutical quality systems. Subject 11 referred to the ICH Q10
description of KM as an enabler of the pharmaceutical quality systems.

Knowledge Maturity in Pharmaceutical firms
This study documented several KM initiatives within the participants’ organisations. All
interviewees mentioned one or more attempts to capture, leverage or share knowledge in their
workplace. These initiatives are argued to overcome (or decrease) the impact of the five main
barriers to KM success in organisations i.e. inefficient communication, lack of sharing culture,
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lack of competence, lack of incentive and lack of interest from the employee (Oliva, 2014).
Some of these initiatives were voluntary actions, while others had a formal firm-wide nature.
For instance, ‘after-action reviews’ were used to learn about specific situations, articulate the
acquired knowledge in the form of learned lessons and reuse the learned lessons in the future.
The interviewees employed document management systems as a secure and reliable method of
document retention and control. Other initiatives took the form of a social event for knowledge
sharing. Knowledge sharing sessions were one of these events to facilitate an informal meeting
of staff where they are encouraged to exchange knowledge about the problems they face.
Subject 7 explained his experience with “Lunch and Learning” initiative:
“something like knowledge sharing lunch when we have once per two
weeks… we gather together for lunch and some of the colleagues… one of
the colleagues can present something related to his area of experience…
his or her area of knowledge to the rest of the team so that they also gain
the knowledge and understanding of this topic from the SME who is
presenting this during lunch time... is something like informal or less
formal knowledge exchange and this is on the level of the small teams and
groups”
Alternatively, the interviews showed that virtual communities and expert finder platforms
were used to facilitate knowledge exchange. However, one drawback of this approach is its
over-reliance on employee participation (Levy, 2009). The interviewee outlined the
significance of regular updates of employee profiles to get the full benefit from this repository.
This step was quite challenging for the organisation to find effective ways to incentivise
employees to stay active on these platforms. Also, the study found that company-owned social
networks were adopted to facilitate knowledge exchange among employees. These networks
were a simulation of Facebook or LinkedIn but exclusively within the company. They were
used for internal job posting, search for talents, expertise locator or to cover social events within
companies, e.g. a visit of the vice president. Microsoft Teams, SharePoint and Yammer are
examples of the widely used applications in this area.
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In contrast, rudimentary Microsoft Excel spreadsheets were also used to build a knowledge
map in relation to product history files (explicit knowledge). There were some individual
initiatives to use free technology to enhance knowledge exchange within small teams. For
example, subject two explained a personal initiative to use WhatsApp groups to exchange
regulatory guidelines and scientific articles with his team. This WhatsApp group was also used
to transfer knowledge to other teams within the same company. He pointed out that “it is not
the company initiative”.
Another approach was to provide a platform where employees can search and find useful
technical resources. It is worth noting that it is not part of the training systems but rather a
repository of technical resources. Individual employees or groups can contribute to this library
of technical media (e.g. successful media fill video record) and they can also improve the
quality of its content. This offered means for knowledge and experience transfer within the
organisation. Regular conference calls are held where each manufacturing site (in a
multinational company) present the contributions to this knowledge repository. Apparently,
this demonstrates a form of Wikis addressed in academic literature (Edwards, 2015a; Jones,
2009).

Another version of these platforms offered a mobile application. Subject three

explained one of these applications in the following paragraph:
“This application on the mobile is user-friendly and can help us a lot get
knowledge and take lecture at home or in your car... at any place you can
take your lecture. It is very well selected tool”.
Supplier Quality Academy was an attempt to transfer knowledge out of the organisation to
the suppliers. Through this system, it was possible to share sessions or presentations which is
believed to be useful to the suppliers. It was evident that the use of IT solutions was going in
parallel with social activities to promote knowledge sharing within these organisations. This
combination of technology and social initiatives is argued to support the tacit dimension of
knowledge which can hardly be managed using IT tools ( Chatzkel , 2007).
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Findings from the interview highlights that KM strategy wasn’t well-defined for most of the
participants, or they are not aware of its existence. Instead, they mentioned other strategies or
policies for training, development or patent disclosure. It was also apparent that KM and
training are sometimes confused among practitioners in the pharmaceutical industry. Subject
seven assumed that they might have KM strategy but under a different name:
“No, I didn't hear the exact terminology... KM development but I think it is
already in practice, but we have different terminology”.
Despite that, some of the knowledge processes were managed through formal procedures,
e.g. knowledge transfer. In fact, WHO has dedicated the annex 7 of TRS961 guideline for
technology transfer. This explains the relative maturity of knowledge transfer for production
and quality control processes as appeared in the interviews.
The perception of KM maturity varied among the practitioners. Some described the current
KM practices as “very immature” as we are on “the very early days” of KM. For others it was
described as a well-established system. The level of maturity of KM systems was also
described as “patchy” i.e. it is different from one organisation to another or even among
departments of the same organisation. Subject 12 clarified his expectations of KM in the
following paragraph:
“I think my expectations are a little bit higher for knowledge management.
I think the pharmaceutical industry has established the first part very well
which is the instructor-led training, basic foundations to the discipline,
even highly specialised discipline where they give additional training in
that aspect is it's very well developed but is it where we need to be? No. I
think there is a level of knowledge lost through attrition of people's leaving
the company for retirement or who developed a lot of learning over the
years that is easily lost because we don't have a way of documenting those
experiences and sharing learnings.”
Training is an educational activity. It aims to accumulate knowledge and skills needed for
better performance of an employee in his/her current role or as a preparation for another
position within the organisation (Scurtu & Neamtu, 2013). Part of the observed controversy is
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due to the unclear distinction between training systems and KM in the studied organisations.
The mechanism of implementing KM away from training is not clear and underdeveloped.
Also, the participants described a lack of suitable effectiveness checks within the traditional
training systems. This means there is no guarantee that knowledge is effectively transferred
after training is completed. They argued that knowledge can be acquired through self-learning
and employees were allowed to independently interpret what they read on some occasions.
Another source of confusion is the lack of differentiation between document control systems
and KM. While these systems can transfer and track changes that happen in processes and
systems, subject 11 highlighted that organisations expect to have information systems that can
manage firm’s knowledge in a way similar to electronic document management systems.
However, almost half of the firm’s knowledge is contained in people’s brains (tacit knowledge)
while the rest is stored in documents and electronic systems (cited in Liao, 2005). Both training
and document control were traditionally seen as a compliance activity rather than a knowledge
transfer process.
“Traditionally training wasn't seen as a knowledge transfer activity was
seen as a compliance activity where you have to do X amount of training
and X amount of qualifications in order to do X amount of tasks”
Subject 11.
Moreover, the interviews discovered a high attention to data protection among interviewees.
Use of data cloud or public servers raised doubts and fears among interviewees. It is believed
that these doubts about confidentiality and protecting proprietary data might hinder KM
initiatives in pharmaceutical organisations (Wang, 2006). For instance, subject nine expressed
his sceptical opinions about the security of social networks as they might rely on public cloud
computing platforms. In contrast, the fear of reputation damage after a data breach encouraged
decision makers to enforce data access controls and to adopt information security management
systems, e.g. ISO 27001. In line with finding from a recent study of Durst & Zieba (2019),
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those fears portray the participants’ reactions to cybercrimes and other technological risks of
KM with possible negative consequences on business, reputation and patients’ health.

Knowledge sharing and transfer
The interviews shed light on another reason of inefficient flow of knowledge in the
pharmaceutical organisation. The interviews suggest that employees get their basic training on
the IT systems by the vendor then each department start coding the knowledge into this new
repository in its own way, using their own terminology and implementing their taxonomy of
data. Over time, the organisation ends to a group of individual silos or isolated islands that
benefits a little form each other’s knowledge. Subject 11 illustrates this situation in the
following quote:
“So, you end up with a system that's impenetrable. You've actually created
locked-in syndrome within the silos because nobody sat down to think
about how might we architect this forever? So that everyone can have
access to it and it's not just relying on this tree structure.”
Similarly, the interviews highlighted a lack of systematic process for knowledge sharing
and transfer among employees. This often leads to hoarding of knowledge among subject
matter experts and project managers who see knowledge as power as they are in this position
because they have something not with everyone. Ultimately, others have little chance to learn
and when these persons leave, the knowledge loss is quite substantial. The subject 12
exemplifies this phenomenon in the next paragraph:
“It is like construction project managers. They maintain their position
throughout their career as the construction project person because it is a
positive feedback loop in which they do a project they learn from it so they
become more careful of doing projects so they're chosen to do more
projects, and then they learn from that too and become more capable and it
goes on and on and on until that person requires that information is lost
they have a continuous influx of people of at different stages of their career
so that when that happens that when someone does retire he'll have people
who are at different levels of capability in which they can cover that person
leaving the company”.
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It was noted that the knowledge sharing is not often a part of the formal roles and
responsibilities. Management doesn’t usually dedicate time (during working hours) to allow
employees to share their knowledge systematically. These findings supports the lack of
knowledge management strategy as explained in (5.4 ).

The value of knowledge measurement from the practitioners’ perspective
The findings of the exploratory study suggest a consensus among the participants on the great
value of the knowledge measurement. One of the proposed applications of knowledge
measurement is employee appraisal. Subject three suggests the evaluation of employees not
only on performance but also on their level of knowledge and how they improve it. He also
added this could work as a motive for continuous learning. He provided a real example of
applying this initiative in the scientific office of his company. However, this does not
contradict with the delimitation of knowledge measurement and the traditional performance
appraisal that has been outlined in chapter two. In fact, the design of a performance appraisal
system can be complex and can involve multiple dimensions (Bayo-Moriones et al., 2019).
Another suggested value of measurement was to assess the effectiveness of any KM initiative
within the company on the employees’ knowledge or in other words the return on investment.
Subject 12 said in that respect:
“So, yes. This short answer is it would be very helpful for the organisation.
It would make sure that we don't lose much money in executing initiatives
and systems that are not helping the organisation in retaining knowledge.”
The interviewed experts added it could offer a lot of help, especially as a selection criterion
during the recruitment and retention of employees. It can also predict the outcome of the
employee based on the level of knowledge he/she holds. It can define the minimum
requirement for each job. Moreover, it can be used as a way to check the knowledge acquired
after training or over a certain period. Others referred to the potential impact on business cost
due to lack of knowledge, e.g. the cost of rework. Similarly, they emphasised that it would save
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money by retaining knowledge within the organisation. It was also described as crucial for
business success and for decision-making process as explained by subject 11:
“How good we are using what we know as an organization to inform our
decision-making processes.”
Embracing Drucker’s Management by Objectives approach (Greenwood, 1981), knowledge
measurement can drive the development plans of the employees in different functions as
explained below:
“I don't want to repeat myself but easy way to see the value would be if I
have indicator that tell me if my department is much higher than the
average knowledge or just at the average or below the average. This might
drive my plans for my people. So, if it is much higher this means I have to
focus on the execution rather than the knowledge building or the
awareness. If I am at the average I need to work side by side. If I am much
lower, it might indicate that I need to change the team to get more
experienced people or knowledgeable people or to do something to
leverage the knowledge of the team to be an average of a bit higher.”
Subject one
This notion was further highlighted by subject 11. She clarified while an employee might use
company resources to enhance their CVs rather than obtaining relevant training and
development, having a comprehensive knowledge measurement and management strategy
would generate knowledge goals for each employee that can benefit both the employee and the
organisation. She said also:
“When you look at the individuals themselves they've got specific goals and
drivers for their career that are not just linked around “I hope I can get
that black belt training on Six Sigma next year on my CV […] So, I think a
tool such as that would be invaluable because again it helps start thinking
about twisting the coin. It's not about building the CV; it's about enhancing
the organizational capacity.”
An additional value of the individual knowledge measurement was to prognosticate
individual strengths and weaknesses. Subject nine argued that a measurement tool could show
him/her what is needed for the development of each employee in his area. This can help deploy
the employees in the right positions and get the best out of them. Subject seven explicate this
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application of individual knowledge measurement tool in the following:
“I think if we have a structured tool which can give us an overview, not an
overview … a deep understanding, strong and fair assessment of the
amount of knowledge our people or talents have I think this will be
important in setting how do we deploy these talents and these
knowledgeable.”
On the other hand, findings suggest that having a knowledge measurement system in place
would build trust in the company decisions. This can provide an advantage during audits or
inspections. The reason behind this, it would provide the auditors with objective evidence that
only qualified persons take decisions that might impact patient health. Subject ten clarify this
notion in the following quote:
“So, auditor has come into companies and they start looking at
pharmaceutical development and you know - defining what we had made
that were made and so on and they start asking questions: why did you
know if you're doing risk assessments why did you use…? why did you
come up with these? this risk assessment… how did you come to these
conclusions and then the obvious question is: are you qualified to actually
make those decisions? Okay, what's your background?”
The measurement tool is claimed to influence the whole corporate not only from a quality
and regulatory perspective but also at the business level. Subject eight argued that this tool
allows the decision-maker to know who has more knowledge objectively and in turn assign
new projects and responsibilities to the suitable person. This is deemed to improve the quality
and business outcome. This supports the notion that the organisational ability to exploit existing
knowledge is a determent of its success and competitiveness (Matoskova, 2016). By the same
token, subject 12 speculated that “the aggregates of the individual speak for the performance
of the site”. As a result, he continued “it starts by individual. If every individual is capable
consequently the whole organisation is strong and healthy”. The findings suggest that the
outcome of the personal knowledge measurement can reflect the knowledge level within the
whole department or even the whole organisation. This also endorses that HC is a unit-level
resource and the measurement must be conducted at the individual level (Moliterno & Ployhart,
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2011). Subject 11 believes that these efforts help link value to knowledge. In turn, when
decision makers see the contribution of knowledge to value creation, this will build maturity
in KM practices in the organisation.
However, one-third of the interviewed managers referred to some potential barriers hindering
the systematic measurement of the employee knowledge within their firms. One of these
barriers is the availability of alternatives. For instance, it is not always possible to have several
employees who have the necessary knowledge about a niche product or a particular process. In
this situation, measuring employee knowledge would offer no more options as the organisation
might not have the luxury to assign a more knowledgeable worker to support this process.
Subject 14 mention this barrier in the following quote:
“If you go to the detailed technical point you don't have the luxury to have
2. 3, 5 persons able to support in this area […] let's have an example. I have
now an issue related to XX manufacturing for example. you have a specific
person, he is educated to support this. He is a global XX steward and he's
supporting this molecule. So, it won't be helpful anyway if I'm gonna assess
his knowledge. What else! I don't have options!”
Similarly, some other firms have a one-year contract of employment policy. This doesn’t
allow the company to take any corrective actions after knowledge measurement. It might not
have a formal performance review process either. By the time the organisation takes any action
based on the measurement process, these employees won’t be there anymore. Subject ten
asserted:
“You know by the time you actually take your corrective action the person's
contract will have expired”.
In addition, it is not always possible to find a standard or a reference to assess the knowledge
against (Borgatti & Carboni, 2007). This is quite apparent in innovative and research-related
activities. The employee is doing a certain task for the first time and nobody knows if this is
the right way to do it or not. Subject ten demonstrated this in the following quote:
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“The work we're doing is research and so the samples there has no history
or no and no one has tested it before. So, we're the first people looking at
this particular measurement and so it's you know it's there is no
reference.”
Poor understanding of the KM and PKM is another barrier to implementation. Interviews
revealed that management are not always aware of the benefits of the personal knowledge
measurement and in turn, they might not support such initiatives in their organisations. Indeed,
the existence of a knowledge-oriented leadership encourages the development and use of KM
and consequently enhances innovation (Donate & Sánchez de Pablo, 2015). In addition, subject
11 asserted that management often looks at the employees’ knowledge in a very static way
where seniority and/or the number of qualifications or certificates are the only ranking criteria
rather than real capabilities. Based on this understanding, they have a wrong assumption that
proper knowledge measurement activities have been already in place.

The knowledge measurement practices in the pharmaceutical industry
Interviewed managers emphasised the regulated nature of the pharmaceutical industry. This
is coupled with the expectation of high-quality standards in all operations. This also implied a
need to have the proper knowledge before involvement in any process in such a controlled
environment (WHO, 2014). The interviews reveal that the pharmaceutical industry has a
global nature where practitioners are speaking the same technical language and refer to the
same global standards. However, some participants argued that albeit there is still a lot to learn
from other sectors such as automotive, nuclear sector, aeronautics as well as oil and gas in the
field of KM. According to subject 11, KM is still “immature” in the pharmaceutical industry.
There is a consensus among the participants that the knowledge measurement practices in
the pharmaceutical industry are still informal activities. Managers might evaluate the
knowledge of their subordinates in a qualitative way missing any objective criteria. The process
is described as a managerial skill which is based on the manager’s personal experience, and it
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varies from one to another.
Direct managers can assess the subordinate knowledge through daily interactions and
performance. Over one third of responses linked the knowledge measurement with the
recruitment process. During this process, the manager often evaluates the knowledge of the
applicants through technical questions. Another form of interviews takes place after major
deviations to ensure that workers hold the required knowledge and can apply it.

The

operational managers also have open discussions with employees during Gemba walks, and
this offers another opportunity to assess their level of knowledge qualitatively. However, the
participants expressed their need to measure the knowledge of their employees in a formal way.
They are looking for a formal and standardised knowledge scale. This would standardise the
assessment process. Subject 12 and one respectively emphasised this meaning in the next
paragraph:
“Yeah we need to know […] how you know you have a gap if you cannot
measure. That is why I said we need to be able to measure it.”
“I don't know the way. I mean if it is true that we have a way to say " in this
department the collective knowledge of employees hit this bar which might
be high standard one…this means this gives great confidence that this
department can make decisions in (desirable) way and if it didn't hit the
bar or was significantly below this bar it might also indicate that
something needs to be improved in the knowledge of the organisation so it
might be a priority to improve.”
Nevertheless, seven out of 15 interviewees showed scepticism about the possibility of
having an objective measurement scale of employee’s knowledge. Statements such as “assess,
I am not sure!”, “you cannot give it a rating” or “I don’t see we can do it” reflects the feelings
of uncertainty in light of the current practices.
Talent management can be described as a relatively established process in at least one-third
of the participating organisations. The process aims to acquire knowledgeable people from the
market and to retain them in the company (Somaya & Williamson, 2011). The findings show
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that talent acquisition starts from the direct manager who nominates the potential talents and
ends with senior management, e.g. the site head who approves these choices. Talent
management, in the studied organisations, is also part of the succession planning where talented
workers are prepared for leading positions. Despite that the talent is not only the knowledge
but also the skills and abilities (Nijs et al., 2014), subject seven affirmed that knowledge is an
important part of the talent. He stated:
“We have a system...the system is supported by IT tool for talent management, and very
important part of talent management is the knowledge… the person knows, the strengths of
this person, in which parts this person is very strong, and how can we develop the person in
this strength knowledge. Further, how can we compensate for the absence of this person in
case of retirement, lay off, rotation to a different job or whatever?”
The paragraph above illustrates the management awareness of the significance of
knowledge loss. People who leave their jobs or retire take their knowledge out of the
organisation. This would also increase the turnover cost when the organisation tries to replace
the lost knowledge holder as subject 14 mentioned below:
“So, if you for example… if you have a very experienced scientist and for
some reason, you will lose this person, and this will cost you a lot to get
somebody else to start over what he used to do.”
Forgetting is another mechanism of losing knowledge (Holan & Phillips, 2004; Watanabe
Wilbert et al., 2019). The interviews reveal that when the organisation fails to document the
experiences and to share the learnings, it is usually not possible to avoid repeating the mistakes
the person who has retired had already faced in the past. Subject matter experts who are retiring
are seen by participants as another threat to the pharmaceutical organisation. There is still no
clear process to transfer their knowledge or to systematically document it in a way that allows
retrieval in the future.
Thus, the findings reveals that when knowledge holders leave and the knowledge hasn’t
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been well documented (or shared), the organisation faces challenges with process and product
related information especially with legacy products and products acquired from other
companies. It has been argued that decision-makers would hardly be able to make the right
decisions, and they could resist any changes as they are not sure about the possible
consequences. Even wrong decisions can be made due to the lack of knowledge and months
might be wasted to discover the root causes of the generated problems instead of using the
current resources for continuous improvement. This supports the notion employees leave the
organisation with the critical knowledge that supports the business leading to negative impacts
on productivity, performance and organisational knowledge base (Massingham, 2018; Parise
et al., 2006).
In this chaos, the study records some attempts (eight out of 15 interviewees) to plan existing
resources and human capital. However, the first challenge they have is that it is not always
possible to identify the knowledge holders. Sometimes management face a particular problem,
and it needs a certain knowledge to solve it, but it is not possible to know exactly who has this
knowledge or skill. As there is no formal process for this, it is totally reliant on manager’s
interactions with his team. Subject ten provide an example of that from his organisation in the
following quote:
“For example, if a problem comes in and requires ion chromatography as
an example, you know, do I know anyone here with Ion chromatography
experience probably not- maybe just people that I can go and ask about it,
but I don't know that I have that expertise. We don't do that… hard to do...
but we should do.”
Four of the participants referred to the organisational endeavours to plan their Human
Capital through the identification of knowledge gaps among staff. This process is limited by
the lack of consist knowledge measurement tool too. This notion was endorsed by subject 12
as he said:
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“How do you know you have a gap if you cannot measure? That is why I
said we need to be able to measure it. You could have a problem with your
knowledge of your organisation and not know. And the only way to know is
to measure.”
One of the used approaches (in two interviews) is to ensure that each critical area is covered
by a backup person(s). The backup person holds all the necessary knowledge, and this ensures
the operation will not be interrupted due to the absence of the needed knowledge holders.
However, interviewees asserted this approach is not always possible especially with highly
technical and specialised roles as it is not possible to have a substitute.
In one of the interviews, the Skills Matrix was introduced as a practical application of both
human capital planning and backup person allocation. It was described as an annually used
tool to assess and manage skills in a function or department. Also, the training and recruitment
needs are determined based on this matrix. It starts by analysing the process into tasks or steps.
The matrix consists of two axes. The first is the processes or tasks to be done in a certain unit
or department. The other axis contains the names of the workers in this area. Each employee
receives a score from one to five based on his capabilities. If the worker cannot undertake the
job at all, he/she receives one. He/she receives two or three if they can complete it without
supervision. The worker receives five when he/she is able not only to undertake the job but
also to train others on it. Despite that, this scoring is still a subjective activity totally dependent
on the supervisor or direct manager’s opinion as shown in the next quote from subject eight:
“It depends on the supervisors’ knowledge and the manager knowledge
about employees, and this this is built through the experience of the whole
year, and this matrix is updated. So, of course, you have seen many
situations during the year that build your knowledge about the employee in
this task.”

The personal knowledge of the pharmaceutical employee
The following section illustrates the key antecedents and measures of employee knowledge
in the pharmaceutical manufacturing sector that have been discovered in the interviews. The
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interviewed managers explain these measures based on the common practices and their
industrial experience. Eight main themes and their underlying subthemes are explicitly
discussed showing the current practices of industry practitioners to assess the personal
knowledge of individual employees.

5.8.1 Regulatory compliance
I. Ability to identify compliance gaps
In such a regulated industry, the ability to understand and interpret regulatory standards to
identify implementation gaps is seen as a measure of knowledge of regulations. Subject seven
refer to this in the following paragraph:
“…understanding and the capability to interpret the quality standards from different bodies
and from different countries is the key knowledge factor.”
This ability to interpret the guidelines can be envisaged in employee compliance to these
regulations in his area and/or his ability to identify implementation gaps (e.g. gap analysis) as
well. Subject four stated:
The gaps you put in your final report [..] give us an indication for how
much you are updated with the new requirements… the main gaps you
find…
II. Familiarity with relevant regulatory standards
In addition to employee’s ability to interpret regulatory standards, seven of the interviewed
managers expressed their concern of their employees’ familiarity with the recent requirements
or expectations of the regulatory bodies. They emphasised the importance of employee’s
knowledge of current Good Manufacturing Practices (cGMP) in addition to the internal
company standards. The knowledge of the latest updates of relevant standards is necessary to
be able to achieve compliance.
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“If the reference of the health authorities- we are dealing with- is the ICH or the WHO then
what are the latest updates in the ICH or WHO (standard) and the level of knowledge you
have related to this standard.” Subject four

5.8.2 Product and process understanding (mastership)
I. Finding knowledge (know-where and know-who)
The ability to find knowledge about the process, product or equipment is one of the
suggested predictors of his/her personal knowledge. As it is impossible to know everything,
findings from five interviews show that it is highly appreciated if the employee knows where
to search to find knowledge. Subject two provide his explication as follow:
“He shouldn't know the info when I asked him for example but should know
where to search where to find”.
The knowledge can be available somewhere in a computer or a server, and it must be
retrievable to be used. Part of the knowledge lost when a person leaves the organisation is the
Know-Who (Jennex, 2014; Parise et al., 2006). Thus, besides the need to know where to find
knowledge, there was an emphasis on the need to know who to go to and who not to go to. In
other words, another important part of process knowledge would be the knowledge of the “go
to person” for each process.
“We'd better if you could just go to someone who had expertise in the area
or working… does know who to go to, who not to go to”. Subject ten
Interviews uncovered some of the KM initiatives that facilitated knowledge findings by
electronic systems such as expertise locators and social networks. Indeed, the existence of
informal personal networks to connect knowledge holders can compensate for the deficiencies
of the formal organisational arrangements (Grabher & Ibert, 2006).
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II. Working without supervision (Skills Matrix)
The application of skills matrix to assess the employees’ knowledge about the process is
explained in detail under (4.8). It relies on the ability to work without direct supervision or
have the knowledge to train others on a certain task as a proxy indicator of the level of process
understanding.

III. Technical knowledge
Two thirds of the participants advocated that knowledge holder should understand and
explain the underlying theories of processes, product and equipment in his/her area.
Understanding of the principles underlying phenomena is described as Know-why (Raghu
Garud, 1997). This reveals the management concerned with employees’ knowledge in basic
science and other technical details of formulation and/or analysis. They argued that a
manufacturing employee must maintain a certain level of knowledge about the scientific
background of processes and product in addition to full awareness of risks and precautions.
This includes also the modern technologies employed in manufacturing.
“.. Even if it is molecule related, or substance
related or the technology itself about the equipment…”
Subject 3
Two of the interviewed managers used technical questions as a knowledge assessment tool
during the recruitment of their subordinates. The technical questions are related to the part of
the operations he/she supports. It might be about the analysis techniques, formulation, or
commissioning and qualification activities. Subject two explains this in the following quote:
“We ask some questions in our industry for the employee to understand if
he has a knowledge about our industry, our guidelines, all the rules which
is covering or which is covering our industry during the normal work.”
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However, the findings suggest that explicit technical knowledge is more appreciated for
junior employees and operational managers rather than senior employees as explained by case
13.

IV. Technical advising
The interviews revealed a form of technical knowledge sharing among employees. This can
take the form of formal assignment of a Subject Matter Expert (SME) or Molecule Steward
based on his/her outstanding process/ product knowledge. Knowledge holder can also be
informally perceived as “the go-to person” by his/her colleagues. However, the improper use
of those SME’s and lack for proper incentives for knowledge sharing might lead to knowledge
hoarding among few of employees who try to protect their knowledge privilege in the
organisation. Subject 11 clarified this in the following quote:
“Subject matter expert and then that gives them maybe an extra 10% in
their pay package or something. So, the incentive for them is actually to
hoard their knowledge right so they become the expert the go-to person
rather than the incentive being the other way of identifying where their
knowledge is where their current knowledge bases what knowledge gaps
they have and where they might be to fill those and then getting them to
share that knowledge as part of the incentive package.”
Finally, knowledge is acquired by participation and involvement (Bakken & Dobbs, 2016)
were contributing to process design, development and improvement can demonstrate a proxy
indicator of personal knowledge.

5.8.3 Performative knowledge
Performative knowledge refers to the skills needed to be able to do something (Mingers,
2008). Management used the performance as a predictor for employee knowledge. In other
words, if the employee holds the required knowledge to do a certain task, management will
expect superior performance and outcomes out of this task. Knowledge holders understand the
process they are responsible for and knows exactly how to do the job from start to end. It is
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about the know-how of the product or the process. Performance is characterized in terms of
“efficiency” and “effectiveness” (Ajith Kumar & Ganesh, 2011) as explained in the following
sections.

I. Achieve the organisational/departmental goals (effectiveness)
Interviews asserted that knowledge can enable the achievement of firm goals and objectives.
Knowledge here is assessed through its outcome. Outcome and deliverables are measures of
employee knowledge.
" If you need to conduct or to make a specific task you can assess from the
outcome and the deliverables of this task how much knowledge about this
task and how much knowledge about the requirements and expectations of
industry this person has though the deliverables of the task and this is
entire year of performance" Subject 7.
Keeping this in mind, subject 9 nominated productivity as another predictor of knowledge.
Knowledgeable employees are deemed to meet their productivity targets and achieve company
goals. In other words, deliverables are the result of employee knowledge. On this ground,
performance reviews measure the contribution of employees over one year including his level
of knowledge and development plans. It measures if the employee is capable of achieving a
certain number of goals that have been tightly linked to departmental and organisational goals.
Performance appraisal was presented as another indicator of personal knowledge in the
following quote by subject seven:
“If you are talking about the assessment of knowledge of persons, I think it
is very core part of the performance review... the semi-annual and annual
performance review and each employee within the company is assessing
the amount of knowledge that key participants are having and how much
knowledge is necessary to perform his job is in place.”
II. Execution and implementation of tasks (efficiency)
Management interprets the way employees interact and execute their job as a proxy
indictor for their knowledge. They referred to these interactions by “day to day
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activities” and “day to day interactions”. Subject eight explains his approach to assess
his subordinates’ knowledge:
“This is not a direct way to (measure knowledge) ... I'm not sitting down
with an employee just to assess their knowledge... It is observed due to day
to day work or tasks performed day to day.”
The involvement of employees in the execution of different processes, holding proper
knowledge to improve product or process and the quality of doing this job reflects how much
knowledge he/she has. This improvement in the performance is summarised by subject two:
“I believe that people whose knowledge is higher, perform better, perform
faster."
Timeliness of doing a task was also linked to employee knowledge. If the employee is
experienced with a certain process, he is expected to be able to do it faster and within the
planned timeline. This can be explained that the employee can use his/her prior experiences if
he did a similar job before and in turn would do it faster.
“It’s more related to the way he is executing his job because the level of
knowledge you have facilitates the job execution. If you participated before
in the job, then when you are trying to validate it would be very easy for
you to execute or to start the protocol or to conclude a report the gaps you
put in your final report”.
Another measure of execution and implementation of tasks is the ability to do it right the
first time. The findings affirm the role that knowledge has to make “doing the job right first
time” possible. This is illustrated in the following quote from subject two:
“When this employee, for example, will have this knowledge, he will do the
right thing, he will take a solid decision, he will do his work right this is a
reason this is a reason for to know this knowledge.”
On top of that, doing the job right first time can be also linked to getting reproducible results.
Knowledgeable employees are argued to maintain the minimum (non-process related)
variability. This can be verified once the same or nearly the same results are obtained when the
job is repeated by different persons. In the case of analytical labs, their results can be even
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compared to the results of an experienced analyst or neutral standards. The following quotes
represent the practitioners’ insights about this point:
“So, I guess we will consider someone to be successful if they've got
reproducible results.” Subject ten
“We need to work more on this part to minimise individual variability.”
Subject 14
5.8.4 Wisdom, problem-solving and decision making
Wisdom is the last layer of the knowledge pyramid (Bernstein, 2011). It was used by
practitioners to describe the judgemental capabilities and the problem-solving capacities of
employees.
Making the right decisions
An important effect of wisdom is the readiness to take critical decisions and use knowledge
properly (Thomas et al., 2017). Interviewees portrayed knowledge as an enabler of right
decision making. In addition, the level of maturity in decision making (e.g. the factors
considered to make a decision) was indicative of the quality of the decision making. One of the
interviewed senior directors (subject one) outlined how knowledge-based on the understanding
of company processes and governmental regulations enables “calculated risk-taking” and
“better decisions”. Another manager (subject two) explicitly referred to the role of knowledge
in decision making:
“…he can take the right decision; this shows that he has a lot of
knowledge.”
Subject 12 emphasised the quality of the decision-making process and the need to consider
the basis upon which the decisions are made. The decision-making skills were presented as a
‘must-have’ capability for each employee to handle his/her job duties. Starting from
onboarding training program confirmed this skill. Management knowledge was also seen as
another enabler to right decision making:
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"I think better decisions when the management has good knowledge
...decision-based knowledge can be very effective in taking decisions based
on knowledge. So, I believe it is a very important tool to be used in taking
decisions." subject three
Trouble shooting
Trouble shooting and problem solving were also highlighted by one third of participants as
a measure of personal knowledge. This was depicted by the ability to close gaps or solve
problems on daily work. The knowledgeable pharmaceutical employee is believed to be
familiar with the possible failure modes of his process and possible solutions. This was seen as
an indicator of knowledge stock and the ability to use this knowledge.
“Understanding of failure modes that may be present in each analysis…”
Subject 3
It also implies the analytical skills necessary to explore vague situations and come with the
right solutions. It was even considered a comparative advantage among individual employees.
“I think this is the knowledge we can assess in employees and compare
between individuals” subject nine
Additionally, accumulated experiences about specific types of problems and the most
effective solutions save both time and effort. Subject ten demonstrated his experience in
solving client companies’ problems with biologics in the following quote:
“When a company comes to us with a new problem; it's a new problem for
them, but it's something that we've seen before. So, we can dip into
previous work that we've done and kind of look at it and say okay we're
gonna use that same approach.”
Critical thinking
As mentioned before in the previous section, taking the right decision needs both a proper
use of knowledge and analytical skills. The employees are informally assessed for their ability
to think critically, apply solid criteria for decision, react well in difficult situations, interpret
the results and finally come with the right decisions or solutions. They have to illustrate this
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clear and rationale way to solve work problems. A senior director (subject 12) expressed his
expectations of his team in the following quote:
“Basis on which the decisions were made[…] what level of maturity they
have when they make those decisions what do they factor-in what do they
not factor-in […] do they underestimate certain things; how do they
communicate them that information how they communicate that decision;
are we leaning towards alt conservatism or are we more taking a more
risky approach that we should? Those are things that I debate through
today those are the kind of knowledge expectations that I want them to
reach.”
Applicable and creative solutions
The fourth element to be considered for problem-solving is the ability to think outside the
box. Personal knowledge is often reflected as creativity and self-expression (Bhatt, 2002).
Knowledge was believed to allow employees to introduce new ideas to improve the process or
product. This can be in the form of business cases or suggestions of improvement initiatives.
“How he can introduce new ideas to the process or the organisation; how he can present
business cases or suggestions to improve the process.”
Subject six

5.8.5 Organisational Understanding
The findings advocate that the personal knowledge of employee is not limited to the
technical aspects. Pharmaceutical industry employees are expected to know about their
organisation mission, vision, operations, functions, culture and values.

Organisational culture
The first component of organisational understanding is organisational culture and values.
Culture refers to shared assumptions or values which are learned within organisations to solve
their adaptation and integration problems (Schein, 2004). The findings show that employees
need to embrace company values and abide with certain ethical rules. From this perspective,
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the employee must know what is right and what is wrong within a specific organisational
context. The code of conduct of every organisation might define some of these values that
should be promoted among workers. These may include and not limited to integrity,
transparency, respect for people, etc. Employees understand the underlying assumptions in
their organisational culture to take the right decisions. Subject 13 explained the importance of
company values as shown in this quote:
“We are calling “Credo”. Credo is our values and one of the very
important point… law is the values that we are committing our customers
our consumer. For that, everyone in the company needs to know or have
knowledge of the credo and have a commitment of this.”
The employee’s understanding of the organisational jargon and technical terminology is
indispensable for the proper understanding of the organisational culture and dynamics.
Nevertheless, this jargon may vary from one manufacturing site to another even within the
same company. The induction training for new employees introduces those terms to new
employees as explained by subject 12.
“So, it is basically to understand the terminologies that are you within the
company's world worldwide and site-wide.”
Subject 12
Organisational mission and vision
Once a new employee joins the pharmaceutical company, he/she commences the necessary
orientation or induction training about the company. This would include the awareness of key
operations in addition to the organisational objectives, mission and vision.
“So, you can know the person who is really knowledgeable about what we
are doing.”
Subject 5
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Understanding his role in the organisation
Participants pointed out that the employee should be aware of his/her role in the organisation
along with the relationship with other teams and functions. Consequently, the employee’s roles
and relationships would be aligned with the organisational goals and objectives.
This can be exemplified by this quote from a senior director (subject seven):
“We assess also the organizational knowledge, how the person
understands the organisation, how the person understands his position in
the organisation, how the person understands the correlation between him
or her and their team with the organization alignment with organizational
objectives”.
Knowledge about other departments
The interviewees described other elements of knowledge on the organisation including
awareness of other operations and activities in other functions particularly in cases of
partnership or involvement with cross-functional project teams.

Common failures
This includes familiarity with historical failures and repetitive out of specifications (OOS)
results. This can be important for understanding the process trends and history of recurrent
issues. Subject three enumerated several actions that were taken to share this type of knowledge
among employees through the use of visual management tools.
“So, we try to make it very simple with pictures just to share the knowledge
most of the analysts fail in.”
5.8.6 Communication and networking skills
During the course of interviews, there was repeated emphasis that business is not only in
need of technical skills but also other social competencies. This agrees with the notion that
knowledge is not just a thing or a process but it can be envisaged as a personal network (Chatti,
2012) and knowledge work is increasingly social (Wright, 2005). Engagement with the team,
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taking the lead, effective communication and motivation of peers are some of the skills
expected by interviewees from the workforce. To achieve this, certain characters were endorsed
by interviewed industry experts, e.g. openness and transparency, practical and pragmatic.

Team player
Certain skills and competencies are expected by the interviewed experts from the
pharmaceutical employee to undertake his job effectively. The employee needs to work with
teams, take the required actions and maintain a good relationship with team members. In other
words, he/she should be a team player who shows high levels of engagement in the assigned
activities.
“The main knowledge is what I want to evaluate is the ability to be team
player” Subject five
This can be understood in light of the high level of maturity in project management in the
pharmaceutical firms (Wakefield, 2005) which requires engaged teams.

Leadership, motivation and upward communications
Participants advised that an employee is required to know how to take the lead in
organisational initiatives. They stated this type of knowledge or skill is even of more
significance at the senior level. It implies also the capability to motivate co-workers and team
members. Participants affirmed that individuals could have a gross impact on team spirit.
Consequently, they need to know how to manage this.
On the other hand, interviewed managers required their employees to know the right way
of dealing with and influencing top management. This comes from their experiences with
escalation and bottom-up (upward) communications. In other words, they need to know how
and when to escalate and use this effectively to communicate with or even influence senior
management.
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Internal and external network
The personal network is an important determinant of the flow of knowledge in the
organisation (Chatti, 2012). This network can be internal or in other words consisting of friends
from the workplace, perhaps colleagues from the same or different functions. It can also be an
external network where the employee has access to what is called the communities of practice
(COP) (Bolisani & Scarso, 2014). This also requires good communication skills with coworkers which is necessary for a manufacturing role. These behaviours that signify openness
and transparency and effective communication are necessary for a successful business. Subject
11 demonstrates types of behaviours which are appropriate for the manufacturing organisation:
“We look at behavioral specialisms as well. So that we're looking at the
types of behaviors that were nominated as being appropriate in our
organisation and knowledge transfer and sharing would be one of those
Ummm…you know, openness and transparency and communications and
things like that.”

5.8.7 Learning and education
Formal education is still a prerequisite for many pharmaceutical manufacturing roles.
During recruitment, each role usually specifies the required qualifications. Participants showed
that it can be even used for comparison between people’s knowledge in the form of “how many
qualifications do you have?”. Likewise, other participants asserted that certificates can also
become a prerequisite before getting a promotion or being qualified for certain jobs.
With regard to training, two sub-themes were discovered: adherence to training and training
effectiveness. Companies develop training programs, and they expect employees to adhere to
this program. Completing 100% of the assigned training courses is the expectation. Companies
use both internal and external training resources. Interviews revealed also that well-known
training companies might supply external training. Also, special training and qualification are
required for critical processes. Training programs start with induction training for new
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employees. There is periodic training and on the job training. Employees might also be trained
on historical issues and OOS. Last but not least, training was confused by some participants
with knowledge sharing or knowledge measurement as shown in the following quotes:
“When they receive a kind of knowledge sharing or knowledge transfer
techniques like the training, for example, they need to be assessed for how
much understanding they get form the training?” Subject seven
“I think I have answered this question before through the qualification
training program. I think that is the only way we have to ensure knowledge
transferred correctly.” Subject eight
“They need to be assessed for how much understanding they gain from this
knowledge” Subject seven
The lack of discrimination between training and knowledge sharing was observed multiple
times with several participants particularly when they discussed training effectiveness. They
described how they measure the knowledge acquired by their employees after training through
training effectiveness checks. The interviewer was aware of this confusion but he didn’t
interfere not to guide the interviewees and to minimise bias in the results. In terms of the
effectiveness criteria, it was primitive and not well-developed for regular training. It was
described as a simple quiz usually taken after reading the relevant standard operating
procedure. Then the trainee is required to solve these questions to be certified for that training.
However, critical tasks have extensive testing under what is called “qualification programs”.
This includes a quiz, essay, oral discussions, presentation, monitoring programs and
certification. Subject 13 clarify this in the following quote:
“I mean if it's something critical to the consumer health, we will have not
only an SOP it will be like guidance, SOPs, standards plus presentation
plus you know like quizzes plus certification that this guy has a completed
the stuff and so on.”
Similarly, subject eight and 12 respectively added:
“This is mandatory and oral discussions are not accepted anymore, so we
have to prove that knowledge transfer is done in a satisfactory manner.”
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“We do have ways to assess those people and their learning through either
questions or some kind of assessment that are done depending on the level
or criticality of the information that being transferred to that person and
we can very well characterize their level of understanding based on those
challenges and those questions and those on that assessment.”
Another type of education highlighted in the interviews includes soft skills and languages
(e.g. English). In fact, the global regulatory guidelines by WHO, FDA, ICH are published in
English. Furthermore, multinational companies have employees from different nationalities
and learning a foreign language can be necessary for communication and knowledge sharing.
This can explain the value of learning foreign languages in particular the English language.
The willingness to learn was also seen as an antecedent of knowledge. This was explained
that people gain knowledge in their areas of interest. Indeed, the ability to assimilate and use
knowledge (Absorptive Capacity) at an individual or organisational level is dependent on the
prior knowledge of a closely related discipline (Cohen & Levinthal, 1990). According to this
notion, if the employee is interested in a particular discipline (e.g. following certain regulatory
guidelines, reading particular books, communicating with industry experts in this field, etc.),
this can be an indicator of his knowledge in this field or a similar field. The next quote can
exemplify this idea from subject one:
“You can see that the people's interests. So, definitely staff or employees
who are interested in following annexes or some different ICH chapters or
looking about those things. This might be an indicator that he is building or
he fed his knowledge.”
Likewise, subject six added:
“you can find someone who always has more knowledge more than at the
task he is performing at the moment; he always has a need to learn and
read about the process […] I think this is the way I can manage I can
assess the knowledge ..can measure the knowledge of the employee.”

5.8.8 Experiential knowledge
Experiential knowledge refers to personal prior experiences particularly about people,
places, events or feelings (Mingers, 2008). This type of knowledge was described by
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interviewees as the knowledge that develops over time. It is usually measured by the years of
experience or job tenure. Moreover, ICH Q10 outlines the prior knowledge and experiences as
one of the sources of pharmaceutical knowledge (ICH, 2008). However, relying on seniority,
length of experience, the number of training courses or qualifications as a sole measure of
knowledge received a lot of criticism from some participants. It is claimed that pharmaceutical
organisations are busy measuring the explicit potential causes of knowledge which are not
always associated with a high level of tacit knowledge. Subject 11 explained the current
process of assessing or comparing employee knowledge as follow:
“You know, and very often they tend to be around seniority rather than
capabilities. you know how many years of experience do you have how
many qualifications do you have, how many training courses have you been
on. So, in my experience is still that are our training organizations that
tend to capture our qualifications and our capabilities… focus more on
again those explicit outcomes rather than that tacit (knowledge) sharing.”
Moreover, the value of experience is seen related to the level of relevance to the current job.
Technical jobs have prerequisite requirements of relevant experiences. This means the
employee spends a certain period doing this job or similar job. The reason behind this, as
explained by a validation leader in one of the multinational pharmaceutical organisations, the
level of performance is proportional to the experience. If the employee did a particular job
before, it would be easier for him to repeat it. Experience facilitates task execution as shown
below:
“Because the level of knowledge you have facilitates your job execution if
you are participated before in the in the job then when you are trying to
validate it would be very easy for you to execute or to start the protocol or
to conclude a report on the gaps.”
The same idea was mentioned by another manager who explained how his team solve
industry problems for their clients using their experiences and pretested solutions as shown in
the following quote:
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“It's a new problem for them, but it's something that we've seen before […]
we're gonna use that same approach.” Subject ten
Over and above, interviewees used the experience to differentiate between two types of
knowledge: explicit knowledge coming from books and documents versus tacit knowledge
(Polanyi, 1966) acquired by socialisation and experience.
“You can learn from documents like research or books or something you can get out of a
library and knowledge based on experience that they have to develop over time.” Subject 12

Framework Development
This study adopts an abductive approach engaging both of the extant literature and the
primary data to develop the research framework (Saunders et al., 2016). The outcome of the
exploratory phase is utilised to develop a measurement framework to identify and measure the
personal knowledge of the pharmaceutical industry employees. The framework consists of
observed indicators (measures or manifestations of the personal knowledge) together with the
underlying latent factors. The proposed framework design is in line with the theoretical
assumptions of Second-Order Hierarchical Confirmatory Factor Analysis (CFA) (Kline, 2015).
The proposed framework identifies 41 personal knowledge measures (observed variables)
reflecting six latent factors describing the main latent variable of the study i.e. the personal
knowledge of knowledge workers in the pharmaceutical manufacturing. Because knowledge
and its underlying factors are latent variables that cannot be measured directly (Bollen &
Lennox, 1984), the research used both primary data from the thematic analysis as well as the
literature when applicable to define the observed measures of the personal knowledge. The six
hypothesised factors are: regulatory compliance, performance, wisdom, organisational
understanding, product and process understanding (mastership) besides communication and
networking skills (Figure 5-2; Table 5-2). Education, KM maturity of organisation, type of
organisation, employee experience, training and job level will be studied as controls.
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The first control is the education level starting from high school and up to PhD level. KM
maturity included four levels of maturity based on Lotti Oliva (2014) framework. The four
levels of KM maturity start from the lack of awareness of KM, the lack of formal KM
processes, isolated implementation of KM to the top level where KM becomes a part of the
holistic organisation strategy. Type of organisation compared domestic, international and
multinational enterprises. Employee experience was included as the total number of years in
the pharmaceutical industry (total experience) and the experience in the current role (current
experience). Training was basically assessed by the percentage of compliance to the training
plan. Finally, the job level included five levels starting from the entry-level or student and up
to senior management.

Figure 5-2 The conceptual framework
Table 5-2 PK measures and the underlying factors
Factor

Measures

Compliance
Identify compliance gaps/deviations in your area/process
and regulatory Associate compliance gaps to a specific clause in a standard,
awareness
SOP or a Pharmacopeia

Code
R1
R2

Find relevant standards or regulatory guidelines

R3

aware of updates to regulatory standards, specifications and
SOPs

R4
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Factor

Measures

Code

Involved in the development and improvement of standards and
specifications in your organisation

R5

Mastership of Locate relevant process and product related information
product/process Carry out assigned responsibilities without supervision
Contribute to the design and
processes/products within your function

Wisdom

development

M1
M2
of

M3

Train others in relation to your current role

M4

Complete relevant records/forms (including electronic records)
associated with products or processes in your department

M5

Explain to colleagues the scientific basis and precautions of
processes in your area

M6

Explain to colleagues the technology utilised in machinery and
equipment in your area

M7

Are involved in the design, validation, control and continuous
improvement of products/processes in your function

M8

Technical advising (colleagues seeks one’s technical advice)

M9

Think critically (clearly and rationally) to solve work problems

W1

Solve daily work problems efficiently

W2/W3

Other people believe you solve daily work problems efficiently

Organisational
understanding

Performance

Other people believe you make the right decisions in work

W4

Your out of the box suggestions are implemented within your
organisation

W5

Understanding his role

O1

Familiarity with processes in other departments of the
organisation.

O2

Understand the terminology used in your organisation

O3

Understand the values of your organisation

O4

Understand the vision, mission and goals of your organisation

O5

Abide by the values of your organisation

O6

Explain the historical Out of Specifications (OOS), failures
and/or any weaknesses in your area

O7

Achieve departmental/organisational goals successfully

P1

Play a key role in successful projects in your area

P2

Complete assigned tasks "right first time"

P3

Complete assigned tasks in a consistent manner

P4

Complete assigned tasks on time

P5

Meet or exceed the required targets

P6
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Factor

Measures

Code

Achieve a strong positive evaluation in annual appraisal by
management (performance management)

P7

Network and Identify the appropriate person to obtain information relating to
communication a specific product/process

N1

Communicate effectively with co-workers to get the job done

N2

Communicate effectively with senior management

N3

Motivate others to achieve organisational goals

N4

Lead others to achieve organisational goals

N5

People see you as a team player

N6

have a wide network of contacts within your organisation

N7

have a wide network of contacts outside your organisation
(pharmaceutical and non-pharmaceutical)

N8

Summary and Conclusion
This chapter demonstrated the findings of the exploratory study and the outcomes of the
thematic analysis. Fifteen interviews were conducted with pharmaceutical industry experts
from nine countries. The interviews explored the practitioner’s definitions of knowledge and
how it is managed in the pharmaceutical manufacturing sector. The study shed light on the
level of KM maturity in the pharmaceutical sector. The chapter discussed the value of the
personal knowledge measurement for the pharmaceutical firm. Finally, personal knowledge
measurement practices and indicators were explored and explained. In light of the thematic
analysis and literature review, the conceptual framework was abductively developed. The next
chapter is data analysis of the quantitative survey in an attempt to confirm and optimise the
proposed conceptual framework.
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Introduction
This chapter focuses on the analysis of the data obtained from the questionnaire. The design
and distribution of the questionnaire is outlined in chapter four. In total, 190 valid responses
were received using Google forms for data collection. The chapter provides the details of the
respondents and their organisations before focusing attention on the analysis of the framework
using CFA tools.

Sample demographics data
6.2.1 Descriptive statistics
At the end of the quantitative data collection phase, 190 valid responses were received
including participants’ self-assessment of their personal knowledge. The questionnaire
included 41 questions (based on Likert scale) representing the proposed 41 observed indicators
of personal knowledge. Table 6-1 demonstrates the descriptive statistics of the selected scores
on Likert scale. The results show that the selected ratings ranged between 1 and 7. Based on
sample mode, (5, 6 and 7) were the most selected scores. However, the mean score is positively
shifted (between 4.9 and 6.2). Sample kurtosis and skewness will be discussed in section 6.3.1
“data preparation”.

Mean

SE Mean

TrMean

StDev

Variance

Minimum

Q1

Median

Q3

Maximum

Range

Mode

N for
Mode

M1

190

5.6

0.08

5.7

1.1

1.3

2

5

6

6

7

5

6

61

M2

190

5.6

0.11

5.8

1.5

2.1

1

5

6

7

7

6

7

63

M3

190

5.5

0.10

5.6

1.4

2.0

1

5

6

7

7

6

7

57

M4

190

5.9

0.08

6.0

1.1

1.3

2

5

6

7

7

5

6

69

M5

190

5.8

0.09

5.9

1.2

1.4

1

5

6

7

7

6

6

73

M6

190

6.0

0.07

6.1

1.0

1.1

2

5

6

7

7

5

6

73

M7

190

5.7

0.08

5.8

1.1

1.3

1

5

6

7

7

6

6

65

M8

190

5.6

0.09

5.7

1.2

1.5

1

5

6

7

7

6

6

67

M9

190

5.8

0.07

5.8

1.0

1.0

2

5

6

6

7

5

6

81

N1

190

5.7

0.09

5.8

1.2

1.5

1

5

6

7

7

6

7

58

Variable

Total
Count

Table 6-1 Descriptive statistics
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StDev

Variance

Minimum

Q1

Median

Q3

Maximum

Range

Mode

N for
Mode

CHAPTER 6: Quantitative Data Analysis

N2

190

6.0

0.07

6.1

1.0

1.0

1

6

6

7

7

6

6

79

N3

190

5.9

0.08

6.0

1.0

1.1

2

5

6

7

7

5

6

75

N4

190

5.7

0.08

5.8

1.1

1.2

2

5

6

6

7

5

6

68

N5

190

5.8

0.08

5.9

1.1

1.2

1

5

6

7

7

6

6

75

N6

190

6.0

0.07

6.0

1.0

1.0

2

5

6

7

7

5

6

76

N7

190

5.9

0.08

6.0

1.1

1.2

2

5

6

7

7

5

6

68

N8

190

5.6

0.09

5.7

1.3

1.6

2

5

6

7

7

5

6

59

O1

190

6.2

0.06

6.3

0.9

0.8

3

6

6

7

7

4

7

87

O2

190

5.8

0.07

5.8

1.0

1.1

2

5

6

7

7

5

5

64

O3

190

6.1

0.06

6.2

0.9

0.8

3

6

6

7

7

4

6

74

O4

190

6.0

0.08

6.1

1.0

1.1

3

5

6

7

7

4

7

71

O5

190

5.7

0.08

5.8

1.2

1.4

1

5

6

7

7

6

6

68

O6

190

5.7

0.09

5.7

1.2

1.4

1

5

6

7

7

6

6

62

O7

190

5.4

0.10

5.5

1.3

1.8

1

5

6

6

7

6

5

54

P1

190

5.9

0.07

5.9

1.0

1.0

1

5

6

7

7

6

6

91

P2

190

6.0

0.07

6.1

1.0

0.9

3

5

6

7

7

4

6

72

P3

190

5.8

0.07

5.9

1.0

1.0

3

5

6

7

7

4

6

82

P4

190

6.0

0.07

6.0

0.9

0.8

3

5

6

7

7

4

6

81

P5

190

5.9

0.07

6.0

1.0

1.0

1

5

6

7

7

6

6

75

P6

190

5.9

0.07

6.0

1.0

1.1

2

5

6

7

7

5

6

74

P7

190

5.9

0.08

6.0

1.2

1.4

1

5

6

7

7

6

79

R1

190

5.2

0.11

5.2

1.5

2.3

1

4

5

6

7

6

R2

190

4.9

0.12

5.0

1.7

2.8

1

4

5

6

7

6

6
5,
6
6

R3

190

5.7

0.09

5.9

1.3

1.7

2

5

6

7

7

5

7

65

R4

190

5.7

0.08

5.8

1.1

1.2

1

5

6

7

7

6

6

68

R5

190

5.5

0.09

5.6

1.3

1.6

1

5

6

6

7

6

6

65

W1

190

6.0

0.07

6.1

0.9

0.8

2

6

6

7

7

5

6

81

W2

190

6.0

0.06

6.1

0.9

0.7

3

6

6

7

7

4

6

86

W3

190

5.9

0.07

6.0

0.9

0.8

3

5

6

7

7

4

6

78

W4

190

5.9

0.07

5.9

0.9

0.8

3

5

6

7

7

4

6

81

W5

190

5.1

0.09

5.2

1.3

1.6

1

4

5

6

7

6

5

62

50
51

6.2.2 Respondents
The review of sample statistics shows that more than two-thirds (70%) of respondents are
males while female respondents represent only 26% of the sample with 4% of respondents
failing to provide this information. The responses reflect the gender imbalance in the
manufacturing sector. According to the statistical office of the European Union, males are
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overrepresented in the manufacturing sector (79%) in comparison to females (Eurostat, 2020).
The sample also includes 49 responses from quality assurance and 50 responses from quality
control constituting 52% of all responses. In addition, 40% of responses were from production,
packaging and technical services. The remainder of respondents is affiliated to other functions
including supply chain, operation excellence and project management roles (Table 6-2). Figure
6-1 depicts the level of education of the respondent. While more than half of the sample
received at least university education, 73 respondents completed postgraduate studies with ten
of the respondents hold a PhD degree.

Figure 6-1 Level of Education

Table 6-2 Participating Functions
Frequency

Percentage

Quality Assurance

49

26%

Production or packaging

39

21%

Quality Control

50

26%

Technical services

37

19%

Other

15

8%

Total

190

Furthermore, the average length of experience of participants from the manufacturing sector
ranged from one year and up to 27 years with an average of approximately 10 years (standard
deviation = 5.314 years). Figure 6-2 depicts the distribution of the number of years of
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experience of respondents. On average, 72% of the participants’ tenure was at the current
function. However, only 51% of the tenure was at the current employer. This reflects the mixed
experiences held by respondents at different functions and different organisations. The sample
varied also at the depth of experience at one department or function ranging from totally new
up to 18 years at the same department.

Figure 6-2 A histogram depicting the experience range of respondents
The sample represented different job levels in the organisation. However, it can be noticed
that middle and senior managers constitute 39% of the sample (Figure 6-3). This relative overrepresentation of managers may be attributed to the design of the two-stage cluster sampling
where contact persons (can be more than one per organisation), who were selected from
managers and senior managers, were solely responsible for distributing the survey within their
organisation. However, some managers provided only a single response per organisation and
apologised that it is not possible to share the survey link within their organisation due to fear
of company’s data breach. Another potential reason for the over-representation of managers is
that the survey was not designed to be distributed to every member of the organisation.
Operators and technicians were out of the scope of this survey. As a result, the survey was
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distributed among fewer professional levels where managers may make a significant portion
of them.

33%

33%
28%

6%

1%

Figure 6-3 Job Level
As the questionnaire language was in English, it was found necessary for data validity
purposes to ensure that participants are able to understand the questions and select the most
accurate answer. Three main language skills were self-assessed by respondents. With regard to
reading skill, 98.4% of respondents described themselves as intermediate, advanced or native.
Despite that English reading skill are the most relevant skill required to complete the
questionnaire properly, other language skills were evaluated too. The survey shows that over
96% of respondents possess intermediate to advanced speaking and listening skills (Table 6-3).
Table 6-3 English Language Fluency

Beginner
Intermediate
Advanced
Native or bilingual

Reading
1.6%
12.1%
71.6%
14.7%
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Speaking
1.6%
35.8%
49.4%
13.2%

Listening
3.2%
27.9%
55.8%
13.2%
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6.2.3 Organisations
More than half of the participants are affiliated to well established pharmaceutical
organisations operating for more than 20 years. Conversely, two percent of responses came
from relatively new firms operating for less than five years (Table 6-4Table 6-4).
Table 6-4 Age of organisation
Frequency
4
22
59
60
45

Less than 5 years
From 5 to 10 years
From 11 to 20 years
From 21 to 50
More than 50 years
Total

Percent
2.1
11.6
31.1
31.6
23.7

190

The European Commission defines small enterprises as an enterprise that employs less than
50 employees while medium enterprise employs more than 50 but less than 250 (EC, 2003).
Forty-four respondents were affiliated to medium size enterprises while only 6 worked for
small enterprises (Table 6-4). Chi-Square test of independence (Table 6-6) revealed a
significant association between the organisation size and age (Pearson Chi-Square =78.059;
df=16; P< 0.000).

Table 6-5 Size of organisation

Less than 50 employees
From 50 to 249 employees
From 250 to 500 employees
From 500 to 1000 employees
More than 1000
Total

6-177

Frequency
6
44
33
28

Percent
3.2
23.2
17.4
14.7

79
190

41.6
100.0
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Table 6-6 Chi-Square Test: Organisation size vs age

Value
78.059
88.865
190

Pearson Chi-Square
Likelihood Ratio
N of Valid Cases

Asymptotic
Significance (2-sided)
.000
.000

df
16
16

40
35

Frequency

30
25
20
15
10
5
0
Less than 5 years

From 5 to 10 years

From 11 to 20 years

From 250 to 500 employees

From 50 to 249 employees

Less than 50 employees

More than 1000

From 21 to 50

More than 50 years

From 500 to 1000 employees

Figure 6-4 Organisation size vs age
Four levels of knowledge maturity were recognised among the organisations of participants
based on Oliva (2014) framework that identified four levels of KM maturity: insufficient,
structured, oriented and integrative (Figure 6-5). Approximately one-third of participants’
organisations belonged to the structured KM maturity level. Only 18% of respondents referred
to a lack of awareness of the need to KM in their organisations. Interestingly, Chi-Square test
of independence showed (Table 6-7) no association between organisational size and the level
of KM maturity (Pearson Chi-Square= 18.357; df=12; P=0.105). Similarly, the test (Table 6-8)
demonstrated a lack of association between the organisation age and the level of KM maturity
(Pearson Chi-Square=19.310; df=12; P=0.081).
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Table 6-7 Chi-Square Test: organisation size vs KM maturity

Pearson Chi-Square
Likelihood Ratio
N of Valid Cases

Value
18.357
20.171
190

Asymptotic
Significance (2-sided)
.105
.064

df
12
12

Table 6-8 Chi-Square Test: organisation age vs KM maturity

Pearson Chi-Square
Likelihood Ratio
N of Valid Cases

Value
19.310
19.309
190

df
12
12

Asymptotic
Significance (2-sided)
.081
.081

Level of KM Maturity
Insufficient

Structured

Oriented

Integrative

32%
27%
23%
18%

There is a general lack of The management is aware of
Formal knowledge
Knowledge management is
awareness of the need for the importance knowledge management initiatives take part of a holistic organisation
knowledge management. management but there are place at some departments strategy and continuously
no or few formal processes (islands of knowledge) but it reviewed by management.
for identifying, capturing,
is not part of an
sharing, transferring, and organisation-wide strategy.
applying knowledge.

Figure 6-5 KM Maturity levels in the sample organisations
Forty-nine percent of respondents described their manufactured product as conventional
pharmaceuticals. Fourteen percent produced biologics and 24% have mixed portfolios. The
remainder of participating manufacturers is specialised in other pharmaceutical products such
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as medical devices, veterinary product or active pharmaceutical ingredients (API). It should
be emphasised that more than 52% of responses were received from multinational and
international enterprises (Table 6-9). Also, 93.2% of the respondents are affiliated to private
sector organisations while the remaining 6.8% work for governmental firms.
Table 6-9 Type of participants’ organisation

Multinational or global
International
Domestic/local
Total

Frequency
100
1
89
190

Percent
52.63 %
0.53 %
46.84 %
100.0 %

Finally, almost two-thirds of participants completed more than 80% of their technical and
GMP training plan at the time of filling the survey (Table 6-10).
Table 6-10 Compliance to training plan among participants

Less than 40%
40-50%
51-60%
61-70%
71-80%
81-90%
More than 90%
Total

Frequency
6
8
4
15
32
60
65
190

Percent
3.2
4.2
2.1
7.9
16.8
31.6
34.2
100.0

Confirmatory Factor Analysis
6.3.1 Data preparation
The data was prepared for further analysis. This included the analysis of missing data,
outliers, data normality and reliability. Data organisation and coding of the variables was
required to prepare them for CFA. Variable codes are presented in chapter five (Table 5-2).
Both SPSS 26 and IBM AMOS 26 were used for data analysis at this stage.
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Missing data and outliers
The risk of incomplete surveys or in other words missing data was mitigated by making the
41 model questions required. However, an initial analysis of the data identified a small
percentage of missing data (less than 1%) as the first ten responses were received before
making all the model questions required (not more than one missing response per variable).
Estimate means and intercepts option in AMOS was selected to compensate the few missed
entries (less than 1%). No further action was taken.
Multivariate outliers are cases whose variables show a pattern of values different from other
cases in the sample. Although there is no consensus on the best action to be taken to deal with
outliers, multivariate outliers possibly caused by data entry mistakes or random responding can
be omitted (Bandalos, 2018). Mahalanobis Distance test in SPSS 26 was used to identify
outliers in the sample. Twelve multivariate outliers were identified in the dataset (P <0.001).
The researcher chose to compare the model estimation and goodness of fit with and without
those outliers. A small and insignificant improvement in model fit was observed after omitting
the outliers from the data. Based on this observation, a decision was made to retain multivariate
outliers.

Normality of variable distribution
One of the basic assumptions of CFA is data normality. According to the probability
theory, normal or Gaussian distribution is a type of continuous probability distribution where
the characteristic bell curve can be defined by the population mean and standard deviation
(Lucey & Lucey, 2002). Reporting the skew and kurtosis indices of all continuous variables
is a recommended practice (Kline, 2011). It has been recommended that the skewness index
should not exceed | 2.0 |. However, more liberal standards have accepted kurtosis up to | 7.0 |
(Bandalos, 2018).
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As outlined in Table 6-11, skewness and kurtosis values are less than | 2.0 | and | 7.0 |
respectively suggesting acceptable data normality. It is noteworthy that all skewness values are
negative. This is in line with Dunning-Kruger effect on self-evaluation of personal knowledge
(Schlösser et al., 2013) which will be discussed in the next chapter. Last but not least, the data
presented in the form of a Likert scale from one to seven. The literature suggests a negligible
bias in parameter estimates can be achieved when the Likert scale is five or more categories as
the data can be treated as continuous (Bandalos, 2014).
Table 6-11 Data Skewness and Kurtosis
Minimum Maximum
M1
M2
M3
M4
M5
M6
M7
M8
M9
N1
N2
N3
N4
N5
N6
N7
N8
O1
O2
O3
O4
O5
O6
O7
P1
P2
P3
P4
P5
P6
P7

2
1
1
2
1
2
1
1
2
1
1
2
2
1
2
2
2
3
2
3
3
1
1
1
1
3
3
3
1
2
1

7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7

Mean

Std.
Deviation

5.61
5.61
5.49
5.90
5.82
5.97
5.70
5.63
5.77
5.68
5.98
5.89
5.68
5.77
5.96
5.88
5.55
6.24
5.75
6.10
5.97
5.73
5.65
5.42
5.86
5.98
5.83
5.98
5.89
5.87
5.87

1.125
1.464
1.421
1.134
1.201
1.028
1.122
1.225
1.010
1.245
1.008
1.041
1.081
1.083
.988
1.097
1.283
.875
1.027
.888
1.038
1.163
1.187
1.330
1.000
.970
.988
.900
1.018
1.031
1.171
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Skewness

Kurtosis

Statistic Std. Error Statistic Std. Error

-.660
-1.161
-.890
-1.077
-1.325
-1.058
-.885
-1.085
-1.053
-1.005
-1.306
-.944
-.916
-1.167
-1.050
-1.105
-.817
-1.354
-.761
-.793
-.882
-1.040
-.972
-.865
-1.345
-.801
-.786
-.674
-1.033
-.973
-1.732

.176
.176
.176
.176
.176
.176
.176
.177
.177
.177
.176
.176
.176
.176
.177
.176
.176
.176
.176
.176
.176
.176
.177
.176
.176
.176
.176
.176
.176
.176
.176

.230
.811
.326
.810
2.160
1.074
1.049
1.525
1.952
1.062
2.876
.733
1.361
2.325
1.406
1.392
.225
2.353
1.058
.143
.218
1.350
1.378
.679
3.314
.194
.334
-.021
1.909
1.183
4.314

.351
.351
.351
.351
.351
.351
.351
.352
.352
.352
.351
.351
.351
.351
.352
.351
.351
.351
.351
.351
.351
.351
.352
.351
.351
.351
.351
.351
.351
.351
.351
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Minimum Maximum

1
1
2
1
1
2
3
3
3
1

R1
R2
R3
R4
R5
W1
W2
W3
W4
W5

7
7
7
7
7
7
7
7
7
7

Mean

5.17
4.89
5.75
5.74
5.48
6.04
6.04
5.89
5.86
5.13

Std.
Deviation

1.527
1.672
1.289
1.082
1.274
.908
.863
.905
.900
1.266

Skewness

Kurtosis

Statistic Std. Error Statistic Std. Error

-.724
-.638
-1.017
-.892
-1.030
-1.028
-.820
-.617
-.608
-.620

.177
.177
.176
.177
.177
.176
.176
.177
.177
.176

-.290
-.535
.345
1.260
1.442
1.674
.718
.310
.336
.497

.352
.352
.351
.352
.352
.351
.351
.352
.352
.351

Reliability
Cronbach’s alpha α was used to assess instrument reliability. Cronbach's alpha is a widely
used measure of the reliability of such multi-item indices (Bonett & Wright, 2014; Cronbach,
1951). The test depends on the number of items k and their intercorrelation r̅.
α𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑𝑖𝑠𝑒𝑑 =

𝐾 r̅
(1+(𝐾−1)r̅)

A high value of Cronbach's alpha implies a high level of reliability or low response variance.
On the other hand, a small value may be an indicator of low instrument reliability or can
indicate that the items do not really measure the same construct (Groves et al., 2004).
As pointed out earlier, the number of test items, item interrelatedness and dimensionality
affect the value of alpha. The commonly acceptable values of alpha range from 0.70 to 0.95
(Tavakol & Dennick, 2011). The calculation of Cronbach’s alpha coefficients for the different
factors ranged from 0.738 to 0.886 indicating acceptable internal consistency between
questions and answers as seen in the table below (Table 6-12).
Table 6-12 Cronbach's alpha
Factor
Mastership of
product/process
Wisdom
Organisational
understanding
Performance

Cronbach's Alpha

Cronbach's Alpha Based
on Standardized Items

.859

.863

.823

.840

.846

.854

.881

.886
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Network and
communication
Compliance and regulatory
awareness

.858

.866

.738

.738

6.3.2 Model Specification
The specified model consists of 41 reflective (effect) indicators (Bollen & Bauldry, 2011)
and six underlying latent factors creating a second-order hierarchical CFA model. Hierarchical
models present the hypotheses in such a way that the higher-order factors have a presumed
direct causal effect on the lower order factors (Kline, 2011). The relationship between the
latent variable and the reflective indicators is theoretically grounded based on the conceptual
framework presented in chapter five and considered as the manifestations of the personal
knowledge of pharmaceutical manufacturing employees. Each of the 41 observed indicators
has a unique variance as shown in Figure 6-6. Unique variance accounts for the measurement
error or the unreliability in a specific indicator in contrast to the common variance
(communalities) accounted for the latent variables in the model (Kenny, 2006). Similarly, each
latent factor of the first order variables has a residual which accounts for the variance
unexplained by the higher-order construct (Kline, 2011). Personal knowledge is a latent
variable that doesn’t have its own observed indicators. Instead, it is indirectly measured by the
observed indicators measuring the first-order constructs (Byrne, 2016).
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Figure 6-6 Specified full model one
For graphical representation, rectangles were used to refer to the observed variables, while
oval shapes referred to the latent variables. Straight arrows describe the direction of the causal
relation in the model. IBM Amos 26 offers three methods for model specification:
programming, graphics and table interface (Byrne, 2016). Amos Graphics user interface was
utilised to specify the model instead of the traditional programming (coding) interface. This
method was found more convenient and poses a lower risk of coding errors. For reasons related
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to model identification, the researcher constrained the regression path of one observed indicator
per each of the six first order constructs to the value of one. Because the impact of the latent
variable (personal knowledge) on the lower order construct and measures is the main interest
of this study, the researcher constrained the variance of personal knowledge to one leaving the
second-order factor loadings freely estimated. All measurement error and residual variables
have a constrained regression coefficient of one. Based on the theoretical background of this
model, cross loadings are fixed to zero.

6.3.3 Model identification
Bollen (1989) suggested three conditions for model identification:
•

Three or more observed variables must load on each latent construct.

•

Measurement error variances are not correlated.

•

Each variable loads on one latent construct.

As shown in the model specification section, all three conditions are met. In CFA, a model
must be either just identified or over-identified (recommended) but cannot be under-identified.
In other words, the number of variance/covariance elements must be equal or more than the
parameter values to be estimated (Bandalos, 2018). The following formula calculates the
number of covariances in the model:
𝑣(𝑣 + 1) 41(41 + 1)
=
= 861
2
2
Where v is the number of observed variables. The total number of variances (41) and
covariances = 41+861 =902. The number of parameter values to be estimated in this model can
be enumerated as follow:
• 41+6 -6 =41 loadings/regression weights for first and second-order variables
excluding 6 constrained regression weights that have been fixed to one.
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• 41measurement error variances.
• 6 residuals variances.
• 41 intercepts
For a grand total of distinct parameters to be estimated = (41+41+6+41) = 129 which is less
than 902 (degrees of freedom = 902-129 = 732). A positive degrees of freedom means that the
model is over-identified and can be estimated (Byrne, 2016) as will be explained in the next
section.

6.3.4 Model estimation
Maximum Likelihood (ML) method was chosen for the model estimation. ML is the default
estimation algorithm in IBM AMOS 26 with assumptions of continuous and normally
distributed data. It is a widely used method offering unbiased, consistent, and efficient results
(Bandalos, 2018). The results of the initial model indicate an average regression weight of 0.7,
the maximum loading equals 0.95 and the minimum loading is 0.4. However, 94% of the
loading values are above 0.5 and 55% are above 0.7 which indicates a moderate to high
correlation with the underlying latent constructs and the latent variable (personal knowledge).
It is argued that moderate to high correlation is a desirable situation when dealing with effect
indicators in a model (Bollen & Lennox, 1984) such as the specified model in this study.
Moreover, all loading values are statistically significant (P< .001) as shown in Table 6-13.
Table 6-13 Model one standardised and unstandardised regression weights
Variables
Performance
Regulatory
Organisational
Network
Wisdom
Mastership
M9

<--<--<--<--<--<--<---

PK
PK
PK
PK
PK
PK
Mastership

Standardised
estimates
.923
.783
.813
.931
.946
.882
.554
6-187

Unstandardised
estimates
.651
.592
.572
.481
.585
.492
1.000

S.E.

P

.076
.083
.083
.087
.087
.066

***
***
***
***
***
***
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Variables
M8
M7
M6
M5
M4
M3
M2
M1
P7
P6
P5
P4
P3
P2
P1
R5
R4
R3
R2
R1
O7
O6
O5
O4
O3
O2
O1
N8
N7
N6
N5
N4
N3
N2
N1
W5
W4
W3
W2
W1

<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<--<---

Mastership
Mastership
Mastership
Mastership
Mastership
Mastership
Mastership
Mastership
Performance
Performance
Performance
Performance
Performance
Performance
Performance
Regulatory
Regulatory
Regulatory
Regulatory
Regulatory
Organisational
Organisational
Organisational
Organisational
Organisational
Organisational
Organisational
Network
Network
Network
Network
Network
Network
Network
Network
Wisdom
Wisdom
Wisdom
Wisdom
Wisdom

Standardised
estimates
.524
.677
.748
.678
.771
.703
.580
.583
.605
.739
.690
.821
.716
.828
.705
.594
.627
.695
.563
.502
.530
.695
.770
.821
.642
.592
.704
.404
.670
.723
.812
.767
.787
.764
.454
.490
.711
.714
.798
.825
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Unstandardised
estimates
1.148
1.359
1.375
1.456
1.563
1.786
1.519
1.174
1.000
1.077
.993
1.043
1.000
1.135
.997
1.000
.897
1.182
1.243
1.013
1.000
1.171
1.271
1.209
.809
.863
.875
1.000
1.417
1.378
1.696
1.601
1.581
1.485
1.091
1.000
1.032
1.040
1.111
1.208

S.E.

P

.195
.194
.185
.208
.207
.249
.240
.185

***
***
***
***
***
***
***
***

.131
.127
.118
.124
.128
.125

***
***
***
***
***
***

.138
.171
.207
.184

***
***
***
***

.173
.178
.164
.125
.140
.128

***
***
***
***
***
***

.271
.257
.305
.293
.287
.272
.248

***
***
***
***
***
***
***

.161
.162
.164
.176

***
***
***
***
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Table 6-14 shows the unique variances (measurement errors and residuals) in the model. It can
be observed that the variance of the second order latent variable (personal knowledge) has been
fixed to one. All other variances were left unconstrained.
Table 6-14 Unique Variances
Variables
PK
Res1
Res2
Res3
Res4
Res5
Res6
9
8
7
6
5
4
3
2
1
16
15
14
13
12
11
10
21

Estimate
1.000
.069
.074
.221
.167
.036
.040
.702
1.081
.678
.464
.775
.519
1.015
1.415
.831
.865
.480
.539
.263
.474
.294
.500
1.045

S.E.

P

.021
.023
.065
.048
.015
.018
.076
.116
.076
.055
.087
.063
.116
.154
.090
.093
.055
.060
.032
.053
.037
.056
.124

***
.001
***
***
.018
.023
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***

Variables
20
19
18
17
28
27
26
25
24
23
22
36
35
34
33
32
31
30
29
41
40
39
38
37
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Estimate
.708
.854
1.903
1.736
1.265
.723
.548
.350
.461
.681
.384
1.369
.660
.462
.399
.479
.409
.421
1.223
1.212
.398
.399
.269
.261

S.E.
.086
.114
.221
.195
.136
.084
.068
.048
.052
.075
.045
.143
.073
.052
.049
.056
.049
.049
.129
.128
.045
.046
.033
.034

P
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
***
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Figure 6-7 Model one with unstandardised estimates
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Figure 6-8 model one with standardised estimates
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6.3.5 Model testing “goodness of fit”
The model that well fits the data as explained in the SEM literature should be able to match
and reproduce the actual covariances among the variables in the study sample (Bandalos,
2018). A survey of the literature reveals that methodologists have proposed many fit indices.
Model chi-square (χ2) is one of the most popular indices of the overall model fit. Significant
chi-square at 0.05 threshold implies a poor model fit. However, this method was criticised for
being over-sensitive to sample size (Hooper et al., 2008). Table 6-15 shows a significant χ2 test
results (P< .05) as an indication of poor model fitting (for model one). However, the literature
shows no consensus on χ2 test as a sole indicator of the overall model fit. In fact, SEM
researchers emphasised that significant χ2 test results don’t necessarily entail model rejection
but further exploration in light of the theories underlying the proposed model (Bandalos, 2018;
Crede & Harms, 2019). In order to mitigate the effect of sample size, the relative or normed
chi-square (χ2 /DF) was proposed as an alternative to chi-square test where a value of five or
less indicates good fit (Tabachnick & Fidell, 2007; West et al., 2012). χ2 /DF equals to 2.668
(Table 6-15). The first row of the table below refers to the model under test (model one), while
the two rows beneath handles the saturated and the independence models. The independence
model can be described as a hypothesised model in which the correlations between its variables
equal to zero. In contrast, the saturated model has the number of parameters to estimate equal
to the variances and covariances of the observed variables and is the least restricted (Byrne,
2016).
Table 6-15 χ2 Test results for model one
Model
Default model
Saturated model
Independence model

No. of
Parameters
129
902
41
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χ2

DF

P

χ2 /DF

2062.208
.000
5694.069

773
0
861

.000

2.668

.000

6.613
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In addition to χ2, two other popular fit indices were consulted. The root mean square error
of approximation (RMSEA) (Steiger, 1980) and the comparative fit index (CFI) (Bentler,
1990). RMSEA is considered as an error of approximation index that can assess the level of
model fit in the population. The test assesses the non-centrality parameter which equals zero
when the model fit is perfect (Kenny, 2006). Literature suggests that RMSEA score between
0.08 and 0.10 indicates a mediocre fit while scores above 0.10 reflect poor fit. However, it is
recommended to have an RMSEA score below 0.08 to guarantee a good model fit (Hooper et
al., 2008). The specified model has a RMSEA score of 0.094 signifying a mediocre model fit.
Comparative Fit Index (CFI) is a modified version of the normed fit index (NFI) adjusted
to avoid the underestimation of model fit when the sample size is small (Bentler, 1990). Similar
to RMSEA, there is no consensus on the cut-off point differentiating good fit from poor fit. In
general, CFI values closer to 1.0 demonstrates better fit. However, a value of CFI ≥0.90 or
0.95 is widely recognised as an indicator of a good fit. The CFI value for the model one is
0.733 suggesting mediocre fit results.
The model fit indices were recalculated without the 12 outliers identified by Mahalanobis
distance test as mentioned before. A slight improvement was observed where the RMSEA
score decreased to 0.09, CFI value increased to 0.758 and chi-square =1874 with df=773 at P<
0.001. In order to investigate the underlying causes of the modest fit of model one, the next
section will discuss model alterations that were carried out with a resulting improved model
fit.

6.3.6 Model respecification / optimisation
A revised abbreviated model was assessed based on the original model (model one). The
second model is based on five factors instead of six where the regulatory awareness (having
the lowest loading) is merged with the Mastership of product and process. The revised model
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assumed that the regulatory awareness e.g. the ability to identify gaps in the process or system
is an integral part of product and process understanding. In other words, the awareness of
specifications and the ability to identify the gaps between the practice and the
standard/specification is a basic part of the Mastership of the process/product. If an employee
is unable to identify non-conformances in his/her work area or unaware of them, this may
reflect a deficiency in his/her product and process knowledge. By the same token, ICH Q10
emphasises that the corrective actions and preventive actions (CAPA) resulting from the
investigation of product/process non-conformances should enhance product and process
understanding (ICH, 2008).
It is worth noting that all the observed measures in the specified model one are reflective
indicators which implies that the observed indicators of each factor are interchangeable (Bollen
& Bauldry, 2011; Kline, 2015). Based on this understanding, interchangeable measures
showing low loading were omitted and the model was re-estimated. Model two (Figure 6-9)
below was generated taking a conservative approach through omitting any reflective indicator
with a loading value ≤ 0.5. It was also considered to maintain three measures per factor as
required for model identification (Byrne, 2016; Schumacker, 2010). Table 6-15 enumerates
standardised and unstandardised regression weights of model two. It can be observed that all
standardised regression weights are greater than 0.63 and significant at P< 0.001.
Table 6-16 Model two standardised and unstandardised regression weights
Variables
Performance
Organisational
Network
Wisdom
Mastership
M7
M6
M4
P5

<--<--<--<--<--<--<--<--<---

PK
PK
PK
PK
PK
Mastership
Mastership
Mastership
Performance

Standardised
estimates
.850
.670
.840
.954
.747
.754
.844
.717
.729
6-194

Unstandardised
estimates
.629
.605
.814
.545
.631
1.000
1.025
.961
1.000

S.E.

P

.066
.077
.069
.061
.074

***
***
***
***
***

.098
.104

***
***
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Variables
P4
P3
O6
O5
O4
N5
N4
N3
W4
W2
W1

<--<--<--<--<--<--<--<--<--<--<---

Performance
Performance
Organisational
Organisational
Organisational
Network
Network
Network
Wisdom
Wisdom
Wisdom

Standardised
estimates
.920
.769
.763
.822
.860
.897
.862
.737
.636
.835
.844

Unstandardised
estimates
1.115
1.024
1.000
1.057
.986
1.000
.959
.789
1.000
1.259
1.338

Figure 6-9 Respecified model (two)
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S.E.

P

.094
.100

***
***

.096
.087

***
***

.062
.066

***
***

.137
.144

***
***
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Figure 6-10 Model two standardised estimates
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Figure 6-11 Model two unstandardised estimates

6-197

CHAPTER 6: Quantitative Data Analysis
Model fit indices were reassessed for the new model showing a significant improvement.
CFI value for model two equals 0.949 (approx. 0.95), RMSEA value equals 0.074, chi-square
test result equals 172.32 with df=85 (P< 0.001) and X2/df equals 2.027 (Table 6-16; Table 618). The revised results suggest a good model fit.
Table 6-17 χ2 Test results for model two
Model
No. of Parameters
χ2
Default model
50
172.320
Saturated model
135
.000
Independence model
15
1820.665

DF
85
0
120

P
.000

χ2 /DF
2.027

.000

15.172

Table 6-18 Unique variances- model two

PK
Res1
Res2
Res4
Res5
Res6
7
6
4
14
13

Estimate
1.000
.315
.152
.448
.277
.029
.540
.303
.622
.483
.124

S.E.

P

.067
.036
.085
.056
.017
.074
.057
.079
.057
.032

***
***
***
***
.088
***
***
***
***
***

12
27
26
25
33
32
31
40
38
37

Estimate
.397
.586
.436
.280
.228
.300
.492
.480
.224
.235

S.E.
.049
.077
.067
.051
.043
.046
.058
.054
.032
.035

P
***
***
***
***
***
***
***
***
***
***

Table 6-18 presents the unique variances (measurement errors and residuals) in the revised
model -two. All variances have significant values (P<0.001) except residual 6 associated with
wisdom construct (P<0.1). Based on the results above, model two is the preferred model with
superior fit and loading values compared with model one (Table 6-19).
Table 6-19 Model fit indices of two models
Model

χ2

DF

P

CFI

RMSEA

One

2062.208

773

.000

0.733

0.094

Two

172.320

85

.000

0.949

0.074
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Covariates (controls)
Covariates are a form of variables in the measurement model to control and minimise
potential bias in estimating the relationship of latent and observed variables that could happen
if covariates were not included. However, covariates are not necessarily measures or causes of
the latent variable (Bollen & Bauldry, 2011). The researcher studied the influence of sample
demographic data on the estimation and fit of the model one (complete 41 measures) and model
two (best fit 15 measures). Seven variables extracted from the sample demographic data
(Education, KM maturity of the organisation, type of organisation, employee experience,
training and job level) were selected as controls - explained in Section 5.9.
Table 6-20 Model one: controls loadings
Controls
PK <--PK <--PK <--PK <--PK <--PK <--PK <---

Education
level
KM Maturity
Type of
organisation
Total
experience
Training
percentage
Current
experience
Job level

Standardised
estimates

Unstandardised
estimates

S.E.

P

.054

.057

.075

.444

.287

.278

.070

***

.002

.003

.076

.973

.189

.039

.014

.007

.131

.323

.174

.063

-.069

-.017

.017

.324

-.024

-.028

.082

.731

Table 6-21 Model two: controls loadings
Controls
PK <--PK <--PK <--PK <---

Total
experience
Current
Experience
(current role)
Type of Org
Job level

Standardised
estimates

Unstandardised
estimates

S.E.

P

.188

.038

.015

.011

-.055

-.013

.018

.448

-.014
-.039

-.015
-.045

.078
.084

.846
.594
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Controls
PK <--PK <--PK <---

Training
percentage
Education
level
KM Maturity

Standardised
estimates

Unstandardised
estimates

S.E.

P

.115

.280

.178

.116

.012

.013

.077

.869

.261

.250

.071

***

Table 6-20 and Table 6-21 illustrate the standardised and unstandardised loadings of the
described controls. Five out of seven controls showed insignificant relationships in both model
one and model two. Knowledge management maturity exhibits a weak to moderate positive
(approx. 0.3) relationship with personal knowledge. This signifies that organisations with welldeveloped KM systems attract and retain knowledge holders. The total experience in terms of
the number of years (job tenure) shows a weak positive relationship at a significance level of
0.05. Figure 6-12 and Figure 6-13 demonstrate the unstandardised estimates of model one and
model two with the covariates. A slight reduction in model fit was observed after the
introduction of the covariates. CFI value for model two equals 0.834, RMSEA value equals
0.091, chi-square test result equals 2636.519 with df=1074 (P< 0.001) and X2/df equals 2.455.
CFI value for model one equals 0.694, RMSEA value equals 0.088, chi-square test result equals
526.351 with df=204 (P< 0.001) and X2/df equals 2.58. This can be attributed to the five
covariates of the insignificant relationship as well as the limited sample size.
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Figure 6-12 Unstandardised estimates of model one with covariates
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Figure 6-13 Unstandardised estimates of model two with covariates
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Summary and Conclusion
In this chapter, the researcher analysed the quantitative data extracted from the survey
responses. Two main phases of data analysis can be distinguished in this chapter: descriptive
statistics and confirmatory factor analysis. Descriptive statistics aimed at the review of
respondents’ demographic data to highlight how it represented the targeted population of the
study. Thereafter, the developed model of personal knowledge was tested and optimised
employing CFA tools. CFA encompassed six steps starting by data preparation, model
specification, model identification, model estimation, model testing of fit then finally model
optimisation. At the optimisation step, an alternative model was proposed as a modification of
the original model one. The final model (two) is the preferred model that showed good fit and
high loadings of all the measures of personal knowledge. Also, the model propounded a
reasonable number of personal knowledge measures facilitating its potential use as a tool for
personal knowledge assessment in the organisational context. Finally, the influence of seven
control variables was assessed where only total experience and KM maturity expressed
significant weak to moderate relationships with the personal knowledge suggesting that
organisations with mature KM systems retain and attract knowledge holders. The outcome of
the quantitative data analysis will be thoroughly discussed and compared to the extant literature
in the next chapter offering a comprehensive explication of the research results.
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CHAPTER 7: Discussion

Introduction
This chapter presents the discussion of the research results that have been demonstrated in
the previous chapters. The researcher adopted sequential mixed methods research (Creswell &
Clark, 2018) starting with a qualitative exploratory phase followed by a survey of
pharmaceutical manufacturing employees to validate the developed framework. The outcome
of the qualitative phase was the development of a theoretical framework of 41 measures of
personal knowledge of pharmaceutical manufacturing employee. The model was tested and
validated using CFA (Schoonenboom & Johnson, 2017) to identify the best fit model
describing the key manifestations of the personal knowledge in a pharmaceutical
manufacturing context.

Personal Knowledge Management in the Pharmaceutical Manufacturing
The researcher received 190 valid responses from more than 50 organisations that presented
all drug product categories (conventional, biologics, devices, etc.) in multinational and
domestic corporates and in the private and governmental sectors. The sample was intended to
cover both genders and all the professional job levels in the organisation and within the
functions specified in the study scope. The KM maturity of the pharmaceutical organisation
was explored during the exploratory study as well as during the explanatory phase. The results
revealed that over 80% of the participant organisations had a form of structured KM system
and 27% had integrated KM with the corporate strategies. This agrees with the findings of
(Oliva, 2014) that knowledge management is typically implemented in all major corporates.
Since 2008, ICH Q10 depicted KM as an enabler of the pharmaceutical quality system
(ICH, 2008). However, the highest percentage of the surveyed companies are still struggling
in the second stage of KM maturity where formal KM strategy is not established. Likewise,
the qualitative phases addressed several initiatives for knowledge sharing and acquisition that
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were widely applied in the pharmaceutical industry. The use of information technology was
commonly adopted as an enabler of KM even though it is not sufficient without a supporting
culture (Chatzkel, 2007). Evidence from the qualitative and the quantitative studies points to
varied levels of KM maturity in the surveyed companies. Also, the survey results agree with
the qualitative study findings as personal knowledge measurement activities were informal and
unstructured. Nearly all the interviewed industry experts confirmed the lack of KM strategy in
their organisations. The Chi-Square test of independence denied any statistically significant
association between KM maturity and either organisation size or age. These results build on
existing evidence that the pharmaceutical industry haven’t developed mature KM capabilities
(Calnan et al., 2018).

Personal Knowledge Measurement
A slightly negative skewness (on average -0.96) was observed in all the variables assessed
by the questionnaire. In other words, the most frequent self-assessment scores are higher than
the mean and median. Also, the mean was shifted towards the positive side of the scale. This
shifting was partially attributed to Dunning-Kruger effect (Kruger & Dunning, 1999) and the
nature of the sample. The Dunning-Kruger effect shows that incompetent people would
overestimate their capabilities in self-assessments due to their doubled curse being unskilled
and unaware (Schlösser et al., 2013). The literature suggests that the only intervention to make
participants more accurate in self-assessments is to educate them to be more competent (Kruger
& Dunning, 1999).
However, it is believed that the Dunning-Kruger effect has a limited impact on the results
of this study aiming to identify personal knowledge measures and the underlying factors rather
than assessing the actual knowledge of participants. In the organisational context, this kind of
knowledge measurement should be conducted as a 360-degree survey to minimise the bias due
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to self-assessment. The other potential factor behind the positive shifting of scoring is the
relative over representation of middle and senior managers constituting 39% of the sample
(Figure 6-3). This relative over-representation may be attributed to the design of the two-stage
cluster sampling as explained in the previous chapter. However, all job levels were represented
in the surveyed sample.

Testing and validation of PK framework
Two second-order CFA models were specified and theoretically grounded on the basis of
the conceptual framework. The initial model included six underlying constructs (first-order)
while the other model (five-factor model) excluded regulatory awareness as an independent
construct. Instead, regulatory awareness was either merged with the Mastership of product and
process. It is worth noting that regulatory awareness had the smallest regression weight in
relation to personal knowledge. Model two was the optimised model that retained only the
measures showing the highest loading values and had the best model fit indices. In all models,
personal knowledge was the second-order latent variable. The revised five-factor model had
better loading values and model fit indices compared to the six-factor original model (Table 618).
Model one shows that the regulatory awareness is the underlying construct of five measures of
personal knowledge:
•

The identification of compliance gaps/deviations in worker’s area/process (R1).

•

The association of compliance gaps to a specific clause in a standard, SOP or a
Pharmacopeia (R2).

•

Finding relevant standards or regulatory guidelines (R3).

•

Awareness of updates to regulatory standards, specifications and SOPs (R4).
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•

Involvement in the development and improvement of standards and specifications in
your organisation (R5).

Although regulatory awareness was a theme fully independent of product and process
understanding in the thematic analysis study, a closer review of the measures of regulatory
awareness highlights the communalities. Prior knowledge of product and process
specifications, standard operating procedure or manufacturing process details is a prerequisite
for identifying any practice to standard gaps. Moreover, the ICH guidelines accentuated that
the adopted corrective or preventive actions to address any potential compliance gap should
enhance product and process understanding (ICH, 2008).

Measures of Personal Knowledge
The review of measurement models shows medium to high correlation with the underlying
latent constructs and the personal knowledge (all regression weights above 0.4). In model one
(which included all the hypothesised measures of personal knowledge), 94% of the loading
values were above 0.5 and 55% are above 0.7 which indicates a moderate to high correlation
with the underlying latent constructs and the latent variable. Moreover, the respecified model
two (five-factor model) showed a noticeable improvement in model fit. Overall, results

suggest that it can provide efficient, reliable, and valid assessment of the personal
knowledge. Five factors were identified as the measures of personal knowledge in the
pharmaceutical manufacturing context as shown in Table 7-1.
Regarding the applicability of the model in the pharmaceutical sector, three items per factor
or a total of 15 measures were found to achieve the required balance between reliability and
speed (see model two). Model two was favoured as it has offered both of these criteria by
retaining only three measures per each factor and achieving best model fit. Unlike formative
measures which cause the underlying latent variable, reflective measures are the effect of the
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underlying latent variable and are known to be interchangeable (Kline, 2015). The
measurement models used reflective observed variables (measures) to reflect the effect of the
underlying factors and latent variable (Bollen, 1989). Consequently, reflective measures under
each of the factors can replace one another.
To create the abbreviated model two, measures that have shown the highest correlation
with the underlying factors were retained to create the optimum model (model two). The items

for the optimised model were chosen balancing concerns for reliability, internal structure,
and content representativeness (representing the five constructs). For convenience, the
optimised PK framework (model two) will be referred to as the Pharmaceutical Personal
Knowledge Framework or the 2P-K Framework.
Table 7-1 The 2P-K Framework (model two)
Factor
Measures
Mastership of Train others in relation to your current role
product/process Explain to colleagues the scientific basis and precautions of
processes in your area
Explain to colleagues the technology utilised in machinery and
equipment in your area
Wisdom
Think critically (clearly and rationally) to solve work problems
Solve daily work problems efficiently
Other people believe you make the right decisions in work
Organisational Understand the values of your organisation
understanding
Understand the vision, mission and goals of your organisation
Abide by the values of your organisation
Performance
Complete assigned tasks "right first time"

Code
M4
M6

Complete assigned tasks in a consistent manner
Complete assigned tasks on time
Network and Communicate effectively with senior management
communication Motivate others to achieve organisational goals
Lead others to achieve organisational goals

P4
P5
N3
N4
N5

M7
W1
W2
W4
O4
O5
O6
P3

7.5.1 Mastership of product and process
The ICH Q10 presents product and process understanding as the core of KM activities and
the outcome of applying scientific approaches across the product lifecycle (ICH, 2008). The
estimation of the 2P-K framework shows regression weights of 0.75, 0.72, 0.84 and 0.75 for
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the mastership factor and the three observed measures respectively reflecting a moderate to
high correlation with personal knowledge. In other words, Personal knowledge explains 56%
(0.752) of variations in the mastership construct. The Mastership of product and process
knowledge was measured by three items reflecting what can be generally described as technical
advising. Interviews revealed that knowledgeable workers are not only capable of doing their
jobs without supervision but also are able to pass their technical knowledge to others. Due to
the unstructured and subjective nature of tacit knowledge, coaching and mentoring are essential
to pass it to other employees. This includes the transfer of subjective understanding, knowhow, know-why, job-specific and expert’s knowledge (Mohajan, 2016).
The transferred knowledge through training can take several forms. While training can
simply imply reading (self-study) what has been explicitly articulated in a document. Mentors
or coaches are often required to transfer the heuristics they unconsciously use (tacit knowledge)
to perform a certain task in a process (Gorman, 2002). Understanding the underlying theoretical
and technology basis of product and process is described as the epistemological knowledge
explaining why things are as they are. This type of knowledge normally goes beyond how
things happen (performative knowledge) to why they happen (Mingers, 2008). Although
sharing product and/or process knowledge with co-workers may be limited by factors such as
personality traits, level of trust and other individual and organisational barriers (Pirozzi &
Ferulano, 2016; Roos et al., 1997; Sveiby, 2010; Tobin, 1969), the ability to pass technical
knowledge to others in the form of formal or informal training as well as to explain the
knowledge beyond certain process can be seen as manifestations of deep knowledge. By the
same token, Mohajan (2016) enumerated several ways for tacit knowledge transfer including
but not limited to: training successors, sharing accumulated knowledge from prior role and
other forms or coaching.
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7.5.2 Wisdom
Three manifestations of personal knowledge were categorised as a reflection of the
underlying latent construct of wisdom: critical thinking, problem-solving and proper decision
making. The estimation of the 2P-K framework shows regression weights of 0.95, 0.84, 0.84
and 0.64 for wisdom factor and the three observed measures respectively reflecting a moderate
to high correlation with personal knowledge. In other words, personal knowledge explains 90%
(0.952) of variations in the wisdom construct. Wisdom is a special type of judgement that
requires prior knowledge to critically reflect on and question prevailing mental models
(Gorman, 2002). Wisdom is depicted as the summit of knowledge hierarchy and as a result of
the underlying knowledge (Ackoff, 1989). It enables the person to anticipate the long-term
consequences of his/her actions (Bernstein, 2011). This can be interpreted in the form of a longterm vision, deep thinking, rationalism and coping with complex uncertain events (Ekmekçi et
al., 2014). Indeed, multidisciplinary PKM approaches emphasise the use of knowledge for
effective decision making and problem-solving (Pauleen, 2009; Wright, 2005). Problemsolving involves understanding of the problem through relevant information, generating
alternatives and finally judgement or selecting the most appropriate solution (Wright, 2005).
That is to say, holding the necessary tacit and explicit personal knowledge about the product
and process is a prerequisite to solving problems which is the core of PKM (Agnihotri & Troutt,
2009).
7.5.3 Organisational understanding
Knowledge workers are expected to use their knowledge to make decisions that affect the
performance of their organisations (Agnihotri & Troutt, 2009). However, values and contextual
information are an integral part of knowledge as defined by Davenport & Prusak, (1998). In
other terms, knowledge workers make their decisions in light of their understanding of their
organisational culture, values, mission and vision. Three manifestations of personal knowledge
were presented as a reflection of the underlying latent construct of the organisational
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understanding: understanding company’s values, understanding its mission, vision & goals and
finally abiding by these values. The estimation of the 2P-K framework shows regression
weights of 0.67, 0.86, 0.82 and 0.76 for organisational understanding factor and the three
observed measures respectively reflecting a moderate to high correlation with personal
knowledge. That is to say that the personal knowledge explains 45% (0.672) of variations in
the organisational understanding construct.
7.5.4 Performance
The literature suggests that personal knowledge is required for better performance of job
tasks (Tajedini et al., 2018). By the same token, the interviewed industry experts proposed that
the personal knowledge of employees can be assessed by the outcome of knowledge i.e.
performance. Performative knowledge (also called procedural or know-how) is the form of
practical knowledge, skills and competencies which enables us to do something (Gorman,
2002; John Mingers, 2008). Hence, it can be evaluated by success to do something. Three
manifestations of personal knowledge were presented as a reflection of the underlying latent
construct of performance: completion of a task right first time, in a consistent manner and on
time. The estimation of the 2P-K framework shows regression weights of 0.72, 0.77, 0.92
and0.73 for performance construct and the three observed measures respectively reflecting a
moderate to high correlation with personal knowledge. That is to say, the personal knowledge
explains 72% (0.852) of variations in the performance construct. Performance can be
understood as the outcome of job activity within a certain period. It is associated with personal
knowledge, experience, self-esteem and motivation (Taba et al., 2016).

7.5.5 Network and communication
The fifth construct in 2P-K framework is the network and communication measures. This
includes the effective upward communication with senior management, motivation of co7-212
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workers and leadership to achieve the organisational goals. Knowledge is not just a thing or a
process, but rather a personal network (Chatti, 2012). Moreover, knowledge work is
increasingly depicted as a social activity (Wright, 2005). Personal network in terms of strength
of ties and the number of contacts was positively related to performance in knowledgeintensive jobs due to transfer of complex knowledge between contacts (Taba et al., 2016). The
estimation of the 2P-K framework shows regression weights of 0.84, 0.74, 0.86 and 0.90 for
the communication construct and the three observed measures respectively reflecting a
moderate to high correlation with personal knowledge. That is to say that the personal
knowledge explains 70% (0.84 2) of variations in the communication and networking construct.
It is important to note that social networking requires “know-who” form of knowledge (Jarrahi
et al., 2019) which is a predominately tacit knowledge impeded in the fluid personal
interactions in the organisation (Grabher & Ibert, 2006).

Controls
The quantitative study assessed the influence of seven covariates on personal knowledge:
education level, KM maturity, type of organisation, total experience, current experience,
training (percentage completed) and Job level. Five out of the seven control showed an
insignificant relationship with the measurement framework. While KM maturity showed a
weak to moderate correlation (approx. 0.3) with the personal knowledge, total experience (job
tenure) was weakly correlated (approx. 0.2) to personal knowledge and its manifestations. The
results suggest that the surveyed organisations which have developed stronger KM systems
also employed the most knowledgeable employees. As lifelong employment is no longer the
norm in modern organisations, continuous learning throughout the career has become the
responsibility of employees in an ever-changing environment to stay competitive (Thornley et
al., 2016). It is argued that mature knowledge processes play a potential role in enhancing
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organisational learning and expanding the learning culture (Chinowsky & Carrillo, 2007;
Thepthepa & Mitsufuji, 2016). In other terms, this prevalence of learning culture in KM mature
organisations can justify the association of KM maturity and personal knowledge.
The job tenure was used as a proxy for employee experience. The available evidence seems
to suggest that experience is necessary for problem-solving and proper decision making
(Mittelmann, 2016). The qualitative study showed that prior experiences help employees find
efficient solutions to problems that had faced the organisation before. The cross relationships
between the length of experience and the knowledge management maturity at one side and
personal knowledge at the other side is consistent with the notion that time is crucial for
knowledge accumulation over a long period through direct experiences and lifelong learning
(Hoe, 2006; John Mingers, 2008).

Theoretical Implications
Successful PKM implies better use of the knowledge of individual employees (Razmerita et
al., 2009b). Therefore, the intellectual output of an organisation is reliant on the personal
knowledge of its employees (Hine et al., 2008). In order to manage this sort of knowledge
predominately stored in people’s brain (Thornley et al., 2016), better understanding and
measurement of the personal knowledge is prescribed. An empirical study of the personnel
knowledge in the pharmaceutical manufacturing sector resulted in the development of the
Pharmaceutical Personal Knowledge (2P-K) framework (the abbreviated form of the original
41-measures model). Due to the context-specific nature of knowledge (Hoe, 2006; Nikkhah et
al., 2018; Nonaka et al., 2000; Vladova et al., 2016), the 2P-K framework addressed the
manifestations of personal knowledge in an industry-specific context. The framework depicted
five constructs illustrating the key manifestations of the personal knowledge of manufacturing
personnel. The 2P-K framework offers researchers and scholars a theoretically grounded model
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for measuring personal knowledge. In order to enhance the applicability of the model, the
number of measures per construct was reduced to three (15 items in total) by retaining the
strongest loading variables and the best fit model. Thus, the model offers an opportunity to be
integrated with future research questionnaires to assess personal knowledge in relation to other
latent variables using structural equation modelling or similar techniques.

Mastership of
product/process

Network and
communication

Organisational
understanding

Personal
Knowledge

Wisdom

Performance

Figure 7-1 The 2P-K Framework
Furthermore, measures of the intellectual capital of organisations such as the replacement
cost of tangible assets (Tobin, 1969), market share (Edvinsson, 1997) or retention excellence
(Wyatt, 2001) are argued to be inaccurate measures of the personal knowledge due to potential
synergism of collective knowledge in organisations (Wright & Mcmahan, 2011).

The

developed 2P-K framework explored the statistical interrelations of 15 manifestations of
personal knowledge in industry-specific context and concluded that a positive correlation
between any two of the five constructs should be attributed to the personal knowledge since
the underlying constructs have low correlations among them. Unlike classical measures of
personal knowledge such as standardised test (Matoskova, 2016) and situational judgment test
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(SJT) (Peeters & Lievens, 2005), the study offers an original personal knowledge explanatory
model supported by the confirmatory factor analysis statistics.

Practical Implications
The literature reveals that knowledge measurement aims to offer a tool to identify and
allocate knowledge assets, benchmark against other companies, monitor the development of
the firm’s HC overtime (Matoskova, 2016). The 2P-K framework can be used as a basis for a
personal knowledge measurement scale (2P-K-S) in the pharmaceutical manufacturing
context. The interviews conducted in the exploratory phase with industry experts concluded
that personal knowledge measurement is reliant on informal subjective activities (if existed).
In order to develop a quantitative and consistent scale of personal knowledge, the
Pharmaceutical Personal Knowledge Scale (2P-K-S) was suggested as a practical application
of 2P-K framework.
The use of structural techniques for organising decision making such as Analytic Hierarchy
Process (AHP) (Saaty, 2000) can offer relative weights for each of the five factors underlying
the personal knowledge latent variable. The AHP allows the use of the experts’ assessments to
estimate the relative weight of each factor through pair-wise comparisons to achieve a
consistent judgement (Li et al., 2019). The assigned weights would be customised to the
relative significance of each of the factors within each organisation. Whereas Spearman
developed the general intelligence test using the g-Factor, underlying a set of cognitive
abilities, as a measure of intelligence (Hally, 2012), the 2P-K scale similarly would measure
the personal knowledge of manufacturing employees by explaining the common variance of
the 15 observed measures of knowledge. Although this study relied on self-assessment, 360degree feedback is recommended for the organisational application of this framework. The
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360-degree feedback is a form of multi-ratter assessment where the feedback is received from
supervisor, peers, subordinates in addition to self-evaluation (Atkins & Wood, 2002).
The practitioners’ interviews demonstrated a consensus on the value of personal knowledge
measurement. It suggested that the personal knowledge measurement tool can help employees’
appraisal. As the appraisal process can be multidimensional (Bayo-Moriones et al., 2019),
evaluation of new and current employees can include the level of personal knowledge. This
might be of particular importance within the learning organisation culture to evaluate the
effectiveness of training and learning programs. It was also suggested as a way to compare and
monitor the knowledge of teams or departments in a consistent way where the aggregates of
personal knowledge echo the collective knowledge of a group (Faucher et al., 2008). The tool
can also highlight the opportunities for development and weakness points of employees to be
considered for future development. As previously discussed, personal knowledge is a predictor
of job performance (Mingers, 2008; Taba et al., 2016). Consequently, awareness of personal
knowledge is associated with performance improvement (Tajedini et al., 2018).
Moreover, all manufacturing personnel are required to have the proper training on their job
responsibilities (WHO, 2014). The identification of knowledge holders within the organisation
can provide evidence that business and quality decisions are made by those who hold the right
knowledge. This is deemed to improve the quality and business outcome by raising the level
of confidence in the decision-making process. This supports the notion that the organisational
ability to exploit existing knowledge is a determinant of a firm’s success and competitiveness
(Matoskova, 2016).

Limitations
The research anticipated few limitations of the developed measurement framework. Firstly,
the proposed measurement framework/scale relies on 360-degree survey to assess the personal
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knowledge of employees. This requires supervisor, peers and subordinates to develop a certain
level of awareness of the performance of the assessed employee. In turn, they should encounter
shared situations, work jointly and share their reflections about daily work problems. The
qualitative study suggests that is not always possible. Some organisations rely on fixed-term
contracts to fill certain jobs. In such a case, the limited employment period does not allow
proper evaluation or corrections. In some other cases, workers might not be part of a team or
in other words, working solely in a particular processor on a niche product. This is deemed to
limit the assessor’s capacity to evaluate his/her peers too. If the assessed knowledge is
associated with a breakthrough product or process, assessors might face difficulties to define
what the proper outcome or performance reflecting the acquisition of this new knowledge.
Secondly, the framework validation in this study relied on self-ratings. This might pose a
risk of social desirability bias. Social desirability bias describes the tendency of respondents to
choose socially desirable answers rather than the answers which describe their true beliefs
(Grimm, 2010). Atkins & Wood (2002) criticised the use of self-rating as a reflection of a
particular competency either by itself or as in aggregation with other ratings from 360-degree
feedback. In order to minimise the impact of social desirability bias, the researcher resorted to
the use of a self-administered electronic questionnaire, anonymous survey of practitioners and
a careful selection of the wording of survey questions (Grimm, 2010). Finally, Dunning Kruger
effect (Kruger & Dunning, 1999; Schlösser et al., 2013) is another source of bias where
unskilled generally lack the metacognitive abilities to realise their incompetency. This agrees
with the findings of Atkins & Wood (2002) where high performers had less propensity to
overestimate their performance compared to low-performers who showed lower selfawareness. For this reason, a 360-degree survey was prescribed for organisational application
as shown before.
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Recommendations and future directions
In order to overcome the limitations of this research, a case study employing the 360-degree
survey in a pharmaceutical manufacturing organisation is recommended for practical testing of
the framework. The use of AHP to determine the relative weights of each of the five factors
would personalise the framework to the priorities of each organisation. Also, the framework
can be estimated in a bigger sample that includes practitioners from similar manufacturing
industries such as chemical, food and beverages.
Finally, as knowledge is context-specific (Nikkhah et al., 2018), the model was developed and
tested in an industry-specific context (pharmaceutical manufacturing). However, comparison
to similar manufacturing industries (e.g. chemical industries) is recommended to assess the
validity of the current model or a modified version of it in other industries.
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Introduction
Knowledge is a dynamic human process to justify our personal belief in pursuit of the truth
(Nonaka et al., 2000). Therein, information is processed and stored in people’s mind (Thornley
et al., 2016). Personal knowledge management and particularly measurement have received
little attention, particularly in pharmaceutical manufacturing. This study offers an original
framework for measuring personal knowledge of knowledge workers in pharmaceutical
manufacturing. The tool has been developed considering the extant literature and guided by
experts’ insights. The proposed framework has been validated and optimised by surveying 190
practitioners from the pharmaceutical sector. The following section depicts how the study
addressed the three research objectives, the contribution to knowledge and finally the author’s
reflections and conclusion.

Understanding Personal knowledge Management and Measurement
In order to develop a framework of personal knowledge in the pharmaceutical industry, it
was important to achieve a deep understanding of the current industry practices and
predominant theories in the extant literature. Research commenced with a comprehensive
literature review of the personal knowledge and knowledge measurement theories as well as
the applications of KM and PKM in pharmaceutical manufacturing. The extant literature
provided dozens of comprehensive definitions of knowledge at its tacit and explicit dimensions
such as “a dynamic human process of justifying personal belief toward the truth” (Nonaka et
al., 2000). In contrast, practitioners’ definitions in the qualitative phase emphasised knowledge
acquired by doing and experience. Regulatory and industry guidelines were reviewed to
understand the regulatory expectations and requirements. The review of 137 empirical studies
revealed a growing interest in KM in the pharmaceutical industry and regulatory endeavours
to enforce KM across the product lifecycle. The review also provided a literature map that
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identified six popular themes in KM literature in pharmaceutical industry. Regarding
knowledge theories, the review identified the dimensions of personal knowledge and key
knowledge measurement frameworks (Pirozzi & Ferulano, 2016; Roos et al., 1997; Sveiby,
2010; Tobin, 1969).
However, as the focus of academic and regulatory literature was set on the organisational
knowledge management, exploratory interviews with pharmaceutical industry experts were
necessary to address this knowledge gap by identifying how personal knowledge is assessed in
the pharmaceutical manufacturing organisations. The thematic analysis of interviews provided
a thorough analysis of the current KM and PKM practices in pharmaceutical manufacturing.
The analysis highlighted the measures of personal knowledge adopted in the organisational
context. Measurement strategies were predominately subjective and informal. Participants
emphasised the value and growing need for consistent and formal measures of personal
knowledge. At the end of the literature review (chapter two and three) and the qualitative study
(chapter five), the research developed the required understanding of how personal knowledge
was conceptualised in pharmaceutical industry context (RQ1) and how it is currently measured
by practitioners (RQ2).
Finally, the level of KM maturity in the pharmaceutical industry was assessed both in the
qualitative and quantitative studies. There was an agreement that the levels of implementation
and maturity of KM practices are not the same in every pharmaceutical organisation. The
quantitative study findings supported this assumption. While most of the surveyed companies
had a sort of structured KM system (more than 80%), they were distributed between the four
levels of maturity (Oliva, 2014) in similar ratios (18%, 32%, 23% and 27%) -RQ3.
Literature review and the exploratory study paved the road for achieving the first research
objective:
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Objective 1 Gain an in-depth understanding of the current practices of the personal knwoledge
management and measurement focusing on the pharmaceutical manufacturing context.

Development of Personal Knowledge Framework
Following an abductive reasoning approach, a conceptual framework was developed taking
into account the exploratory interviews and literature review findings. The thematic analysis
provided the required insights about research phenomenon from the practitioners’ perspective.
Developing a theoretically grounded model was a prerequisite for the next phase of framework
testing and validation. The personal knowledge measurement conceptual framework was
hypothesised as a second-order model with 41 observed measures. By the end of chapter five
the second research objective was achieved.
Objective 2 The development of a personal knowledge measurement framework for
knowledge workers in the pharmaceutical manufacturing context.

Personal Knowledge Framework Validation and Optimisation
A survey of 190 manufacturing employees at different job levels was used to achieve the
third research objective. Confirmatory factor analysis using IBM AMOS 26 was the chosen
technique to estimate the proposed models and to select the most reliable model that best-fit
the data with a reasonable number of measures. Model two was the favoured measurement
framework (2 P-K) that combined both speed and reliability through 15 observed measures of
personal knowledge with five underlying factors that have shown high loading on the latent
variable and good model fit. The five underlying factors are: Mastership of product and
process, wisdom, organisational awareness, communication and networking as well as
performance. Thus, the third objective was addressed.
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Objective 3 Validate and optimise the proposed PK measurement framework in the
pharmaceutical manufacturing sector.

Contribution to knowledge
8.5.1 Development of the Pharmaceutical Personal Knowledge (2P-K) framework
As explained in chapter one, PKM is a relatively new research discipline that has not
received proper attention (Cranefield & Prusak, 2016). The research offers a theoretically
grounded and validated framework explicating personal knowledge and its manifestations. As
knowledge is context-specific (Hoe, 2006; Nikkhah et al., 2018; Nonaka et al., 2000; Vladova
et al., 2016), pharmaceutical manufacturing was adopted as the context for the development
and testing of 2P-K framework. Due to the limited knowledge on the measurement strategies
of personal knowledge particularly in the manufacturing context, the research commenced with
an exploratory phase. The exploratory phase merged the knowledge available in literature and
industry guidelines with the experiences of industry experts to deductively develop the
conceptual framework in the study.
Thematic analysis was the vessel where knowledge from primary and secondary data
interacted to hypothesise the measures of personal knowledge and the underlying factors. A
theoretically grounded framework was a prerequisite for the following testing phase using
structural equation modelling (Kline, 2011). A quantitative survey of 190 practitioners in the
pharmaceutical manufacturing was used to test and optimise the proposed models. Finally, the
2P-K framework was developed to explain personal knowledge through its manifestations in a
pharmaceutical manufacturing context.
The developed 2P-K framework provides researchers and scholars in the area of PKM with
a multifaceted explanation of personal knowledge. The theoretical framework can assist PKM
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future researches as an indirect tool to measure PK (which is a latent variable) in relation to
other variables.

8.5.2 A basis for PK measurement instrument in manufacturing
The study offers a reliable and flexible measurement framework that can be adopted in
pharmaceutical manufacturing to assess the level of personal knowledge of employees based
on the manifestations and outcome of knowledge itself. Unlike currently applied subjective
and informal personal knowledge assessment strategies (as identified in the exploratory study),
the framework provides the basis for a systematic objective tool to measure personal
knowledge. However, the use of 360- Degree feedback is recommended to avoid bias due to
social desirability or Dunning-Kruger effect and consequently achieve accurate results.
In order to enhance the applicability and flexibility of the framework, the final optimised
model (2P-K framework) was an abbreviated (15-item) form of the original 41-observed
variable framework. In addition, the abbreviated framework showed better model fit than the
original model reflecting its accuracy and reliability. The author anticipates that the proposed
framework can be applied in organisational context to measure personal knowledge in a way
similar to Spearman IQ test where the underlying g-Factor (intelligence) is used to explain the
variances in the cognitive abilities (Hally, 2012).

8.5.3 Taxonomic analysis of KM literature
KM is a relatively new research discipline with limited applications in the pharmaceutical
industry (Ramy et al., 2018). This study contributed by developing a taxonomic map (Figure
3-4) of the predominant themes in the academic journal articles with direct applications in the
pharmaceutical industry. Similarly, the review of more than 128 pharmaceutical industry and
regulatory guidelines brought forth a literature map of KM related themes addressed in these

8-225

CHAPTER 8: Conclusion
guidelines (Figure 3-5). The literature review findings have been published in the Knowledge
Management Research and Practice (KMRP) Journal.

Summary and Conclusion
This thesis presents original research to explore and explain the personal knowledge
management and measurement in literature and practice. After a comprehensive review of
knowledge measurement theory and application literature, fifteen industry experts were
interviewed to obtain a greater understanding of personal knowledge management and
measurement practices. The fruit of that stage was the development of an explanatory
theoretical framework that describes personal knowledge, knowledge manifestations and the
underlying factors of those manifestations. The framework was validated and optimised
through a survey of 190 practitioners from pharmaceutical manufacturing where confirmatory
factor analysis statistics were applied to test and validate the key measures of the personal
knowledge as demonstrated by the 2P-K framework.

(End)
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e Pharmaceutical Personal Knowledge Scale
(2P KS)
A Personal knowledge Measurement Scale for individual employees in the Pharmaceutical
Manufacturing sector
*Required

In response to an increasing regulatory and business needs for knowledge management across the commercial life
of the drug product, this survey comes as a part of a comprehensive academic study to develop a knowledge
assessment scale for pharmaceutical manufacturing employees. It is hoped that the results of this study will
enhance the ability to identify knowledge assets and enhance decision-making capabilities within the
pharmaceutical industry.
The study is conducted by the College of Business, Technological University Dublin and embracing its research
ethics. To ensure confidentiality, we will guarantee the anonymity of both participant and company information.
The survey responses are accessible only by the authorised research team members and the academic supervisor
Dr. Lorraine Sweeney (lorraine.sweeney@TUDublin.ie). Mindful of your busy schedule, we are kindly inviting you to
participate in this survey which should only take an average of 15 minutes. Your participation in this survey means
you consent that your data will be exclusively used for academic research.
As an incentive to complete this survey, we will donate $1 (one US dollar) per completed survey for the Egyptian
National Cancer Institute - Cairo (http://www.nci.cu.edu.eg/).
For further enquiries about the survey, kindly contact Ahmed.Ramy@TUDublin.ie.
Thanks for your kind participation
Ahmed Ramy, MSc
PhD Candidate
3S Group, College of business
TU Dublin

1.

Which one of the following best describes your role in the orgainsation? *
Mark only one oval.
Support and administration roles (e.g. accounting, IT, HR, Training, admin, etc.).
Manufacturing (e.g. quality, production, warehouse, manufacturing R&D, etc.)

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit
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Demographic data

2.

Please indicate the approximate size of your organisation (all the sites and affiliates). *
Mark only one oval.
Less than 50 employees
From 50 to 249 employees
From 250 to 500 employees
From 500 to 1000 employees
More than 1000

3.

Please indicate the category of drug products manufactured at your organisation/site *
-Choose all that apply

Tick all that apply.
Conventional
Biologics
Veterinary
Medical devices
API
Other:

4.

Please indicate the age of your organisation (the whole organisation worldwide) *
Mark only one oval.
Less than 5 years
From 5 to 10 years
From 11 to 20 years
From 21 to 50
More than 50 years

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit
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5.

Please indicate the ownership of your organisation. *
Mark only one oval.
Public (Governmental)
Private
Other:

6.

Please indicate the type of your organisation. *
Mark only one oval.
Domestic
Multinational or Global
Other:

7.

Please indicate your current department or function. *
Mark only one oval.
Quality Assurance
Quality Control
Production or packaging
Warehousing
Technical service
Other:

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit
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8.

Please indicate your current position/title. *
Mark only one oval.
Senior manager or director
Manager
Supervisor
Specialist/Representative/Associate
Other:

9.

Please indicate the highest level of education you have obtained. *
Mark only one oval.
High school
Technical certificate/diploma
Bachelor degree
Postgraduate certificate/diploma
Masters Degree
PhD
Other:

10.

Please indicate your gender.
Mark only one oval.
Male
Female
Prefer not to say

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit
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11.

Please indicate your total experience in the pharmaceutical manufacturing (in years). *

12.

Out of your total manufacturing experience (previous question), how many years have you
spent in the current department/function? *

13.

Out of your total manufacturing experience , how many years have you spent with the current
employer? *

14.

Please indicate your level of compliance to technical training requirements (including GMP
training) *
Mark only one oval.
Less than 40%
40-50%
51-60%
61-70%
71-80%
81-90%
More than 90%

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit
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15.

Please indicate your proficiency with English language (reading, speaking and listening) *
Tick all that apply.
Beginner

Intermediate

Advanced

Native or bilingual

Reading
Speaking
Listening

16.

Which of the following statement best describes the knowledge management practices in your
organisation: *
Mark only one oval.
There is a general lack of awareness of the need for knowledge management.
The management is aware of the importance of knowledge management but there are
no or few formal processes for identifying, capturing, sharing, transferring, and applying
knowledge.
Formal knowledge management initiatives take place at some departments (islands
of knowledge) but it is not part of an organisation-wide strategy.
Knowledge management is part of a holistic organisation strategy and continuously
reviewed by management.

Section
two

17.

Please indicate the extent to which you are confident that you are able to undertake ( or would
be able to , if required) the following:

Identify compliance gaps/deviations in your area/process. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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18.

Associate compliance gaps to a specific clause in a standard, SOP or a Pharmacopeia. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

19.

To a great extent

Find relevant standards or regulatory guidelines. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

20.

To a great extent

Locate relevant process and product related information. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

21.

To a great extent

Identify the appropriate person to obtain information relating to a specific product/process. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent

7/17

6/1/2020

The Pharmaceutical Personal Knowledge Scale (2P-KS)

22.

Carry out assigned responsibilities without supervision. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

23.

To a great extent

Contribute to the design and development of processes/products within your function. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

24.

To a great extent

Train others in relation to your current role. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

25.

To a great extent

Complete relevant records/forms (including electronic records) associated with products or
processes in your department. *
Mark only one oval.
1

2

3

4

5

6

Not at all

7
To a great extent

Please indicate the extent to which you are confident that you are able to undertake ( or would be able to , if
required) the following:

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit
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26.

Explain to colleagues the scientific basis and precautions of processes in your area. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

27.

To a great extent

Explain to colleagues the technology utilised in machinery and equipment in your area. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

28.

To a great extent

Achieve departmental/organisational goals successfully *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

29.

To a great extent

Play a key role in successful projects in your area. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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30.

Complete assigned tasks "right first time". *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

31.

To a great extent

Complete assigned tasks in a consistent manner. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

32.

To a great extent

Complete assigned tasks on time. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

33.

To a great extent

Meet or exceed the required targets. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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34.

Think critically (clearly and rationally) to solve work problems. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

To a great extent

Please indicate the extent to which you are confident that you are able to undertake ( or would be able to , if
required) the following:

35.

Communicate effectively with co-workers to get the job done. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

36.

To a great extent

Communicate effectively with senior management. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

37.

To a great extent

Motivate others to achieve organisational goals. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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38.

Lead others to achieve organisational goals. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

39.

To a great extent

Solve daily work problems efficiently. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

To a great extent

Please indicate the extent to which you:

Section three

40.

Understand your role within you organisation. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

41.

To a great extent

Understand processes within other departments in your organisation. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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42.

Understand terminology used in your organisation. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

43.

To a great extent

Understand the values of your organisation. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

To a great extent

44.

Please provide examples of the values of your organisation (at least three):

45.

Understand the vision, mission and goals of your organisation. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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46.

Abide by the values of your organisation. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

47.

To a great extent

Explain the historical Out of Specifications (OOS), failures and/or any weaknesses in your area.
*
Mark only one oval.
1

2

3

4

5

6

7

Not at all

48.

To a great extent

Are aware of updates to regulatory standards, specifications and SOPs. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

49.

To a great extent

Are involved in the development and improvement of standards and specifications in your
organisation. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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50.

Are involved in the design, validation, control and continuous improvement of
products/processes in your function. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

To a great extent

Please indicate the extent to which:

Section four

51.

Other people seek advice or information from you relating to products, processes and systems
(including computer systems). *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

52.

To a great extent

Other people believe you solve daily work problems efficiently. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

53.

To a great extent

Other people believe you make the right decisions in work. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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54.

Other people see you as a team player. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

55.

To a great extent

Your out of the box suggestions are implemented within your organisation. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

56.

To a great extent

You achieve a strong positive evaluation in annual appraisal by management. *
Mark only one oval.
1

2

3

4

5

6

7

Not at all

57.

To a great extent

You have a wide network of contacts within your organisation. *
Mark only one oval.
1

2

3

4

5

6

Not at all

https://docs.google.com/forms/d/1bH-H0QMNl10op7m28VBCQXu7svQY7GwrBgDOzxsrVsg/edit

7
To a great extent
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58.

You have a wide network of contacts outside your organisation (pharmaceutical and nonpharmaceutical). *
Mark only one oval.
1

2

3

4

5

6

Not at all

7
To a great extent

This content is neither created nor endorsed by Google.
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ABSTRACT

The purpose of this paper is to explore the current research trends in Knowledge Management
(KM) through a scientometric analysis of all literature published in KMRP between 2003 and 2015
(506 articles). The review framework explores three sets of review questions addressing Research
Productivity, Research Themes and Methods, and Citation Analysis. The study elucidates wide
global interest in KM and an increasing trend towards multi-author collaboration. Although more
than 55 different industries have featured in the journal, certain knowledge-intensive sectors
remain underrepresented. Country productivity shows few nations taking the lead with an
interesting correlation between research activity and economic prosperity. Moreover, a growing
tendency towards empirical methods is observed in contrast to a decrease in literature review
papers, coupled with a recent rise in articles that integrate KM and Information Technology (IT).
In terms of citation and influences, few published articles have stood out in the journal’s history.
This is the first comprehensive scientometric research of KMRP describes the state-of-the-art
value and provides an outlook of the future.

1. Introduction
Knowledge management (KM) has become a predominant field within the business and management landscape
for both researchers and practitioners (Moustaghfir &
Schiuma, 2013). The recognition of the fundamental
role of knowledge in value creation spawned the concept of the Knowledge Economy, making it one of the
pillars of contemporary management thinking (Roberts,
2009; Weir, Huggins, Schiuma, Lerro, & Prokop, 2010).
Economic growth is no longer reliant on physical capital and labour only as established in nineteenth century
theories, but also on the human capital comprised of
“knowledge workers” whose innovative capabilities lead
the advancement of the current “knowledge society”
(Drucker, 1994). This was highlighted by a 1999 World
Bank report which provided one of the first comprehensive accounts of the emerging role of knowledge in
economic development through a focus on acquisition,
application, and transfer of knowledge (World Bank
Annual Report, 1999). By the end of the twentieth century, the notion of managing knowledge had evolved at
the corporate level as organisations acknowledged the
need to leverage and exploit their knowledge resources
(Carmeli & Tishler, 2004). KM is now considered a vital
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organisational function and a key source of sustainable
competitive advantage (Davenport & Völpel, 2001). On
the other hand, progressive academic works have also
established KM as an independent and rich scientific
discipline. As a research field, KM has witnessed an
exponential growth rate in publications amounting to
50% per year, supported by the foundation of a number
of dedicated KM journals and conferences (Serenko,
Bontis, Booker, Sadeddin, & Hardie, 2010).
One of the key peer-reviewed journals in the KM
field is Knowledge Management Research and Practice
(KMRP). Available online since 2003, KMRP is the first
KM journal to gain an impact factor (Thomson Reuters,
2015). Its aim is to provide an outlet for high-quality
peer-reviewed publications including both academic
and practical dimensions and the relationship between
both perspectives. The journal pays particular attention
to cross disciplinary research, mixtures of techniques,
and differing schools of thought adopting a broad spectrum of publication themes including empirical research
and case studies as well as conceptual and theoretical
papers (Springer, 2017). Moreover, KMRP was placed
third in 2008 then the second in 2013, according to
expert survey rankings conducted on a sample of 25 key
KM journals (Serenko & Bontis, 2013a).
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While the KM field continues to grow, reflections on
literature can allow for more efficient future deliberations on subjects within the discipline, minimise repetition, and create starting points for further advancements
in KM theory and practice. This paper provides insights
into KM research published in the KMRP, which could
arguably apply to the whole KM domain considering
that KMRP is a representative example of the wider
KM literature. To present the work, the paper is divided
into five sections. Following the introduction, the second section offers a brief survey of relevant literature
and presents the study’s research questions. Section 3
details the study’s methodology and the development
of the review framework. Findings are presented and
analysed in the fourth section, while the final section
discusses the work’s conclusions and implications for
future research.

2. Background and research questions
A literature review is a “critical analysis of a segment
of a published body of knowledge through summary,
classification, and comparison of prior research studies”
(Jafari & Kaufman, 2006). It helps to interpret what is
known about a research field and to identify gaps in the
existing knowledge (Jesson, Matheson, & Lacey, 2011).
Several reviews covered KM publications and journals
using a number of methods over different time periods. These include but are not be limited to: Citation
Analysis (Huang, Chen, & Stewart, 2010; Ma & Yu,
2010; Ribière & Walter, 2013; Serenko & Bontis, 2013a;
Serenko & Dumay, 2015) Content Analysis (Fteimi &
Lehner, 2016), Journal Ranking (Serenko & Bontis,
2009, 2013b), Meta-review (Serenko & Bontis, 2004)
and Scientometric Analysis, the approach adopted in
this study (Serenko, Bontis, & Grant, 2009; Serenko et
al., 2010).
Scientometrics is science about science with distinct
identity and methodology (Garfield, 2009). The term has
grown in popularity and recognition in the last decades,
especially after the founding of the dedicated Journal
of Scientometrics by Tibor Braun in 1978. It is used to
describe the study of science including growth, structure,
interrelationships and productivity of a certain research
discipline (Hood & Wilson, 2001). Scientometrics portrays a comprehensive picture of research activity within
the field and is able to present existing trends supported
by quantitative data. In this study, the scientometric
approach is adopted to investigate three main research
issues within KMRP during the review timeframe:
(1) Productivity – Demographic patterns in the
production of KMRP research;
(2) Themes and methods – Trends in topics examined and research tools applied; and
(3) Citation – Analysis of referencing frequency of
the journal’s papers.
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Accordingly, three groups of research questions were
formulated to guide the research process as follows.
Research productivity in KMRP
RQ1. What are the dominant trends in authorship
distribution?
RQ2. What is the prevailing affiliation of KMRP authors
(Academics vs Practitioners)?
RQ3. Which countries are leading in KM research?
RQ4 . Is there a relationship between a country’s economy and its contribution to KM research?
RQ5. What is the institutional productivity in the
journal?
Research themes and methods in KMRP
RQ6. Which research methodologies are most used by
authors?
RQ7. What are the most popular industrial sectors in
KM research?
RQ8. What are the main research themes in the journal?
RQ9. What is the degree of integration of Information
Technology in KM research?
Citation analysis of KMRP
RQ10. Which articles are the most influential in the
journal’s history?

3. Methodology
The research methodology adopted in this study can be
summarised in a series of steps. First, the boundaries of
article selection for analysis were drawn using criteria
for inclusion and exclusion. This set initially included
506 articles published in KMRP between the year 2003
– when the first issue was published – and up to 2015.
Editorials, position papers, and book reviews were
excluded from the article list. Accordingly, a total of 344
peer-reviewed journal articles was retained for analysis,
while 162 were excluded. Second, the research framework was synthesised in light of previous similar works
(Fteimi & Lehner, 2016; Serenko & Bontis, 2004; Serenko
& Dumay, 2015; Serenko et al., 2010). The subsequent
design allows exploration into the various attributes of
publications within the selected sample (Table 1).
A pilot review of 10 articles was initially conducted by
two researchers for validation purposes. The outcomes
of this exercise led to minor modifications of the framework, and helped identify what the authors refer to as
grey areas, which are article attributes within the framework that are subjective in nature and can vary according
to the views of the coder. Grey areas are mainly confined
to two review parameters: research method and research
topic where the same article can be classified under more
than one category within the coding scheme. In such
cases, the researchers agreed to code the article under the
most predominant theme then cross-check their results.
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Table 1. Research framework.
Theme
Productivity

Variables
• Number of authors – Single vs. multiple authors
• Aﬃliation of author – Academic vs. Practitioner
• Country of residence – where the author is based, not where the work was conducted

Research method
Includes data collection method, more than one can be selected

•
•
•
•
•
•

Case study
Interviews
Literature review
Modelling tools
Surveys
Other qualitative – e.g., Focus groups, Delphi, site observation, action research, content analysis, ethnography

Research Topic
Most prominent topic in the paper, more than one can be selected

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Intellectual capital
Innovation
Organisational learning
Culture and Social issues (social capital)
Performance management
Information system
Communities of practice
Knowledge measurement
Knowledge philosophy/ontology
Other knowledge management
Knowledge sharing
Knowledge transfer
Knowledge creation
Knowledge process
Knowledge acquisition
Knowledge exchange
Use of knowledge
Knowledge audit
Other

Technology adoption

• Use of Technology (yes/no)
Type of KM Technology:• Knowledge management system
• Internet
• Communication technology
• Wiki
• Social Media
• Prototype
• Database
• Blogs
• Decision support systems
• Other

Referencing

• Number of citations from Google Scholar database
• Keywords

In the subsequent stage, the articles were mutually
coded by both researchers. Finally, full analysis of the
resultant data-set was undertaken to identify patterns.
When addressing Research Questions 2–5 pertaining to
Research Productivity, methods utilising credit analysis
were enacted and the researcher had to select the most
appropriate method. Authorial credit is generally provided using one of four methods depicted in Table 2.
The Equal Credit Method was selected because it
avoids the shortcomings of the three other methods and
provides mostly unbiased authorial credit. In addition to
Equal Credit, the Direct Count Method was employed in
Research Questions 2 and 3 as well and results of both
methods were compared. It is worth noting that studies
have suggested that the Direct Count, Author Position,
and Equal Credit methods can produce similar results,
particularly when utilising aggregate data (Serenko,
Cocosila & Turel, 2008).
In addressing Research Question 10 regarding citation impact of influential KMRP publications, each

paper’s citation impact index was computed to determine the single most highly cited article. The most
commonly used measure is the calculation of the total
number of citations of each paper since its publication.
However, according to Holsapple, Johnson, Manakyan,
and Tanner (1994), the weakness of this method is that
it does not consider the publication date of the article.
It will provide the same score to two publications that
are cited the same number of times even if they are published in different years, although the most recent of
them would have a higher average number of citations
per year. This suggests that the latter publication has
had a higher contribution to the field having achieved
the same number of citations in a shorter time period,
an aspect which the traditional citation index overlooks.
To overcome this drawback, Holsapple et al. (1994) propose the use of Normalised Citation Impact Index (NCII)
which accounts for the paper’s longevity thus reflecting
the relative contribution of each article. It is calculated
by dividing the number of times the article has been

Values are assigned according to the author’s order in the citation

A value of 1.0 is assigned to each author

Each author receives an equal credit equivalent to the inverse of the number of authors,
regardless of author position

Author position

Direct count

Equal credit

Source: Table adapted from Chua and Cousins (2002), Lowry, Karuga, and Richardson (2007).

Description
Number of pages is divided by the number of authors

Method
Normalised page size

Table 2. Methods for assigning author credit.
Example
For 15 pages and 3 authors:
Author 1 = 5
Author 2 = 5
Author 3 = 5
For 4 authors:
Author 1 = 0.415
Author 2 = 0.277
Author 3 = 0.185
Author 4 = 0.123
For 3 authors:
Author 1 = 1
Author 2 = 1
Author 3 = 1
For 3 authors:
Author 1 = 0.333
Author 2 = 0.333
Author 3 = 0.333

• Avoids the drawbacks of previous methods

• Gives advantage to researchers who co-author numerous papers regardless of their
contribution

• Co-authors are sometimes listed in alphabetical order; so those whose names are
earlier in the alphabet are unjustly favoured
• Does not consider cases where authors have equal contributions

Criticism
• Assumes longer papers make higher contribution
• Aﬀected by journal pages’ limits
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2003-2008
2009-2015

40

Percentage

referenced by the number of years the article has been
available [NCII = Total Citations (count)/Longevity in
years]. The NCII method is hence adopted in this study
in order to provide more reliable results. Individual article citations obtained from the Google Scholar database
are used to compute the NCII for each article and publications are ranked in descending order according to
their indices.
Finally, author keywords were extracted from the
review pool using the open-source bibliography reference software JabRef. Keywords were then electronically
sorted and counted as a part of trend analysis.
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Figure 1. Number of authors.

4. Findings
In an attempt to identify the trends within the current
sample, the analysis results are presented over two time
periods (2003–2008) and (2009–2015). This format
helps to highlight the major changes in the nature of
research work published in the journal over its lifetime.
4.1. Authorship trends
The average number of authors within the sample is 2.28
authors per paper, however, a growing trend towards
multi-authored papers is evident. While the average
paper authorship in the first time period (2003–2008)
is 1.96 authors per paper, it increased to 2.46 authors
per paper in the second time period (2009–2015). The
median number of authors has also increased from two
to three after 2013 (Table 3). The percentage of single
authored papers dropped from 40% in 2003–2008 to less
than 20% in 2009–2015, whereas papers with two, three,
and four authors witnessed significant increases of 1.5,
8.5, and 9.8%, respectively, (Figure 1). This confirms the
findings of Akhavan, Ebrahim, Fetrati, and Pezeshkan
(2016) who observe a decline in single-authored works
over time and the emergence of collaboration patterns
among KM scholars.
4.2. Author affiliations
From an affiliation perspective, more than 90% of
authors have an academic background and are in direct
affiliation with educational and/or research institutions
(Figure 2). The remaining 10% of authors are practitioners from service or industrial sectors. Both the Direct
Count and Equal Credit methods are used to compute

Percentage of Papers %

70
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40
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E.Credit count ( Academic Authors)
E.Credit count ( Practitioner Authors)

Figure 2. Author aﬃliation.

the contribution of practitioners and academic authors
and no statistically significant difference is found
between the results of both methods (p-value = 0.592).
4.3. Country productivity and GDP
In order to identify the leading countries in the KM
field, the relative contributions of 57 countries whose
papers are published in the KMRP are traced and ranked
using both the Equal Credit and Direct Count methods. Similar results from both methods are obtained
and the Pareto Principle or “The Law of Vital Few” is
heavily observed (Pareto, 1971). The majority of publications originate from roughly 20% of participating
countries as shown in Figure 3 and Table 4. To confirm
the findings, the number of citations from each country
is counted using the NCII method for all the countries.
The same countries of the highest contribution to the
journal are found to be on the top of the articles citation
list. Statistical analysis also revealed a moderate positive
correlation (0.559) between the country Gross Domestic
Product (GDP) and contribution to KM research.

Table 3. Co-authorship Distribution – Number of Authors.
Year
Mean
Median
Year
Mean
Median

2003
1.78
2
2010
2.34
2

2004
1.93
2
2011
2.48
2

2005
1.61
1
2012
2.34
2

2006
2.07
2
2013
2.48
2

2007
2008
2009
2.32
1.86
2.18
2
2
2
2014
2015
2.83
2.58
3
3

4.4. Institutional productivity
When examining institutional productivity, Equal
Credit is the method of choice for organisations as well.
Analysis revealed that, to-date, more than 400 unique
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Figure 3. Country productivity (equal credit score).
Source: Authors.
Table 4. Country productivity ranking.
Equal credit method
Rank
1
2
3
4
5
6
7
8
9
10

Country
UK
USA
Australia
Spain
France
Italy
Taiwan
Canada
Germany
Rest of the world

Direct count method
Percentage
13.76
12.37
8.13
7.94
5.89
5.81
4.93
4.29
3.91
32.95

Country
UK
USA
Spain
Australia
Italy
France
Canada
Taiwan
Germany
Rest of the world

institutions have published articles in the KMRP. The
noticeable finding is the minimal variation among individual contributions of each institution where no single institution dominates publications in the journal as
shown in Table 5 (range = 3.8, standard deviation = 0.65).
By the same token, the top fifth of contributions comes
from more than 27 different institutions. It is also noted
that two-thirds of papers are the product of a single
institution and 38.6% of the papers are the outcome of
multi-institutional collaboration. Furthermore, the top
20% contributors are all academic organisations, which
coincide with the prevalence of academic authorship as
previously mentioned.
4.5. Research methods
Research methods can be described as all the data collection and analysis techniques that are used for conduction
of research activities to solve research problems (Kothari,
2004). Nearly half of the articles (47%) utilised a single
method, while the rest of articles used two or more. A

Percentage
12.74
12.02
7.69
7.69
5.53
5.05
4.81
4.09
3.85
36.54

NCII
Country
UK
USA
Japan
Spain
Canada
Italy
Finland
Germany
France
Rest of the world

Percentage
12.92
12.52
8.95
7.67
7.49
6.74
4.25
4.14
4.10
31.22

mild to moderate increase in published empirical studies, both quantitative and qualitative, is observed in the
second review time period (2009–2015) in comparison to
conceptual models and literature reviews which are prevalent in the first review period (Figure 4). Nevertheless,
modelling tools and frameworks are still the most used
methodology by KMRP researchers, followed by case
studies.
4.6. Industrial sectors
Expanding on the findings from the previous section,
articles were thoroughly surveyed for industries which
are selected as research fields. While 33% of studies are
classified as conceptual studies and thus have no industries, the other two-thirds are conducted in more than
57 different industries and service sectors. Moreover,
15% of papers do not specify a single sector used in data
collection. Instead, a mixture of different businesses is
used as a non-industry specific convenience sample. This
is expected since researchers often tend to gather data
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Table 5. Institutional productivity.
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28

Institution
National Technical University of
Athens
University of Sydney
Tampere University of Technology
Queens University
University of Southampton
University of Hull
National Taiwan Ocean University
Universidad Computense de Madrid
University of Sao Paulo
Politecnico di Milano
Hitotsubashi University
University of South Australia
University of Southern Queensland
Kingston University
University of Salento
University of Sheﬃeld
Loughborough University
Bangkok University
Edith Cowan University
Politecnico di Bari
Robert Gordon University
Soochow University
University of Akureyri
University of Alicante
University of Castilla La Mancha
University of Melbourne
University of New South Wales
Other 375 unique institutions

Equal credit
3.999

Percentage
1.16

3.999
3.998
3.916
3.5
3.166
3
3
3
2.75
2.5
2.5
2.499
2.333
2.333
2.333
2.166
2
2
2
2
2
2
2
2
2
2
N/A

1.16
1.16
1.14
1.02
0.92
0.87
0.87
0.87
0.80
0.73
0.73
0.73
0.68
0.68
0.68
0.63
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.58
0.58
79.36

Cumulative sum (%)
1.16
2.33
3.49
4.63
5.64
6.56
7.44
8.31
9.18
9.98
10.71
11.43
12.16
12.84
13.52
14.19
14.82
15.40
15.99
16.57
17.15
17.73
18.31
18.89
19.47
20.06
20.64
100

Percentage of Publications

37%37%
33%
30%

31%

29%29%

28%
23%
19%

18%
13%

Case study

Interview

L iterature
Review

Modeling
Tools

2003-2008

2009-2015

Survey

Other
Qualitative

Figure 4. Research methods.

from companies in their network and the ones that they
have access to.
Moreover, research and education institutions are on
the top of the popularity list. Approximately 12% of the
studies are conducted either within universities, research
labs and/or rely on the classroom as a case study. Once
again, this could be simply attributed to convenience.
Information and Communication Technologies (ICT),
Healthcare, and High-Tech firms come in the second,
third, and fourth places, respectively. Nonetheless, some
knowledge-intensive industries such as Pharmaceuticals,
Aerospace, and Energy have not received adequate attention in industry-specific publications. Table 6 illustrates
the main industry/service sectors in the articles and their
relative percentage.

4.7. Research themes
Two approaches are adopted to identify the common
research themes within the KMRP body of literature.
First, two researchers qualitatively categorised the papers
according to their research topic as explained in the
review framework. A counter review of the same papers
by the other researcher was used to confirm the categorisation of each paper under a single theme. In cases
where researchers coded a paper differently, the article
was jointly reviewed by both researchers until a classification is agreed, or third opinion was sought. Secondly,
a quantitative keywords analysis is used in parallel in
order to compare the findings of the thematic analysis.
Results show that 61% of research papers falls within
five topics; (1) Knowledge Sharing, (2) Intellectual
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Table 6. Industrial sectors.
Rank
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Industry
Multi Sectoral
Research & Education
ICT
Healthcare
Technology
Civic Society
Consulting and Training
Automotive
Unspecified
Construction
Engineering
Entertainment
Insurance
Metal industry
Oil and Gas
Aerospace
Banking
Pharmaceuticals
Other industries
Conceptual (none)

%
14.8
11.6
8.7
5.2
4.1
2.3
2.0
1.7
1.7
1.2
1.2
1.2
1.2
1.2
1.2
0.9
0.9
0.9
13.1
32.8

Capital, (3) Knowledge Creation, (4) Knowledge
Transfer, and (5) Culture. Some research themes indicate significant growth in the second review time
period (2009–2015) in comparison to the first period
(2003–2008). For example, there is a growing interest
in Intellectual Capital, Knowledge Transfer, Innovation
and Culture, while issues such as Knowledge Creation,
Knowledge Measurement, Organisational Learning,
Information Systems, Communities of Practice have
received less interest (Figure 5).
4.8. Keyword analysis

Percentage of Publications

A comprehensive keyword analysis of KMRP articles
between 2003 and 2012 undertaken by Ribière and
Walter (2013) demonstrate that Knowledge Sharing is
the most used keyword in the journal. A similar exercise extending until 2015 conducted in this research
unsurprisingly yielded the same outcome (Figure 6).
The predominance of Knowledge Sharing as a keyword,
as well as a research theme, confirms the validity of the

Figure 5. Research themes.

thematic analysis outcomes of the previous section. It
also elucidates the emphasis researchers have placed on
the knowledge sharing process as a precursor of effective KM. Whether the objective is spreading best practice, disseminating innovative ideas, or creating digital
repositories, sharing knowledge is often at the core of
KM initiatives.
4.9. KM technology
The role of Information Technology (IT) in KM is widely
discussed in the literature (Ragab & Arisha, 2013). A
common view is that KM should not be reduced to a
solely IT-based project as there is a tacit dimension of
knowledge which cannot be managed using technological tools (Chatzkel, 2007; Schiuma, 1998). IT is rather
envisaged as an essential KM catalyst and an enabler of
knowledge sharing processes within and between organisations (Tsui, 2005). This view seems to be reinforced
by scientometric figures as, overall, 91% of papers did
not include reference to IT.
However, by contrasting the first review period
(2003–2008) to the second (2009–2015) in regards to
discussing technology, an increase from 4.2 to 11.6%
is observed (Figure 7). This demonstrates a movement
towards further integration of IT in KM. In this area, the
Internet, Databases, and Social Media are the most popular IT solutions within the published papers, a trend
in tandem with the digital revolution and the explosive
growth of social networking (Figure 8).
4.10. Citation analysis
By examining citation frequency, three articles stand
out as the most influential articles in the journal’s history based on their NCII (Table 7). It is noted that the
top three articles gained 11.8% of the NCII score for all
the articles and approximately 80% of citations came
from the top 144 articles (≈40%). Interestingly, the most

30.0
25.0
20.0
15.0
10.0
5.0
0.0

2003-2008

73

2009-2015
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Figure 6. Keyword analysis.

Decision
Support
System
Blogs 6%

Other
6%

10%

Internet
42%

Database
19%

Protoype
13%

Figure 7. Integration of IT in KM research.

cited article is authored by renowned KM thinker Ikujiro
Nonaka and extends on his SECI model (Nonaka, 1994)
of knowledge creation, which is regarded as one of the
most seminal and highly-cited theories in the history of
KM at large, cited 21,360 times.

5. Implications and conclusion
In a global economy of knowledge-intensive nature, KM
efforts have become a necessity for any organisation to
survive and prosper (Davenport & Prusak, 1998). The

Social Media
19%

Wiki
3%

Communication
Technology
13%

Figure 8. IT technologies.

capacity of an organisation to create value is tied to its
ability to identify, manage, and renew its key knowledge assets (Stewart & Ruckdeschel, 1998). The journal of Knowledge Management Research and Practice
(KMRP) depicts one of the key scientific outlets that has
significantly contributed to the development of main
research streams in the field of KM. KMRP publications have paid considerable attention to models, tools,
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Table 7. Highest cited KMRP articles.
Author
Nonaka, Ikujiro, and Toyama, Ryoko
Baskerville, Richard, and Dulipovici, Alina
Usoro, Abel; Sharratt, Mark W; Tsui, Eric, and Shekhar, Sandhya

Title
The Knowledge-Creating Theory Revisited: Knowledge Creation as a
Synthesising Process
The Theoretical Foundations of Knowledge Management
Trust as an Antecedent to Knowledge Sharing in Virtual Communities
of Practice

factors, and mechanisms that can support managers in
translating knowledge into business performance. After
almost 15 years since the foundation of KMRP by the
Operations Research Society, the scientometric analysis
in this study portrays a comprehensive picture of the
growth, structure, interrelationships, and productivity
of the published research activities within the journal.
Initially, the study elucidates an increasing trend
towards multi-author collaboration especially in recent
years. This posits an indication of the maturity of the KM
domain where authors develop relationship networks
and collaborate to overcome the current increasingly
challenging journal acceptance rates. The findings are
also in line with the broader bibliometric studies of Metz
(1989) and Terry (1996) which report a general phenomenon of progressive trends in co-authorship in other
research disciplines. An additional indicator of maturity
is represented in the findings of unbiased distribution of
papers among a wide range of research and professional
organisations. Over 400 institutions are involved in KM
research, either in individual or cooperative studies,
emphasising the growing interests in knowledge-based
research.
Looking at research methods, there is an increasing
propensity towards empirical methods in contrast to a
decrease in literature review studies. This is further suggestive of maturity and an ongoing shift from theory to
practice where field studies are increasingly undertaken
to explore KM issues in real-life contexts and collect
first hand data. This tendency seems to be a general
trend in the KM field, as indicated by results of similar
studies. For example, a recent content analysis of the
proceedings of the European Conference of Knowledge
Management (ECKM) between 2006 and 2013 revealed
that model and framework development were the most
favoured research method followed by case studies and
questionnaires (Fteimi & Lehner, 2016). With respect
to the contribution of practitioners, the study reveals
it is academic authors and institutions who dominate
publications with the percentage of practitioners averaging around 10% over the years. Despite the apparent
stability in the percentages of practitioners to academic
authors in KMRP over the years (Figure 2), other studies
have shown otherwise. A study by Serenko et al. (2009)
revealed that the number of practitioners declined from
approximately one third of all contributors in the late
1990s to 10% by 2008. These findings suggest an impetus
to deeper engagement of practitioners in KM research

Year
2003

NCII
77.1

2006
2007

26.8
18.8

to support the movement towards the development of
applied KM solutions.
While this study encompasses a multitude of research
topics, knowledge sharing emerges as the leading choice
of researchers. Along the same line, knowledge sharing
technologies (e.g., internet and social media) are the
leading IT solutions employed to support the KM process. The prevalence of the knowledge sharing theme
elucidates the emphasis researchers have placed on the
knowledge sharing process as a precursor of effective
KM. Whether the objective is spreading best practice,
cultivating and disseminating innovative ideas, or creating digital repositories, sharing knowledge is often at
the core of KM initiatives. KM work often focuses on the
role of knowledge flows among individuals and between
individuals and the organisation to drive value creation
(Bolisani & Oltramari, 2012; Schiuma, 2006). It is hence
not surprising that the most influential article published
by the journal extends Nonaka’s work on the SECI Model,
a fundamental theory of knowledge creation and sharing
antecedents within organisations.
Furthermore, statistical analysis has revealed a correlation between KM research activity and economic
prosperity as the leading contributing countries are in
North America, Western Europe, and Australia. The
link between the focus on knowledge and national
wealth reinforces the theory established by Drucker
(1994) in his discussion of the post-Second World
War (WWII) economic transformations from goods to
intangibles in what is dubbed today as the Knowledge
Economy. Nevertheless, from an industry perspective,
key knowledge-intensive industries remain underrepresented in KM research. This could be considered as an
opportunity for future researches to direct their efforts
towards such relatively under-published sectors. The
fact that most KM research is conducted in education
and research institutions could be simply attributed to
convenience. Researchers often find access within their
own organisations, or in similar academic ones, more
feasible than the challenge of penetrating new industries
to obtain data. Unless sectorial comparison is sought,
limited access could also explain why 15% of authors
opted to gather data from multiple sectors within the
same study.
In conclusion, this study provides evidence that the
field of KM is reaching maturity which poses at least two
challenges. Firstly, the need to identify key future trends
of research development in the field, and second, the
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need to conduct research of more applied nature. KMRP
publishes both quantitative and qualitative papers, however, the discriminating factor to bear in mind is the
relevance of the contribution to KM practice. Emphasis
must be placed upon the consideration that while managers are interested in knowledge and its management,
it is often not for the sake of mere KM theories. Rather,
their interest is rooted in the need to understand how
organisational knowledge assets can be translated into
drivers that positively impact and enhance business
value creation mechanisms.
Limitation of this study lies in the fact that it encompasses only one single journal (i.e., KMRP). While
KMRP is one of the most established periodic in the
KM field, exclusion of others does not ensure the generalisability of findings across wider KM landscape. It
is, therefore, recommended that a similar review framework would be applied to other KM journals in future
studies to enable comparison and validation of results
garnered from this project.
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ABSTRACT
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The pharmaceutical sector is one of the pillars of the world’s economy. A significant proportion
of its value lies in intellectual assets generated through continuous innovation and lengthy
development cycles within a strictly regulated environment. The purpose of this paper is to
address the gap between knowledge management (KM) as an expanding academic discipline
in the pharmaceutical industry and at the same time a growing regulatory expectation.
A systematic review of 137 refereed KM articles revealed six empirical research themes in the
pharmaceutical industry. In a subsequent step, the discovered themes and subthemes were
compared with the extant regulatory expectations as explained in 128 regulatory guidelines.
Findings shed the light on the gap between academic KM research and the current thinking of
regulatory bodies. Some regulated knowledge processes were underrepresented in academic
literature. The paper offers also novel insights and recommendations for future developments
in academic research, regulations, and/or industry.
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1. Introduction
The acknowledgement of knowledge as a pivotal strate
gic resource in the current smart economy has impelled
considerable organisational change. This progressive
movement by individuals and organisations to manage
their intellectual assets developed into KM (Davenport
& Völpel, 2001). The Pharmaceutical industry is not an
exception to this trend, not only as a knowledgeintensive industry but also as a leading economic
partner with transcendent investments in innovation
and research. According to European Federation of
Pharmaceutical Industries and Associations (EFPIA),
The Pharmaceutical industry employs more than
750,000 employees in Europe, 16% of them working in
Pharmaceutical Research and Development (R&D)
(EFPIA, 2018).
It is not strange that the significance of KM is also
realised by major pharmaceutical regulatory authori
ties. International Council for Harmonisation (ICH)
recommends management of drug and process knowl
edge from development and up to product disconti
nuation as an enabler of effective quality management
systems. From this perspective, KM creates the basis
for the manufacturing process, control strategy, and
ongoing continual improvement (ICH, 2009). On the
other hand, there are some signs of regulatory imma
turity of KM. The term “knowledge” is relatively new
in regulatory publications and is routinely replaced by
indirect words such as “science” or “product/process
understanding” (Calnan et al., 2018). Moreover, KM
CONTACT Ahmed Ramy
Ahmed.Ramy@TUDublin.ie
Paper type Literature review
© Operational Research Society 2020.
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is seen by ICH only as an enabler of The
Pharmaceutical quality system (ICH, 2009).
Thus, as knowledge is another core product of
the pharmaceutical industry (Riddell & Goodman,
2014), managing stocks and flows of knowledge in
this sector emerges as a key economic and regula
tory objective as well as a growing area of academic
research. Nonetheless, some knowledge-intensive
industries such as pharmaceuticals have not
received adequate attention in industry-specific
publications (Ramy et al., 2017). This paper comes
as a comprehensive industry-specific systematic
review of KM literature between the academic
research and regulatory expectations.

2. Review methodology
The high expectations of improving the quality of
reviews through well-defined methodologies led to
the development of systematic review protocols
(Jesson et al., 2011). Systematic review protocol
encompasses specific research questions, the popu
lation that is the focus of the study, the search
strategy, and terms for identification of the relevant
studies. Studies that meet all inclusion criteria and
manifest none of the exclusion criteria need to be
integrated into the review (Davies & Crombie,
1998; Tranfield et al., 2003). The authors com
menced his review by identifying three research
questions:
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Q.1 How is the KM literature in pharmaceutical/bio
pharmaceutical industry developing?
Q 2. What are the expectations of regulatory agencies
with regard to the identified research themes?
Q 3. What is the future of KM research within the
pharmaceutical industry?
After refining the review questions, the timeframe of
review is set to be the last twenty years (1996–2016).
This time period represents the prosperous period of
KM research (Ragab and Arisha, 2013a). Furthermore,
the timeframe took into account the relative novelty of
online KM journals. According to Serenko and Bontis
(2013) ranking of the KM journals, the top-ranked
four KM journals (JKM, KMRP, IJKM, and JIC) have
been published online only since 1997, 2003, 2005, and
2000, respectively.
The criteria for inclusion comprise peer-reviewed
electronic business journals in the English language
retrieved from Emerald Insight and Science Direct data
base (Table 1). Pharmaceuticals related search strings in
the titles, keywords, or abstracts were used to identify
the relevant articles. Search strings were synthesised by
combining terms like “pharmaceutical” or “pharmaceu
tical industry” with the most popular KM keywords
(such as knowledge sharing, intellectual capital, knowl
edge transfer, or innovation) extracted from two com
prehensive keyword analysis studies in the KM
discipline: Fteimi and Lehner (2016) along with
Ribière and Walter (2013). After a brainstorming ses
sion by the authors, potential search strings were
approved. The list was updated during the search pro
cess. It was meant not to tightly plan the review process
as this may inhibit researchers’ capacity to explore,
discover, and develop ideas (Tranfield et al., 2003).
After the exclusion of duplicates, Articles that
have been retrieved from the search results were
screened against the inclusion and exclusion criteria
by reviewing the titles and abstracts (Pati &
Lorusso, 2018). A full-text assessment followed
where the full-text articles were scrutinised to assess
relevance to the review questions. The retained
articles addressed a KM related topic exclusively in
the field of pharmaceutical industry or in conjunc
tion with other industries. To mitigate the risk of
bias of the reviewed studies (Moher et al., 2015),
141 eligible articles were quality-assessed for the

clarity of research objectives, adequacy of descrip
tion of the data collection methods and finally the
link between data, results, and conclusion as
advised by Kitchenham and Charters (2007). Four
articles were excluded at this stage due to ambigu
ous methodology and irrelevance to pharmaceutical
industry. Ultimately, only 137 articles were retained
for analysis after application of inclusion/exclusion
criteria and quality assessment. A limited number of
non-business journal papers (e.g., medical journals)
and papers identified through cross-referencing and
hand searching were included (Figure 1).
After acknowledgement of main themes and pro
cesses in KM literature; the identified themes were
scrutinised in the regulatory guidelines of five major
regulatory bodies. The reviewer collected all the pub
lished guidelines for pharmaceutical industry on the
official websites of World Health Organisation
(WHO), FDA, ICH, The Pharmaceutical Inspection
Convention and Pharmaceutical Inspection Cooperation Scheme (jointly referred to as PIC/S) and
EudraLex- European Union (EU) Legislation. At the
end, 128 guidelines were searched for KM related
topics in light of the identified themes from academic
literature review. The analysis was meant to recognise
the significance of research themes from regulatory
perspective as well as the possible research gaps in
this field.

3. Findings
3.1. Scientometric trends
Initially, findings indicate that KM in the Pharmaceutical industry has become a well-established aca
demic research area. Authorship trends show that
approximately 93% of articles are published by aca
demic researchers, while the remaining 7% is the pro
duct of practitioner work. Over the past ten years,
a significant increase in collaborative research from
62% to 85% is also evident. Among the articles which
do specify the function under study (approx. 40%), 83%
fall within pharmaceutical development and innovation
functions in contrast to only 8% in production, 4% in
sales and 4% in supply chain. In order to identify the
leading countries in the KM field, the relative contribu
tions of 36 countries whose papers were included in this
review are traced and ranked using the Equal Credit
counting method (Chua & Cousins, 2002; Lowry et al.,

Table 1. Inclusion and exclusion criteria.
Inclusion criteria
KM theories and processes
With applications in pharmaceutical industry
Peer reviewed journal articles
In English language
Published online between 1996 and 2016

Exclusion criteria
Not related to KM
Applied exclusively in other industries
Editorials and position papers
Articles that use languages other than English
From journals that don’t have online domains and unpublished work.

Records identified through
database searching (n=2046)

3

Additional records identified
through other sources (n=18)

Records after titles
and abstract screening
(n= 141)

Records excluded
(n= 1218)

Eligibility

Records after duplicates removed
(n= 1359)

Full-text articles
assessed for eligibility
and quality (n= 141)

Full-text articles
excluded with reasons
(n= 4)

Included

Screening

Identification
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Studies included in the
qualitative and
quantitative synthesis
(n=137)

Figure 1. Systematic review process – PRISMA flow diagram (Moher et al., 2015).

2007). The USA and UK were ranked highest with
regards to productivity (18% and 11%, respectively, of
all reviewed articles); followed by Iran (7%), Australia
(7%) and India (6%). It is worth noting that country
contribution in this research addresses the country of
residence of the author not necessarily where the
research was held (Figure 2).
In terms of methodology, only 29% of the articles
adopt literature review as the research strategy; while
over 70% are empirical studies employing one or more
data collection methods, e.g., surveys (29%), case stu
dies (10%) and interviews (17%).
3.2. Research themes
A hybrid method of quantitative keyword analysis
and qualitative thematic analysis is proposed to

Figure 2. Country productivity.

identify the common research topics or themes. The
most frequent themes and keywords (after exclusion
of generic keywords, e.g., knowledge management,
pharmaceutical . . ., etc..) are presented in (Table 2).
The identified themes and keywords offer a birds-eye
view of the KM landscape. The paper presents
a classification of KM publications into six areas: knowl
edge sharing and technology transfer, Intellectual
Property Protection (IPP), knowledge measurement
and Intellectual capital (IC) reporting, innovation and
knowledge creation (KC), organisational knowledge cul
ture and structure as well as Pharmaceutical firm perfor
mance (Figure 3). The rest of articles falls in
miscellaneous category that includes other themes such
as: organisational learning, knowledge management
maturity, data mining, etc. Table 3 presents the key
articles under each of the featured themes.
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Table 2. Themes and keyword analysis.
Rank
1
2
3
4
5
6
7
8
9
10

Themes & K. processes
Intellectual Capital
Innovation
Knowledge Transfer
Knowledge Sharing
Organisational Performance
Organisational Culture
Intellectual Property
Knowledge Creation
New Product Development
Organisational Learning

Frequency
29
25
14
13
12
12
10
9
6
6

Keywords
Intellectual Capital
Innovation
Knowledge Sharing
Knowledge Transfer
New Product Development
Research and Development
Intangible Assets
Organisational Learning
Organisational Culture
Project Management

Frequency
27
18
10
10
9
9
8
7
5
5

Figure 3. Literature map.

Table 3. Key articles under the featured themes.
Category
Knowledge Sharing and Technology (Wakefield, 2005); (Styhre et al., 2008); (Qureshi & Evans, 2015); (Akhavan et al., 2015); (Pedroso & Nakano, 2009);
Transfer
(Mets, 2006); (Lilleoere & Hansen, 2011); (Lawson & Potter, 2012); (Hemmert, 2004); (Gray et al., 2011); (Dooley
& Kirk, 2007); (Delaney, 1999); (Criscuolo, 2005); (Coradi et al., 2015); (Chávez & Víquez, 2015); (Brachos et al.
2007); (Bourouni et al., 2015); (Azan and Huber Sutter 2010); (Allen et al., 2016); (Santos, 2003); (Mohan, Jain,
and Ramesh 2007); (Malik, 2012); (Iwasa and Odagiri 2004); (Filieri et al. 2014); (Chang, Yeh, and Yeh 2007);
(Buchel et al. 2013); (Bourouni et al., 2015)
Pharmaceutical Firm Performance
(Mehralian et al. 2012); (Malik, 2012); (Kim et al., 2014); (Vishnu & Gupta, 2014); (SubbaNarasimha et al., 2003);
(Sharabati et al., 2010); (Pal & Soriya, 2012); (Kamath, 2008); (Garcia Morales et al., 2008); (Bollen et al., 2005)
Research, Innovation and
(Terziovski and Morgan 2006); (Styhre et al., 2002); (Sternitzke, 2010); (Standing and Kiniti 2011); (Sharma and
Knowledge Creation
Goswami 2009); (Roth, 2003); (Parisi and Hockerts 2008); (Palacios-Marqués, Popa, and Mari 2016); (O’Dwyer
et al. 2015); (Nightingale, 2000); (Mehralian et al. 2014); (Lowman et al., 2012); (Lauto and Valentin 2016);
(Kneller, 2003); (Khemka & Gautam, 2010); (Kazadi, Lievens, and Mahr 2015); Kale & Little, 2005; Huang, 2011;
Hohberger, 2016; (Herrmann and Peine 2011); (van Geenhuizen and Reyes-Gonzalez 2007); (Gassmann &
Reepmeyer, 2005); (Garcia Morales et al., 2008); (Filieri et al. 2014); (Chen, Jiao, and Zhao 2008); (Chang et al.
2007); (Cardinal & Hatfield, 2000); (Styhre et al., 2008); (Mets, 2006); (Lowman et al., 2012); (Lauto and Valentin
2016); (Kazadi et al. 2015); (Gassmann & Reepmeyer, 2005); (Cardinal & Hatfield, 2000); (Boasson and Boasson
2015); (Mohan et al. 2007)
Intellectual Property Protection
(Yang et al. 2014); (Iwasa and Odagiri 2004); (Boasson and Boasson 2015); (Allarakhia & Walsh, 2011); (Sternitzke,
2010); (Kale and Little 2005); (Hohberger, 2016); (Chávez & Víquez, 2015); (Russell 2016); (Bollen et al., 2005)
Knowledge Culture and
(Wang, Ashleigh, and Meyer 2006); (Mehralian et al., 2016); (Magnier-Watanabe & Senoo, 2008); (MagnierOrganisational Structure
Watanabe & Senoo, 2010); (Magnier-Watanabe et al., 2011); (Magnier-Watanabe & Senoo, 2009); (Lindner &
Wald, 2011); (Guzman, 2008); (Evans & Brooks, 2005); (Ebrahimi et al., 2008); (Bigliardi et al., 2012); (Filieri et al.
2014)
Knowledge Measurement and IC
(Vishnu & Gupta, 2014); (Tahvanainen and Hermans 2005); (SubbaNarasimha et al., 2003); (Singh & Kansal, 2011);
Disclosure
(Sharabati et al., 2010); (Palacios-Marques & Garrigos-Simon, 2003); (Pal & Soriya, 2012); Narula, 2016;
Naidenova &Parshakov, 2013; (Mehralian et al. 2013); (Mehralian et al. 2013); (Kamath, 2008); (Huang and Wu
2010); (Hine, Helmersson, and Mattsson 2008); (Ghosh & Mondal, 2009); (Erickson & Rothberg, 2009); (Hosein
Chizari et al., 2016); (Bollen et al., 2005); (Boekestein, 2006); (Boekestein, 2009); (Abhayawansa & Azim, 2014);
(Sydler et al., 2014); (Russell, 2016); (Rossi et al., 2015); (Nito, 2005); (Mehralian et al. 2012); (Mehralian et al.
2014); (Huang et al., 2011)
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3.3. Publication years
The review shows that the majority of included articles
have been published between 2004 and 2016 as shown
in (Table 4).

3.4. Knowledge Sharing (KS) and technology
transfer
More than 19% of reviewed articles addressed knowl
edge sharing and transfer signifying that Knowledge
transfer (KT) holds a special significance in the
Pharmaceutical industry. Therefore, the WHO dedi
cates Annex 7 of Technical Report Series no.961 to
discuss dynamics and controls of technology transfer
occurring at some stage in the lifecycle of most pro
ducts in the pharma industry. However, the real sig
nificance of KS comes from the fact that it is the
component that facilitates continuous knowledge
creation (Akhavan et al., 2012) and is a key driver of
long-term success in a knowledge-intensive organisa
tion (Coradi et al., 2015). Accordingly, Qureshi and
Evans (2015) identify nine categories of deterrents of
KS in the pharmaceutical organisation. They can be
broadly classified as either structural barriers, cultural
barriers, or managerial barriers.
Other studies focused on the attitudes necessary to
enhance knowledge sharing (Akhavan et al., 2015).
Also, Knowledge Networks (KN) are increasingly con
sidered vital channels to achieve strategic objectives in
project-based organisations particularly Pharma R&D
(Bourouni et al., 2015). By the same token, structural
indexing and knowledge dictionaries can identify
knowledge agents and evaluate intra-organisational
knowledge sharing. Enhancing knowledge flow
among R&D stages can be crucial to shorten the pro
duct to market timing (Wakefield, 2005).
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As physical proximity is one of the suggested bar
riers for Knowledge Sharing and Technology Transfer
(Lilleoere & Hansen, 2011), several studies handle this
topic in pharma explicitly. For instance, studies con
ducted in the R&D department of multinational drug
manufacturer Novartis reveal that co-location of dis
persed project teams leads to faster and more precise
flow of knowledge (Coradi et al., 2015).
On a macro scale, an equally significant aspect of
inter-organisational KS is geographic distribution.
Higher quality risk can accompany offshore manufac
turing due to challenges of KT from headquarters
(Gray et al., 2011). Pharmaceutical firm location is
found to influence the intensity of communication
between different firms but not the innovation.
Relocation (e.g., into industry clusters) and expensive
real estate investments can be replaced by enhancing
the social connections through technology (Allen
et al., 2016). In spite of that, having an R&D laboratory
near corporate headquarter enhances new drug pro
ductivity as proximity is necessary for the integration
of R&D with other functions (Cardinal & Hatfield,
2000).
3.5. Intellectual Propriety Protection (IPP)
There is no industry where firms build their competi
tive advantage more closely to IPP than the pharma
ceutical industry. However, in response to dramatic
transitions in bioscience and computational chemis
try, biopharmaceutical companies commence newer
approaches for managing their IP and innovation
including open access, exclusive and non-exclusive
licencing (Allarakhia & Walsh, 2011). Although the
exclusive licencing is more preferred in the pharma
ceutical industry (2:1), non-exclusive licencing pro
vides a strategic advantage to the company and

Table 4. Publications per year.
Year
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016

Intellectual
property
protection

Knowledge culture
Knowledge shar
and organisational Knowledge measurement ing and technol
structure
and IC disclosure
ogy transfer

Pharmaceutical
firm
performance

1

2
1
2

1
1
1
2
2

1
1

3
1

3
1
1
2
1

2
4
2
2
2
3
4
1
3

1
1

1
2
2
1
4
1
1
1
2
2
1
1
6
1

1
1
2
1
3
2

Research, innova
tion and knowl
edge creation
Miscellaneous Total
1
1
1
1
1
1
1
3
1
4
1
2
3
2
3
4
1
2
3
2
2
4
4

1
1
5
5
2
4
9
3
2
3
1
3
4
3
3

2
7
8
17
7
11
21
10
10
13
11
7
15
16
14
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reduces market uncertainty by decreasing competition
(Malik, 2012).
The real significance of IP for the pharmaceutical
industry comes from the belief that patents are used as
a proxy indicator of knowledge creation (Nerkar,
2003). Also, patent citations studies in pharma exploit
patent-related data to estimate the quality of innova
tion, diffusion of knowledge and geographic localisa
tion of knowledge (Chávez & Víquez, 2015). For this
reason, patents can affirm firm’s value and market
performance. Association between company value,
reported intangible assets and R&D capitals is proven
(Russell, 2016).
In a highly dynamic global economy, enforcing IP
protection laws implies significant costs particularly
on developing economies (Mazzoleni & Nelson, 1998).
Nevertheless, IPP is an important incentive for inno
vation in advanced countries enjoying both a superior
technological infrastructure as well as a rich market
for new drug (WHO, 2006a).
3.6. Knowledge measurement and IC disclosure
Empirical evidence supports the notion that the nature
and value of knowledge assets differ from industry to
another with a direct impact on investment decisions.
By using Tobin’s Q model for knowledge measurement,
it is noticed that not only the level of intellectual capital
(IC) and competitive intelligence are both higher in
consumer industries (such as pharmaceuticals) in com
parison to business to business industries, but also
investments in knowledge assets are more promising
(Erickson & Rothberg, 2009). Measurement of pharma
ceutical IC at organisational level relies on the identifi
cation of most relevant constructs or indicators in each
industry (Palacios-Marques & Garrigos-Simon, 2003).
For example, management experience and technical
knowledge are on the top of HC indicators in pharma.
Regarding structural capital, organisational culture, the
ratio of investment in R&D and the number of R&D
projects are the highest priority indicators. Additionally,
mutual trust with customers and their satisfaction are
the highest priority RC indicators (Mehralian et al.,
2013).
However, the disclosure of IC in balance sheet (BS)
is still a measurement barrier and an opportunity for
improvement in the pharmaceutical industry, particu
larly in developing countries. The lack of standardised
accounting guidelines on this vital asset results in
unreporting of resources of billions in firm’s annual
reports with an impact on their performance in the
stock market (Abhayawansa & Azim, 2014).
Intellectual capital is widely adopted as a predictor
for firm’s profitability in pharmaceutical sector (Sydler
et al., 2014). Healthcare patents reflect firm’s innova
tive capabilities and enhance the capacity to raise
necessary start-up capital (WHO, 2006a). However,

no significant relationship was observed either
between IC and productivity or market valuation
(Ghosh & Mondal, 2009; Pal & Soriya, 2012). This
argument is subject to controversy as companies
which generate more profits are able to invest more
in IC (Naidenova & Parshakov, 2013).
In the pharmaceutical industry, Merger and
Acquisition (M&A) is used as a cost-effective way to
gain access to new product platforms, technologies
and patents; traditional pharmaceutical companies
with dried-out research pipelines but sufficient cash
acquire innovative biotech firm as a source of new
products (Rossi et al., 2015). M&A can be seen as an
opportunity to overcome the underestimation of
intangible assets under current accounting systems in
pharma companies (Boekestein, 2009).
3.7. Research, innovation, and Knowledge
Creation (KC)
The emergence of new discoveries in the twenty-first
century will urge Pharmaceutical manufacturing to
employ innovation and cutting-edge technology as
ways of doing business (FDA, 2004b). Nowadays,
pharmaceutical industries do not typically fit to the
classic economy of scales theories as they transformed
into R&D intensive rather than production intensive
(Gassmann & Reepmeyer, 2005). Pharmaceutical
industry becomes more than other industries depen
dent on scientific advances, particularly in basic
sciences, developed in public sector (Sternitzke,
2010). Historically, public sector role in drug discov
ery was limited to basic research to elucidate the basic
pathological mechanisms. However, this role has sig
nificantly expanded in the biotechnology era (Stevens
et al., 2011). In contrast with publically funded drug
research model in EU and US universities, it is noticed
that drug discovery in Japanese companies occurs
predominately in-house which may be no longer com
patible with global competitiveness (Kneller, 2003).
In such a complex R&D environment, information
sharing and intrinsic motivation are recognised as
important drivers for organisational creativity
(Sundgren et al., 2005). There is a significant influence
of knowledge transfer on firm innovative capability
(r = 0.893) too (Palacios-Marqués et al., 2016). As
the bulk costs of R&D come from the clinical phases,
sharing knowledge and experiences coming from ter
minated projects would be of high significance (Styhre
et al., 2008).
Surveyed literature highlights some of the dynamics of
innovation within pharma organisation. Management
support and effective management of knowledge are
found indispensable if the organisation wants to adopt
an innovative environment. Additionally, Job satisfaction
explains up to 25% of the variance in innovation
regression models (Khemka & Gautam, 2010).
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Transformational leadership shows a positive relation
ship with innovation (Garcia Morales et al., 2008). Also,
a significant positive relationship is established between
organisation capital and innovation confirming the
remarkable role of intangible assets in generation and
enhancement of innovative capabilities (Huang et al.,
2011).
Conversely, outsourcing of R&D and clinical stu
dies for new product development (NPD) and the
associated knowledge losses as well as regulatory
delays create innovation risks (Lowman et al., 2012).
Likewise, FDA warned from the threats of broad inter
pretations of 21 CFR part 11 (electronic records and
electronic signatures) on innovation and technological
advances without any benefit for patient health (FDA,
2003).
3.8. Knowledge culture and organisational
structure
FDA encourages management to implement quality
systems and procedures that support a communicative
culture. Under such work culture, employee sugges
tions are appreciated and used for continual improve
ment (FDA, 2006). Along the same line, beliefs and
knowledge-related values (love, care and trust) can be
potential sources of competitive advantages in pharma
(Magnier-Watanabe & Senoo, 2009).
Knowledge culture is a way of organisational life that
empowers people to create, share, and use knowledge
for the good of the organisation (Oliver & Kandadi,
2006). In the pharmaceutical industry, knowledge cul
ture is believed to compensate for the lack of organisa
tion memory in temporary project teams where
information Communication Technology (ICT) sys
tems are not enough alone for ensuring the exchange
of knowledge (Evans & Brooks, 2005; Lindner & Wald,
2011). Organisation memory held by ageing workers
can be transferred to the younger workers through
bridges of socialisation and adequate organisational
climate (Ebrahimi et al., 2008).
Organisational characteristics of pharmaceutical
firm such as structure and strategy affect knowledge
acquisition activities including knowledge storage, dif
fusion, and application (Magnier-Watanabe & Senoo,
2008). In fact, organisational characteristics can have
even more influence over KM than national culture
(Magnier-Watanabe & Senoo, 2010). For example,
open culture where employees can raise questions
and feel at ease explains 31% of the variance in four
modes of SECI process compared to only 16% for
bureaucratic culture (Magnier-Watanabe et al.,
2011). In pharmaceutical R&D, bureaucratic culture
has a negative impact on knowledge workers’ job
satisfaction while innovative or supportive culture
positively influences them (Bigliardi et al., 2012).
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3.9. Pharmaceutical firm performance
Human and Relational Capital is deemed to positively
impact business performance of the pharmaceutical
firm (Sharabati et al., 2010). Several empirical studies
have underlined this paradigm utilising either return
on asset (ROA) as performance measures (Vishnu &
Gupta, 2014); whereas, Value Added Intellectual
Coefficient (VAIC) (Chizari et al., 2016) or generation
of new patents were used as proxies for technical
knowledge of firms (SubbaNarasimha et al., 2003).
Even more striking is the fact that each of the three
components of IC is not only individually related to
firm performance, but also they collaborate together in
the way they influence firm performance (Bollen et al.,
2005). KM performance is considered as a predictor of
superior financial performance in terms of higher
profit ratios (ROA, ROS) and lower cost ratios
(OPEX) (Holsapple & Wu, 2011).
KM strategies can influence organisational perfor
mance in pharma. Information system maturity in the
pharmaceutical firm as well as knowledge intensity
would be the determinants for the most effective KM
strategy (Kim et al., 2014). Internal organisational
tensions between tacit-oriented and explicit-oriented
strategies, which are difficult to reconcile, would nega
tively impact the performance (Choi et al., 2008).
3.10. Regulatory insights
A thorough exploration of KM in 128 Good Practice
(GxP) quality guidelines (Table 5) has revealed
a slightly different pattern of interests and expecta
tions in comparison with the academic business jour
nals (Figure 4).
An overview of the current thinking and expecta
tions of key regulatory bodies regarding KM is pre
sented as follow:
3.11. ICH
From the previous review sections, KM expresses
a considerable level of maturity as an academic
research field in the pharmaceutical industry. Despite
that, KM shows less mature roles at industry level
which might hinder the achievement of ICH Q10
desired state (Calnan et al., 2018). KM received mea
gre attention by regulatory agencies (Rathore et al.,
2017). For instance, ICH Q10 considers KM together
with QRM as the enablers of its effective implementa
tion throughout the product lifecycle. Proper imple
mentation of ICH Q10 guidelines is deemed necessary
for innovation and continual improvement and
strengthening the link between pharmaceutical devel
opment and manufacturing activities. Last but not
least, ICH Q10 suggests monitoring of all innovations

Pharmaceutical Firm Performance

Knowledge Culture

Research, Innovation and Knowledge
Creation

Knowledge Measurement and IC Disclosure

IPP

ICH
FDA
WHO
ICH Q9 on quality risk management (4.5.);ICH Q9 on FDA Guidance for Industry: Contract Manufacturing
WHO TRS 1003 Annexe 4 (4.1.1.2.);WHO TRS 996
quality risk management. (II.3);ICH Good
Arrangements for Drugs: Quality Agreements (1.e.);
Annexe 4 (1.1.);WHO TR S 996 Annexe 1 (4);WHO
Manufacturing Practice Guide for Active
FDA Guidance for Industry: Contract Manufacturing
TRS1003 Annexe 4 (1.5.);WHO TRS 953 (2.1.3.);WHO
Pharmaceutical Ingredients Q7 (17.60);ICH Q11 –
Arrangements for Drugs: Quality Agreements (1.d.);
TRS 953 (2.1.9);WHO TRS 953 (2.1.13);WHO TRS 953
Development and Manufacture of Drug Substances
FDA Guidance for Industry: Contract Manufacturing
(8.1);WHO TRS 953 (8.1.1);WHO TRS 953 (17);WHO
(9);ICH Quality Risk Management Q9 (II.3.);ICH
Arrangements for Drugs : Quality Agreements (1.e.);
TRS 1003 Annexe 4 (4.2.4.3.);WHO TRS 1003 Annexe
pharmaceutical quality system Q10 (1.6.1);ICH
FDA Guidance for Industry: Quality Systems
4 (4.4.);WHO TRS 981 Annexe 2 (1.1.);WHO TRS 981
pharmaceutical quality system Q10 (3.1.2)
Approach to Pharmaceutical CGMP Regulations (3);
Annexe 2 (glossary);WHO TRS 961 Annexe 7;WHO
CFR Title 21 Part 820 Quality System Regulations
TRS 957 Annexe 2 (17.60);WHO TRS996 Annexe 5
(7.6.);WHO TRS996 Annexe 5 (Appendix 1);WHO TRS
973 Annexe 4 (1.4.);WHO TRS 973 Annexe 4 (3.3.);
WHO TRS 986 Annexe 2 (1.4.);WHO TRS 986 Annexe
2 (7.17);WHO TRS 981 Annexe 2 (1.2.);WHO TRS957
Annexe 5 (14.11);WHO TRS 953 (8.2.)
N/A
N/A
N/A
WHO TRS1003 Annexe 4 (1.6.); WHO TRS 953 (2.1.7.,
2.1.11)
EudraLex Annexe
ICH pharmaceutical quality system Q10 (2.8.)
FDA Guidance for Industry: PAT: A Framework for
WHO TRS 961 Annexe 7 (1.4)
15: Qualification
Innovative Pharmaceutical Development,
and Validation
Manufacturing, and Quality Assurance (1.d.)
N/A
ICH Q11 – (3.1.3.); ICH Q10 (Glossary); ICH Q10 (1.1); FDA Guidance for Industry: Part 11, Electronic Records; WHO TRS 981 Annexe 2 (1.1)
ICH Q10 (1.5.3.);ICH Q10 (1.6.);ICH Q10 (1.6.1.);ICH
Electronic Signatures – Scope and Application (III.
Q10 (3.2.3.);
B.); FDA Guidance for Industry: Process Validation :
ICH Q10 (4.2.b);
General Principles and Practices (1);FDA Guidance
for Industry: Data Integrity and Compliance With
CGMP (Draft) (III.1.c)
N/A
N/A
FDA Guidance for Industry: Quality Systems Approach WHO TRS 996 Annexe 5 (1.4.)
to Pharmaceutical CGMP Regulations (B.2.)
N/A
N/A
N/A
Knowledge strategies:
WHO TRS 996 Annexe 5 (1.4., 5.4., 5.5.,7.5.)

KM theme
EU GMP
Knowledge Sharing and Technology Transfer: N/A

Table 5. Regulatory insights into knowledge management.
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Figure 4. Key themes in regulatory guidelines.

that might enhance QMS (ICH, 2008). Other ICH
guidelines refer sporadically to KM with a focus on
KS/KT. ICH Q9 suggested the need for further studies
related to technology transfer should be assessed
through QRM (ICH, 2005). ICH Q11 endorses the
management and sharing of product/process-related
d knowledge throughout product lifecycle including
knowledge related to drug substance and its manufac
turing process. This is supposed to enhance the man
ufacturing process and establish a control strategy
especially in cases of product ownership changes.
3.12. WHO
For the purpose of earlier detection of potential pro
blems, WHO guidelines pay close attention to regula
tory harmonisation and participation in information
(e.g., from inspections and clinical studies) sharing
networks among regulatory agencies with special con
siderations to confidentiality and intellectual property
issues (e.g., WHO, 1999, 2003, 2017). Parallel efforts
are exerted to contain escalating costs of drug prices
by minimising duplication of inspection activities
through: better networking, enhanced collaboration,
and increased mutual trust (WHO, 1999). Information
sharing efforts with the European Directorate for the

Quality of Medicines & Healthcare (EDQM) extends
to certification programmes (WHO, 1999). Risk com
munication and sharing risk-related knowledge are
also addressed in WHO guidelines (WHO, 2013).
Finally yet importantly, sharing public alerts and
warning alerts for imported drugs or medical devices
can prevent similar faulty products from being
exported to other markets (WHO, 2017).
WHO identifies the technology transfer as the mid
dle stage in the drug lifecycle where GMP regulations
must apply (WHO, 2013, 2014). The organisation
requires validation of the process of data transfer
(WHO, 2016). Whenever the transfer involves analy
tical methods, it is required to conduct this validation
by the development before transfer to manufacturing
quality control. Periodic checks are necessary to
ensure the accuracy and reliability of the process
(WHO, 2006b). As a general requirement, mechan
isms should be addressed to facilitate the transfer of
information not only between manufacturers and cus
tomers but also to the relevant regulatory bodies
(WHO, 2010a).
With regard to IPP, The International Medical
Products Anti-Counterfeiting Taskforce (IMPACT)
is led by WHO, where the focal point is public health
protection from the implications of counterfeiting
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(WHO, 1999). The ever-changing business strategies
and their accompanying intra- and intercompany
transfers of technology obliged the WHO Expert
Committee on Specifications for Pharmaceutical
Preparations in its 42nd report to assign a special
guideline to address this issue (TRS 961 Annexe 7).
However, this guideline is meant to be a flexible fra
mework rather than rigid technology transfer gui
dance. Although a multifunctional team is proposed
to manage the transfer process, it is affirmed to be
under the umbrella of a quality system (WHO, 2011).
WHO requires pharmaceutical manufacturers to
build their quality decisions and regulatory commit
ments on science-based understanding of the process
and QRM which can offer a greater freedom of how to
comply, hence enhances innovation (WHO, 2013).
Development of quality culture in the pharmaceutical
organisation is believed to improve transparency
about failures and ensure good data management
strategies are in place. Besides, data integrity and pro
tection occupied a featured position in WHO regula
tions. Pharmaceutical firms are expected to develop
appropriate tools and strategies for the management of
data integrity risks based upon their own GxP activ
ities, technologies, and processes (WHO, 2016).
3.13. EU GMP
Furthermore, EU Guidelines for Good Manufacturing
Practices (EudraLex) have adopted Good Documentation Practices as an enabling tool for knowledge
management throughout different stages of product
lifecycle (EudraLex, 2015). Similar to WHO, PIC/S
and ICH recommendations, the guidelines encourage
agents, brokers, distributors, repackers, or relabellers to
share regulatory and quality information with the man
ufacturers and customers (EudraLex, 2014; ICH, 2000;
PIC/S, 2017; WHO, 2010b). EudraLex requires analyti
cal method transfer protocol (EudraLex, 2006) with no
explicit transfer framework as in WHO TRS961 Annexe
7. However, it confirmed the coverage of technology
transfer by cGMP regulations as a part of product life
cycle (EudraLex, 2011).
3.14. FDA
FDA pays special attention to process understanding
and knowledge management as effective strategies
for preventing and detecting data integrity issues
(FDA, 2016c). On the other hand, FDA accentuates
on knowledge sharing and transfer in contract man
ufacturing as explained in the quality agreement
(FDA, 2016a). The agency highlights the role of
senior management in the creation of communica
tive organisational culture as a tool for improving
knowledge sharing and communication in addition

to cross-functional groups to share ideas for
improvement purposes (FDA, 2006).In addition,
FDA encourages data acquisition and accumulation
over the lifecycle as an important way for continuous
improvement which in turn can facilitate the scien
tific communication with the agency (FDA, 2004a).
Similarly, following process validation FDA guide
lines would support process improvement and inno
vation (FDA, 2011).

3.15. PIC/S
In response to the increasingly complex global supply
chains in the pharma industry, PIC/S facilitates voluntary
inspection data-sharing between member authorities.
This is deemed to enable risk-based assessment of the
need for inspections based on shared confidence in
inspected firms (PIC/S, 2011b). It has not escaped our
notice that data sharing and transfer in PIC/S guides is
focused on inspection data rather than knowledge created
in pharmaceutical firms. The statute of the International
Medicinal Inspectorates Database (IMID), which aims at
establishing a database of GMP inspections carried out by
IMID participating Regulatory Authorities, was adopted
by PIC/S to reduce the number of duplicative inspections
(PIC/S, 2012). Besides, the PIC/S committee is cooperat
ing with other global agencies such as WHO, EMA,
the ICMRA (International Coalition of Medicines
Regulatory Authorities) and United Nations Children’s
Fund (UNICEF) with regard to training and sharing of
inspections’ information (PIC/S, 2011a, 2015, 2016b;
WHO, 2003).
Because data integrity is essential for successful
implementation of GMP, the requirements for good
data management are embedded in the current PIC/S
guidelines to GMP/GDP for Medicinal products.
Good data management practices (GDMP) are envi
saged as fundamental enabler for the integrity of the
generated data. The manufacturer or distributor
undergoing inspection is required to enforce GDMP
that ensure the accuracy, completeness, and reliability
of data (PIC/S, 2016a).
The data lifecycle (from generation till discard at
the end of retention period) is also featured in GMP
guidelines including data transfer throughout the pro
duct lifecycle. In case of computerised systems, inter
faces should be assessed and addressed during
computer system validation to guarantee the correct,
accurate, and complete transfer of data (PIC/S, 2016a,
2017). Risk review should be considered specially for
supply chains and outsourced activities to assess the
extent of data integrity controls required (PIC/S,
2016a). It is noteworthy that PIC/S has repeatedly
warned of inappropriate interpretation of guidelines
making them barriers to technical innovation or the
pursuit of excellence (e.g.PIC/S, 2011c).
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Organisational culture and behaviour are
a complementary part of the effective data governance
system when combined with an understanding of data
criticality, data risk, and data lifecycle. The value
behind this appears in the empowerment of employees
to report failures and opportunities for improvement.
This reduces the incentive to falsify, alter, or delete
data (PIC/S, 2016a). GMP inspectors have to be sensi
tive to the effects of organisational culture and struc
ture on the organisation behaviour where data
reporting differs between open and close cultures. In
order to ensure data integrity within the pharmaceu
tical organisation, appropriate values, believes, think
ing and behaviours need to be demonstrated
consistently by management, team leaders, and quality
personnel (PIC/S, 2016a).

4. Discussion and implications
The pharmaceutical industry is not only one of the
knowledge-intensive sectors, but also an industry with
a direct effect on health promotion (Mehralian et al.,
2016). It comprises distinct characters making phar
maceutical knowledge management a unique process.
Being research-intensive, highly innovative and a great
source of IC (Kamath, 2008), building networks of
R&D personnel with research institutions, providing
ultimate protection of IP rights, having high influence
of political, legal, and administrative factors on tech
nology acquisition (Hemmert, 2004), achieving high
level of maturity in project management (Wakefield,
2005), involving suppliers in product development
activities (Lawson & Potter, 2012), involving colla
borative research with universities and governments
(Dooley & Kirk, 2007), presenting sophisticated drug
discovery and development systems (Criscuolo, 2005),
facing challenges of regulated prescription drugs
(Pedroso & Nakano, 2009), being one of the fast grow
ing economic sector (Singh & Kansal, 2011), together
with huge economic productivity and high number of
employees (Bigliardi et al., 2012) are some of reasons
for choice of pharmaceutical industry as empirical
research field in KM literature.
Based on an in-depth review of the literature, few
trends emerge. Domination of academic authorship
(93% of authors) and empirical research (>70%) in 36
countries along with 20% increase in co-authorship
reflects the academic maturity of the research area.
Participation of practitioners is relatively limited (7%) in
spite of the colossal investments in KM by pharma com
panies (Riddell & Goodman, 2014). This also validates
the notion that the role which “knowledge” plays in the
pharmaceutical industry is still immature and disabling
the ICH Q 10 desired pharmaceutical quality system
(Calnan et al., 2018). This can also accentuate what has
been described by M. A. F. Ragab and Arisha (2013) as
a theory-practice gap in KM literature in general.
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Since R&D is considered the key space for knowl
edge creation (Ingelgård et al., 2002; Parisi et al.,
2006), most of the studies ignored other functions
(e.g., manufacturing, sales or quality) or other sources
of knowledge in pharmaceutical organisation (e.g.,
process validation studies; manufacturing experience,
continual improvement, and change management
activities). From a regulatory perspective, managing
the knowledge throughout commercialisation and
manufacturing phases until product discontinuation
is supposed to be as important as managing drug
development knowledge (ICH, 2009).
Taxonomical analysis of literature affirms six main
knowledge processes/themes extensively covered by
researchers (Figure 3). In spite of that, the research in
some other potential areas is relatively scarce (e.g.,
knowledge acquisition). In addition, the current think
ing of the pharmaceutical regulatory bodies does not
match the trending themes in business literature. For
example, technology transfer and method/process
transfer are regulated practices under pharmaceutical
quality systems (ICH, 2009; WHO, 2011); case studies
or empirical research is quite limited in this area.
IC is the most frequently used keyword and
research theme in pharmaceutical KM literature. The
influence of pharmaceutical IC on profitability, pro
ductivity, and market value is addressed in several
papers (e.g., Pal & Soriya, 2012). Pharmaceutical IC
reporting in BS suffers from inconsistency and lack of
standardised guidelines. Yet, Intellectual Capital,
knowledge measurement or disclosure are not recog
nised by cGMP guidelines. While M&A implications
were a subject of academic research in pharma com
panies, regulatory publications focus on knowledge
transfer after product/process acquisition or data
acquisition during product lifecycle (FDA, 2004a).
Although KM at product and process level is
explicitly required in ICH Q10 1.6.1. (ICH, 2008),
regulatory authorities did not suggest any framework
for either measurement or disclosure of IC. With
poor reporting and disclosure of IC in pharma
(Abhayawansa & Azim, 2014), further research is
needed to induce industry-specific measurement fra
meworks not only at organisational IC level but also
at the individual knowledge level. As a part of com
pany intangible capital, patent-related keywords are
mentioned 10 times in the review pool (e.g., patent
citation, analysis, research, count, etc.) reflecting the
importance of IP rights as a research subject.
Governmental role in innovation, either through the
outputs of basic science or public funding of growing
industry R&D, is emphasised in the literature. Dynamics
of innovation as managed by the Triple Helix model can
be a meticulous explication of this phenomenon
(Etzkowitz & Leydesdorff, 2000; Leydesdorff & Meyer,
2006). When the FDA announced the Pharmaceutical
cGMPs for the Twenty-first Century in 2006; corrective
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actions, innovation, and continuous improvement were
considered as three complementary improvement
approaches in Pharmaceutical Manufacturing (FDA,
2004b). However, only innovation has received enough
attention in the surveyed literature. It is worth noting
that the term “creation” was mainly used by the regula
tors to signify creation of data and/or electronic records
(FDA, 2016b).
The review explored the role of pharmaceutical
organisational culture and structure in knowledge
management. The review confirmed the notion that
some values are found to be associated with the pros
perity of knowledge within workspace (Remy
Magnier-Watanabe & Senoo, 2009) and a new tech
nology is not able alone to bring about a successful
KM system (Chatzkel, 2007). The KM performance of
the company was found in general related to its mar
ket performance. Unlike pharmaceutical quality sys
tem (ICH, 2008), organisational performance as
a function of its KM practices was not considered by
any of the four regulatory bodies.

5. Conclusion and limitations of research
According to the pharmaceutical regulatory guidelines,
personnel must be qualified and knowledgeable with
functions related to their work activities (FDA, 2006;
WHO, 2014). It is a requirement to manage product
and process knowledge throughout the product lifecycle
(ICH, 2008). However, the academic research interests in
pharmaceutical knowledge as presented in the extant KM
literature partially overlap with the regulatory concerns.
This incomplete overlap offers an opportunity for busi
ness researchers to design their future work to help
industry meet regulatory expectations. Regulatory bodies
recommended knowledge management but did not pro
vide comprehensive frameworks to manage knowledge of
pharmaceutical firms at the time industry practitioners
refrain from serious contribution to academic research.
This supports the notion that knowledge management in
pharmaceuticals is still a growing research area, particu
larly in non-research and development functions.
The review has the limitation of being restricted to
articles extracted from the Emerald Insight and Science
Direct databases. Knowledge management conference
proceeding and other academic portals can be
explored in future studies. Despite the limitations,
this paper offers an integrative and comprehensive
taxonomy of KM literature in an industry-specific
context that offers valuable insights for future
research.
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Structured Abstract
Purpose - The purpose of this paper is to explore the current research trends in
Knowledge Management (KM). To achieve this objective, a scientometric analysis of all
literature published in Knowledge Management Research and Practice (KMRP), a leading
journal, is conducted ranging from the year 2003 to 2015.
Design/Methodology/Approach - A comprehensive literature review framework is
synthesised from previous studies in KM. The analysis is designed based on three sets of
review questions addressing Research Productivity, Research Themes and Methods, in
addition to Citation Analysis. A total of 344 articles are reviewed and coded according to
the adopted framework. To examine research output, Equal Credit and Direct Count
methods are applied to assign authorial credit, while Normalized Citation Impact Index
(NCII) is used for research impact analysis. A qualitative approach is introduced for
thematic and methodological analysis.
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Practical Implications – The study elucidates an increasing trend towards multi-author
collaboration especially in recent years. The KMRP’s publication list includes more than
400 academic and research institutions showing the wide global interest in KM research.
It also points at no particular dominant institution in the field. More than 50 different
industries are represented in the ranking of sector application. Nevertheless, certain
knowledge-intensive business fields have featured less such as pharmaceuticals and
aerospace. Country productivity shows few nations taking the lead with research
initiatives. Interestingly, statistics reveal a correlation between research activity and
economic prosperity. There is a growing tendency towards empirical methods in contrast
to a drop in literature review papers which is a sign of the field’s maturity. Results have
also demonstrated that there is an increased contribution from practitioners. It is noticed
that there is a recent rise in number of articles that present the integration between KM
and Information Technology (IT). This is a natural trend given the current inconceivable
advances in technology. This study also looked at the most influential publications in the
journal’s history, taking into consideration their issuing date. Finally, insights on the
current status of the KM research landscape is discussed in line with future trends.
Originality/Value - It is the first comprehensive scientometric research of KMRP. The
paper describes the state-of-the-art value and provides an outlook of the future.
Keywords – Scientometric Analysis, KMRP, Knowledge, Knowledge Management,
Intellectual Capital.
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Introduction
Knowledge management (KM) has become a predominant field within the business and

management landscape for both researchers and practitioners. The recognition of the
fundamental role of knowledge in value creation spawned the concept of the Knowledge
Economy, making it one of the pillars of contemporary management thinking (Roberts,
2009). Economic growth is no longer reliant on physical capital and labour only as
established in nineteenth century theories, but also on the human capital comprised of
“knowledge workers” whose innovative capabilities lead the advancement of the current
“knowledge society” (Drucker, 1994). This was highlighted by a 1999 World Bank report
which provided one of the first comprehensive accounts of the emerging role of
knowledge in economic development through a focus on acquisition, application, and
transfer of knowledge (World Bank Annual Report, 1999). By the end of the twentieth
century, the notion of managing knowledge had evolved at the corporate level as
organisations acknowledged the need to leverage and exploit their knowledge resources
(Carmeli and Tishler, 2004). KM is now considered a vital organisational function and a
key source of sustainable competitive advantage (Davenport and Vo, 2006). On the other
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hand, progressive academic works have also established KM as an independent and rich
scientific discipline. As a research field, KM has witnessed an exponential growth rate in
publications amounting to 50% per year, supported by the founding of a number of
dedicated KM journals and conferences (Serenko et al., 2010).
One of the key peer-reviewed journals in the KM field is Knowledge Management
Research and Practice (KMRP). Available online since 2003, KMRP is the first KM
journal to gain an impact factor (Thomson Reuters, 2015). Its aim is to provide an outlet
for high quality peer reviewed publications, which include articles on all aspects of KM
whether this is academic or in practice. The journal pays particular attention to cross
disciplinary research, mixtures of techniques, and differing schools of thought adopting a
broad spectrum of publication themes including empirical research and case studies as
well as conceptual and theoretical papers (Springer, 2017). Moreover, KMRP was placed
third in 2008 then the second in 2013, according to expert survey rankings conducted on a
sample of 25 key KM journals (Serenko and Bontis, 2013a).
While the KM field continues to grow, reflections on literature can allow for more
efficient future deliberations on subjects within the discipline, minimise repetition, and
create starting points for further advancements in KM theory and practice. This paper
provides insights into KM research published in the KMRP, which could arguably apply
to the whole KM domain considering that KMRP is a representative example of the wider
KM literature. To present the work, the paper is divided into five sections. Following the
introduction, the second section offers a brief survey of relevant literature and presents
the study’s research questions. Section 3 details the study’s methodology and the
development of the review framework. Findings are presented and analysed in the fourth
section, while the final section discusses the work’s conclusions and implications for
future research.
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Background and Research Questions
A literature review is a “critical analysis of a segment of a published body of

knowledge through summary, classification, and comparison of prior research studies”
(Jafari and Kaufman, 2006). It helps to interpret what is known about a research field and
to identify gaps in the existing knowledge (Jesson et al., 2011). Several reviews covered
KM publications and journals using a number of methods over different time periods.
These include but are not be limited to: Citation Analysis (Huang et al., 2010; Ma and Yu,
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2010; Ribière and Walter, 2013; Serenko and Dumay, 2015) Content Analysis (Fteimi
and Lehner, 2016), Journal Ranking (Serenko and Bontis, 2009, 2013b), Meta-review
(Serenko and Bontis, 2004) and Scientometric Analysis, the approach adopted in this
study (Serenko et al., 2009, 2010).
Scientometrics is science about science with distinct identity and methodology
(Garfield, 2009). The term has grown in popularity and recognition in the last decades,
especially after the founding of the dedicated Journal of Scientometrics by Tibor Braun in
1978. It is used to describe the study of science including growth, structure,
interrelationships, and productivity of a certain research discipline (Hood and Wilson,
2001). Scientometrics portrays a comprehensive picture of research activity within the
field and is able to present existing trends supported by quantitative data. In this study, the
scientometric approach is adopted to investigate three main research issues within KMRP
during the review timeframe:
(1) Productivity - Demographic patterns in the production of KMRP research;
(2) Themes and Methods - Trends in topics examined and research tools applied; and
(3) Citation - Analysis of referencing frequency of the journal’s papers.
Accordingly, three groups of research questions were formulated to guide the research
process as follows:
Research Productivity in KMRP
RQ1.

What are the dominant trends in authorship distribution?

RQ2.

What is the prevailing affiliation of KMRP authors (Academics vs

Practitioners)?
RQ3.

Which countries are leading in KM research?

RQ4.

Is there a relationship between a country’s economy and its contribution to KM

research?
RQ5. What is the institutional productivity in the journal?
Research Themes and Methods in KMRP
RQ6. Which research methodologies are most used by authors?
RQ7. What are the most popular industrial sectors in KM research?
RQ8. What are the main research themes in the journal?
RQ9. What is the degree of integration of Information Technology in KM research?
Citation Analysis of KMRP
RQ10.Which articles are the most influential in the journal’s history?
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Methodology
The research methodology adopted in this study has a number of steps. First, the

boundaries of article selection for analysis are drawn using criteria for inclusion and
exclusion. This set initially included 506 articles published in KMRP between the year
2003 - when the first issue was published – and up to 2015. Editorials, position papers,
and book reviews are excluded from the article list. Accordingly, a total of 344 articles
are retained for analysis, while 162 are excluded. Second, the research framework is
synthesised in light of previous similar works (Fteimi and Lehner, 2016; Serenko et al.,
2010; Serenko and Bontis, 2004; Serenko and Dumay, 2015) and subsequent design
allows exploration into the various attributes of publications within the selected sample
(Table 1).
Table 1: Research Framework
Theme

Productivity
Research
Method
Includes data collection
method, more than one can be
selected

Research Topic
Most prominent topic in the
paper, more than one can be
selected

Variables
Number of authors
Affiliation of author -Academic vs. Practitioner
Country of Residence - where the author is based, not where
the work was conducted.
Case study - single or multiple
Interviews
Literature review
Modelling tools
Surveys
Other qualitative - Focus groups, Delphi, site observation,
action research, content analysis, ethnography.
Intellectual Capital
Innovation
Organizational Learning
Culture & Social Issues (Social Capital)
Performance Management
Information System
Communities of Practice
Knowledge Measurement
Knowledge Philosophy/Ontology
Other Knowledge Management
Knowledge Sharing
Knowledge Transfer
Knowledge Creation
Knowledge Process
Knowledge Acquisition
Knowledge Exchange
Use of Knowledge
Knowledge Audit
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Use of Technology (yes/no)

Technology
Adoption

Referencing

Type of KM Technology:
Knowledge management system
Internet
Communication technology
Wiki
Social Media
Prototype
Database
Blogs
Decision support systems
Number of citations from Google Scholar database
Keywords

For cross-validation, coding process has been structured so that each researcher
conducts a round of ten articles before they compare the codes for agreement. The
outcomes of this exercise led to minor modifications of the framework, and helped
identify what the authors refer to as grey areas - article attributes within the framework
that were subjective in nature and could vary according to the views of the coder. For
example, the same article could be classified under more than one category within the
coding scheme. In this case, the authors have agreed to code the article under the most
predominant theme and then cross-check their results. In the third stage, the articles are
mutually coded by both researchers, and results are cross-checked to minimise grey coded
articles. Finally, the full analysis of the resultant dataset is conducted to identify patterns.
When addressing Research Questions 2-5 pertaining to Research Productivity, methods
utilising credit analysis are enacted. Authorial credit is generally provided using one of
four methods depicted in Table 2 below.
Table 2: Methods for Assigning Author Credit
Method

Description

Example

For 15 pages
Number of pages is and 3 authors:
Normalised
divided by the number Author 1= 5
Page Size
of authors.
Author 2= 5
Author 3= 5
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Criticism
- Assumes longer papers make
higher contribution.
- Affected by journal pages’
limits

For 4 authors:
Values are assigned Author 1= 0.415
according
to
the
Author 2= 0.277
author’s order in the
Author 3= 0.185
citation.
Author 4= 0.123

- Co-authors are sometimes
listed in alphabetical order;
thus those whose names are
earlier in the alphabet are
unjustly favoured.
- Does not consider cases where
authors
have
equal
contributions.

Direct
Count

For 3 authors:
A value of 1.0 is Author 1= 1
assigned
to
each
Author 2= 1
author.
Author 3= 1

- Gives advantage to researchers
who
co-author
numerous
papers regardless of their
contribution.

Equal
Credit

Each author receives
an
equal
credit
equivalent
to
the
inverse of the number
of authors, regardless
of author position.

- Avoids the drawbacks
previous methods.

Author
Position

For 3 authors:
Author 1= 0.333
Author 2= 0.333
Author 3= 0.333

of

Adapted from Chua and Cousins (2002) and Lowry et al. (2007)

The Equal Credit Method is selected because it avoids the shortcomings of the three
other methods and provides mostly unbiased authorial credit. In addition to Equal Credit,
the Direct Count Method is employed in Research Questions 2 and 3 as well and results
of both methods were compared. It is worth noting that studies have suggested that the
Direct Count, Author Position, and Equal Credit methods can produce similar results,
particularly when utilising aggregate data (Serenko et al., 2008).
In addressing Research Question 10 regarding citation impact of influential KMRP
publications, each paper’s citation impact index is computed to determine the single most
highly cited article. The most commonly used measure is the calculation of the total
number of citations of each paper since its publication. However, according to Holsapple
et al. (1994), the weakness of this method is that it does not consider the publication date
of the article. It will provide the same score to two publications that are cited the same
number of times even if they are published in different years, although the most recent of
them can have a higher average number of citations per year. This suggests that the latter
publication has had a higher contribution to the field having achieved the same number of
citations in a shorter time period, an aspect which the traditional citation index overlooks.
To overcome this drawback, Holsapple et al. (1994) proposed the use of Normalized
Citation Impact Index (NCII) which accounts for the paper’s longevity thus reflecting the
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relative contribution of each paper. It is calculated by dividing the number of times the
article has been referenced by the number of years the article has been available [NCII =
Total Citations (count) / Longevity in years]. The NCII method is hence adopted in this
study in order to provide more reliable results. Individual article citations obtained from
the Google Scholar database are used to compute the NCII for each article and
publications are ranked in descending order according to their indices.

4

Findings
In an attempt to identify the trends within the current sample, the analysis is presented

over two time periods (2003 – 2008) and (2009 – 2015). This format facilitates in
highlighting the major changes in the nature of research work published in the journal
over its lifetime.
4.1

Authorship Trends

Figure 1: Number of Authors

The average number of authors within the sample was 2.28 authors per paper, however,
a growing trend towards multi-authored papers is evident. While the average paper
authorship in the first time period (2003 – 2008) was 1.96 authors per paper, it increased
to 2.46 authors per paper in the second time period (2008 – 2015). The median number of
authors has also increased from two to three after 2013 (Table 3). The percentage of
single authored papers dropped from 40% in 2003-2008 to less than 20% in 2009-2015,
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whereas papers with two, three, and four authors witnessed significant increases of 1.5%,
8.5%, and 9.8% respectively (Figure 1). This confirms the findings of Akhavan et al.
(2016) who observe a decline in single-authored works over time and the emergence of
collaboration patterns among KM scholars. This is justified by the maturity of the KM
domain where authors develop relationship networks and collaborate to overcome the
current increasingly challenging journal acceptance rates. The findings are also in line
with the broader bibliometric studies of Cline et al. (1979), Metz (1989), Terry (1996)
which report a general phenomenon of progressive trends in co-authorship in other
research disciplines.
Table 3: Co-authorship Distribution - Number of Authors

4.2

Year

2003

2004

2005

2006

2007

2008

2009

Mean

1.78

1.93

1.61

2.07

2.32

1.86

2.18

Median

2

2

1

2

2

2

2

Year

2010

2011

2012

2013

2014

2015

Mean

2.34

2.48

2.34

2.48

2.83

2.58

Median

2

2

2

2

3

3

Author Affiliations

Figure 2: Author Affiliation

From an affiliation perspective, more than 90% of authors have an academic
background and are in direct affiliation with educational and/or research institutions. The
rest of authors are practitioners from service or industry sectors. Both the Direct Count
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and Equal Credit methods are used to compute the contribution of practitioners and
academic authors and no statistically significant difference is found between the results of
both methods (p-value=0.592). Despite the apparent stability in the percentages of
practitioners and academic authors in KMRP over the years (Figure 2), other studies have
shown otherwise. A study by Serenko et al. (2009) revealed that the number of
practitioners decline from approximately one third of all contributors in the late 1990s to
10% by 2008. Their findings suggest that there is room for further engagement of
practitioners in KM research and publication.
4.3

Country Productivity and GDP

Figure 3: Country Productivity

In order to identify the leading countries in the KM field, the relative contributions of
57 countries whose papers were published in the KMRP are traced and ranked using both
the Equal Credit and Direct Count methods. Similar results from both methods are
obtained and the Pareto Principle or “The Law of Vital Few” is heavily observed. The
majority of publications originate from roughly 20% of participating countries as in Table
4 (Pareto, 1971). To confirm the findings, the number of citations from each country is
counted using the NCII method for all the countries. The same countries of the highest
contribution to the journal are found to be on the top of the articles citation list. Moderate
positive correlation (0.559) is discovered between the country Gross Domestic Product
(GDP) and contribution to KM research. This explains the finding that the majority of
leading contributors are in North America, Western Europe, and Australia. The link
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between knowledge and wealth reinforces the theory established by Drucker when he
discussed the post-WWII transformation of the American economy from goods to what
we call today the Knowledge Economy (Drucker, 2011).
Table 4: Country Productivity Ranking
Equal Credit Method

Direct Count Method

NCII

Rank

4.4

Country

Percentage

Country

Percentage

Country

Percentage

1.

UK

13.76%

UK

12.74%

UK

12.92%

2.

USA

12.37%

USA

12.02%

USA

12.52%

3.

Australia

8.13%

Spain

7.69%

Japan

8.95%

4.

Spain

7.94%

Australia

7.69%

Spain

7.67%

5.

France

5.89%

Italy

5.53%

Canada

7.49%

6.

Italy

5.81%

France

5.05%

Italy

6.74%

7.

Taiwan

4.93%

Canada

4.81%

Finland

4.25%

8.

Canada

4.29%

Taiwan

4.09%

Germany

4.14%

9.

Germany

3.91%

Germany

3.85%

France

10

Rest of the
world

32.95%

Rest of the
world

36.54%

Rest of the
world

4.10%
31.22%

Institutional Productivity

When examining institutional productivity, Equal Credit is the method of choice for
organisations as well. Analysis revealed that, to-date, more than 400 unique institutions
have published articles in the KMRP. The noticeable finding is the minimal variation
among individual contributions of each institution where no single institution dominated
publications in the journal as shown in Table 5 (range = 3.8, standard deviation = 0.65).
Approximately 20% of contributions come from 27 different institutions which indicates
unbiased distribution of papers between a wide range of research and professional
organisations. It is also noted that two thirds of papers are the product of a single
institution and 38.6% of the papers are the outcome of multi-institutional collaboration.
Furthermore, the top 20% contributors are all academic organisations, which coincides
with the prevalence of academic authorship as previously mentioned.
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Table 5: Institutional Productivity
Institution

Equal
Credit

Percentage

Cumulative Sum

1.

National Technical University of
Athens

3.999

1.16%

1.16%

2.

University of Sydney

3.999

1.16%

2.33%

3.

Tampere University of Technology

3.998

1.16%

3.49%

4.

Queens University

3.916

1.14%

4.63%

5.

University of Southampton

3.5

1.02%

5.64%

6.

University of Hull

3.166

0.92%

6.56%

7.

National Taiwan Ocean University

3

0.87%

7.44%

8.

Universidad Computense de Madrid

3

0.87%

8.31%

9.

University of Sao Paulo

3

0.87%

9.18%

10.

Politecnico di Milano

2.75

0.80%

9.98%

11.

Hitotsubashi University

2.5

0.73%

10.71%

12.

University of South Australia

2.5

0.73%

11.43%

13.

University of Southern Queensland

2.499

0.73%

12.16%

14.

Kingston University

2.333

0.68%

12.84%

15.

University of Salento

2.333

0.68%

13.52%

16.

University of Sheffield

2.333

0.68%

14.19%

17.

Loughborough University

2.166

0.63%

14.82%

18.

Bangkok University

2

0.58%

15.40%

19.

Edith Cowan University

2

0.58%

15.99%

20.

Politecnico di Bari

2

0.58%

16.57%

21.

Robert Gordon University

2

0.58%

17.15%

22.

Soochow University

2

0.58%

17.73%

23.

University of Akureyri

2

0.58%

18.31%

24.

University of Alicante

2

0.58%

18.89%

25.

University of Castilla La Mancha

2

0.58%

19.47%

26.

University of Melbourne

2

0.58%

20.06%

27.

University of New South Wales

2

0.58%

20.64%

28.

Other 375 unique institutions

N/A

79.36%

100

Rank
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4.5

Research Methods

Research methods can be described as all the data collection and analysis techniques
that are used for conduction of research activities to solve research problems (Kothari,
2004). Nearly half of the articles (47%) utilised a single method, while the rest of articles
used two or more. A mild to moderate increase in published empirical studies, both
quantitative and qualitative, is observed in the second review time period (2009-2015) in
comparison to conceptual models and literature reviews which are prevalent in the first
review period (Figure 4). Nevertheless, modelling tools and frameworks are still the most
used methodology by KMRP researchers, followed by case studies. This rise in case study
and survey work along with the decline in literature reviews suggests an ongoing shift of
KM research from theory to practice where first hand studies are increasingly held with
knowledge workers to explore knowledge related phenomena in real-life organisational
contexts. This tendency seems to be a general trend in the KM field, as indicated by the
results of other similar studies. For example, a recent content analysis of the proceedings
of the European Conference of Knowledge Management (EKCM) between 2006 and
2013 revealed that model and framework development were the most preferred research
method followed by case studies and questionnaires (Fteimi and Lehner, 2016).

Figure 4: Research Methods
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4.6

Industrial Sectors

Expanding on the findings from the previous section, articles are thoroughly surveyed
for industries which are selected as research fields. While 33% of studies are classified as
conceptual studies and thus have no industries, the other two thirds are conducted in more
than 57 different industries and service sectors. Moreover, 15% of papers do not specify a
single sector used in data collection. Instead, a mixture of different businesses is used as a
convenience sample that is non-industry specific. This is expected since researchers often
tend to gather data from companies in their network and the ones that they have access to.
Moreover, research and education institutions are on the top of the popularity list.
Approximately 12% of the studies are conducted either within universities, research labs
and/or rely on the classroom as a case study. Once again, this could be simply attributed
to convenience. Researchers often find access within their own organisations, or in
similar academic ones, more feasible than the challenge of penetrating new industries to
obtain data. Information and Communication Technologies (ICT), Healthcare, and HighTech firms come in the second, third, and fourth level places respectively. Nonetheless,
some knowledge intensive industries such as Pharmaceuticals, Aerospace, and Energy
have not received adequate attention in industry-specific publications. This could be
considered as an opportunity for future researches to direct their efforts towards such
relatively under-published sectors. Table 6 illustrates the main industry/service sectors in
the articles and their relative percentage.
Table 6: Industrial Sectors
Rank

Industry

%

Rank

Industry

%

1

Multi Sectoral

14.8%

11

Engineering

1.2%

2

Research &
Education

11.6%

12

Entertainment

1.2%

3

ICT

8.7%

13

Insurance

1.2%

4

Healthcare

5.2%

14

Metal industry

1.2%

5

Technology

4.1%

15

Oil and Gas

1.2%

6

Civic Society

2.3%

16

Aerospace

0.9%

7

Consulting &
Training

2.0%

17

Banking

0.9%

8

Automotive

1.7%

18

Pharmaceuticals

0.9%

9

Unspecified

1.7%

19

Other industries

13.1%

10

Construction

1.2%

20

Conceptual (none)

32.8%

14

4.7

Research Themes

Two approaches are adopted to identify the common research themes within the KMRP
body of literature. First, two researchers qualitatively categorised the papers according to
their research topic as explained in the review framework. A counter review of the same
papers by the other researcher is used to confirm the categorisation of each paper under a
single theme. In cases where researchers coded a paper differently, the article is jointly
reviewed by both researchers until a classification is agreed, or third opinion is sought.
Secondly, a quantitative keywords analysis is used in parallel in order to compare the
findings of the thematic analysis.
Results show that 61% of research papers fell under only five topics; (1) Knowledge
Sharing, (2) Intellectual Capital, (3) Knowledge Creation, (4) Knowledge Transfer, and (5)
Culture. Some research themes indicate significant growth in the second review time
period (2009-2015) in comparison to the first period (2003 – 2008). For example, there is
a growing interest in Intellectual Capital, Knowledge Transfer, Innovation and Culture
(Figure 5). Nevertheless, themes such as Knowledge Creation, Organisational Learning,
Information Systems, Communities of Practice (CoP) have received less interest.

Figure 5: Research Themes
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4.8

Keyword Analysis

A comprehensive keyword analysis of KMRP articles between 2003 and 2012
undertaken by Ribière and Walter (2013) demonstrate that Knowledge Sharing is the most
used keyword in the journal. A similar exercise extending until 2015 conducted in this
research unsurprisingly yielded the same outcome. The predominance of Knowledge
Sharing as a keyword, as well as a research theme, confirms the validity of the thematic
analysis outcomes of the previous section. It also elucidates the emphasis researchers
have placed on the knowledge sharing process as a precursor of effective KM. Whether
the objective is spreading best practice, disseminating innovative ideas, or creating digital
repositories, sharing knowledge is often at the core of KM initiatives.

Figure 6: Keyword Analysis
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4.9

KM Technology

The role of Information Technology (IT) in KM is widely discussed in the literature. A
common view is that KM should not be reduced to a solely IT-based project as there is a
tacit dimension of knowledge which cannot be managed using technological tools
(Chatzkel, 2007). IT is rather envisaged as an essential KM catalyst and an enabler of
knowledge sharing processes within and between organisations (Tsui, 2005). This view
seems to be reinforced by scientometric figures as, overall, 91% of papers did not include
reference to IT. However, by contrasting the first review period (2003-2008) to the
second (2009-2015) with regards to discussing technology, an increase from 4.2% to
11.6% is observed indicating a movement towards further integration of IT in KM. In this
area, the Internet, Databases and Social Media were the most popular IT solutions in the
published papers (Figure 8), a trend in tandem with the digital revolution and the
explosive growth of social networking.

Figure 7: Integration of IT in KM Research
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Figure 8: IT Technologies

4.9 Citation Analysis
By examining citation frequency, three articles stood out as the most influential articles
in the journal’s history based on their NCII (Table 7). It is noted that the top three articles
gained 11.8% of the NCII score for all the articles and approximately 80% of citations
came from the top 144 articles ( 40%). Interestingly, the most cited article is authored by
renowned KM thinker Ikujiro Nonaka and extends on his SECI model of knowledge
creation, which is regarded as one of the most seminal and highy-cited theories in the
history of KM at large.

Table 7: Highest Cited KMRP Articles
Author
Nonaka, Ikujiro & Toyama,
Ryoko
Baskerville, Richard &
Dulipovici, Alina
Usoro, Abel; Sharratt, Mark
W; Tsui, Eric & Shekhar,
Sandhya

Title
The Knowledge-Creating Theory Revisited:
Knowledge Creation as a Synthesizing
Process
The Theoretical Foundations of Knowledge
Management

Year
2003

NCII
77.1

2006

26.8

Trust as an Antecedent to Knowledge
Sharing in Virtual Communities of Practice

2007

18.8

18

5

Discussion and Implications
The journal of Knowledge Management Research and Practice (KMRP) stands for one

of the key scientific outlet in the field of knowledge management and has significantly
contributed to the development of the research streams related to strategic knowledge
management, learning organisation, intellectual capital measurement and management,
and knowledge-based information technologies, just to name few fundamental domains of
investigation.
With the economy and organisations showing increasingly a knowledge-intensive
nature, in today’s business landscape managing knowledge is acknowledged as a
necessary condition to survive and prosper. The ability of an organisation to create value
is tied to its ability to identify, manage and renew the key knowledge assets at the basis of
organisational competences and, in turn, processes affecting company value creation
dynamics. KMRP has contributed to shed light and disclose the functions, factors and
mechanisms characterising knowledge as a resource and source of organisational
competitiveness as well as the processes, models, approaches and tools that can support
managers in translating knowledge into business performance.
After almost 15 years since the foundation of KMRP from Operation Society, this
study proposes a scientometric analysis of the studies published by the journal. This helps
to provide a comprehensive picture and to understand the growth, structure,
interrelationships, and productivity of the published research activities within the field of
managing knowledge.
The study elucidates an increasing trend towards multi-author collaboration especially
in recent years. The KMRP’s publication list includes more than 400 academic and
research institutions showing the wide global interest in KM research. More than 50
different industries are represented in the ranking of sector application, although it is
surprising that certain knowledge-intensive business fields have featured less such as
pharmaceuticals and aerospace. The majority of leading contributors are in North
America, Western Europe and Australia. Interestingly, statistics reveal a correlation
between research activity and economic prosperity. There is a growing tendency towards
empirical methods in contrast to a drop in literature review papers which is a sign of the
field’s maturity. Results have also demonstrated that there is an increased contribution
from practitioners, although there is a dominant position of academia’s contribution. This
denotes the efforts of scholars to set up the foundation of the theory of managing
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knowledge integrating evidences from practice, but at the same time as the field is
progressively becoming more mature it indicates a potential shortcoming related to the
lack of a stronger involvement of practitioners in order to make sure that the research
outputs are relevant to advance the practice as well as for theory building. The study
shows that 61% of research papers fell under only five topics; (1) Knowledge Sharing, (2)
Intellectual Capital, (3) Knowledge Creation, (4) Knowledge Transfer, and (5) Culture. In
particular, the topic of Knowledge Sharing emerges a predominant indicating that it is
considered as one of the key process at the core of managing knowledge, in terms of
spreading best practice, disseminating innovative ideas, or creating digital repositories,
and sharing knowledge. This points out that one of the fundamental reasons for
implementing knowledge management initiatives is related to the need of moving
knowledge from individual to individual, from individual to team and organization, from
organisation to organisation, and from organisation to artefacts. In other words,
knowledge sharing is the key strategic knowledge process to support learning
organisation and the translation of knowledge into organisational and business
performance. In this light it is not surpsising that the modt influnecial article published by
the journal are those focusing on the SECI model of Nonaka and on the antecedents and
factors affecting the knowledge sharing characteristics of an organisation.
Concluding this study provides evidences that the field of knowledge management is
reaching a maturity which poses at least twofold challenges. On the one hand to identify
what are the future key trends of research development in the field, and on the other hand
the need to adopt more empirical based investigation. KMRP publishes both quantitative
and qualitative papers, however the discriminating factor to bear in mind is the relevance
of the contribution. From this point of view we need to remind that managers are
interested to knowledge and its management not for the sake of knowledge and
knowledge management, but because they need to understand how they can translate
organisational knowledge assets into drivers that positively impact and enhance the
business value creation mechanisms.
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ABSTRACT
Simulation modeling is extensively applied to address hospital challenges. To build the right model,
unbiased accurate conceptual model has first to be produced. Conventional modeling process requires all
data and information to be collected by interviews and/or focus groups then collated maually to produce a
coceptual model before validation. This paper embraces modeling hybridization by introducing process
mining for conceptual modeling stage in order to enhance the time factor of developing the model and
equally increase accuracy of the conceptual model. Patient’s pathways will be generated using data-driven
approach (i.e. data from an Emergency Department - ED). The hybrid framework demonstrates the high
variance in patient pathways and then identify the system bottlenecks. A Dicrete-Event Simulation (DES)
model is complementing the solution by adding the stochastic layer of the system dynamics. Results show
that the unblocking of ED outflows by in-patient bed management rather than increasing capacity of the
ED.
1

INTRODUCTION

Health-care management are currently under constant pressure to control rapidly escalating expenses, while
still responding to growing demands for better patient service levels and safe medical treatment. Addressing
these challenges requires a thorough understanding of health-care system constraints, which can be an
overwhelming task, given the high levels of uncertainty and interdependence. Simulation modeling has
contributed strongly to the understanding of different level of complexity within healthcare processes
(Arisha and Rashwan 2016). Discrete event simulation (DES), agent-based simulation (ABS), Monte Carlo
simulation (MCS), and system dynamics (SD) are widely used in healthcare appications (Brailsford et al.
2009; Katsaliaki and Mustafee 2011). Each of these simulation techniques addresses a particular level of
complexity within the system. Modelers are often challenged to accurately model the system complexity in
order to provide managers with effective results resembling reality (Lynch et al. 2014). Research indicated
that the use of hybrid simulation will improve the capabilities of simulation solutions (Brailsford 2008;
Djanatliev and German, 2013; Viana 2014; Zulkepli and Eldabi 2015; Gao et al. (2015). Despite the
growing number of hybrid simulation studies, there are still a number of challenges that has not been
addressed adequately. For instance, most reported hybrid simulation cases have attained their findings
mainly on model implementation phase rather than considering other phases such as conceptual modeling.
In addition, the human behavior in healthcare processes and activities has always been a challenge for most
of the simulation approaches (Daellenbach 2001). Therefore, hybrid approach has to extend to reach the
conceptual modelling (Robinson 2008), data collection, model optimization, analysis and implementation.
This approach of a hybrid Modeling and Simulation (M&S) study applies various interdisciplinary methods
in the wider simulation study has been discussed in (Powell and Mustafee 2016). A hybrid M&S study is
characterized by the use of methods from fields such as Operations Research (OR), Computer Science,
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Systems Engineering, Information Systems and Distributed Computing; these methods are applied to
specific stages of a simulation study.
Most of the simulation studies develop the process model using documentation, direct system
observations and interviews with stakeholders and experts (e.g. consultants, nurses…etc.). This manual
process is time-consuming, and arguably the longest stage of any M&S project. This lengthy process
significantly affects the validity and effectiveness of the M&S study recommendations. In addition, the
perception of the actual process is influenced by the experience of the individual studying the system and
this often results in biased models. Therefore, it is essential for any successful M&S healthcare study to
develop conceptual models that are unbiased, reusable, and close reflection of reality in a timely manner.
To do so, a data-driven process mining approach can be adopted using event logs (van der Aalst 2011).
Through the application of process mining techniques, healthcare organizations can: discover the actual
patient pathways that are conducted in reality (Saunders, Makens, and Leblanc 1989); understand the high
variance in clinical pathways taken by diverse groups of patients; and gain insights into bottlenecks and
resource utilization (McGregor, Catley, and James 2011; Abo-Hamad 2017).
The aim of this research is to introduce a hybrid framework that integrates process mining techniques
in the conceptual modeling phase. This will minimize the latency between the occurrence of events and
decision-making. The main objective is to automatically identify patients’ pathway patterns that are
consistent with the observed dynamic behavior. Hence, a more accurate and unbiased process model for
patients’ journey is obtained in a timely manner. Using this model then as an input for simulation model
and for what-if scenario analysis. The proposed framework is tested on a real-world case study of an
emergency department of one of the leading hospitals in Ireland.
2
2.1

PROPOSED FRAMEWORK
Literature Review

Conceptual modeling has been identified as potentially the most significant stage of any simulation
study, however, it is the most underestimated aspect (Law 1991). Building a valid and credible model is a
sophisticated process (Law et al. 2001). Data collection for conceptual model construction can be
complicated due to confidentiality, security or subjectivity concerns. Although organizations utilize
procedures to manage its processes, usually procedures are either informal, not documented or entirely
different from reality (van der Aalst 2012). Process Mining (PM) techniques have emerged to handle the
discrepancy between what should be done and how processes operate in the real world (Turner et al. 2012).
The input data of PM is an event log (i.e. dataset of traces). Each trace has a sequence of ordered process
activities (i.e. events). By utilizing evolutionary computational intelligence techniques (e.g. Artificial
Neural Networks, Fuzzy logic, and Support Vector Machines), PM can provide an unbiased view of the
underlying processes based on what is actually happening, and not on subjective views of the system (Maita
et al. 2015). On the one hand, PM techniques can bridge the gap between data capabilities and process
modeling analytics. Event logs can be exploited in three main approaches: discovery, conformance, and
enhancement. In discovery approach, process models are discovered automatically by analyzing event logs
without using any further information. Conformance process mining can be used to compare an existing
process model with real life data expressed in event log (van der Aalst 2011). Whereas conformance and
enhancement techniques can improve current process models through checking conformance, analyzing
deviations and enriching existing models with conformance-related diagnostics (Centobelli, Converso, and
Gallo 2015; Rovani et al. 2015).
The proposed framework in this paper focuses only on the Process Discovery step that studies the event
log activities and results in the creation of a conceptual model. The Alpha-Algorithm (van der Aalst,
Weijters, and Maruster 2004), the Fuzzy Miner (Günther and Aalst 2007), and the Heuristic Miner
(Weijters, van der Aalst, and Medeiros 2006) are the most reported techniques for process discovery.
Process mining can be considered as a relatively new research discipline with a successful record in
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Healthcare applications. A recent extensive literature review (more than 74 articles) conducted by Rojas et
al. (2016) on the application of process mining in healthcare has identified the research opportunities with
this area. Interestingly, only one paper in their review has attempted to combine process mining with
simulation models for an outpatient clinic model (Zhou, Wang, and Li 2014).
2.2

Proposed Framework

The proposed hybrid framework consists of three phases; Formulation and Data Analysis, Conceptual
Modeling, and Model Development (Figure 1). Typically, each hospital department has its own database
that supported its functions. The database usually contains information on patients and records detailed
information regarding the journey or movements of patients within the hospital. Process mining techniques
usually use a transactional event log data set. Therefore, the “extraction” step in the framework is used to
construct the event log data set from the raw database. Each row in the transactional event log corresponds
to an event that was executed in the process. Multiple events are linked together in a process instance or
case where each case forms a sequence of events—ordered by their timestamp. In contrast, data mining
techniques uses the raw database directly where each row represents a complete process instance (i.e.
patient episode). In the conceptual modelling phase, process mining algorithms are used to analyze the
event log.

<Patient ID><Triage Category><Presenting Complaint>
<Gender><Date of Birth>

Transactional Event
log

Problem
Definition

<Case id><Event><Start Timestamp><Complete Timestamp>

Input Data Analysis
(Data Mining)

Process Mining
(Fuzzy Miner)

Data Preparation
Inter-arrival Time
Data Seasonality

Process Models

Simulation

Conceptual Modeling

Extraction

Model Development &
Experimentation

Hospital Information
System

Formulation & Data
Analysis

Data Collection and Extraction

Figure 1 An overview of the proposed process-mining-based M&S Framework
Due to the unstructured nature of healthcare process, the selection of the process mining discovery
algorithm is crucial. The Fuzzy miner (Günther and Aalst 2007) is more suitable for unstructured processes
and for the purposes of simulation and managerial analysis. Other algorithms such as Alpha-algorithm
produces a very complicated process models which shows all process details without distinguishing what
is crucial and what is unnecessary. On the other hand, fuzzy miner algorithm observe complex processes at
different levels of granularity and provides meaningful abstraction and different views. This is achieved by
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applying two fundamental metrics: significance and correlation. The significance metric assesses the
relative importance of a precedence relation between two event classes, i.e. the more often two event classes
are observed after one another, the more significant their precedence relation. The correlation metrics
indicates how closely two events (i.e. activities) are following each other. Therefore, fuzzy mining could
reduce and focus the displayed event classes by applying the two metrics on the discovered process map to
achieve different levels of aggregation and abstraction. Therefore, various process models of different
abstraction levels (number of activities and pathways) can be produced. The discovered process models
combined with the analysis of patients’ records are used in the model development and experimentation
phase. Depending on the model scope and objective, the model can be implemented using a single
simulation technique such as Monte Carlo simulation (MCS), discrete event simulation (DES), system
dynamics (SD) and agent-based simulation (ABS) or a hybrid between these simulation techniques.
3
3.1

CASESTUDY
Project Background

The hospital studied in this paper is an acute public teaching hospital located in North Dublin, Ireland. This
570-bed hospital includes a 24-hour Emergency Department (ED) which services over 50,000 patients
annually. The ED is operating at approximately 99% occupancy, according to the task force report in 2007,
which is an indication of inadequate physical space and infrastructure. This is often aggravated by delays
in patients transfer to critical care (ICU/HDC) beds. Consequently, the ED is not compliant with volume
and waiting time targets (6-hour Length of Stay target). A detailed simulation model for the ED was
developed in (Abo-Hamad and Arisha, 2013), and some improvement strategies were proposed to achieve
the national target. Although these strategies were effective, the model was not flexible to accommodate
the constant changes in patient care pathways and to sustain improvement efforts. To overcome these issues,
the process model of the ED (that was developed manually) should be updated to capture the changes in
patient flow. Following the manual process of developing and updating the ED process model would take
6 – 8 weeks. Given the fast changes in healthcare process, by the time the model is completed the process
model will not be reflective. Therefore, process mining techniques were applied to discover patients'
pathways from historical data automatically.
3.2

Dataset

A real-time patient tracking information system was used to track the patient’s journey within the ED. The
hospital managers have provided a one-year historical data with anonymous patients' records. The dataset
was provided in an event log structure with a total of 229,971 event logs representing 40,777 patients. Each
log in the table represents an event (i.e. one process stage of the patient journey in the ED) with the
following attributes (patient ID, Triage Category, Presenting Complaint, Date of Birth, Gender, Event ID,
Tracking Step Name, Tracking Step Date Time, Location, Staff). Events with the same name, patient ID
and timestamp were removed which resulted in a total of 210,180 records in the ED event log.
3.3

Patient pathway discovery and analysis

The event log for patients was analyzed to discover patient’s pathways and to extract statistics on their
characteristics and types. Upon their arrival, patients are assigned a clinical priority (triage category)
according to the Manchester Triage System (Cronin 2003). The MTS uses a five-level scale for classifying
patients according to their care requirements; immediate, very urgent, urgent, standard, and non-urgent.
Immediate and very urgent patients represent 15%, urgent patients (triage category 3) represent the largest
group of attendees to the ED annually (59% average), while standard and non-urgent patient 26% of all
patients. As advised by ED consultants, the analysis of these patients’ groups is critical as each group of
patients can have a different journey within the ED and hence a different pathway.
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3.3.1 Patient Pathway Discovery
The main building block of patient pathways are the activities that patients go through during their journey
in the ED. Twenty-two different activities within the ED are identified from the event log data. The fuzzy
miner has then applied on the whole event log to construct the first top-level process map of the overall ED
(Figure 2a).

a) ED process model with all
activities and paths

b) The process model with main
activities and paths

Figure 2 The discovered patient flow model of the emergency department
The resulted complete map is complex and hard to interpret due to the high variances in patients’
pathways. This confirms the perception of the complex nature of patient journeys within the ED; there will
always be patients presenting to the ED with non-standard characteristic that would require the patient to
follow a different or new care pathway. This complexity is what doctors and nurses deal with daily, and
make them not believe that system engineering techniques can contribute to help with patient flow
complexity. But the fact is that the fuzzy miner allows observing complex processes at different levels of
granularity by applying two fundamental metrics: significance and correlation. The significance metric
assesses the relative importance of a precedence relation between two event classes, i.e. the more often two
event classes are observed after one another, the more significant their precedence relation. On the other
hand, the correlation metrics indicates how closely two events (i.e. activities) are following each other.
Therefore, fuzzy mining can reduce and focus the displayed event classes by applying the two metrics on
the discovered process map to achieve different levels of aggregation and abstraction. Fuzzy process miner
has therefore applied to the data to show the main highway paths for patients and to hide less frequent paths
(Figure 2b). The count inside each rectangle (Figure 2) shows how many times an activity has been executed
(e.g. activity ‘Doctor Seen’ occurred 31,571 times). While, the count on the arc represents the co-occurrence
frequency between any two activities. For example, the co-occurrence frequency between ‘Doctor Seen’
and ‘Referred for Admission’ is 7,205. Due to excluding low frequent paths there are differences between
the numbers of activities shown on incoming arrows and activity boxes on the process maps. Further
analysis of this model revealed that there are 1,984 different patient pathway patterns (Table 1).
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Table 1 Discovered patient pathway patterns
Pathway Cases

Relative
Events Step 1
frequency

Step 2

1

9374

23%

4

Attended Triaged

2

3406

8%

4

Attended

3

3264

8%

3

Attended

4

3005

7%

3

Attended

5

1949

5%

6

Attended

.
.
.

.
.
.

.
.
.

.
.
.

.
.
.

1984

1

0.002%

6

Attended

Step 3

Step 4

Step 5

Step 6

Doctor Seen Discharged
Seen by
Triaged Advanced Nurse Discharged
Practitioner
Doctor
Discharged
Seen
Triaged
Discharged
Referred for Patient Awaiting Admitted to
Triaged Doctor Seen
Admission
Admission
Hospital
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Did Not
Referred for
Admitted to
Triaged
Doctor Seen
Answer
Opinion
Hospital

…

Step
13

.
.
.

Over 60% of these patterns are one-off path and only 31 patterns account for 80% of ED patients.
Therefore, the remaining 1,951 patterns, which accounts to 20% of patients, were filtered out in order to
reflect the common behavior of the ED. However, the filtering process output will depend on the project
objectives. For example, the one-off paths can be the focus if the project is to investigate the reasons of the
variations in patients’ flow. The fuzzy miner was applied again on the resulted 31,447 patients to drive final
top-level process map of the ED (Figure 3). The most followed paths are shown with thick arcs between
activities. However, the analysis of exceptional pathways (paths with very low frequency) can give deep
insights for medical professionals regarding the main factors behind these patterns.

Figure 3 The top-level process map of patient pathways
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3.3.2 Performance and Bottleneck Analysis
By considering the timestamp of events in the dataset, the ED performance and bottlenecks can be identified
and analyzed (Figure 4). The number inside the rectangle represents the average activity time while the
numbers on the arcs represents the waiting time between any two activities. The average length of stay
(LOS) for all patients from arrival to departure (whether discharged or admitted to the hospital) is 9.1 hours
which is 3 hours above the national target of 6-h average LOS in Ireland. However, the waiting time for
admitted patients is 14 hours on average (with an average LOS of 18 hrs). Patients have to wait 3.3 hours
on average to be seen by a doctor and 5.1 hours afterwards to be discharged from the department. The main
bottlenecks in the ED are the “Seen by Doctor” and “Patients waiting admission” activities.

Figure 4 Performance analysis of the top-level process map
To gain a deeper understanding of the process flow of patients and the causes of these bottlenecks, the
process model was analyzed at a more fine-grained level. The “Triage Category” attribute was used to
divide patients into three groups; Immediate and very urgent, non-urgent and standard, and urgent patients.
The process map of each patient group was constructed using the fuzzy miner and pathway patterns that
reflect the common behavior for each group was analyzed (Figure 5). There are obvious variances in the
associated pathways for patients with different urgency categorization (i.e. triage). The first patient groups
(Immediate and Very Urgent) represents 15% of all patients with the majority of them have been admitted
to the hospital with an average waiting time of 13.7 hrs. for the admission process to be completed (Figure
5a). While 26% of all patients are Standard and Non Urgent patients whom have a shorter pathway with a
discharge outcome and 5.1hrs average LOS. The “Did not Answer” activity represents patients who left the
ED after being triaged without waiting to be investigated by a physician (whether a doctor or advanced
nurse practitioner) (Figure 5b). Patients leave the ED after being triaged (9.6% of all patients) due to the
overcrowding of the ED and the prolonged waiting times.
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a) Immediate & Very Urgent

b) Standard & non-Urgent

c) Urgent patients

Figure 5 Performance Analysis for patients with different Triage Categories
Urgent patients represent almost 60% of all patients with 10.1 hrs average LOS. This group are
presented to the ED with a wide range of complaints with 27% are referred for admission and the remaining
are discharged with an average waiting time of 5.2 hrs (Figure 5c). The insights from this analysis enabled
the ED decision makers to identify the bottlenecks for each group of patients and the challenges that they
need to address.
3.3.3 Staff and Resources Analysis
The department has officially, 12 monitored trolley spaces; 3 of these trolley spaces (resuscitation area) are
reserved for major trauma and critical care patients. Besides, the ED has an ambulatory car area with a
capacity of six trolley spaces. Two rapid assessment triage bays and two triage rooms are also provided by
the ED. As a 24hr department, the ED has eleven nurses during the day and nine nurses at night which
collectively are divided into six types of nurses; Advanced Nurse Practitioner (ANP), triage nurse,
resuscitation nurse, respiratory nurse, majors/minors nurse, and healthcare assistant. Physicians (excluding
the 3 Consultants who provide shop floor cover between 9-5 or 8-8 with 24/7 on-call provision) are divided
into two types: registrar/specialist registrar and Senior House Officer (SHO). Two types of resources were
recorded in the eventlog for each record; location and staff type. Therefor resource requirement was
analyzed for different activities in patients’ pathways (Table 2). The resource analysis gives deep insights
regarding the gap between the guidelines that should be followed and what is actually happening. For
example, the triage activity should take place in the triage room by a registered nurse (RGN). However, the
analysis reveals that 68% this activity takes place in the triage room and 77% of the times is performed by
the RGN. This is a clear evidence of the overcrowding of the ED and quantify how fare this activity from
the guidelines. Similarly, the “Doctor seen” activity is performed by SHOs (58%) and registrars (20%) in
the Majors area in the ED (55%) and in the Resuscitation room (18%). This highlights the actual time spent
by doctors in this activity and the actual locations where this is happening. These insights helped the ED
managers to understand the actual allocation of staff and resources within the ED and to identify the gaps
between best practices and the actual performance.
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Table 2 Resource analysis for the main activities in patient pathways
Triaged

Doctor Seen by Referred for
Seen
ANP Admission

ED Consultant

46%

Medical Staff

ANP
15%

RGN

77%

11%

4%

3%

3%

10%

1%

13%

11%

58%

36%

51%

30%

20%

7%

10%

12%

5%

9%

13%

Intern

7%

Majors Area (9)

6%

55%

Resuscitation Room (3)

6%

18%

Ambulatory Care Unit (6)

3%

11%

Rapid Assessment Triage (2)

17%

9%

Triage Room (2)

68%

Physical
Location

95%

1%
76%

Registrar

Admitted to
Hospital

21%

0%

ADN
SHO

Discharged

10%

24%

SPR

CNM

57%

ANP: Advanced Nurse Practitioner
RGN: Registered General Nurse
CNM: Clinical Nurse Manager

3.4

Referred for
Opinion

7%

4%

65%

57%

71%

72%

31%

29%

4%

24%

3%

14%

23%

2%

SPR: Specialist Registrar
SHO: Senior Hospital Officer
ADN: Associate Degree in Nursing

Model Development and Experimentation

A discrete event simulation model is developed using the discovered process models along with
analysis of the staff, and resources, and performance (Figure 6).

Figure 6 The ED Simulation Model
The simulation results of the baseline represent runs for one year (Table 3). The results are very close to
the information extracted from the event log as following: average length of stay (LOS) is 9 hour vs 9.1
hour, average waiting time for triage is 19.9 min vs 20.6 min, average waiting for first clinical contact either
by a doctor or ANP is 190.8 mins and 57.5 min vs 198 min and 58.3 min respectively, and percentage of
patients left without being seen (L.W.B.S) by clinician (due to extended waiting time) is 10% vs 9.6%.
Accordingly, simulation results have a satisfactory level of inaccuracy and that allows the model to be
deemed as a valid model for experimentation. Based on the simulation results and process mining outcomes,
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the main bottlenecks in the workflow are the “Seen by Doctor” and “Patients waiting admission” activities.
Therefore, the simulation scenarios tested were the impact of variation in medical staffing (an increase of
25%), increasing clinical assessment space (an increase of 50%), and finally assessing the impact of
incorporating a ‘zero-tolerance’ policy regarding exceeding the national 6-hour boarding time. According
to the ED managers, the goal of the ‘zero-tolerance’ policy is to assess the performance of the ED if the
average LOS of patients complies with the HSE 6 hour target and to identify the real factors that contribute
the unacceptable overcrowding status of the ED; inappropriate physical space, insufficient staffing levels,
or operational difficulties beyond the direct control of the ED. This scenario is implemented in the
simulation model by dismissing patients from the ED model who are waiting to be admitted to the hospital
and their LOS exceeds 6 hour. The rationale beyond this is that hospitals can provide a short stay unit, with
an appropriate capacity, for patients who are waiting to be admitted but there are no available beds in the
hospital. The simulation results of these scenarios are shown in Table 3.
Table 3 Simulation results of Baseline and Scenarios
Avg. W. T. Triage (mins)
Avg. W. T. Doctor (mins)
Avg. W. T. ANP (mins)
Avg. # of Pts in W.R.
% of Pts L.W.B.S
Avg. LOS Discharged Pts (hrs)
Avg. LOS Admitted Pts (hrs)
Avg. LOS All Pts (hrs)

Baseline Scenario 1 +/- (%) Scenario 2 +/- (%)
19.9
19.6
-1%
19.8
0%
186.9
-2%
2.5
190.8
-99%
57.5
60.7
6%
65.6
14%
13.4
13.1
-2%
1.2
-91%
10%
9%
0.01% -100%
-3%
7.5
7.5
-1%
5.2
-30%
17.7
0%
15.9
-11%
17.8
9.0
9.0
0%
7.0
-23%

Scenario 3
20.4
12.2
62.5
1.7
0.01%
4.1
2.8
3.9

+/- (%)
3%
-94%
9%
-87%
-100%
-45%
-84%
-56%

The simulation model shows that adoption of the cost-neutral scenario 3 has the highest impact on patients
LOS at every stage, especially among patients who are discharged directly after ED care (45% improvement
LOS). Furthermore, while scenario 3 improves the LOS of boarders, the more expensive Scenarios 1 and 2
have negligible impact on ED boarding times.
4

CONCLUSION

Hybrid modeling approach is used in this paper to demonstrate the impact of using process mining
techniques to support the development of simulation models for healthcare applications. Using the
healthcare information systems, event log data can be generated for patient-care activities and this can feed
into the analysis process. Process mining approach aims to utilize these event logs in order to find out the
patients’ pathway patterns that are consistent with the observed dynamic behavior. This process secures a
more accurate process model for patient treatment paths and provides a better foundation to develop an
effective simulation model. The proposed framework was tested using a case study of an Emergency
Department with event logs of 210,000 records. The discovered process model revealed that there are 1,984
different patient pathway patterns with only 31 patterns account for 80% of ED patients. However,
infrequent behaviors show variants in clinical pathways, and thus require to be investigated. A more finegrained level analysis was also performed for different patient groups to gain better insights on the treatment
of patients within ED. The average length of stay (LOS) for all patients from arrival to departure (whether
discharged or admitted to the hospital) is 9.1 hours – 3 hours above the national target of 6 hours average
LOS in Ireland. However, the waiting time for admitted patients is 14 hours on average (with an average
LOS of 18 hours). Patients had to wait 3.3 hours on average to be seen by a doctor and 5.1 hours afterwards
to be discharged from the department. A dicrete-event simulation model is used to implement the
discovered process models and to examine the impact of potential what-if scenarios. The simulation
scenarios tested were the impact of variation in medical staffing (an increase of 25%), increasing clinical
assessment space (an increase of 50%), and finally assessing the impact of incorporating a ‘zero-tolerance’
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policy regarding exceeding the national 6-hour boarding time.The results show that the unblocking of ED
outflows by in-patient bed management had the highest impact on patients LOS at every stage, especially
among patients who are discharged directly after ED care (45% improvement LOS) with 87% improvement
for patients waiting times. Furthermore, the embeded process mining cababilities within the hybrid
framework resulted in a 85% reduction in the time required to develop conceptual model and equally
increased its accuracy.
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